parallel sessions - International Society for Blood Transfusion

XXIX th International Congressof theInternational Societyof Blood TransfusionCape Town, South Africa2-7 September 2006Cape Town International Convention CentrefinalprogrammeFINAL PROGRAMMEISBT2006

ISBT20062ACKNOWLEDGEMENTSTABLE OF CONTENTS3The Local Organising Committee of the XXIX th International Congress of the InternationalSociety of Blood Transfusion, is grateful that the following companies are willing tosupport the congress:Major SponsorSponsorsWORDS OF WELCOMEMESSAGE FROM THE PRESIDENTORGANISATION – COMMITTEESFUTURE ANNUAL ISBT CONGRESSESSCIENTIFIC PROGRAMMEProgramme per DaySaturday, 2 September (Pre Congress Day)Sunday, 3 September (Educational and State of Art Reviews)Monday, 4 SeptemberTuesday, 5 SeptemberWednesday, 6 SeptemberThursday, 7 SeptemberISBT BUSINESS MEETINGSKEY INFORMATIONSCIENTIFIC INFORMATIONISBT AWARDSREGISTRATION INFORMATIONSOCIAL PROGRAMMEEXCURSION PROGRAMMEFLOORPLANS CTICCEXHIBITIONMAP OF CAPE TOWNSPEAKERS INDEXISBTXXXXXXXXxxxxxxxxxxxxxxXXXXXXXXXXXXXXXXXXXXXXXXINTERNATIONAL SOCIETY OF BLOOD TRANSFUSION XXIX TH INTERNATIONAL CONGRESS OF THE ISBT

ISBT2006WORDS OF WELCOME5It is with great joy and pride that we welcome you all to Cape Town and our wonderfulcountry. We trust that you will all enjoy what promises to be an excellent congressat which international speakers will be presenting the most up to date scientificdiscoveries and practices in the varied fields of transfusion medicine. The scientificforums will include educational programmes, symposia, plenary sessions and concurrentsessions.The programme will pay attention to the needs of resource limited countries with lessdeveloped blood transfusion services. Testing, prevention and inactivation strategiesfocusing on transfusion transmitted diseases, including HIV that ironically originatedin Africa and that have changed the landscape of transfusion medicine, will be alsobe widely covered. The congress thus will provide an ideal opportunity for all participantsto discuss and debate their own special interests and priorities with expertsand colleagues.We have prepared an exciting social programme that will give you the opportunity toenjoy one of the world’s most beautiful cities and its scenic environs. We hope youalso make use of your visit to join some of the pre- and post-conference tours aroundSouth and Southern Africa and view the diverse and unique flora and fauna synonymouswith this region. We extend our appreciation to our main sponsors and all the othercontributors and participants who have made this congress possible.This is the first time that an ISBT congress is being held on African soil and thus hasgreat significance for your hosts the South African Blood Alliance and the Africa Societyfor Blood Transfusion.We hope your stay in South Africa will be a memorable one!Anthon HeynsCongress President.Graham ThurtellCongress ChairmanXXIX TH INTERNATIONAL CONGRESS OF THE ISBT

ISBT20066WELCOME ADDRESS FORSCIENTIFIC PROGRAMMEMESSAGE FROM THE PRESIDENTDear Colleagues,7The scientific programme has aimed to cover the whole spectrum of blood transfusionpractice from donor management through to clinical practice. Compared to previousyears there is perhaps relatively more emphasis on donor management, qualitymanagement systems and resource limited countries but there will be something ofinterest for everyone.I would like to thank the members of the Scientific Steering Committee and also theinternational review panel for their invaluable contributions. Also many thanks to all thespeakers for giving their valuable time to share their expertise and we look forward toa stimulating programme.It is with great pleasure that I welcome you to the ISBT International Congress held forthe first time on the African Continent, in Cape Town South Africa, a magnificent andlively city.By reading through the programme, you will understand why this congress is so important.Indeed, the Scientific Committee has prepared an exciting programme coveringtopics relevant for all of us involved in the blood supply chain from the donor to recipientregardless of where we come from.I wish to thank everyone who has worked to make this congress happen and I also wantto thank you, congress participant, for being here and being involved. You are trulythe measure of ISBT’s congress’s success.Thanks to all our sponsors and exhibitors for their financial support which allowed usto organize this excellent conference.Finally, why not combine science with pleasure by attending the very powerful socialevents and networking with colleagues from all over the world.Here’s to an excellent congress and a pleasant stay in Cape Town.Arthur BirdChairman Scientific CommitteeFrancine DécaryPresident of the ISBTINTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

ISBT20068ORGANISATION – COMMITTEESORGANISATION – COMMITTEES9ORGANISATIONISBT Executive Committee (2004-2006)Francine Décary, PresidentShigeru Takamoto, President-electYong Ming Zhu, Vice-PresidentMahmut Bayik, Vice-PresidentHans Erik Heier, Past-PresidentGeoffrey Lane, TreasurerPaul Strengers, Secretary GeneralISBT Board of Directors (2004-2006)Yasmin AyobCelso BiancoJudith ChapmanMagdelena LetowskaMaria Cristina MartinezFaten MoftahRachanee O’CharoenDiana TeoGraham ThurtellLocal Scientific CommitteeArthur Bird, ChairmanAnthon du P. HeynsRobert CrookesVis PoovalingamCONGRESS ORGANISATIONCongress OrganiserEUROCONGRES CONFERENCE MANAGEMENTJan van Goyenkade 11, 1075 HP Amsterdam, The NetherlandsTel.: +31 20 679 3411, Fax: +31 20 673 7306E-mail: isbt.capetown@eurocongres.comOfficial Housing and Travel AgentTurners Conferences and Conventions (Pty) Ltd.37 Jonsson Lane, Durban 4001, South AfricaTel: + 27 31 3321 1451, Fax: +27 31 368 6623E-mail: gills@turnergroup.co.zaLocal Organising CommitteeAnthon du P. Heyns, Congress PresidentGraham Thurtell, ChairmanIan Simpson, Vice-ChairmanBronwyn Blades, TreasurerPam Larkin, SecretaryArthur Bird, Coordinator Scientific CommitteeMalcolm Kahn, Coordinator Social ProgrammeIan Simpson, Coordinator Sponsoring and ExhibitionINTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

ISBT200610FUTURE ANNUAL ISBT CONGRESSES2007XVII th Regional Congress of the ISBT, EuropeMove to 8!Location : Madrid, SpainDate : 23 - 28 June2007XVIII th Regional Congress of the ISBT, Asia1 2 3 4 5 6 7 8Grifols DG Gel ® , the unique 8-column format gel card.Grifols DG Gel ® provides maximum flexibility for a range of profiles,unique & complete card configurations plus better cost-effectiveness.LocationDate: Hanoi, Vietnam: 10 - 13 November2008XXX th International Congress of the ISBTLocation : Macao, ChinaDate : 7 -12 JuneMore information: www.isbt-web.org/congresses8=6+2. Math never lies.We’ll be happy to explain you the formula. Visit us at booth n. 20INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONwww.grifols.com

Programme per DayISBT2006Programme per Day12SUNDAY, 3 SEPTEMBERMONDAY, 4 SEPTEMBER1308.30 10.00 10.30 12.00 12.15 13.45 14.00 15.30 16.00 17.30 17.45 18.45 20.45 08.30 10.00 10.30 12.00 12.15 13.45 14.00 15.30 16.00 17.30 18.30 Auditorium Ballroom West Ballroom East Room 1.61 - 1.64 Room 1.41 - 1.44E1 - Progenitor CellsE2 - Transfusion inResource LimitedCountriesE3 - Evidence BasedTransfusion MedicineE4 - Transfusion inResource LimitedCountriesSatellite SymposiumOCDSatellite SymposiumPall MedicalE5 - Advances inHaemostasisE6 - Transfusion inResource LimitedCountriesE7 - New Frontiers inBlood TransfusionE8 - PaediatricTransfusionPracticeOpening CeremonyAuditorium Ballroom West Ballroom East Room 1.61 - 1.64 Room 1.41 - 1.44P1 - TransmissibleSpongiformEncephalopathiesS3 - DonorManagement-Developing a DonorProgramS1 - QualityManagement in BTS5 - BacterialContamination ofBlood ProductsS2 - PaediatricTransfusion PracticeS4 - PlasmaDerivatives inClinical PracticeSatellite SymposiumGambroSymposiumISBT WorkingParty on TTDS9 - Structure andGovernance of BTSS6 - LeucocyteDepletionS7 - Auto-transfusionS10 - CellularTherapiesS8 - NationalBlood InventoryManagementS15 - Red CellImmunohaematologyS11 -HepatitisS12 - NATASymposium:The Anaemia ofChronic DiseaseS14 - Non-infectiousHazards ofTransfusionS13 - Platelet andMegakaryocyteImmunologyExhibition/Poster AreaOpening of the TradeExhibition / WelcomeCocktail PartyExhibition/Poster AreaPoster Walk 1(snacks and drinks)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Programme per DayISBT2006Programme per Day14TUESDAY, 5 SEPTEMBERWEDNESDAY, 6 SEPTEMBER1508.30 09.30 10.00 11.30 11.45 13.00 13.15 14.45 15.00 15,15 19.00 08.30 10.00 10.30 12.00 12.15 13.45 14.00 15.30 16.00 17.30 18.30 19.00 24.00 Auditorium Ballroom West Ballroom East Room 1.61 - 1.64 Room 1.41 - 1.44P2 - ISBT AwardLecturesP3 - ISBT PresidentialAward SymposiumISBTGeneral AssemblySatellite SymposiumChironSatellite SymposiumOctapharmaSatellite SymposiumCerusGeneral Excursion to Chapman’s PeakAuditorium Ballroom West Ballroom East Room 1.61 - 1.64 Room 1.41 - 1.44P4 - Ethical Issues inBlood TransfusionPracticeS19 - DonorManagementS17 - ImmuneHaemolyticAnaemiasS20 - TransfusionTransmittedDiseases (TTD)S18 - IPFASymposiumS16 - EvidenceBased TransfusionMedicineSatellite SymposiumBioRadSatellite SymposiumRoche MolecularSystemsS23 - HIVS21 - HaemostasisS25 - DonorManagementS22 - ArtificialO 2 Carriers: Statusin 2006S24 - Update ofBTS/Practicein AfricaS28 - Nucleic AcidAmplificationTesting (NAT)S26 - Role ofInternationalOrganisations inStrengthening/Supporting BTSS29 - HaemovigilanceSystemsS30 - Rare DonorProgrammeS27 - Resuscitation/Massive TransfusionAfrican Theme EveningExhibition/Poster AreaExhibition/Poster AreaPoster Session 2(snacks and drinks)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

ISBT2006Programme per DayTHURSDAY, 7 SEPTEMBER1708.30 10.00 10.30 12.00 12.15 13.15 Auditorium Ballroom West Ballroom East Room 1.61 - 1.64 Room 1.41 - 1.44S31 - PromotingBlood Donation -Art, Science orGuesswork?S33 - HaemopoieticStem CellsS34 - PathogenReduction /InactivationS32 - RBC AntigenModificationS35 - Automationand Data Processingin BTS37 - West NileVirus and otherEmerging PathogensS39 - EmergingTechnologiesS36 - ThromboticThrombocytopaenicPurpura (TTP)S40 - History ofBlood TransfusionS38 - QualityManagement in BTClosing CeremonyExhibition/Poster AreaXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Saturday, 2 SeptemberISBT2006Sunday, 3 September18PRE CONGRESS DAY17.00 – 19.00 Room: 1.41 - 1.42EDUCATIONAL AND STATEOF THE ART REVIEWSBlood Transfusion update in Eastern Mediterranean RegionChair: F. Moftah, Egypt17.00 – 17.05INTRODUCTIONF. Moftah (National Blood Transfusion Service, Giza, Egypt)17.05 – 17.30PLASMA AS A SOURCE MATERIAL FOR FRACTIONATION Specificities of plasma for fractionation with recommendationA. Padilla (WHO, Geneve, Switzerland) Development of plasma contract fractionation protocolT. Burnouf (Human Plasma Product Services, Lille, France)17.30 – 17.45VIRAL INACTIVATION OF BLOOD COMPONENTS IN BLOOD CENTERSM. El-Ekiaby (Red Crescent Society, Cairo, Egypt)17.45 – 18.00NEW APPROACH FOR BTS MANAGEMENT IN EGYPT, MODEL FOR EMRF. Moftah (National Blood Transfusion Service, Giza, Egypt)18.00 – 18.15UPDATE ON TRANSFUSION PRACTICES IN SAUDI ARABIAS. Hindawi (National Blood Transfusion Service, Jeddah, Saudi Arabia)18.15 – 18.30UPDATE ON WBDD 2006 ACTIVITIESN. Dhingra (WHO, Geneva, Switserland)18.30 – 19.00ROUND TABLE DISCUSSIONAll participants08.30 - 10.00 Ballroom EastE1: Progenitor CellsChair: R.L. Crookes08.30 - 09.151ED-01-01 STEM CELL PLASTICITYM. Pepper (Netcare Molecular Medicine Institute, Pretoria, South Africa)09.15 - 10.001ED-01-02 HAEMOPOIETIC STEM CELL THERAPYJ. Kurtzberg (Duke University Medical Center, Durham, United States of America)08.30 - 10.00 Ballroom WestE2: Transfusion in Resource Limited CountriesChair: D. Mvere08.30 - 09.151ED-02-01 HOW TO ESTABLISH A NATIONAL BLOOD POLICYAND NATIONAL BLOOD PROGRAMMEN. Dhingra (WHO, Geneva, Switzerland)09.15 - 10.001ED-02-02 PRINCIPLES OF ESTABLISHING A VOLUNTARY DONOR BASEC.K. Lin (Hong Kong Red Cross Blood Transfusion Service, Hong Kong, China)10.00 – 10.30COFFEE BREAK19INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Sunday, 3 SeptemberISBT2006Sunday, 3 September20EDUCATIONAL AND STATEOF THE ART REVIEWS10.30 - 12.00 Ballroom EastE3: Evidence Based Transfusion MedicineSATELLITE SYMPOSIASATELLITE SYMPOSIUM12.15 – 13.45 Room 1.61 – 1.64Satellite Symposium organised by OCD21Chair: V. Poovalingam10.30 - 11.151ED-03-01 WHY DO WE BELIEVE IN BLOOD COMPONENT THERAPY?B. McClelland (Scottish National Blood Transfusion Service, Edinburgh, United Kingdom)11.15 - 12.001ED-03-02 TRANSFUSION ASSOCIATED GRAFT VS. HOST DISEASEGlobal Automation and Process Excellence ....Today, Tomorrow and the FutureThis event will highlight the benefits of full automation in the area of donor validation testingand patient pre-transfusion testing. It will also include customer presentations on ORTHOAutoVue ® Innova and the new donor screening platform, the ORTHO Paradigm ® , as well asa virtual reality tour through the donor screening laboratory of the future.P.V. Holland (University of California, Davis Medical Center, Sacramento,United States of America)AUTOMATION IN THE TRANSFUSION LABORATORY:10 YEAR EXPERIENCEJ. Wallis (Freeman Hospital- Newcastle upon Tyne, United Kingdom)10.30 - 12.00 Ballroom WestE4: Transfusion in Resource Limited CountriesChair: G.M. Thurtell10.30 - 11.151ED-04-01 TESTING STRATEGIESJ.P. Allain (University of Cambridge, Cambridge, United Kingdom)11.15 - 12.001ED-04-02 PRACTICAL PROBLEM SOLVING IN BLOOD BANKSA. Devenish (National Blood Service, London, United Kingdom)A MULTICENTRIC STUDY ON SECOND LEVEL AUTOMATIONIN IMMUNOHEMATOLOGYM. Ripamonti (HTS Santa Chiara - Trento, Italy)THE DONOR CENTRE PERSPECTIVEK. Grundon (Automation Lead Engineer Ortho-Clincal Diagnostics)12.00 – 14.00LUNCH BREAK AND SATELLITE SYMPOSIAINTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Sunday, 3 SeptemberISBT2006Sunday, 3 September22SATELLITE SYMPOSIASATELLITE SYMPOSIUM12.15 – 13.45 Room 1.41 – 1.44Satellite Symposium organised by Pall MedicalEDUCATIONAL AND STATEOF THE ART REVIEWS14.00 - 15.30 Ballroom EastE5: Advances in Haemostasis23Prions in Transfusion MedicineChair: A. Ross, Pall Corporation, United States of AmericavCJD AND BLOOD TRANSFUSION - INCIDENCE AND RISKSM. Turner (Scottish National Blood Transfusion Service, United Kingdom)PRION REDUCTION - THE FRENCH APPROACHChair: A.R. Bird14.00 - 14.451ED-05-01 RECENT ADVANCES IN THE BIOLOGY OF HAEMOSTASISE. Tuddenham (Royal Free Hospital, London, United Kingdom)14.45 - 15.301ED-05-02 ADVANCES IN THE THERAPY OF HAEMOSTATIC DISORDERSJ. Coste (Etablissements Français du Sanguine, Montpellier, France)P. Giangrande (Chuchill Hospital, Oxford, United Kingdom) FROM LEUKOCYTE DEPLETION TO PRION REDUCTION -EVOLVING STEPS TO INCREASE BLOOD SAFETY14.00 - 15.30 Ballroom WestJ. Ortalano (Pall Corporation, United States of America)E6: Transfusion in Resource Limited CountriesChair: J. Emmanuel14.00 - 14.451ED-06-01 OVERALL STRATEGY FOR BLOOD SAFETY AND AVAILABILITYK. Boukef (Centre Nat. De Transf. Sanguine, Tunis, Tunisia)14.45 - 15.301ED-06-02 APPROPRIATE CLINICAL USE OF BLOOD IN CHILDREN INRESOURCE CONSTRAINED SETTINGSE. Molyneux (Queen Elizabeth Central Hospital, Blantyre, Malawi)15.30 – 16.00TEA BREAKINTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Sunday, 3 SeptemberISBT2006Monday, 4 SeptemberEDUCATIONAL AND STATEOF THE ART REVIEWSPLENARY LECTURES08.30 - 10.00 Auditorium2416.00 - 17.30 Ballroom EastE7: New Frontiers in Blood TransfusionChair: R. Reddy16.00 - 16.451ED-07-01 MICROARRAYS AND BEYONDR. Eglin (National Blood Service, London, United Kingdom)16.45 - 17.301ED-E7-02 STRUCTURE AND FUNCTION OF RED CELL SURFACE ANTIGENSG. Daniels (National Blood Service, Bristol, United Kingdom)PLENARY LECTURES 1: Transmissible Spongiform Encephalopathies (TSEs)Chairs: S. Takamoto, A. Heyns08.30 - 09.152PL-01-01 HUMAN PRION DISEASES: BIOLOGY ANDTRANSMISSION BY BLOODJ. Ironside (University of Edinburgh, Edinburgh, United Kingdom)09.15 - 10.002PL-01-02 CONTROLLING THE BLOOD-BORNE SPREAD OFHUMAN PRION DISEASEC.V. Prowse (SNBTS, Edinburgh, United Kingdom)2516.00 - 17.30 Ballroom WestE8: Paediatric Transfusion PracticeChair: G. Bellairs10.00 – 10.30COFFEE BREAK16.00 - 16.451ED-08-01 PATHOGENETIC MECHANISMS OF THE ANEMIA OF PREMATURITYR. Strauss (University of Iowa College of Medicine, Iowa City, United States of America)16.45 - 17.301ED-08-02 RBC TRANSFUSION AND/OR RECOMBINANT EPO THERAPYOF THE ANEMIA OF PREMATURITYR. Strauss (University of Iowa College of Medicine, Iowa City, United States of America)17.45 - 18.45 AuditoriumOPENING CEREMONY18.45 – 20.45 Exhibition AreaWELCOME RECEPTIONINTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Monday, 4 SeptemberISBT2006Monday, 4 SeptemberPARALLEL SESSIONSPARALLEL SESSIONS10.30 - 12.00 Ballroom West10.30 - 12.00 Room: 1.61 - 1.64S1: Quality Management in Blood TransfusionS2: Paediatric Transfusion PracticeChairs: P.J. Coghlan, Y.M. ZhuChairs: A.R. Bird, A. Brand2610.30 - 11.002PS-01-01 GLOBALISATION AND BLOOD SAFETYA. Farrugia (Therapeutic Goods Administration, Wooden, Australia)11.00 - 11.152PS-01-02 VIRAL RISKS OF PLASMA-DERIVED MEDICINAL PRODUCTSC.L. van der Poel, M.P. Janssen, B.A. van Hout, J. Over, H.T.M. Cuijpers (UMC Utrecht,Utrecht, Netherlands)11.15 - 11.302PS-01-03 EU-Q-BLOOD-SOP: DEVELOPMENT OF PAN EUROPEANQUALITY MANAGEMENT IN TRANSFUSION MEDICINE.C. Seidl, R. Henschler, E. Schellenberg, A. McMillan Douglas, C. Smit Sibinga, M. Gorham,10.30 - 10.552PS-02-01 THE IMPACT OF KANGAROO MOTHER CARE ON THEPREVALENCE OF BLOOD PRODUCT TRANSFUSIONS IN INFANTS

Monday, 4 SeptemberISBT2006Monday, 4 SeptemberPARALLEL SESSIONSPARALLEL SESSIONS11.30 - 11.452PS-03-03 LEVERAGING DONOR LOYALTY FOR A STRONGER GLOBALBLOOD SUPPLY - ALLIANCE OF BLOOD OPERATOR PIAG (PERFORMANCEIMPROVEMENT ADVISORY GROUP) DONOR LOYALTY GROUP10.30 - 12.00 Ballroom EastS5: Bacterial Contamination of Blood ProductsChairs: M. Blajchman, J.P. Aubuchon28F. Gogarty, J. Nugent, A. Harding, J. Granato, S. Pohlen (National Blood Service, Herts,United Kingdom)10.30 - 11.002PS-05-01 THE RELIABILITY OF BACTERIAL DETECTION IN PLATELETS2911.45 - 12.002PS-03-04 THE ESTABLISHMENT OF HLA PHENOTYPE DATA BANKFOR BLOOD DONORS TO REDUCE NON-HEMOLYTIC TRANSFUSIONREACTION AND PLATELET INFUSION INEFFICACYJ.P. Aubuchon (Dartmouth - Hitchcock Medical Centre, Lebanon, United States of America)11.00 - 11.152PS-05-02 HEMA-QUEBEC'S EXPERIENCE WITH BACTERIAL CULTURE OFWHOLE-BLOOD DERIVED PLATELET CONCENTRATES (WBDPC)Q. Wu, M.L. Liu, J. Qi (Shaanxi Blood Center, Xi`an, China)G. Delage, P. Robillard, F. Bernier, M. Tremblay, J. Dion (Hema-Quebec, St-Laurent, Canada)10.30 - 12.00 Room: 1.41 - 1.4411.15 - 11.302PS-05-03 RESIDUAL RISK OF SEPTIC TRANSFUSION REACTIONS FROMBACTERIAL-TESTED APHERESIS PLATELETSS4: Plasma Derivatives in Clinical PracticeC.T. Fang, F. Eder, P. Notari, R.Y. Dodd, R.J. Benjamin (American Red Cross, Rockville,Chairs : C. Rochat, H. ChapelMaryland, United States of America)10.30 - 11.002PS-04-01 IV IMMUNOGLOBULINS IN CLINICAL PRACTICEH. Chapel (Oxford Radcliffe Hospital, Oxford, United Kingdom)11.00 - 11.152PS-04-02 CHARACTERIZATION OF THE SERUM AUTOANTIGENS RECOGNIZEDBY INTRAVENOUS IMMUNOGLOBULINS (IVIg) USING 2D-PAGE AND LC-MSR. Lemieux, R. Bazin, A. Laroche, C. Philippeau, T. Tremblay (Hema-Québec, Sainte-foy,Québec, Canada)11.30 - 11.452PS-05-04 THE IMPORTANCE OF THE SAMPLING TIME AFTER THEPREPARATION OF PLATELET CONCENTRATES FOR THE DETECTION OFBACTERIAL CONTAMINATIONE. Dickmeiss, M. Bidstrup, J. Salado (Rigshospitalet, Copenhagen, Denmark)11.45 - 12.002PS-05-05 COMPARISON OF THREE BACTERIAL DETECTIONMETHODS UNDER ROUTINE CONDITIONS11.15 - 11.452PS-04-03 VOLUME EXPANDERS: CRYSTALLOIDS VS. PLASMACOLLOIDS VS. SYNTHETIC COLLOIDSM.S. Schmidt, A. Karakassopoulos, J. Burkhart, R. Deitenbeck, J. Asmus, T.H. Mueller,F. Weinauer, E. Seifried, G. Walther-Wenke (German Red Cross Institute Frankfurt, Frankfurt,Germany)M. James (Groote Schuur Hospital, Cape Town, South Africa)11.45 - 12.002PS-04-04 FIBRIN GLUE PREPARED FROM SINGLE DONORALLOGENOUS PLASMAM.J. Dijkstra-Tiekstra, C.J. van Delden, J. de Wildt-Eggen, W. Kuipers, A. Setroikromo,12.00 – 14.00LUNCH BREAK, VISIT TO THE EXHIBITION AND POSTERSAND SATELLITE SYMPOSIAW.M. Smid, M.M.W. Koopman, D. de Korte (Sanquin Blood Bank North East Region,Groningen, Netherlands)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Monday, 4 SeptemberISBT2006Monday, 4 SeptemberSATELLITE SYMPOSIASATELLITE SYMPOSIA30SATELLITE SYMPOSIUM12.15 – 13.45 Ballroom WestSatellite Symposium organised byNEW IDEAS… NEW ENERGY (From one of the world’s foremostrenaissance thinkers at the Gambro BCT satellite symposium)Part 2: Feasibility and clinical yield of NAT in high prevalence areas12.30 – 12.40P-110 SEROLOGICAL AND MOLECULAR CHARACTERISTICS OF HBV DNAPOSITIVE/ HBSAG NEGATIVE BLOOD DONORS*E. Brojer, M. Letowska, G. Liszewski, P. Grabarczyk, M. Mikulska (Institute of Haematologyand Blood Transfusion, Warsaw, Poland)31HOW TO THINK LIKE LEONARDO DA VINCI (Seven steps to genius everyday. Experience in the energy and intelligence of innovation and creativity expertMichael J. Gelb (www.bigspeak.com). His entertaining seminar will teach you to:balance analysis and imagination; cultivate an innovative working environment;sustain continuous learning)12.40 – 12.50P-018 DETECTION OF HIV-1 INFECTION IN BLOOD DONORS DURING THEIMMUNOLOGICAL WINDOW PERIOD BY IMPLEMENTATION OF NUCLEICACID AMPLIFICATION TECHNOLOGY*P.S.P. Scuracchio, A.G. Oliveira Filho, M.M.M. Lemos, M.C.C. Poli, R. Colella,M.M.C. Magri, N.J.F. Cavalcanti, E.C. Sabino, N.A. Salles, D.A.F. Chamone(Banco de Sangue de São Paulo, São Paulo, Brazil)ISBT WORKING PARTY SYMPOSIUM12.15 – 13.45 Ballroom EastSymposium organised by ISBT Working Party on Transfusion Transmissible DiseasesGlobal experience with nucleic acid amplification (NAT)systems for blood donor screeningChairs: S. Wendel, K. Roth, M. Busch, J-P. Allain12.50 – 13.00P-136 EVALUATION OF ACCEPTED BLOOD DONORS WITH A MULTIPLEXNUCLEIC ACID TEST (NAT) AT CHIANG MAI UNIVERSITY HOSPITAL,THAILAND*L.T. Thaikruea, N.N. Niwes, S.T. Thongsawat, L.N. Litrakoon, L.F. Fonksatidkil,P.S. Sompan, A.H. Heaton, D.N. Nichols, K.N. Nelson (Department of CommunityMedicine, Chiang Mai, Thailand)Part 1: Comparison of performance between two commercialHIV/HCV/HBV NAT systems12.00 – 12.10P-128 COMPARISON OF THE CHIRON PROCLEIX ® TIGRIS ® ANDROCHE COBAS S 201 NUCLEIC ACID TESTING (NAT) SYSTEMS FORSIMULTANEOUS DETECTION OF HIV/HCV RNA AND HBV DNA*C.K. Lin, A.R. Margaritis, S. Brown, C.R. Seed, P. Kiely, B. D'Agostino, A.J. Keller(Australian Red Cross Blood Service, Perth, Australia)12.10 – 12.20P-108 HEAD TO HEAD COMPARISON OF TWO NEW AUTOMATED NATSYSTEMS CHIRON: PROCLEIX TIGRIS SYSTEM VS ROCHE COBAS S 201*A. Assal, V. Barlet, C. Cornillot, M. Deschazeaux, I. Dupont, P. Gallian, C. Guitton, P. Morel,G. Andreu (EFS Centre Atlantique, Tours, France)13.00 – 13.10P-106 IMPLEMENTATION OF A POST-DONATION TRIPLEX HIV/HCV/HBVNAT IN A TEACHING HOSPITAL TRANSFUSION MEDICINE UNITIN KUMASI, GHANA*S. Owusu-Ofori, G. Bedu-Addo, D. Candotti, A. Nsiah-Asare, F. Sarkodie, J-P Allain(Komfo Anokye Teaching Hospital, Kumasi, Ghana)13.10 – 13.30DISCUSSIONJ-P Allain (University of Cambridge, Cambridge, United Kingdom)* Abstracts to be found in the poster section12.20 – 12.30DISCUSSIONM.P. Busch (Blood Systems Research Institute, San Francisco, United States of America)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Monday, 4 SeptemberISBT2006Monday, 4 SeptemberPARALLEL SESSIONSPARALLEL SESSIONS3214.00 - 15.30 Ballroom WestS6: Leucocyte DepletionChairs: A.R. Bird, M. James14.00 - 14.402PS-06-01 UNIVERSAL LEUCOCYTE DEPLETION: PRO15.15 - 15.302PS-07-04 PREOPERATIVE AUTOLOGOUS BLOOD DONATION IN 2005:EXPERIENCE OF A BLOOD CENTRE IN PARIS REGIONG. Woimant, C. Fretz, M.M. Sterlin, D. Benomar, P. Anceau, E. Pelissier, J.L. Beaumont,P. Bierling (EFS Ile de France, Paris, France)33M. Blajchmann (McMaster University, Hamilton, Canada)14.40 - 15.202PS-06-02 UNIVERSAL LEUCOCYTE DEPLETION: CONE.C. Vamvakas (University of Ottawa, Ottawa, Canada)15.20 - 15.30DISCUSSION TIME14.00 - 15.30 Room: 1.41 - 1.44S8: National Blood Inventory ManagementChairs: R. Reddy, J.F. Chapman14.00 - 14.302PS-08-01 THE BENEFITS OF DATA COLLECTION FOR EFFECTIVEINVENTORY MANAGEMENTJ.F. Chapman (Blood Stocks Management Scheme, NBS, London, United Kingdom)14.00 - 15.30 Ballroom EastS7: Auto-TransfusionChairs: M.H. Sayers, L.T. Goodnough14.00 - 14.452PS-07-01 PREDEPOSIT AUTOLOGOUS DONATIONSL.T. Goodnough (Stanford University Medical Center, Stanford, United States of America)14.45 - 15.002PS-07-02 PREOPERATIVE AUTOLOGOUS BLOOD DONATION CAUSESIMMUNOMODULATION IN PATIENTS UNDERGOING ELECTIVE HIPREPLACEMENT SURGERYR. Karger, C. Weber, J. Schmidt, V. Kretschmer (Philipps University Marburg, Marburg, Germany)15.00 - 15.152PS-07-03 TEN YEARS EXPERIENCE WITH BLOOD SALVAGE IN CANCERSURGERY AND ITS EFFECT ON OUTCOME14.30 - 15.002PS-08-02 CENTRALISED MANAGEMENT OF THE BLOOD INVENTORY -FROM THE BLOOD CENTRE TO HOSPITALSM. Koh (Health Sciences Authority, Singapore, Singapore)15.00 - 15.152PS-08-03 EXPERIENCES WITH FROZEN BLOOD PRODUCTS IN THENETHERLANDS MILITARYF. Noorman, C.C.M. Lelkens, J.G. Koning, B. de Kort, I.B.G. Floot(Military Bloodbank, Leiden, Netherlands)15.15 - 15.302PS-08-04 A NOVEL APPROACH TO OPTIMAL BLOOD PLATELETS LOGISTICSC.Th. Smit Sibinga, N. van Dijk, R. Haijema, J. van der Wal (Academic Institute IDTM,Groningen, Netherlands)E.N. Hansen, G. Roth, V. Bechmann, M.T. Pawlik (University of Regensburg, Regensburg, Germany)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Monday, 4 SeptemberISBT2006Monday, 4 SeptemberPARALLEL SESSIONSPARALLEL SESSIONS3414.00 - 15.30 AuditoriumS9: Structure and Governance of Blood Transfusion ServicesChairs: M. Bayik, L. Mpuntsha14.00 - 14.202PS-09-01 CANADA15.00 - 15.152PS-10-03 THE IMMUNOMODULATORY AND CLINICAL EFFECT OFEXTRACORPOREAL PHOTOCHEMOTHERAPY IN PATIENTS WITH CHRONICGVHD AND CTCL. THE ROLE OF DENDRITIC CELLS IN THE PROCEDUREZ.G. Gasova, R.S. Spisek, L.D. Dolezalova, I.M. Marinov (Institute of Hematology and BloodTransfusion, Prague, Czech Republic)35G. Sher (Canadian Blood Services, Ottawa, Canada)14.20 - 14.402PS-09-02 THE BLOOD SYSTEM IN QUÉBECF. Décary (Hema-Québec, Québec, Canada)15.15 - 15.302PS-10-04 EXTRACORPOREAL PHOTOCHEMOTHERAPY FOR ACUTE ANDCHRONIC GVHD, A REPORT OF 75 PATIENTS TREATED IN A SINGLEINSTITUTION14.40 - 15.002PS-09-03 ENGLAND: NATIONAL BLOOD SERVICE (NBS)E. Dann, A. Badian, T. Stravets, L. Kertsman, A. Olivan, L. Bonstein, J.M. Rowe(Rambam Medical Center, Haifa, Israel)M. Gorham (NBS, London, United Kingdom)15.00 - 15.202PS-09-04 A CORNER STONE OF ADEQUATE SUPPLY OF SAFE BLOOD15.30 – 16.00TEA BREAKY.M. Zhu (Shenzhen Blood Center, Shanghai, China)15.20 - 15.30DISCUSSION TIME16.00 - 17.30 Ballroom WestS11: HepatitisChairs: H. Alter, J.P. Allain14.00 - 15.30 Room: 1.61 - 1.64S10: Cellular TherapiesChairs: J. McCullough, N. Novitzky14.00 - 14.302PS-10-01 CELLULAR THERAPIES FOR MALIGNANT ANDNON-MALIGNANT DISORDERSS. Slavin (Cell Therapy & Transplantation Research, Jerusalem, Israel)14.30 - 15.002PS-10-02 STEM CELL THERAPY FOR MYOCARDIAL INFARCTIONE. Seifried (German Red Cross Institute Frankfurt, Frankfurt, Germany)16.00 - 16.252PS-11-01 EPIDEMIOLOGY OF HBV INFECTION AND HBV-RELATEDHEPATOCELLULAR CARCINOMA IN AFRICA: NATURAL HISTORYAND CLINICAL OUTCOMEM. Kew (University of the Witwaterbrand and NHLS, Johannesburg, South Africa)16.25 - 16.502PS-11-02 APPROACHES TO HEPATITIS SAFETY IN SUB - SAHARAN AFRICAJ.P. Allain (University of Cambridge, Cambridge, United Kingdom)16.50 - 17.152PS-11-03 ADVANCES IN THE TREATMENT OF HEPATITIS B AND CR. Hift (Groote Schuur Hospital, Dept. of Medicine, Cape Town, South Africa)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Monday, 4 SeptemberISBT2006Monday, 4 SeptemberPARALLEL SESSIONSPARALLEL SESSIONS3617.15 - 17.302PS-11-04 MORTALITY IN HEPATITIS C VIRUS (HCV) INFECTED BLOODDONORS: A LARGE, RETROSPECTIVE COHORT STUDYE.L. Murphy (Univ California San Francisco and BSRI, San Francisco, United States of America)16.00 - 17.30 Ballroom East16.00 - 17.30 Room 1.41 - 1.44S13: Platelet and Megakaryocyte ImmunologyChairs: A. Heyns, C. Kaplan Gouet16.00 - 16.252PS-13-01 PLATELET IMMUNOLOGY, PRESENT AND FUTUREW. Ouwehand (University of Cambridge, Cambridge, United Kingdom)37S12: NATA Symposium - The Anaemia of Chronic diseaseChairs: A. Maniatis, F. Décary16.00 - 16.302PS-12-01 HOW MANY RED CELL UNITS ARE NEEDED FOR APOPULATION? DATA FROM SCOTLAND 2002B. McClelland (Scottish National Blood Transfusion Service, Edinburgh, United Kingdom)16.25 - 16.502PS-13-02 PLATELET BIOLOGY: COLLAGEN ACTIVATION MECHANISMSAND THEIR RELEVANCE TO TRANSFUSION MEDICINEP. Smethurst (National Bloodservice Cambridge Centre, Cambridge, United Kingdom)16.50 - 17.152PS-13-03 HOW THE PLATELET ACTUALLY WORKS16.30 - 16.502PS-12-02 PATHOPHYSIOLOGY OF THE ANAEMIA OF CHRONIC DISEASEL.T. Goodnough (Stanford University Medical Center, Stanford, United States of America)F. de Groot (UMC, Thrombosis and Haemostasis Laboratory, Utrecht, Netherlands)17.15 - 17.302PS-13-04 FEEDBACK ON THE 2006 PLATELET IMMUNOLOGY WORKSHOP16.50 - 17.102PS-12-03 CAN WE AVOID TRANSFUSION IN TREATING THE ANAEMIA OFINFLAMMATORY BOWEL DISEASE?K. Erichsen (Childrens Clinic, Bergen, Norway)Z. Foxcroft (South African National Blood Service (SANBS), Roodepoort, South Africa)16.00 - 17.30 Room 1.61 - 1.64S14: Non-Infectious Hazards of Transfusion17.10 - 17.302PS-12-03 TREATING THE ANAEMIA OF CANCERM. Auerbach (Baltimore, United States of America)Chairs: G. Bellairs, M.A. Popovsky16.00 - 16.302PS-14-01 TRANSFUSION-RELATED ACUTE LUNG INJURY ANDTRANSFUSION-ASSOCIATED CIRCULATORY OVERLOADM.A. Popovsky (Haemonetics Corporation, Braintree, United States of America)16.30 - 17.002PS-14-02 HAEMOLYTIC REACTIONSM. Contreras (National Blood Service, London, United Kingdom)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Monday, 4 SeptemberISBT2006Monday, 4 SeptemberPARALLEL SESSIONSPOSTER WALK 13817.00 - 17.152PS-14-03 HAEMOVIGILANCE REPORTS OF POST-TRANSFUSION PURPURAAND TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE BEFOREAND AFTER IMPLEMENTATION OF UNIVERSAL LEUCOCYTE DEPLETIONIN THE UKL.M. Williamson, D. Stainsby, H. Jones, E. Love, C. Chapman, A. Casbard, H. Cohen(University of Cambridge/NBS, Cambridge, United Kingdom)17.15 - 17.302PS-14-04 OUTCOME AMONG RECIPIENTS OF ABO NON-IDENTICAL BUTABO COMPATIBLE PLASMA: A SWEDISH-DANISH REGISTER-BASEDCOHORT STUDYA. Shanwell, K. Rostgaard-Petersen, M. Ahlgren, H. Hjalgrim, M. Reilly(Karolinska University Hospital, Stockholm, Sweden)Poster walks are going to be held for the first time this year. This new event is introducedin order to gain a maximum benefit from the scientific work presented andto create a lively interaction between poster authors, moderators and interestedcongress participants. Poster walks will be organised during the poster sessionson Monday, 4 September and on Wednesday, 6 September (17.30 – 18.30 hours).The poster area is located next to the exhibtion.Poster authors, moderators and interested congress participants are kindly requestedto be present at the first poster in their poster session at the beginning of the presentationtime (17.30 hours).Snacks and drinks will be served.39THE FOLLOWING POSTERS WILL BE DISCUSSED ON MONDAY:16.00 - 17.30 AuditoriumS15: Red Cell ImmunohaemotologyChairs: G. Daniels, E. Smart16.00 - 16.302PS-15-01 RECENT PROGRESS IN MOLECULAR UNDERSTANDING OFABO&P-RELATED BLOOD GROUPSM.L. Olsson (Lund University, Lund, Sweden)16.30 - 17.002PS-15-02 BLOOD GROUP MOLECULAR GENOTYPINGC.E. van der Schoot (Sanquin Research, Amsterdam, Netherlands)17.00 - 17.152PS-15-03 RHD GENE CARRIERS AMONG SEROLOGICALLY D NEGATIVEDONORS: ALLELES AND POPULATION FREQUENCY IN CENTRAL EUROPEA. Flegel, I. Von Zabern, F. Wagner (IKT Ulm, Ulm, Germany)17.15 - 17.302PS-15-04 THE TRUE CHEMICAL BASIS OF THE A1 AND A2 PHENOTYPESL. Svensson, L. Rydberg, S. Henry (Sahlgrenska University Hospital, Gothenburg, Sweden)Topic 01.1. Blood Safety - TTD - HIV P-001 – P-012Topic 01.2. Blood Safety - TTD - Hepatitis P-025 – P-055Topic 01.3. Blood Safety - TTD - TSEs P-086 – P-093Topic 01.4. Blood Safety - TTD - West Nile Virus P-086 – P-093Topic 01.5. Blood Safety - TTD - Emerging Pathogens P-100 – P-113Topic 01.7. Blood Safety - TTD - Bacterial Contamination P-141 – P-149Topic 01.8. Blood Safety - TTD - Parasites P-160 – P-167Topic 02.1. Red Cells - Immunohaematology P-168 – P-231Topic 02.2. Red Cells - Immune Haemolytic Aneamias P-284 – P-301Topic 02.3. Red Cells - Antigen Modification P-302 – P-305Topic 02.4. Red Cells Transfusion P-306 – P-326Topic 03.1. Haemostasis - Recent Therapeutic Advances P-349 – P-352Topic 03.3. Haemostasis - TTP P-360 – P-364Topic 04.1. Pathogen Reduction/Inactivation - Red Cells P-365Topic 04.2. Pathogen Reduction/Inactivation - Platelets P-366 – P-380Topic 05.1. Donor Management - Developing Donor Programs P-390 – P-402Topic 05.2. Donor Management - Recruiting and ManagingDonors (incl Management) P-413 – P-427Topic 06.1. Plasma Derivatives and Fractionation - ClinicalIndications for Plasma Derivatives P-427 – P-441INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Monday, 4 SeptemberISBT2006Tuesday, September 5POSTER WALK 1PLENARY LECTURES40Topic 07.2. Clinical Transfusion Preactice - MassiveTransfusion/Resuscitation P-482 – P-485Topic 07.4. Clinical Transfusion Practice - Blood Substitutes P-493 – P-497Topic 08.1-3. Auto-Transfusion P-512 – P-522Topic 09.2. Stem Cells - Umbilical Cord Blood Stem Cells P-538 – P-546Topic 10.1. Platelet - Transfusion P-553 – P-568Topic 10.2. Platelet - Immunology P-585 – P-596Topic 11.1. Quality Management - Regulatory P-609 – P-617Topic 11.3. Quality Management Industry Perspective P-628 – P-639Topic 14.0. Transfusion in Resource Limited Countries P-682 – P-692Topic 15.0. Emerging Technologies P-705 – P-724Topic 16.0. Evidence Based Transfusion Medicine P-725 – P-737Topic 17.0. Other - History of Blood Transfusion P-738 – P-74208.30 - 09.30 AuditoriumPLENARY LECTURES 2: ISBT Award LecturesChairs: F. Décary (President of the ISBT), H.E. Heier (Chairman of the Jean Julliard PrizeCommittee)08.30 - 09.003PL-02-01 JEAN JULLIARD PRIZE AWARD LECTURE:HIGH THROUGHPUT GENOTYPING FOR RED CELL BLOOD GROUPSAND PLATELET ANTIGENS IN TRANSFUSION MEDICINEM. de Haas (Sanquin Diagnostic Services, Amsterdam, Netherlands)09.00 - 09.303PL-02-02 INTERNATIONAL WOMAN IN TRANSFUSION AWARD LECTURE:SELECTED LESSONS LEARNED FROM BLOOD GROUPSM.E. Reid (New York Blood Center, New York, United States of America)4109.30 – 10.00COFFEE BREAK10.00 - 11.30 AuditoriumPLENARY LECTURES 3: ISBT Presidential Award Symposium: FromWhole Blood to Blood Component Transfusion: Where Are We Now?Chairs: F. Décary (President of the ISBT), W.G. van Aken (President of theFoundation Transfusion Medicine)10.00 - 10.053PL-03-01 INTRODUCTIONC.Th. Smit Sibinga (Member of the Foundation Transfusion Medicine)10.05 - 10.303PL-03-02 IMPROVEMENT IN PREPARATION TECHNIQUESFOR BLOOD COMPONENTSR.N.I. Pietersz (Sanquin Blood Bank North West Region, Amsterdam, Netherlands)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Tuesday, September 5ISBT2006Tuesday, September 5PLENARY LECTURESSATELLITE SYMPOSIA10.30 - 10.553PL-03-03 PLATELET TRANSFUSION: CURRENT STATUS OF QUALITYREQUIREMENTS AND STORAGE BACTERIAL CONTAMINATION OF PLATELET COMPONENTS –TODAY’S SOLUTIONSE. Seifried (German Red Cross Institute Frankfurt, Frankfurt, Germany)42P. Rebulla (Foundation IRCSS, Milan, Italy)10.55 - 11.203PL-03-04 WHAT QUALITY OF RED BLOOD CELLS SHALL WEOFFER THE TRANSFUSED PATIENTC.F. Högman (Winner of the ISBT Presidential Award)11.20 - 11.303PL-03-05 PRESENTATION OF THE ISBT PRESIDENTIAL AWARDF. Décary (President of the ISBT)THE INTERCEPT BLOOD SYSTEM – A HIGHER STANDARD IN BLOODCOMPONENT PROCESS CONTROL AND SAFETYL. Corash (Cerus Corporation, Concord, United States of America)SATELLITE SYMPOSIUM13.15 – 14.45 Room 1.61 – 1.64Satellite Symposium organised by Octapharma43FFP or Biopharmaceutical Plasma; A Real Therapeutic Dilemma?11.45 – 13.00 AuditoriumISBT GENERAL ASSEMBLY OCTAPLAS ® : GMP MANUFACTURING -QUALITY AND SAFETY STANDAARDT-E Svae (Octapharma Pharmazeutika Produktions gmbH, Vienna, Austria)SATELLITE SYMPOSIUM13.15 – 14.45 Room 1.41 – 1.44Satellite Symposium organised by CerusThe INTERCEPT Blood System: solving today’s challenges intransfusion safety (Chikungunya virus, protozoa and bacteria)Chairs: S. Wendel, E. Seifried RISK OF TRANSFUSION-TRANSMITTED PARASITIC DISEASE –IS TESTING THE ONLY ANSWER TO TRANSFUSION SAFETY?S. Wendel (Hospital Sírio Libanes, Sao Paulo, Brazil)MANAGEMENT OF AN EMERGING PATHOGEN – IMPLEMENTATIONOF THE INTERCEPT BLOOD SYSTEM IN FRANCEJ-P Cazenave (Etablissement Français du Sang - Alsace, Strasbourg, France)FFP OR BIOPHARMACEUTICAL PLASMA: HOW TO DECIDEP. Hellstern (City Hospital. Ludwigshafen, Germany)ADVERSE REACTIONS OF PLASMA TRANSFUSION;A PARTICULAR CASE: TRALIJ.H. Sachs (Justus Liebig University Giessen, Giessen, Germany)EXPERIENCES WITH UNIVERSAL BIOPHARMACEUTICAL PLASMAC. Rochat (National Bioproducts Institute, Pinetown, South Africa)SUMMARYB. Solheim (Riks Hospitalet, Radium Hospitalet, Oslo, Norway)QUESTIONSINTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Tuesday, September 5ISBT2006Wednesday, 6 SeptemberSATELLITE SYMPOSIUMPLENARY LECTURES44SATELLITE SYMPOSIUM13:15 – 15.15 Ballroom EastSatellite Symposium organised by ChironImpact of individual donation (ID) Nucleic Acid Testingon blood safety13.15 – 13.20 WELCOME AND OPENINGA. Heaton (Chief Medical Officer, Chiron)Introduction of Moderator: Arthur Bird MD. CEO, Western Province Blood Transfusion(WPBTS), Cape Town13.20 – 13.30 BLOOD SAFETY REASONS FOR NAT TESTINGIN A SOUTH AFRICAN ENVIRONMENTA. Heyns (South African National Blood Service, Johannesburg, South Africa)08.30 - 09.30 AuditoriumPLENARY LECTURES 4: Ethical Issues in Blood Transfusion PracticeChairs: P.F.W. Strengers, C. Bianco08.30 - 09.154PL-04-01 GROUP RIGHTS VS. THE RIGHTS OF THE INDIVIDUALS. Benatar (Groote Schuur Hospital, Dept. of Medicine, Cape Town, South Africa)09.15 - 10.004PL-04-02 ETHICS OF STEM CELL COLLECTION, STORAGE AND CLINICALAPPLICATIONA. Van Niekerk (University of Stellenbosch, South Africa)10.30 – 11.004513.30 – 13.55 AUTOMATED INDIVIDUAL DONOR NAT TESTING AND ITSIMPLICATIONS FOR POST TRANSFUSION HIV TRANSMISSION RISK INSOUTH AFRICACOFFEE BREAKR. Crookes (South African National Blood Service, Johannesburg, South Africa)13.55 – 14.20 5 YEARS OF NAT TESTING IN SINGAPORE: TRANSITIONFROM SEMI-AUTOMATED HIV/HCV (DUPLEX) TESTING TO AUTOMATEDHIV/HCV/HBV (TRIPLEX) TESTING ON PROCLEIX ® TIGRIS ® SYSTEMD. Teo (Health Sciences Authority, Singapore, Singapore)14.25 – 14.50 HBV WORLDWIDE: POLICY IMPLICATIONS OFNAT DIAGNOSIS AND EPIDEMIOLOGYB. Carman (West Scotland Specialist Virology Center, Glasgow, Scotland, United Kingdom14.50 – 15.15 DISCUSSION ON IMPLICATIONS FOR INTERMEDIATEPREVALENCE COUNTRIESModerator: Arthur Bird, Cape Town, South AfricaPanel speakers: Kap-No Lee (Korean Red Cross, Seoul, South-Korea), A. Hatzakis(National Retrovirus Reference Center, Athens, Greece)15.15 CLOSURE15.00 GENERAL EXCURSION CHAPMANS PEAK TOUR.FOR MORE INFORMATION SEE PAGE 175INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Wednesday, 6 SeptemberISBT2006Wednesday, 6 SeptemberPARALLEL SESSIONSPARALLEL SESSIONS4610.30 - 12.00 Room: 1.41 - 1.44S16: Evidence Based Transfusion MedicineChairs: E.C. Vamvakas, W.G. van Aken10.30 - 11.004PS-16-01 NEW TRIALS TO GUIDE TRANSFUSION PRACTICE-WHAT'S NEW IN THE LAST 2 YEARSB. McClelland (Scottish National Blood Transfusion Service, Edinburgh, United Kingdom)11.00 - 11.304PS-16-02 EVIDENCE-BASED TRANSFUSION MEDICINE: TOP TENMISTAKES WHEN DOING CLINICAL RESEARCH – ARE YOU GUILTY?11.30 - 11.454PS-17-04 DOES A NEGATIVE DIRECT ANTIGLOBULIN TEST EXCLUDE WARMAUTOIMMUNE HEMOLYTIC ANEMIA? A PROSPECTIVE STUDY OF 504 CASESJ.H. Sachs, S. Santoso, G. Bein (Justus Liebig University Giessen, Giessen, Germany)11.45 - 12.004PS-17-05 EFFECT OF A SINGLE GIFT OF ANTENATAL ANTI-D-PROPHYLAXISWITH 1000 IU IN WEEK 30 ON THE INCIDENCE OF RHESUS-D-IMMUNIZATIONIN THE FIRST TRIMESTER OF NEXT PREGNANCYJ.M. Koelewijn, M. de Haas, T.G.M. Vrijkotte, G.J. Bonsel, C.E. van der Schoot(Sanquin Research and Landsteiner Lab, Amsterdam, Netherlands)47N. Heddle (McMaster University, Hamilton, Canada)11.30 - 12.004PS-16-03 QUALITATIVE RESEARCH IN TRANSFUSION MEDICINE:CLOSING THE GAP10.30 - 12.00 Room: 1.61 - 1.64S18: IPFA Symposium: Quality and safety of plasma andplasma productsS. Whittaker (McMaster University, Hamilton, Canada)Chairs : T. Burnouf, A. Padilla10.30 - 12.00 Ballroom WestS17: The Immune Haemolytic AnaemiasChairs : W. Mayr, M. Contreras10.30 - 10.504PS-17-01 PATHOGENESIS OF AUTOIMMUNE HAEMOLYTIC ANAEMIAS(AIHA)10.30 - 10.504PS-18-01 PLASMA FRACTIONATION: PROGRESS AND CURRENT ISSUEST. Burnouf (Human Plasma Product Services, Lille, France)10.50 - 11.104PS-18-02 THE IMPACT OF THE PLASMA MASTER FILE ON BLOODAND PLASMA COLLECTION ORGANIZATIONSR. Buchel (PPTA Source / EPCC, Brussels, Belgium)J. Semple (St Michael's Hospital, Toronto, Canada)10.50 - 11.104PS-17-02 TREATMENT OF AIHA11.10 - 11.304PS-18-03 WHO RECOMMENDATIONS ON THE PRODUCTION,CONTROL AND REGULATION OF PLASMA FOR FRACTIONATIONP. Ness (John Hopkins Medical Institution, Baltimore, United States of America)A. Padilla (World Health Organization, Geneve, Switzerland)11.10 - 11.304PS-17-03 LABORATORY APPROACH TO DIAGNOSIS ANDTRANSFUSION POLICY IN AIHA11.30 - 11.504PS-18-04 CLINICAL OUTCOMES FROM THE EVOLUTION IN QUALITYOF PLASMA-DERIVED PRODUCTSM. de Haas (Sanquin, Diagnostics Services, Amsterdam, Netherlands)C. Dash (Sanquin, Amsterdam, Netherlands)11.50 - 12.00DISCUSSION TIMEINTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Wednesday, 6 SeptemberISBT2006Wednesday, 6 SeptemberPARALLEL SESSIONSPARALLEL SESSIONS10.30 - 12.00 Auditorium10.30 - 12.00 Ballroom EastS19: Donor Management - Recruiting and Managing DonorsS20: Transfusion Transmitted Diseases (TTD)Chairs: G.M. Thurtell, S. DaigneaultChairs: R. Dodd, S. Wendel10.30 - 10.554PS-19-01 BUILDING DONOR LOYALTYP.V. Holland (University of California, Davis Medical Center, Sacramento,United States of America)10.30 - 11.004PS-20-01 TRANSFUSION TRANSMITTED AMERICAN AND AFRICANTRYPANOSOMIASIS (CHAGAS DISEASE AND SLEEPING SICKNESS):NEGLECTED OR REALITY?4810.55 - 11.154PS-19-02 THE DONATION EXPERIENCE: TURNING DATA INTO SUCCESSS. Daigneault (Hema-Quebec, Saint Laurent, Canada)S. Wendel (Hospital Sírio Libanes, Sao Paulo, Brazil)11.00 - 11.304PS-20-02 TTD POTPOURI4911.15 - 11.304PS-19-03 EXPERIENCE WITH SCREENING VOLUNTEER BLOOD DONORSFOR CARDIOVASCULAR DISEASE RISK. AN INNOVATIVE APPROACH TOMOTIVATION AND HEALTH AWARENESSD. Leiby (American Red Cross, Rockville, United States of America)11.30 - 12.004PS-20-03 PRESENT AND FUTURE CONCERNS OVER VARIANT CJDJ. Ironside (University of Edinburgh, Edinburgh, United Kingdom)M.H. Sayers, J. Centilli, S. Eason, S. Myers, S. Goudar (Carter BloodCare, Bedford,United States of America)11.30 - 11.454PS-19-04 AVOIDING 'MARKETING MYOPIA' IN VOLUNTARY BLOODDONATION (WHAT IS WRONG WITH THE PROMOTION OF VOLUNTARYBLOOD DONATION?)12.00 – 14.00LUNCH BREAK, VISIT TO THE EXHIBITION AND POSTERSAND SATELLITE SYMPOSIAI.B. Petrovic (University of Belgrade, Beograd, Serbia and Montenegro)11.45 - 12.004PS-19-05 THIRD PARTY INFORMATION,SUBJECTIVE DONORASSESSMENT AND SEROCONVERSION RATES IN BLOOD DONORSV. Poovalingam, R. Patak, P. Knox (South African National Blood Service, Durban, South Africa)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Wednesday, 6 SeptemberISBT2006Wednesday, 6 SeptemberSATELLITE SYMPOSIAPARALLEL SESSIONSSATELLITE SYMPOSIUM12.15 – 13.45 Room 1.41 – 1.44Satellite Symposium organised by Roche Molecular SystemsCOST-EFFECTIVENESS OF SCREENING STRATEGIES IN ADDITIONTO ANTIBODY SCREENING FOR HIV AND HCV IN GHANA, THAILANDAND THE NETHERLANDSM. van Hulst (PharmD, University Center for Pharmacy, Groningen, Netherlands)50Perspectives on Approaches for NAT AutomationNAT AND BLOOD SCREENINGJ. Saldanha (Roche Molecular Systems, Pleasanton, United States of America)COBAS S 201 SYSTEM: EUROPEAN EVALUATION STUDIESL. Jarvis (Scottish National Blood Transfusion Services, Edinburgh, United Kingdom)“WEB-BASED HEALTH ECONOMICS TOOLKIT FOR BLOOD BANKSCREENING TO SUPPORT POLICY DECISIONS”G.A.A. Hubben (MSC, REMEDA, Groningen, Netherlands)“CLOSING THE WINDOW : NAT VERSUS AG/ABJ. Barbara (University of West England, United Kingdom)51NAT SYSTEM FOR THE DEFECTION OF BLOOD-BORNE VIRUSSES:STATE OF THE ARTM. Nuebling (Paul-Ehrlich Institute, Munich, Germany)14.00 - 15.30 Ballroom WestS21: HaemostasisChairs: J. Mahlangu, E. TuddenhamSATELLITE SYMPOSIUM12.15 – 13.45 Ballroom WestSatellite Symposium organised by BioRadPerformance and Cost-Efficiency of HIV and HCV ComboSimultaneous Antigen and Antibody Detection: An AffordableAlternative to N.A.T. in Blood Bank?Chair: J. Barbara DETECTION OF HCV AG/AB : A VIABLE ALTERNATIVE TO NAT ?A. Kitchen (Head, National TM Reference Laboratory, United Kingdom)SPECIFICITY STUDY OF THE NEW GENSCREEN ULTRA HIV AG-ABCOMBO ASSAY IN BLOOD BANK ROUTINE TESTINGT. Levayer (Etablissement Français du Sang, Montpellier, France)SENSITIVITY STUDY OF NEW GENERATION HIV AG-AB COMBOASSAYS REGARDING NAT AND HIV ANTIGEN DETECTIONST.D. Ly (Laboratoire Claude Levy, Ivry sur Seine, France)14.00 - 14.304PS-21-01 R VIIA FOR NON-HAEMOPHILIACS; HELP OR HYPE -A CRITICAL REVIEW OF OFF-LABEL USE OF R VIIAS. Dzik (Brookline, Mass, United States of America)14.30 - 15.004PS-21-02 GENE THERAPY FOR HAEMOPHILIA: THE PROS AND CONSE. Tuddenham, P. Giangrande (United Kingdom)15.00 - 15.154PS-21-03 REDUCED APC CATALYZED INACTIVATION OF FACTOR VABOUND TO STORAGE INDUCED MICROPARTICLESE.J.P. Magdeleyns, J.F.W. Keuren, C. Van der Zwaan, S. Meijer, J. Curvers (Sanquin BloodBank Southeast region, Maastricht, Netherlands)15.15 - 15.304PS-21-04 CLINICAL EVALUATION OF FIBRIN SEALANT PRODUCED BYCRYOSEAL ® FS SYSTEM IN PATIENTS UNDERGOING LIVER RESECTION:A MULTICENTER RANDOMIZED CLINICAL TRIALD. Franceschi, T. Madsen, C. Weatherford, V. Kumar, J. Chapman (University of Miami Schoolof Medicine, Miami, United States of America)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Wednesday, 6 SeptemberISBT2006Wednesday, 6 SeptemberPARALLEL SESSIONSPARALLEL SESSIONS14.00 - 15.30 Room: 1.61 - 1.64S22: Artificial O 2Carriers: Status 2006Chairs: E. Briët, N. Novitsky14.00 - 14.304PS-22-01OVERVIEW OF ARTIFICIAL O 2CARRIERS15:15 - 15:304PS-23-04 PK BLOOD GROUP ANTIGEN: A NATURALRESISTANCE FACTOR TO HIV INFECTIONN. Lund, D. Sakac, C.A. Lingwood, C. Levene, A. Hellberg, M.L. Olsson, D.R. Branch(University of Toronto, Toronto, Canada)A. Pape (Johann Wolfgang Goethe - University, Frankfurt Am Main, Germany)5214.30 - 15.004PS-22-02 HEMOSPAN ® : SCIENTIFIC FOUNDATIONSAND CLINICAL DEVELOPMENT14.00 - 15.30 Room: 1.41 - 1.44S24: An Update on Blood Transfusion Services/Practice in AfricaChairs: J. Emmanuel, J.B. Tapko53B. Winslow (Sangart Inc., San Diego, United States of America)15.00 - 15:304PS-22-03 BOVINE HEMOGLOBIN (HEMOPURE): CLINICAL USE INSOUTH AFRICAL.J. Levien (Milpark Hospital, Johannesburg, South Africa)14.00 - 14.05WELCOME AND INTRODUCTION OF AFSBT PRSIDENTJ. Emmanuel (Malawi Blood Transfusion Service Project, Malawi)14.05 - 14.10PRESIDENTIAL ADDRESSK. Boukef (National Blood Transfusion Service, Tunis, Tunisia)14.00 - 15:30 AuditoriumS23: HIVChairs: R.M. Wood, M.P. Busch14.00 - 14:304PS-23-01 HAEMATOLOGICAL MANIFESTATIONS OF HIV IN PAEDIATRICPRACTICE AND TRANSFUSION MANAGEMENT OF HIVG. Gray (Perinatal HIV Research Unit, University of the Witwatersrand, Diepkloof, South Africa)14:30 - 15.004PS-23-02 BIOLOGY OF HIV IN AFRICAC. Williamson (HDMM, University of Cape Town, Cape Town, South Africa)15.00 - 15:154PS-23-03 GENITAL HERPES (HSV-2) EXPOSURE CORRELATESSTRONGLY WITH PREVALENT HIV-1 INFECTIONS IN SOUTH AFRICANBLOOD DONORS: A PILOT STUDYR.J. Benjamin, C.T. Fang, A. Puren, B.D. Schoub, M. Vermeulen, C. Coleman, A. du P. Heyns,R.L. Crookes (American Red Cross Blood Services, Dedham, United States of America)14.10 - 14.194PS-24-01 CURRENT STATUS OF THE BLOOD PROGRAMME IN NAMIBIA:IMPROVING BLOOD SAFETY AND ADEQUACY AND FUTURE CHALLENGESR. Redeker, R. Wilkinson (Blood Transfusion Service, Namibia)14.19 - 14.284PS-24-02 NIGERIA: EMERGENCE OF THE RUDIMENTS OF CENTRALIZED,NATIONALLY-COORDINATED BLOOD SERVICE - THE GOALS, SUCCESSES,CHALLENGES AND FUTURE PLANSF. Ayo (Federal Ministry of Health Nigeria, Abuja, Nigeria)14.28 - 14.374PS-24-03 THE CONCEPT TO PROVISION OF SAFE BLOODIN A DEVELOPING COUNTRY: THE LAGOS STATE MODELR. Olatunji (Lagos State Health Service Commission, Lagos, Nigeria)14.37 - 14.464PS-24-04 ANTI - U IDENTIFIED IN ERITREAG. Williams (National Health Laboratory, Asmara, Eritrea)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Wednesday, 6 SeptemberISBT2006Wednesday, 6 SeptemberPARALLEL SESSIONSPARALLEL SESSIONS5414.46 - 14.554PS-24-05 QUALITY MANAGEMENT IN THE WHO AFRO -ANGLOPHONE REGIONN. Rosin (South African National Blood Service (SANBS), Roodepoort, South Africa)14.55 - 15.044PS-24-06 A RAPID SCALE UP OF THE BLOOD TRANSFUSIONPROGRAMME IN ZAMBIAK. Muyinda, K. Mulenga, N. Chikwese (Zambia National Blood Transfusion Servic, Lusaka, Zambia)15.04 - 15.134PS-24-07 CURRENT STATE OF BLOOD COLLECTION ANDTRANSFUSION IN KENYAJ. Mwangi, J.A. Nyamongo, L.H. Marum (Centers for Disease Control and Preventi, Nairobi, Kenya)15.13 - 15.224PS-24-08 BLOOD TRANSFUSION IN BURKINO FASO: EXPERIENCEOF BOBO DIOULASSO BLOOD TRANSFUSION CENTREH. Dahourou (Centre Régional de Transfusion Sanguine (CRTS), Bobo-Droulasso, Borbina, Fasso)14.45 - 15.004PS-25-03 ANALYSIS OF COMPLAINTS RECEIVED BY THE UK BLOODSERVICES CONCERNING THE POLICY BARRING HOMOSEXUAL MENFROM DONATING BLOODF. Boulton, S. Curtis (National Blood Service England, Southampton, United Kingdom)15.00 - 15.154PS-25-04 DEVELOPMENT OF A WORKBOOK TO INCLUDE COMPETENCYASSESSMENTS FOR USE IN INTRA-OPERATIVE CELL SALVAGE TRAININGJ. Jones, C.A. Howell (Welsh Blood Service, Cardiff, United Kingdom)15.15 - 15.304PS-25-05 APPLICATION AND EVALUATION OF POLYMERASE CHAINREACTION (PCR) IN DETECTION OF MALARIA INFECTION IN DONORSOF TRANSFUSION CENTERS IN SISTAN -BALOOCHESTAN PROVINCEM. Moghtadaei, S. Amini kafiabad, G. Edrissian, S. Samiei (Iranian Blood TransfusionORG.research, Tehran, Iran)5515.22 - 15.30GENERAL DISCUSSION AND CLOSUREJ. Emmanuel (Malawi Blood Transfusion Service Project, Malawi)15.30 – 16.00TEA BREAK14.00 - 15.30 Ballroom EastS25: Donor ManagementChairs: V. Poovalingam, D. Teo14.00 - 14.254PS-25-01 COUNSELLING THE HIV AND HEPATITIS POSITIVE DONORC. Sims (Western Province Blood Transfusion Service, Howard Place, South Africa)14.25 - 14.454PS-25-02 IMPACT OF ADVERSE DONOR REACTIONS ONBLOOD CENTRES AND THE DONORM.A. Popovsky (Haemonetics Corporation, Braintree, Mass, United States of America)16.00 - 17.30 Ballroom WestS26: Role of International Organisations in Strengthening/SupportingBlood Transfusion ServicesChairs: K. Boukef, P.F.W. Strengers16.00 - 16.204PS-26-01 WHO INITIATIVESN. Dhingra (WHO, Geneve, Switzerland)16.20 - 16.404PS-26-02 CDC INITIATIVES - PEPFAR (PRESIDENT'SEMERGENCY PLAN FOR AIDS RELIEF)L. Marum (Centres for Disease Control and Prevention, Nairobi, Kenya)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Wednesday, 6 SeptemberISBT2006Wednesday, 6 SeptemberPARALLEL SESSIONS16.40 - 17.004PS-26-03 ISBTP.F.W. Strengers (Secretary General ISBT)PARALLEL SESSIONS16.25 - 16.454PS-28-02 IMPACT OF NAT ON SEROLOGICAL SCREENING OF TTDS.L. Stramer (America Red Cross, Gaithersburg, United States of America)17.00 - 17.204PS-26-04 ADRPS. Churchill (Mayo Clinic Blood Donor Program, Rochester, United States of America)16.45 - 17.054PS-28-03 NAT TESTING OF BLOOD RECIPIENTS TO PROSPECTIVELYMONITOR TRANSFUSION ASSOCIATED INFECTIONS5617.20 - 17.304PS-26-05 ALLIANCE OF BLOOD OPERATORS: GLOBAL PERFORMANCEIMPROVEMENT THROUGH BENCHMARKINGS. Morgen (NHSBT International, Bristol, United Kingdom)H. Alter (National Institute of Health, Bethesda, United States of America)17.05 - 17.304PS-28-04 THE IMPACT OF INDIVIDUAL DONOR NAT SCREENINGON BLOOD SAFETY - THE SOUTH AFRICAN EXPERIENCE57A. Heyns (South African National Blood Service, Johannesburg, South Africa)16.00 - 17.30 Room 1.41 - 1.44S27: Resuscitation/Massive TransfusionChairs: M. James, E. Steyn16.00 - 17.30 Ballroom EastS29: Haemovigilance Systems16.00 - 16.304PS-27-01 RECENT ADVANCES IN TRAUMA SURGERYA. Nichol (Groote Schuur Hospital, Cape Town, South Africa)16.30 - 17.004PS-27-02 DAMAGE CONTROL SURGERYE. Steyn (Christiaan Barnard Memorial Hospital, Cape Town, South Africa)17.00 - 17.304PS-27-03 MASSIVE TRANSFUSION IN TRAUMA PATIENTST. Hardcastle (University of Stellenbosch, Cape Town, South Africa)Chairs: R. de Vries, S. Asmal16.00 - 16.304PS-29-01 HAEMOVIGILANCE SYSTEMS: AN OVERVIEW ANDUSE OF DATA FOR EVALUATIONP. Robillard (Quebec Public Health Institute, Montreal, Canada)16.30 - 16.454PS-29-02 SURVIVAL AFTER BLOOD TRANSFUSION - A STUDYOF MORE THAN ONE MILLION TRANSFUSION RECIPIENTSK. Titlestad, M. Ahlgren, H. Hjalgrim, K. Rostgaard Petersen, A. Shanwell, G. Edgren,E. Tynell, R. Norda (Department of Clinical Immunology, Odense C, Denmark)16.00 - 17.30 AuditoriumS28: Nucleic Acid Amplification Testing (NAT)16.45 - 17.004PS-29-03 POTENTIAL BENEFITS OF AN INFORMATION MANAGEMENTSYSTEM TO MONITOR HEMOVIGILANCEChairs: S. Kleinman, N. LelieJ.G. van der Wijst, A.G. van den Bos, B. de Pauw (University Hospital St Radboud,16.00 - 16.254PS-28-01 APPLICATION OF NUCLEIC ACID AMPLIFICATION TESTS TOSTUDY TRANSFUSION-ASSOCIATED MICROCHIMERISM – A NEWCOMPLICATION OF BLOOD TRANSFUSIONS IN TRAUMA PATIENTSNijmegen, Netherlands)17.00 - 17.154PS-29-04 HAEMOVIGILANCE IN FRANCE: CONTRIBUTION TO THEIMPROVEMENT OF TRANSFUSION PROCESS AND PRACTICEM.P. Busch (Blood Systems Research Institute, San Francisco, United States of America)C. Caldani, N. Ounnoughene, M.P. Vo Mai, K. Martiniere, B. Willaert, J.F. Legras, P. Zorzi(AFSSaPS, Saint-Denis, France)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Wednesday, 6 SeptemberISBT2006Wednesday, 6 SeptemberPARALLEL SESSIONSPOSTER WALK 217.15 - 17.304PS-29-05 THREE YEAR TRENDS IN TRANSFUSION ASSOCIATEDADVERSE EVENTS IN CANADA, 2002-2004S Leduc, P. Robillard, N. McCombie, J. Egan, M. Cator (Public Health Agency of Canada,Ottawa, Canada)Poster walks are going to be held for the first time this year. This new event is introducedin order to gain a maximum benefit from the scientific work presented andto create a lively interaction between poster authors, moderators and interestedcongress participants. Poster -walks will be organised during the poster sessionson Monday, 4 September and on Wednesday, 6 September (17.30 – 18.30 hours).The poster area is located next to the exhibtion.5816.00 - 17.30 Room 1.61 - 1.64S30: Rare Donor ProgrammeChairs: S. Nance, E. Smart16.00 - 16.204PS-30-01 THE INTERNATIONAL RARE DONOR PANELJ. Poole (IBGRL, NBS, Bristol, United Kingdom)16.20 - 16.354PS-30-02 SOUTH AFRICAN RARE DONOR PANELE. Smart (South African National Blood Service, Pinetown, South Africa)16.35 - 16.504PS-30-03 TESTING FOR RARE BLOOD DONORS FOR DNA ANALYSISC. Lomas-Francis (New York Blood Center, New York, United States of America)16.50 - 17.054PS-30-04 THE AMERICAN RARE DONOR PROGRAM – A COLLABORATIVEPROGRAM OF THE AMERICAN RED CROSS AND THE AABBS. Nance (American Red Cross, Philadelphia, United States of America)17.05 - 17.204PS-30-05 SCREENING FOR BLOOD DONORS WITH RARE PHENOTYPESBY MULTIPLEX PCR WITHOUT DNA PURIFICATIONF. Wagner, R. Bittner, A. Döscher, E.K. Petershofen (DRK Blutspendedienst NSTOB,Springe, Germany)17.20 - 17.354PS-30-06 RARE BLOOD PROGRAMME IN CHINAZ. Zhu (Shanghai Blood Center, Shanghai, China)Poster authors, moderators and interested congress participants are kindly requestedto be present at the first poster in their poster session at the beginning of the presentationtime (17.30 hours).Snacks and drinks will be served.THE FOLLOWING POSTERS WILL BE DISCUSSED ON WEDNESDAY:Topic 01.1. Blood Safety - TTD - HIV P-013 – P-024Topic 01.2. Blood Safety - TTD - Hepatitis P-056 – P-085Topic 01.4. Blood Safety - TTD - West Nile Virus P-095 – P-099Topic 01.5. Blood Safety - TTD - Emerging Pathogens P-114 – P-140Topic 01.7. Blood Safety - TTD - Bacterial Contamination P-150 – P159Topic 02.1. Red Cells – Immunohaematology P-232 – P-283Topic 02.2. Red Cells - Immune Haemolytic Aneamias P-284 – P-301Topic 02.4. Red Cells Transfusion P-327 – P-348aTopic 03.2. Haemostatis - Related to Blood Transfusion P-353 – P-359Topic 04.3. Pathogen Reduction/Inactivation - Plasma P-381 – P-389Topic 05.1. Donor Management - Developing Donor Programs P-403 – P-412Topic 05.2. Donor Management - Recruiting and ManagingDonors (incl Management) P-442 – P-472Topic 07.1. Clinical Transfusion Practice - Leucocyte Depletion P-475 – P-481Topic 07.3. Clinical Transfusion Practice - Paediatric TransfusionPractice P-486 – P-492Topic 07.5. Clinical Transfusion Practice – Non-infectiousHazards of Transfusion P-498 – P-511Topic 09.1. Stem Cells - Pheriphal Blood and Bone MarrowProgenitor Cells P-523 – P-53759INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Wednesday, 6 SeptemberISBT2006Thursday, 7 SeptemberPOSTER WALK 2PARALLEL SESSIONS60Topic 09.3. Stem Cells - Cellular Therapies P-547 – P-552Topic 10.1. Platelet – Transfusion P-569 – P-584Topic 10.3. Platelet – Biology P-597 – P-608Topic 11.2. Quality Management - Industry Perspective P-618 – P-627Topic 11.4. Quality Management – Haemovigilance P-640 – P-655Topic 12.0. Blood Inventory Management, includingDisaster Management P-656 – P-669Topic 13.0. Structure and Governance of Blood TransfusionServices P-670 – P-681Topic 14.0. Transfusion in Resource Limited Countries P-693 – P-70408.30 - 10.00 AuditoriumS31: Promoting Blood Donation: Art, Science or Guesswork?Chairs: J. Simpson, P.J. Coghlan08.30 - 09.005PS-31-01 POPULATION AND DONOR MOTIVATION:EVIDENCE BASED RESULTSF. Décary (Hema-Québec, Québec, Canada)09.00 - 09.305PS-31-02 NATIONAL STUDY OF BLOOD DONOR ANDNON-DONOR DECISION MAKINGC. Hillyer (Emory University Hospital, Atlanta, United States of America)6109.30 - 10.005PS-31-03 BLOOD DONATION AS SOCIAL CAPITALP.J. Coghlan (Australian Red Cross Blood Service, Melbourne, Australia)08.30 - 10.00 Room: 1.61 - 1.64S32: RBC Antigen ModificationChairs: G. Daniels, M.L. Olsson08.30 - 09.005PS-32-01 ENZYMATIC CONVERSION OF RED CELLS FORABO-UNIVERSAL TRANSFUSION: AN UPDATEM.L. Olsson (Lund University, Lund, Sweden)09.00 - 09.305PS-32-02 PEGylated RED CELLST. Fisher (USC Keck School of Medicine, Los Angeles, United States of America)09.30 - 09.455PS-32-03 KODE TM TECHNOLOGY ALLOWS THE ATTACHMENT OFCARBOHYDRATE BLOOD GROUP ANTIGENS TO RED CELLSS.M. Henry, T. Carroll, T. Frame (AUT University, Auckland, New Zealand)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Thursday, 7 SeptemberISBT2006Thursday, 7 SeptemberPARALLEL SESSIONSPARALLEL SESSIONS08.30 - 10.00 Ballroom West08.30 - 10.00 Ballroom EastS33: Haemopoietic Stem CellsS34: Pathogen Reduction/InactivationChairs: N. Novitzky, J. McCulloughChairs: A.R. Bird, R. Benjamin08.30 - 09.005PS-33-01 QA OF UCSC COLLECTION, PROCESSING AND STORAGEJ. McCullough (University of Minnesota, Minneapolis, United States of America)08.30 - 08.455PS-34-01 RED BLOOD CELL PATHOGEN REDUCTION:IN SEARCH OF SEROLOGICAL AGNOSTICISM6209.00 - 09.155PS-33-02 ISOLATION AND EXVIVO EXPANSION OF HUMAN UMBILICALCORD BLOOD–DERIVED CD34+ STEM CELLS AND THEIR COTRANS-PLANTATION WITH OR WITHOUT MESENCHYMAL STEM CELLSB. Delalat, A. Pourfathollah, H. Mozdarani, M. Soleimani, A. Movassaghpour, S. Kaviani(Tarbiat Modarres University, Tehran, Iran)R.J. Benjamin (American Red Cross Blood Services, Dedham, United States of America)08.45 - 09.005PS-34-02 INACTIVATION OF PATHOGENS IN RED BLOOD CELLS BY AMODIFIED TREATMENT PROCESS UTILIZING S-303 AND GLUTATHIONEL. Corash, L. Sawyer, R. Mababangloob, N. Patel, J. Kinsey, A. Sampson-Johannes,D. Hanson (Cerus Corporation, Concord, United States of America)6309.15 - 09.305PS-33-03 FRENCH CORD BLOOD REGISTRY: A 6 YEAR EXPERIENCE09.00 - 09.205PS-34-03 PLASMA/PLATELET PATHOGEN INACTIVATIONI. Desbois, V. Lapierre, B. Dazy, M. Benbunan, E. Marry, C. Gerdil, C. Raffoux, P. HerveT. Hervig (Haukeland University Hospital, Bergen, Norway)(Etablissement Français du Sang, La Plaine Saint Denis, France)09.30 - 09.455PS-33-04 LONG-TERM STORAGE OF PERIPHERAL BLOOD PROGENITORCELLS (PBPC) AT -80°C RESULTS IN A PRONOUNCED DECREASE OFMEMBRANE INTEGRITY AND CLONOGENIC POTENTIAL COMPAREDTO STORAGE AT

Thursday, 7 SeptemberISBT2006Thursday, 7 SeptemberPARALLEL SESSIONS09.00 - 09.305PS-35-02 RFID: AN EXPERIENCE IN TRANSFUSION MEDICINER. Knels (DRK-Blutspendedienst Sachsen GmbH, Dresden, Germany)09.30 - 10.005PS-35-03 ISBT 128 - IMPROVING SECURITY BY INTERNATIONALSTANDARDIZATIONP. Ashford (ICCBA Inc., Cardiff, United Kingdom)PARALLEL SESSIONS10.30 - 12.00 AuditoriumS37: West Nile Virus and Other Emerging PathogensChairs: M.P. Busch, S.L. Stramer10.30 - 11.005PS-37-01 WEST NILE VIRUS AND TRANSFUSION SAFETY IN NORTHAMERICA: RESPONSE TO AN EMERGING PATHOGENS. Kleinman (U. British Columbia, Victoria, Canada)10.00 – 10.3011.00 - 11.305PS-37-02 OTHER EMERGING VIRAL PATHOGENS64COFFEE BREAK10.30 - 12.00 Ballroom EastR. Dodd (ARC Holland Lab, Rockville, United States of America)11.30 - 11.455PS-37-03 SPECIFIC ANTI-B19 ANTIBODIES AND B19 INFECTIVITY INPARVOVIRUS-B19-DNA-POSITIVE DONORS AND RISK OF TRANSMISSION65S36: Thrombotic Thrombocytopaenic Purpura (TTP)A. Brand, C.A. McDonald10.30 - 10.555PS-36-01 OVERVIEW OF THE PATHOGENESIS OF TTPC. Hillyer (Emory University Hospital, Atlanta, United States of America)10.55 - 11.205PS-36-02 THE PATHOGENESIS OF HIV-RELATED THROMBOTICTHROMBOCYTOPENIC PURPURA – IS IT DIFFFERENT?M.S. Schmidt, M. Di Giambattista, P. Caillet-Fauquet, M.-L. Draps, Th. Branckaert,A. Themann, Y. de Launoit, E. Seifried, M.K. Hourfar, W.K. Roth, R. Laub(German Red Cross Institute Frankfurt, Frankfurt, Germany)11.45 - 12.005PS-37-04 BLOOD DONOR SCREENING FOR INFLUENZA VIRUSINCLUDING H5N1- IS IT NECESSARY AND FEASIBLE?M.S. Schmidt, M.K. Hourfar, A. Themann, M. Eickmann, M. Matrosovitch, P. Puthavathana,T. Laue, E. Seifried (German Red Cross Institute Frankfurt, Frankfurt, Germany)K. Gunther (University of the Witwaterbrand and NHLS, Johannesburg, South Africa)11.20 - 11.455PS-36-03 IN TTP, WHO BENEFITS FROM PLASMA INFUSION VS.PLASMA EXCHANGE10.30 - 12.00 Room: 1.41 - 1.44S38: Emerging TechnologiesChairs: J. Coste, B. MendelowN. Novitzky (Groote Schuur Hospital, Cape Town, South Africa)11.45 - 12.00*P-467 GEOGRAPHICAL MODELING OF DONOR ACTIVITY IN RELATIONTO TRANSFUSION INFRASTRUCTURE BY DEFINED DONOR CENTRECATCHMENT AREA, TO ENABLE EFFECTIVE DEPLOYMENT OFRESOURCES AND MAXIMIZE SAFE DONATIONS10.30 - 11.005PS-38-01 THE BLOODGEN PROJECT: TOWARD MASS SCALECOMPREHENSIVE GENOTYPING OF BLOOD DONORS IN THEEUROPEAN UNION AND BEYONDD. Avent, A. Martinez, W. Flegel, M. Olsson, N. Nogues, M. Pisacka, M. Scott, G. Daniels,M. de Haas (University of the West of England, Bristol, United Kingdom)R.A. Wagner, R. Swanevelder (Strategis, Centurion, South Africa)* Abstract to be found in the poster sectionINTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Thursday, 7 SeptemberISBT2006Thursday, 7 SeptemberPARALLEL SESSIONS11.00 - 11.305PS-38-02 INNOVATIVE TECHNOLOGIES TO ADDRESS LOGISTICDIFFICULTIES AFFECTING BLOOD BANKSB. Mendelow (NHLS, Johannesburg, South Africa)11.30 - 11.455PS-38-03 APPLICATION OF PROTEOMICS METHODS TOTHE ANALYSIS OF THE PLATELET STORAGE LESIONV. Devine, J. Thon, P. Schubert, K. Serrano, J. Kast (Canadian Blood Services,Vancouver, Canada)PARALLEL SESSIONS11.30 - 11.455PS-39-04 QUALITY ASSESSMENT OF PLASMA UNITS OBTAINED BYDIFFERENT METHODS OF PREPARATIONT. Vuk, M. Balija, I. Jukic (Croatian Institute of Transfusion Medic, Zagreb, Croatia)11.45 - 12.005PS-39-05 GRANULOCYTE APHERESIS: THE FIRST STEPH. Vrielink, P.F. van der Meer, R.N.I. Pietersz, M.M.W. Koopman (Sanquin Blood BankNorth West Region, Amsterdam, Netherlands)6611.45 - 12.005PS-38-04 COMPUTATIONAL SIMULATION OF PLATELET COLLECTIONPROCESS WITH LATHAM BOWL10.30 - 12.00 Room: 1.61 - 1.64S40: History of Blood Transfusion67S.I. Inaba (Kanagawa Red Cross Blood Center, Yokohama, Japan)Chairs: P.V. Holland, H. Alter10.30 - 12.00 Ballroom West10.30 - 11.005PS-40-01 HISTORY OF ASPECTS IN THE EARLY YEARS OF BLOODTRANSFUSION IN SOUTH AFRICAS39: Quality Management in Blood TransfusionA. Heyns (South African National Blood Service, Johannesburg, South Africa)Chairs: P.J. Coghlan, N. Rosin10.30 - 11.005PS-39-01 ACCREDITATION OF BLOOD TRANSFUSION SERVICESIN SOUTH AFRICAL. Bust (Western Province Blood Transfusion Service, Cape Town, South Africa)11.00 - 11.155PS-39-02 A SURVEY OF QUALITY CONTROL DATA TO FIND OUT THEBATCH WISE VARIATION OF WBC-REDUCTION FILTERS11.00 - 11.305PS-40-02 BLOOD AND AIDS: AN INTERNATIONAL POLITICAL HISTORYP. Schmidt (Florida Blood Services, Tampa, United States of America)11.30 - 11.455PS-40-03 THE INTRODUCTION OF BLOOD TRANSFUSION TOSUB-SAHARAN AFRICAH. Schneider (Indiana University, Indianapolis, United States of America)M. Eronen, E. Laitinen, L. Aho (Finnish Red Cross Blood Service, Helsinki, Finland)11.15 - 11.305PS-39-03 DIFFERENCES BETWEEN SOURCE AND RECOVERED PLASMAFOR FURTHER MANUFACTURING- QUALITY ASPECTS AND CHALLENGES12.00 – 13.00 AuditoriumCLOSING CEREMONYK.E.J. Seidel (ZLB Plasma Services GmbH, Marburg, Germany)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 01.1The posters areon display fromMonday - ThursdayTOPIC 01.168Topic 01.1.Blood Safety - TTD - HIVP-001 IMPLEMENTATION OF HIV P24 ANTIGEN AND ANTIBODY COMBINEDSCREENING ASSAYS IN BLOOD TRANSFUSION INSTITUTE NOVI SADS. Bogdanovic, N. Bujandric, M. Krga-Milanovic (Blood Transfusion Institute Novi Sad,Novi Sad, Serbia and Montenegro)P-002 USING THE HARMONIC MEAN TO ESTIMATE BLOOD DONORSRECENTLY INFECTED BY HIV AND TO CALCULATE THE RISK THEYPOSE TO THE SOUTH AFRICAN BLOOD SUPPLYG.C. Buckle, G.L. Webb (N.A., Pennington, South Africa)P-003 HTLV I/II INFECTION IN BLOOD DONORS: SEROPREVALENCEAND PERFORMANCE OF DIFFERENT KITSA.O. Chiera, G. Larranaga, C. Bonacina, N. Etchenique (Hemotherapy Institute of BuenosAires Pr, La Plata. Provincia De Buenos Aires, Argentina)P-004 PATTERNS OF BLOOD PRODUCT TRANSFUSIONAT A TERTIARY GYNAECOLOGY UNITF. Botha, J. Nvdlovu, G. Dreyer (Altana Madaus, Woodmead, South Africa)P-005 SURVEILLANCE OF TRANSFUSION TRANSMITTEDINFECTION IN FIRST TIME BLOOD DONORSV. Durro, A. Abazaj, S. Spahiu, S. Seferi (NBTSA, Tirana, Albania)P-006 BLOOD DONORING, PROGRESS IN THE TESTING ON HIV VIRUSC. Gavrancic, B. Gavrancic, T. Jakica (Blood Transfusion Institute, Novi Sad, Yugoslavia)P-009 TRENDS IN INCIDENCE OF MAJOR TRANSFUSION TRANSMISSIBLEVIRAL INFECTION IN FARS BLOOD DONORS FROM 2002 TILL END OF 2006L. Kasraian, A. Torab Jahromi, B. Farahangiz, A. Torab Jahromi, B. Farahangiz(Ibto Research Center, Shiraz, Iran)P-010 A SURVEY OF EPIDEMIOLOGICAL STATUS AND PREVALENCE RATEOF HIV CASES IN BLOOD DONORS DURING 2005 IN SHIRAZ BLOODTRANSFUSION ORGANIZATIONL. Kasraian, A. Torab Jahromi, B. Farahangiz (Ibto Research Center, Shiraz, Iran)P-011 RISK BEHAVIOR AMONG BLOOD DONORS WHO GIVE BLOOD INORDER TO BE TESTED FOR HIV IN SHIRAZ BLOOD TRANSFUSION IN 2005L. Kasraian, A. Torab Jahromi, B. Farahangiz (Ibto Research Center, Shiraz, Iran)P-012 REDUCING THE RISK OF BLOOD BORNE TRANSMISSION HBS, HCVAND HIV THROUGH BLOOD TRANSFUSION BY DONOR SELF-DEFERRALL. Kasraian, A. Torab Jahromi, B. Farahangiz (Ibto Research Center, Shiraz, Iran)P-013 THE TRANSFORMATION OF THE BOTSWANA NATIONAL BLOODTRANSFUSION SERVICEM.K.A. Kayembe, C. Pule, C.I. Tema, J. van Hasselt, S.M. Gaolekwe, B. Gibbs(National Health Laboratory, Gaborone, Botswana)P-014 PREVALENCE OF BLOOD BORNE DISEASE MARKERS ANDRESIDUAL RISK IN BLOOD DONORS AT CROATIAN INSTITUTE OFTRANSFUSION MEDICINE 1995-2005L.M. Lovric, I. Mihaljevic, K. Strahija Tomic, B.M. Balija, J.I. Jukic (Croatian Institute ofTransfusion Medici, Zagreb, Croatia)69P-007 THE PREVALENCE OF HUMAN HERPESVIRUS 8 (HHV-8)AMONG TEHRAN BLOOD DONORS, HAEMODIALYSIS PATIENTS,AND HIV POSITIVE INDIVIDUALSA. Gharehbaghian, A. Zaghal, M. Farhadi Langerudi, S. Sadri (The Research Center of IBTO,Tehran, Iran)P-008 COST-EFFECTIVENESS OF HIV SCREENINGOF BLOOD DONATIONS IN GHANAM. van Hulst, K.W.C. Sagoe, J.E. Vermande, W.P.A. Van der Tuuk Adriani, E.K. Torpey, J. Ansah,J.A. Mingle, C.Th. Smit Sibinga, M.J. Postma (GUIDE/Martini Hospital, Groningen, Netherlands)P-015 A REVIEW OF BLOOD DONOR RISK MODEL IN ZIMBABWET. Mapako, A. Mvere (National Blood Service Zimbabwe, Harare, Zimbabwe)P-016 AN ANALYSIS OF HIV RISK FACTORS FROM POST-DONATIONCOUNSELLING RECORDST. Mapako, S. Shamu, A. Mvere, J. Parirewa (National Blood Service Zimbabwe, Harare, Zimbabwe)P-017 HIV-1 INCIDENCE IN BLOOD DONORS IN FRANCE BETWEEN 1992AND 2004: USE OF AN IMMUNOASSAY TO IDENTIFY RECENT INFECTIONSJ.P. Pillonel, F. Barin, S. Laperche, P. Bernillon, S. le Vu, B. Liandier, G. Andreu,J.C. Desenclos (Institut de Veille Sanitaire, Saint-Maurice, France)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 01.1TOPIC 01.2The posters areon display fromMonday - ThursdayP-018 DETECTION OF HIV-1 INFECTION IN BLOOD DONORS DURINGTHE IMMUNOLOGICAL WINDOW PERIOD BY THE IMPLEMENTATIONOF NUCLEIC ACID AMPLIFICATION TECHNOLOGYTopic 01.2.Blood Safety - TTD - HepatitisP.S.P. Scuracchio, A.G. Oliveira Filho, M.M.M. Lemos, M.C.C. Poli, R. Colella, M.M.C. Magri,N.J.F. Cavalcanti, E.C. Sabino, N.A. Salles, D.A.F. Chamone (Banco de Sangue de Sao Paulo,P-025 UTILITY OF SIMULTANEOUS DETECTION OF HEPATITIS C VIRUSANTIGEN AND ANTIBODIES IN HEMODIALYSIS PATIENTS.São Paulo, Brazil)J.C. Alados Arboledas, L. Calbo, S. de Tena, M.D. Lopez, J.L. de Francisco, C. de MiguelP-019 A STATISTICAL DONOR STATUS MODEL THAT MINIMISES THE RISKOF TRANSFUSION-TRANSMITTED HIV IN SOUTH AFRICAJ.P. Swanevelder, A. Heyns, R. Reddy, M.P. Busch (South African National Blood Service(Hospital Del Sas De Jerez, Jerez De La Frontera (Cadiz, Spain)P-026 INCIDENCE OF HBSAG, ANTI-HCV, ANTI-HIV ANTIBODIES IN BLOODDONORS IN OHRID MUNICIPALITY-REPUBLIC OF MACEDONIA(SANBS), Roodepoort (Johannesburg), South Africa)A.M. Aleksioska (Medical Center, Ohrid, Macedonia)P-020 COPREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS ANDHEPATITIS B VIRUS AMONG VOLUNTEER BLOOD DONORSP-029 EPIDEMIOLOGICAL INVESTIGATION OF TRANSFUSIONTRANSMISSIBLE INFECTIONS IN BULGARIA70B. Tiwari, P. Ghimire (Central Blood Transfusion Service, Kathmandu, Nepal)P-021 DOES A HIGH RESULT FOR A QUALITY CONTROL SAMPLE INDICATEA HIGHER FALSE REACTOR RATE IN THE ABBOTT PRISM ASSAYS USEDFOR BLOOD DONOR SCREENING?S. Bakalova, P. Kirova, A. Slivov (National Center of Hematology and Transfusion, Sofia, Bulgaria)P-030 THE ELEVATED ALANINE AMINOTRANSFERASE ANDHEPATITIS IN BLOOD DONORSE. Berberi, N. Borici, I. Seferi (National Blood Transfusion Centre, Tirana, Albania)71S.K. Walker, B. Francis, K. Smeh, S. Ismay, E.M. Dax, M. Karakaltsas (National SerologyReference Laboratory, Fitzroy, Australia)P-022 TRENDS IN INCIDENCE AND PREVALENCE OF MAJOR TRANSFUSION-TRANSMISSIBLE VIRAL INFECTIONS IN UKRAINIAN BLOOD DONORSP-031 HEPATITIS B IN BLOOD DONORS: ANALYSIS OF TESTING RESULTSIN THE PERIOD 2000-2005 IN BLOOD TRANSFUSION INSTITUTE NOVI SADB.N. Bujandric, B.S. Bogdanovic, M. Krga-Milanovic (Blood Transfusion Institute Novi Sad,Novi Sad, Serbia and Montenegro)M. Zadorin (Clinical research Institute, Kiev, Ukraine)P-023 C-REACTIVE PROTEIN IN HIV POSITIVE SUBJECTSF. Tarabadi, M. Mostakhdemi, M. Shaeigan, G. Babaei, M. Aghaeepour (Iranian BloodP-032 BENEFITS OF HCV ANTIGEN/ANTIBODY TESTING; A COMPARISONOF THE NEW ABBOTT MUREX HCV AG/AB COMBINATION ASSAY WITHANTIBODY ONLY TESTING AND A COMPETITOR HCV COMBINATION ASSAYTransfusion Organization R, Tehran, Iran)J. Burch, B. Rodgers, J. James, N. Napier, E. Furze, H. Trencher, S. Blincko, D. Trotter,P-024 SOME HEMATOLOGICAL PARAMETERS IN HIV-AIDSPATIENTS IN ILE-IFE, NIGERIAA.O. Adeloye, M.A. Durosinmi (Obafemi Awolowo University, Ile-ife, Nigeria)L. McBryne (Abbott Murex, Dartford, Kent, United Kingdom)P-033 HEPATITIS B VIRUS GENOTYPES, CORE PROMOTER AND PRE-COREMUTATIONS IN SCOTTISH BLOOD DONORSF. Davidson, C. Lycett, E. Erwin, J. Petrik, B. Dow (Scottish National Blood Transfusion Serv,Edinburgh, United Kingdom)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 01.2TOPIC 01.2P-034 DEVELOPMENT OF A NEW HEPATITIS B SURFACE ANTIGENASSAY WITH IMPROVED SENSITIVITY TO WILD TYPE AND VARIANTHBSAG FOR USE ON THE ORTHO CLINICAL DIAGNOSTICS VITROSECIQ IMMUNODIAGNOSTIC SYSTEMA. Diment, M. van Cleve, S. Son, H. Todd, C. Ching, B. Herring, J. Zheng, P. Kilmartin(Ortho Clinical Diagnostics, High Wycombe, United Kingdom)P-041 HBV-DNA AND HBCAB IGG IN BLOOD DONORS’ POPULATIONG.P. Ghiazza, E. Cesale Ros, G. Cornagliotto, G. Demarin, G. Demarchi, V. Gariglio,R. Marinoni, A. Martinelli, M. Ricotti, M. Trive, F. Eliantonio, A. Garofalo, G. Ghisetti, M. Lupo,F. Palazzo, M. Palazzo, B. Tea, L. Albin (A.S.O. OIRM-S.Anna, Torino, Italy)P-035 NAT HBV: TRANSFUSION SAFETY AND INFECTIVE RESIDUAL RISKM. D'Onofrio, L. Paesano, E. Perna, S. Formisano (AOU "Federico II", Napoli, Italy)P-042 PREVALENCE OF TRANSFUSION-TRANSMISSIBLE VIRAL INFECTIONIN FIRST-TIME BLOOD DONORS IN UNITED ARAB EMIRATESH. Gohar (Sharjah Blood Transfusion Center, Sharjah, United Arab Emirates)P-036 SERO-PREVALENCE OF ANTI- HBC AND ANTI-HBS IN ECONOMICIMMIGRANTS BLOOD DONORS IN A BLOOD TRANSFUSION CENTERV. Fakitsa, K. Kourenti, M. Papakonstantinou, J. Chaniotis, A. Flangini, G. Lyrakos, P. Karida,B. Restermont, S. Stefanakou, E. Mpotsaki, E. Theologou, K. Sofraniadou (District GeneralHospital of Nikea, Athens, Greece)P-043 REACTIVITY OF GENOTYPICALLY DISTINCT HEPATITIS BVIRUS SURFACE B VIRUS ANTIGENS (HBSAG) BY AN AUTOMATEDCHEMILUMINESCENT MICROPARTICLE IMMUNOASSAYN.S.L. Gonçales, M.C. Favarelli, P.A. Tonetto, R.G.F. Domínguez, J.B.A. Neto, F.L. Goncales(University of Campinas-UNICAMP, Campinas, Brazil)72P-037 EVALUATION OF THE INTRODUCTION OF OTHER MARKERS OFHEPATITIS B IN ROUTINE TESTINGK. Farmaki, C. Papa, I.T. Tzoumari, M.S. Sotiraki, A.C. Chrysanthou, M. Savvanos (GeneralHospital of Corinth, Corinth, Greece)P-044 EVALUATION THE PERFORMANCE OF QUANTITATIVE HEPATITIS BSURFACE ANTIGEN (HBSAG) BY AN AUTOMATED CHEMILUMINESCENTMICROPARTICLE IMMUNOASSAY, IN A BRAZILIAN BLOOD BANK.N.S.L. Gonçales, M.C. Favarelli, J.B.A. Neto, R.G.F. Domínguez, G.Q. Prado, R. Guedes(University of Campinas-UNICAMP, Campinas, Brazil)73P-038 A PROTEOMIC APPROACH IN HUMAN PLASMA TO INVESTIGATEPOTENTIAL BIOMARKERS FOR RESOLUTION OF ACUTE HEPATITIS CVIRUS INFECTIONC. Fournier-Wirth, S. Molina, D. Misse, F. Veas, P. Maurel, J. Coste, C. Fournier-Wirth(Etablissement Français du Sang, Montpellier, France)P-045 DEVELOPMENT OF HUMAN ANTI-CMV IGG ASSAYFOR THE ARCHITECT ANALYZERJ. Herzogenrath, I. Curdt, H. Christ, S. Bernhardt, R. Stricker, R. Stricker, M. Hausmann(Abbott GmbH & Co. KG, Wiesbaden, Germany)P-039 POLYMORPHISM OF THE HLA-DQ5 PROMOTER REGION INFLUENCESHUMORAL IMMUNE RESPONSE IN HBSAG VACCINATION AND SISTEMICLUPUS ERITHEMATOSUSV. Galvani, V. Dolzan, B. Vidan-Jeras (General Hospital Izola, Izola, Slovenia)P-040 PREVALENCE OF HBSAG, HCV, HIV AMONG POTENTIALVOLUNTARY NON-REMUNERATED BLOOD DONORS:TWELVE YEARS OF OBSERVATION (1994-2005)G. Garozzo, L. Morando, E. Parrino, G. Bussetti, P. Bonomo (Az. Ospedaliera Civile-Mparezzo,Ragusa, Italy)P-046 COMBINATION HEPATITIS C VIRUS ANTIGEN AND ANTIBODYIMMUNOASSAY AS A NEW TOOL FOR EARLY DIAGNOSIS OF INFECTIONG.C. Icardi, F. Ansaldi, C. Sticchi, C. Riccio, P. Lai, B. Bruzzone (University of Genoa, Genoa, Italy)P-047 THE FIRST NATIONAL REPORT OF TT( TRANSFUSION TRANSMITTED)VIRUS PREVALENCE IN DIFFERENT RACIAL GROUPS ADMITTED TO AHWAZTRANSFUSION SERVICE (IRAN) BY POLYMERASE CHAIN REACTION(PCR)M.A. Jalali Far, T. Zanieh, S.A. Emam, A.A. Pourfathollah (IBTO Research Center, Ahwaz, Iran)P-048 RELATION OF HEPATITIS C VIRUS (HCV) PREVALENCE, ABO AND RHBLOOD GROUPS AND OTHER RISK INDICATORS AMONG BLOODDONORS IN PORT HARCOURT, NIGERIAA. Jeremiah, B. Koate (Rivers State University of Sci & Tech, Port Harcourt, Nigeria)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 01.2TOPIC 01.2P-049 EVALUATION OF THE ENHANCED ARCHITECT ® ANTI-HCV ASSAYFOR DONOR SCREENINGG. Jonas, C. Beckert, C. Pelzer, M. Hausmann, H.-P. Kapprell (Abbott GmbH & Co. KG,Wiesbaden, Germany)P-058 HEPATITIS B VIRUS GENOTYPES AND SURFACE ANTIGEN VARIANTSIN FRENCH BLOOD DONORSS. Laperche, A. Sevant-Delmas, F. Bouchardeau, A. Girault, M. Mercier, F. Wind, M.H.Elghouzzi (INTS, Paris, France)P-050 A CASE CONTROL OF EPIDEMIOLOGICAL STATUS OF HEPATITIS BPOSITIVE CASES AMONG SHIRAZIAN BLOOD DONORS IN 2005L. Kasraian, A. Torab Jahromi, B. Farahangiz (IBTO Research Center, Shiraz, Iran)P-059 HEPATITIS C VIRAL INFECTION AMONG BLOOD DONORS - ROUTEOF TRANSMISIONI. Libek, D. Mijovic Nikolic (Clinical Hospital Zemun, Belgrade, Serbia and Montenegro)P-051 A SURVEY OF EPIDEMIOLOGICAL STATUS OF HEPATITIS CINFECTION AMONG SHIRAZIAN BLOOD DONORS IN 2005L. Kasraian, A. Torab Jahromi, B. Farahangiz (IBTO Research Center, Shiraz, Iran)P-060 SEROPREVALENCE OF VIRAL HEPATITIS A IN BLOOD DONORS INMARIBORB.M.V. Majcen Vivod, V.U.S. Urlep Salinovic, L. Lokar, B.B. Bizjak, I.M. Maracic (MariborTeaching Hospital, Maribor, Slovenia)74P-052 RISK BEHAVIOUR AND MOTIVATION OF HEPATITIS C CASES INBLOOD DONORS DURING 2005L. Kasraian, A. Torab Jahromi, B. Farahangiz (IBTO Research Center, Shiraz, Iran)P-053 EVALUATION OF THREE AUTOMATED ANALYZERS FOR VIRALSCREENING TESTS IN BLOOD DONORSM.J. Kim, D.H. Seo, K.N. Lee, H.R. Chung, D.J. Oh, Q. Park, N.S. Cho, Y.J. Cha, B.M. Shin(Korean Red Cross, Seoul, South-Korea)P-054 REACTIVATION OF HEPATITIS B VIRUS (HBV) IN A MULTI-TRANSFUSED PATIENT - CONFIRMATION BY LOOK-BACK STUDYUSING STORED SPECIMENSS Kino, Y. Tomoda, R. Endo, K. Shibusa, K. Ikuta, K. Sato, Y. Kogo, K. Morishita, S. Sato,T. Kato, H. Ikeda (Asahikawa Medical College Hospital, Asahikawa, Japan)P-061 HEPATITIS B AND MOLECULAR SCREENING ASSAYS: EVIDENCEFOR DIFFERENT OUTCOMES OF THIS INFECTIONM. Miceli, P. Iudicone, G. Isacchi, A. Agresti, M. Palange, A. Di Lorenzo, E. Mannella (AziendaOspedaliera S. Camillo-Forlanini, Rome, Italy)P-062 LOW RATE OF OCCULT HEPATITIS B VIRUS INFECTION AMONGANTI-HBC POSITIVE BLOOD DONORS IN YOUNG VOLUNTEER DONORSOF KOREAH.K. Min, C. Ihm, Y.G. Kim (Medical & Quality Management Office, Dae, Taejeon, South-Korea)P-063 INCREASED RISK OF HEPATITIS IN TAIWANESE MALECONSCRIPTEES WITH TATTOOSD.E.R. Ming-der (Yung-Kang Veterans Hospital, Yuan-kang City, Tainan, Taiwan)75P-055 CONFIRMATION FOR DISCOVERED HCV-AB TO VOLUNTEERDONORS IN THE DEPARTMENT FOR TRANSFUSION IN TETOVO DURING2005 BY USING PCR TECHNIQUEE. Kocovska, S. Kostovska, T.T. Timova (Tetovo Hospital, Tetovo, Macedonia)P-064 EVOLUTION OF HCV GENOTYPES IN LISBON REGIONAL BLOODCENTERM.I. Neves, J. Pereira, F. Ferreira, G. Sousa (Instituto Português do Sangue/CRSL, Lisboa, Portugal)P-056 PREVALENCE OF ANTI-HBC ANTIBODIES IN BLOOD DONORS INTHE SOUTH REGION OF POLANDJ. Kusmierczyk, J. Zatorska, J. Ras, A.S. Swierk, A. Glista, Z.B. Banach, A.G. Gasiorkiewicz,A.K. Kolbusz (Regional Blood Centre, Cracow, Poland)P-065 THE PREVALENCE OF HEPATITIS MARKERS AMONG THE PATIENTSWITH ALLT. Nurka, R. Çina, G. Kuli, S. Lako, V. Kardhashi (National Blood Transfusion Service,Tirana, Albania)P-057 OCCURRENCE OF HBSAG MUTANTS IN TWO KOREAN BLOOD DONORSS.Y. Kwon, K.W. Youn, O.J. Kwon, S.W. Ryu, E.J. Kim, U.S. Joung, M.W. Hwang, D.H. Seo,N.S. Cho (Korean Red Cross, Seoul, South-Korea)P-066 PREVALENCE OF HEPATITIS B SURFACE ANTIGEN (HBSAG)SEROPOSITIVITY IN SICKLE CELL ANAEMIA PATIENTS IN BENIN CITYE.C. Okocha, O.A. Ejele (Nnamdi Azikiwe University, Nnewi, Nigeria)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 01.2TOPIC 01.2P-067 SEROLOGICAL MARKERS FOR HBV INFECTION IN PORTUGUESEBLOOD DONORSM. Queiros, C. Carvalho, S. Neto, J. Leal, P Mota, C. Moreira, C. Castro (IPS Centro Regionaldo Porto, Porto, Portugal)P-075 SEROLOGICAL AND MOLECULAR MARKERS OF HEPATITIS B VIRUSIN SPANISH BLOOD DONORS: EVIDENCE OF OCCULT HEPATITIS BS. Sauleda, R.M. Maymo, M. Piron, D. Candotti, J.P. Allain, J.M. Hernandez, L.l. Puig,N. Casamitjana (Banc de Sang i Teixits, Barcelona, Spain)P-068 EVALUATION OF THE COBAS TAQSCREEN MPX TEST FOR THESIMULTANEOUS DETECTION OF HCV, HBV, HIV-1 GROUP M, HIV-1 GROUPO AND HIV-2. EXPERIENCE OF THE PORTO REGIONAL BLOOD CENTREL. Queiros, A. Tender, A. Aguiar, J. Azevedo (Centro Regional de Sangue do Porto, Porto,Portugal)P-076 EPIDEMIOLOGY OF HIV, HCV AND HBV INFECTIONS IN ABOUT 1.4MILLION VOLUNTARY, NON-REMUNERATED BLOOD DONATIONS OF THEGERMAN RED CROSS BLOOD DONOR SERVICE BADEN-WUERTTEMBERG-HESSEN IN THE YEAR 2005.E. Schellenberg, S. Findhammer, K. Frank, K. Gubbe, A. Karl, G. Geusendam, A. Vosberg,T. Dengler, U. Mayr-Wohlfahrt, M. Loehr, E. Gruenelt, M. Schmidt, W. Sireis, E. Seifried(Red Cross Blood Donor Service Ba-Wue-He, Frankfurt am Main, Germany)76P-069 THE IMPORTANCE OF NEOPTERIN TESTING FOR DIAGNOSTICSA. Ragimov, N. Dashkova, N. Nikishova (National Research Center of Surgery, Moscow,Russian Federation)P-070 ANTI-HBC TESTING OF BLOOD DONORS IN INDIA - VALUE ANDFOLLOW-UP STRATEGIES TO IMPROVE BLOOD SAFETY WITH MINIMUMLOSSESH. Ranganathan, J. Diment, K. Kulathu, N. Iyer (Global Hospital, Hyderabad, India)P-071 HCV INFECTION IN MULTI-TRANSFUSED AND PUTATIVEIMMUNO-COMPROMISED PATIENTS IN ARGENTINAM.C.R. Remesar, C. Gamba, S. Oknaian, M. Batalla, A.E. Del Pozo (Hospital de PediatriaGarrahan, Buenos Aires, Argentina)P-072 EVALUATION OF A NEW HCV COMBINATION ASSAY INTHE TAIWANESE BLOOD DONOR POPULATIONC. Rodgers, K.T. Lin, Y.W. Wu, Y.J. Lee, J.W. Chen, K.C. Lin (Abbott Laboratories, Dartford,United Kingdom)P-073 EVALUATION AND ONE-YEAR EXPERIENCE USING HCV NAT BASEDON NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION FOR SCREENINGBLOOD DONATIONS IN ARGENTINAE. Rodriguez, A. Guichón, M.E. Acevedo, L. Tomasone, R.J. Fernández (FundaciónHemocentro Buenos Aires, Buenos Aires, Argentina)P-074 MOLECULAR EPIDEMIOLOGY OF HCV IN PORTUGALS.S. Sargento, A.M. Almeida, C. Ferreira, E. Silva, P. Neto, C. Colaborators (Hospitais daUniversidade de Coimbra, Coimbra, Portugal)P-077 ANTI-HBC SCREENING OF BLOOD DONORS - A COMPARISON OFSEVEN ANTI-HBC SCREENING ASSAYSM.S. Schmidt, M.K. Hourfar, A. Vosberg, T. Dengler, K. Janetzko, K. Gubbe, K. Frank, A. Karl,M. Loehr, E. Gruenelt, W. Sireis, W.K. Roth, E. Seifried, G. Geusendam (German Red CrossInstitute Frankfurt, Frankfurt, Germany)P-078 IMPLEMENTATION OF ANTI-HBC-TESTING INTO BLOOD DONORSCREENING IN GERMANYM.S. Schmidt, M.K. Hourfar, A. Vosberg, T. Dengler, K. Janetzko, K. Gubbe, K. Frank, A. Karl,M. Loehr, E. Gruenelt, W. Sireis, E. Seifried, G. Geusendam (German Red Cross InstituteFrankfurt, Frankfurt, Germany)P-079 PREVALENCE OF ANTI-HBC ANTIBODIES IN SWISS BLOOD DONORS,A 4 MONTH SURVEY AT THE BLOOD TRANSFUSION CENTER BASELC. Stebler, L. Infanti, B. Eiche, M. Santoro, C. Doepfner, T. Rüefli, M. Rüesch (BloodTransfusion Center Basel, Basel, Switzerland)P-080 TRANSFUSION OF BLOOD FROM TWO DANISH BLOOD DONORSINFECTED WITH HEPATITIS B VIRUS ESCAPE MUTANTS – DIFFERENTOUTCOME IN 10 RECIPIENTSH. Ullum, L. Harritshøj, U. Wend, P. Platz, H. Ring-Larsen, E. Dickmeiss, W.G. Wolfram(Rigshospitalet, Copenhagen, Denmark)P-081 HCV GENOTYPE DISTRIBUTION AMONG NORTHEAST-THAI BLOODDONORSY. Urwijitaroon, C. Sengthong, S. Barusrux (Fac.Associated Medical Sciences, Khon Kaen,Thailand)77INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 01.2TOPIC 01.3The posters areon display fromMonday - ThursdayP-082 HBV DNA DETECTION IN HBSAG NEGATIVE/ANTI-CORE POSITIVEITALIAN FIRST TIME BLOOD DONORSP-089 ABILITY OF THE MACOPHARMA PRION CAPTURE (P-CAPTTM)FILTER TO REMOVE BRAIN PRPRES IN LEUKOREDUCED HUMAN RBCC. Velati, L. Romanò, L. Fomiatti, G. Cambiè, A. Zanetti (Dipartimento di MedicinaL.G. Gregori, B. Lambert, R. Rohwer (VA Medical Center, Baltimore, United States of America)Trasfusionale, Sondrio, Italy)P-083 TRANSFUSION-TRANSMITTED DISEASES AND THEIR FREQUENCYCHANGE BY THE YEARS IN BLOOD DONORS OF A HOSPITAL BLOODBANK IN GREECEP-090 IN VITRO EVALUATION OF RED CELL CONCENTRATES AFTERFILTRATION OVER THE NEW COMPOSAFE PR SYSTEM (SYSTEM FORPRION REDUCTION FROM LEUKOCYTE DEPLETED RCC)D. de Korte, R. Vlaar, C.W.N. Gouwerok, M. Kleine, S. Borghi, A.J. VerhoevenK. Ziciadis, F. Karabini, E. Xanthi, A. Tzolou, E. Chrisostomou, E. Zervou (University Hospital of(Sanquin Research, Amsterdam, Netherlands)Ioannina, Ioannina, Greece)P-084 THE STRATEGY FOR ELIMINATING HBV. TRANSMISSION THROUGHBLOOD TRANSFUSION IN UNITED ARAB EMIRATESP-091 DETECTION OF INFECTIOUS PRION IN BLOOD BY PROTEINMISFOLDING CYCLIC AMPLIFICATION TECHNOLOGY (PMCA)F. Leon, C. Segarra, J. Coste (Etablissement Français du Sang, Montpellier, France)78A.H.A. Al Amiri (Ministry of Health, Sharjah, United Arab Emirates)P-085 EVIDENCE ON ANTI-HBc REACTIVITY AMONG GREEK BLOODDONORS AND CORRELATION BETWEEN ANTI-HBc TITRE AND THEPRESENCE OF HBV DNAP-092 REMOVAL OF THE ENDOGENOUS TSE INFECTIVITY PRESENT INBLOOD USING PRDT TSE AFFINITY LIGANDS AND INTEGRATION OF THELIGANDS INTO THE MACOPHARMA P-CAPT(TM) FILTERG. Rohwer, L. Gregori, P. Gurgel, J. Lathrop, P. Edwardson, B. Lambert, R.G. Carbonell,79A. Varaklioti, I. Kalfa, A. Kapsalis, A. Kouramba, P. Kotsi, A. KarafoulidouS.J.B. Burton, D.J.H. Hammond (VA Maryland Health Care System, Baltimore,(2nd Blood Transfusion Center, Athens, Greece)United States of America)Topic 01.3P-093 WHAT DIFFERENCE IN PRION PROTEIN EXPRESSION ANDPROCESSING IN HUMAN BLOOD CELLS BETWEEN METHIONINE HOMO-ZYGOUS AND VALINE DONORS AT CODON 129 OF THE PRNP GENEBlood Safety - TTD - TSEsC. Segarra, S. Lehmann, J. Coste (Etablissement Français du Sang, Montpellier, France)P-086 HIGH RATE OF VCJD TRANSMISSION IN MICE BY INTRAVENOUSINOCULATION OF WHOLE BLOODL. Cervenakova, O. Yakovleva, C. McKenzie (J.H.Holland Laboratory, ARC, Rockville,United States of America)Topic 01.4.Blood Safety - TTD - West Nile VirusP-087 PERFORMANCE CHARACTERISTICS OF PALL’S ENHANCEDLEUKOTRAP AFFINITY PRION REDUCTION FILTERP-094 WEST NILE VIRUS (WNV) AND DENGUE VIRUS (DV) ARE LOW RISKFOR TRANSFUSION IN GHANAO. Coker, F. Andrade, S. Pesci, T. Budziak, F. Madraswalla, J. Peterson, B. Selman,J.P. Allain, C. Li, K. Danso, E. Addo-Yobo, S. Owusu-Ofori (University of Cambridge,G. DelGiacco (Pall Corporation, Port Washington, United States of America)Cambridge, United Kingdom)P-088 CREUTZFELDT-JAKOB DISEASE LOOK-BACK STUDY: AN UPDATEK.A. Dorsey, S. Zou, E.P. Notari, C.T. Fang, R.Y. Dodd, L.B. Schonberger (American RedP-095 MONITORING OF GENETIC VARIABILITY OF WEST NILE VIRUS INBLOOD DONOR SPECIMENS USING A MICROARRAY-BASED ASSAYCross, Rockville, United States of America)M. Rios, A. Grinev, S. Daniel, M. Laassri, V. Chizhikov, K. Chumakov, I.K. Hewlett(CBER/FDA, Bethesda, United States of America)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 01.5The posters areon display fromMonday - ThursdayTOPIC 01.6The posters areon display fromMonday - ThursdayP-096 RESULTS OF NAT- AND ANTIBODY-SCREENING FOR WEST NILEVIRUS IN GERMANY AND AUSTRIAM.K. Hourfar, C. Pfleiderer, J. Eckert, A. Themann, E. Seifried, M. Nuebling, M. Schmidt(German Red Cross, Institute Frankfurt, Frankfurt, Germany)P-104 INACTIVATION OF CHIKUNGUNYA VIRUS IN PLASMA AND PLATELETSUSING HELINX TECHNOLOGY, AS UTILIZED IN THE INTERCEPT BLOODSYSTEML. Corash, L. Sawyer, K. Dupuis, A. Sampson-Johannes, T. Dubensky, D.L. Vanlandingham,K. Tsetsarkin, S. Higgs (Cerus Corporation, Concord, United States of America)P-097 PROTECTIVE ROLE OF NATURAL ANTIBODIES IN WNV INFECTION:IN VITRO INFECTIVITY OF WNV ID NAT REACTIVE PLASMAS CONTAININGSPECIFIC ANTIBODIES (IGM AND/OR IGG)M. Rios, S. Daniel, S.L. Stramer, S. Caglioti, O. Wood, I.K. Hewlett (CBER/FDA, Bethesda,United States of America)Topic 01.6.Blood Safety - TTD - Nucleic Acid Amplification Technology (NAT)P-098 YIELD OF MINIPOOL AND INDIVIDUAL DONATION NUCLEIC ACIDAMPLIFICATION TESTING FOR WEST NILE VIRUS RNA IN UNITED STATESBLOOD DONORS, 2003-2005L. Stramer, G.A. Foster, J.P. Brodsky, S.G. Caglioti, D.M. Strong (American Red Cross,Gaithersburg, United States of America)P-105 THE CONTRIBUTION OF NUCLEID ACID TESTING (NAT) IN BLOODTRANSFUSION SAFETY. DETECTION OF FOUR NAT HBV DNA POSITIVE,HBS AG NEGATIVE IN SINGLE BLOOD DONATIONSC. Politi, V. Dimitra, L. Kavallierou, V. Triantaltillou, (G.Gennimatas Hospital, Athens, Greece)80Topic 01.5.Blood Safety - TTD - Emerging PathogensP-106 IMPLEMENTATION OF A POST-DONATION TRIPLEX HIV/HBV/HCVNAT IN A TEACHING HOSPITAL TRANSFUSION MEDICINE UNIT INKUMASI, GHANAJ.P. Allain, S. Owusu-Ofori, G. Bedu-Addo, D. Candotti, A. Nsiah-Asare, F. Sarkodie(University of Cambridge, Cambridge, United Kingdom)81P-100 IMMUNOGLOBULIN G ANTIBODIES AGAINST ENVIRONMENTALMOULDS IN A NORWEGIAN HEALTHY POPULATION SHOWS A BIMODALDISTRIBUTION FOR ASPERGILLUS VERSICOLORG. Hetland, B. Rydjord, V. Svenningsen, H.G. Wiker (Ulleval University Hospital, Oslo, Norway)P-107 PREVALENCE OF HCV AND HGV INFECTION AMONG THALASSEMICS,HEMOPHILICS, AND HEMODIALYSIS PATIENTS WITH CHRONIC HEPATITISS. Amini Kafi-abad, A. Talebian, S. Samiee, F. Ranjbar Kermani, M.M. Moghtadaie,F. Ferdowsian, N.P. Pasandideh, Z. Ataie, M. Kavari, A. Gharehbaghian (Research Center ofIranian Blood Transfusion, Tehran, Iran)P-101 THE NEEDS OF LOOK BACK ON SCREENING OF HUMAN T CELLLYMPHOTROPIC VIRUS TYPE 1 AND 11 (HTLV I / II) AMONG BLOODDONORS IN SAUDI ARABIAS. ibrahim Hindawi, G.A. Damanhouri, I.S. Kawashti, I. Felemban, M. Alshawa, M. Khanbashi(KAUH, Jeddah, Saudi Arabia)P-108 HEAD TO HEAD COMPARISON OF TWO NEW AUTOMATED NATSYSTEMS CHIRON PROCLEIX TIGRIS SYSTEM VS ROCHE COBAS S 201A. Assal, V. Barlet, C. Cornillot, M. Deschazeaux, I. Dupont, P. Gallian, C. Guitton, P. Morel,G. Andreu (EFS Centre Atlantique, Tours, France)P-102 TRANSFUSION-TRANSMITTED HUMAN PARVOVIRUS B19 INFECTIONIN A THALASSAEMIA PATIENTSM. Mahmoodian Shooshtari, M. Nabi Foroghi, Z. Sharifi (Research Center of IBTO, Tehran, Iran)P-109 WINDOW PERIOD OF HIV INFECTION IN A REPEAT BLOOD DONORL. Barea, R. Gonzalez, J.l. Bueno, L. Muñoz, A. Garcia, E. Castro (Centro de Transfusión CruzRoja Española, Madrid, Spain)P-103 IN VITRO EVALUATION OF CELL-MEDIATED IMMUNITY TO EPSTEINBARR VIRUSM. Mahmoodian Shooshtari, M. Bani Talebi Dehkordi, Z. Sharifi (Research Center of IBTO,Tehran, Iran)P-110 SEROLOGICAL AND MOLECULAR CHARACTERISTICS OF HBV DNAPOSITIVE/ HBSAG NEGATIVE BLOOD DONORSE. Brojer, M. Letowska, G. Liszewski, P. Grabarczyk, M. Mikulska (Institute of Haematologyand Blood Transfusion, Warsaw, Poland)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 01.6TOPIC 01.6P-111 HIGH THROUGH-PUT, INDIVIDUAL DONOR TESTING (IDT) USING THEPROCLEIX TIGRIS SYSTEM: A 5-MONTH EXPERIENCER. Cable (Western Province Blood Transfusion Servi, Cape Town, South Africa)P-119 PERFORMANCE CHARACTERISTICS OF A NEW MULTIPLEX NATSCREENING TEST FOR HBV, HCV AND HIV: THE COBAS TAQSCREEN MPXTEST ON THE COBAS S 201 SYSTEMS. Herman, Y. Ohhashi, E. Kyger, H. Halait, M. Wiedmann, M. Zauke, L. Pietrelli(Roche Molecular Systems, Inc., Pleasanton, United States of America)P-112 INTERPRETATION OF HBV NAT RESULTS IN HEALTHY SUBJECTSG. Cambie, A. Degiuli, S. Conca, E. Parabiaghi, L. Vignati, M.L. Nardella, M. D'Agostino,F. D'Agostino (Azienda Ospedaliera di Lodi, Lodi, Italy)P-113 ACUTE PHASE AND OCCULT HBV INFECTIONS WITH MULTIPLEMUTATIONS IN THE SURFACE ANTIGEN “A” DETERMINANT DETECTEDBY HBV/HCV/HIV-1 TMA SCREENING OF SPANISH BLOOD DONORSE. Castro, P. Torres, R. González, A. Ontañón, L. González Ponte, M. Sedeño,J.M. Echevarría, M. Koppelman, H. Zaaijer, J.M. Hernández, N. Lelie (Centro de TransfusiónCruz Roja Española, Madrid, Spain)P-120 EXPERIENCE OF A LARGE GERMAN RED CROSS BLOOD DONORSERVICE WITH NAT-TESTING: RESULTS OF SCREENING MORE THAN 9MILLION BLOOD DONATIONS FOR HIV-1, HCV AND HBVM.K. Hourfar, W.K. Roth, A. Themann, K. Gubbe, U. Mayr-Wohlfart, E. Seifried, M. Schmidt(German Red Cross, Institute Frankfurt, Frankfurt, Germany)P-121 SIMULTANEOUS SCREENING FOR HCV, HIV-1 AND HBV IN BLOODDONATIONS WITH THE FULLY AUTOMATED SYSTEMP. Iudicone, M. Miceli, A. Agresti, M. Palange, A. Di Lorenzo, S. Berardini, C. Amedeo,A. Tudisco, R. Colaceci, E. Mannella (A.O. S.Camillo-Forlanini, Rome, Italy)82P-114 ANALYTICAL PERFORMANCE OF PROCLEIX DUPLEX AND TRIPLEXTMA ASSAYS IN AN HISTORICAL PROFICIENCY PROGRAMMEA. van Drimmelen, P.N. Lelie, D. Jardine (AcroMetrix Europe, Alkmaar, Netherlands)P-115 REAL- TIME PCR ASSAY BY LIGHT CYCLER FOR THE DETECTIONOF PLASMODIUM SPECIESS. Dupont, A. Berry, J.M. Fondere, C. Segarra, C. Maugard, T. Levayer (EFS PyrénéesMediterranée, Montpellier, France)P-116 AN HCV SEROCONVERSION DETECTED USING A NAT TESTPROCEDURE DURING SCREENIG OF BLOOD AND BLOOD COMPONENTSIN A DONOR POPULATION IN ITALIAN CAMPANIA REGIONC. de Felice, C. de Felice, F. Morelli, A. Miscioscia, D. Ametrano, C. Fasulo, S. Guardascione,M. Macrì (A.O.R.N. A. Cardarelli, Naples, Italy)P-122 QUALITY CONTROL PROGRAMME FOR NUCLEIC ACID SCREENINGIN BLOOD SERVICE LABORATORIESK. Jardine, B.R.J. Dent, T. Pham, W. Dimech, E.M. Dax (National Serology ReferenceLaboratory, Fitzroy, Australia)P-123 EVALUATION OF THE COBAS TAQSCREEN MULTIPLEX TEST ANDS201 AUTOMATED NAT PLATFORM IN THE SCOTTISH NATIONAL BLOODTRANSFUSION SERVICE.L. Jarvis, A. Cleland, T. Dunsford, K. Mulligan, J. Petrik (SNBTS, Edinburgh, United Kingdom)P-124 HBV AND HCV INFECTED BLOOD DONATIONS INTERDICTED BYINDIVIDUAL DONATION NUCLEIC ACID TESTING (ID-NAT) IN LITHUANIAV. Kalibatas, J. Irzikeviciene, N. Lelie (National Blood Centre, Vilnius, Lithuania)83P-117 INDIVIDUAL HEPATITIS B VIRUS NUCLEIC ACID TESTING (HBV-NAT)ON 61.825 BLOOD DONATIONS IN MADRID, SPAINR. Gonzalez, J.M. Echevarría, A. Avellon, L. Barea, J.L. Bueno, E. Castro (Centro deTransfusión Cruz Roja Española, Madrid, Spain)P-125 ANALYTICAL AND CLINICAL PERFORMANCE OF THE PROCLEIXULTRIO HIV-1/HCV/HBV ASSAY IN LOW VIRAL LOAD SAMPLESA. Katsoulidou, Z. Moschidis, V. Sypsa, M. Chini, G. Papatheodoridis, N. Tassopoulos,K. Mimidis, A. Karafoulidou, A. Hatzakis (Athens University Medical School, Athens, Greece)P-118 EVALUATION OF SINGLE NAT IN A NATIONAL BLOOD SERVICEA. Gottreich, B. Cohen, L. Shvartz, V. Arad, O. Frenkel, V.B. Yahalom, E. Shinar (Magen DavidAdom, Tel-hasomer, Israel)P-126 THE IMPORTANCE OF IMPLEMENTING THE HBV DNA SCREENING USINGNAT TESTING FOR TRANSFUSIONAL VALIDATION IN A HIGH HBV RISK AREAM. Manca, A. Spano, R. Occhineri, F. Fadda, P. Manchia, F. Lumbau, P. Murgia, G. Tala,G. Sanna, G. Cossu (AUSL 1 - Sassari, Sassari, Italy)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 01.6TOPIC 01.7The posters areon display fromMonday - ThursdayP-127 HCV, HIV-1, HBV MOLECULAR SCREENING FOR BLOOD DONATION:FROM SEMI-AUTOMATE SYSTEMS TO THE FULLY AUTOMATEDINSTRUMENT PLATFORME. Mannella, P. Iudicone, M. Palange, A. Agresti, R. Colaceci, A. Tudisco, C. Amedeo,S. Berardini, M. Miceli (Azienda Ospedaliera S. Camillo-Forlanini, Rome, Italy)P-135 NAT SCREENING FOR HIV/HCV (PROCLEIX, CHIRON) IN SINGLEDONATION IN COIMBRA, PORTUGAL (2000-2006)J.N. Teixeira, F. Henggeler, R. Diniz, B. Caldeira, N. Mateus, H. Gonçalves (Portuguese BloodInstitute, Coimbra, Portugal)P-128 COMPARISON OF THE CHIRON PROCLEIX ® TIGRIS ® ANDROCHE COBAS S 201 NUCLEIC ACID TESTING (NAT) SYSTEMS FORSIMULTANEOUS DETECTION OF HIV/HCV RNA AND HBV DNAA.R. Margaritis, S. Brown, C.R. Seed, P. Kiely, B. D'Agostino, C.K. Lin, A.J. Keller(Australian Red Cross Blood Service, Perth, Australia)P-136 EVALUATION OF ACCEPTED BLOOD DONORS WITH A MULTIPLEXNUCLEIC ACID TEST (NAT)AT CHIANG MAI UNIVERSITY HOSPITAL,THAILANDL.T. Thaikruea, N.N. Niwes, S.T. Thongsawat, L.N. Litrakoon, L.F. Fonksatidkil, P.S. Sompan,A.H. Heaton, D.N. Nichols, K.N. Nelson (Department of Community Medicine, Chiang Mai50200, Thailand)P-129 BENEFITS OF THE TEST CHIRON PROCLEIX ULTRIO ASSAYHCV/HIV/HBB IN THE IMPROVEMENT OF BLOOD SAFETYF. Morelli, C. de Felice, M.M. Macrì (A.O.R.N. A. Cardarelli, Naples, Italy)P-137 NAT SCREENING FOR HCV, HIV AND HBV ON BLOOD DONATIONS IN ITALYC. Velati, L. Fomiatti, L. Romanò, L. Baruffi, A. Zanetti (Dipartimento di Medicina Trasfusionale,Sondrio, Italy)84P-130 AUTOMATED HANDLING OF LARGE POOLS FOR MULTIPLEX NATSCREENING OF HCV, HIV-1 (GROUPS M & O), HIV-2, AND HBV ON THECOBAS S 201 SYSTEMJ. Nunes, H. Rothe, C. Parkhouse, I. Trefil, J. Weinberger, G. Velasco-Corpuz, J. Sopher(Roche Molecular Systems, Pleasanton, United States of America)P-138 ANALYTICAL PERFORMANCE CHARACTERISTICS OF THE PROCLEIXULTRIO HIV-1/HCV/HBV ASSAY ON TIGRIS IN A LARGE SCALE EVALUATIONOF INDIVIDUAL DONATION NAT IN SOUTH AFRICAM. Vermeulen, W. Sykes, L. Gaggia, N. Lelie, R. Reddy, E. Kuun, A. Neil(South African National Blood Service (SANBS), Johannesburg, South Africa)85P-131 HCV, HIV, HBV GENOME DETECTION IN BLOOD DONORS WITH THEUSE OF A NEW MOLECULAR ASSAYE. Perna, M. D'Onofrio, L. Paesano, G. Ciardiello, E. D'Agostino, S. Formisano(AOU Federico II, Naples, Italy)P-139 DETECTION OF BRUCELLA AMONG VOLUNTARY BLOOD DONORSIN TURKEY BY USING NEW REAL TIME PCR METHODT. Yavuz, D. Kaya (Duzce University Medical School, Duzce, Turkey)P-132 HBV DNA TESTING IN BLOOD DONORS REACTIVE FOR ANTI HBCANTIBODY - A PILOT STUDY FROM SOUTH INDIAH. Ranganathan, N. Iyer, D. Saranath, K. Kulathu (Global Hospital, Hyderabad, India)P-140 DRUG RESISTANCE INHIBITION IN KEUKEMIC CELLS BYANTISENSE OLIGONUCLEOTIDESF. Nadali, A.A. Pourfatollah, K. Alimoghaddam (School of Medicine, Isfahan, Iran)P-133 PREVALENCE OF CMV-DNA IN IRANIAN HEALTHY BLOOD DONORSF. Ranjbar Kermani, S. Amini, A. Talebian, S. Samiei, F. Ferdowsian, M. Sobhani (Iranian BloodTransfusion Research Center, Tehran, Iran)Topic 01.7.Blood Safety - TTD - Bacterial ContaminationP-134 EARLY EXPERIENCE WITH INDIVIDUAL DONATION HBV/HCV/HIV-1NUCLEIC ACID AMPLIFICATION TESTING (ID-NAT) IN THE SOUTH AFRICANNATIONAL BL0OD SERVICEW. Sykes, M. Vermeulen, A. Neill, E. Kuun, N. Lelie, J. Mitchell, L. Pillay, R. Reddy(South African National Blood Service, Pinetown, South Africa)P-141 ROUTINE BACTERIAL MONITORING OF PLATELETS AT THE WELSHBLOOD SERVICER. Ahya, G. Rowe, M. Hayward, S. Pearce, R. Jones (Welsh Blood Service, SouthGlamorgan, United Kingdom)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 01.7TOPIC 01.7P-142 DETECTION OF MICROBIAL CONTAMINATION OF POOLED WHOLEBLOOD-DERIVED PLATELET-RICH PLASMA PLATELETS IN THE GREATESTBLOOD BANK ROUTINE OF LATIN AMERICAG.A.O.B. Barna, R.K.F. Guillaume, C.R. Kamakura, S.R. Matana, M.V. Moço, P.C. Sierra,S.M. Winkaler, P.E. Dorlhiac-Llacer, D.A.F. Chamone (Pro-Sangue Sao Paulo Blood Center,Sao Paulo, Brazil)P-150 EVALUATION AND ROUTINE PERFORMANCE OF A "BEST PRACTICE"DONOR ARM DISINFECTION PROCEDURE: CHLORAPREP ®C.P. McDonald, C. Biggs, B. Lees, N. Beckman, J. Kellington, G. Evans (National BloodService, London, United Kingdom)86P-143 BACTERIA RAPID DETECTION IN NON LEUCOCYTE REDUCEDWHOLE BLOOD PLATELETSI. Besson Faure, I. Besson Faure, A. Raimondo, A.E. Houlle Declomesnil (Hemosystem,Marseille, France)P-144 AUTOMATION OF THE SCANSYSTEM PROCESSI. Besson Faure, R. Chollet, A.E. Houlle Declomesnil (Hemosystem, Marseille, France)P-145 PREVENTION OF TRANSFUSION-TRAMSMITTEDBACTERIAL INFECTIONSE.K. Klausa, B.M. Muzala - Bogdan, J.K. Korsak (Regional Centre of Transfusion Medicine,Wroclaw, Poland)P-151 BACTERIAL CONTAMINATION OF BLOOD COMPONENTSS.M. Milosavljevic, A.M. Andjelic, N.N. Nedeljkovic, V.P. Poprzen, D.V. Vidanovic(National Blood Transfusion Institute, Belgrade, Serbia and Montenegro)P-152 PLATELET BACTERIA SCREENING - HOW TO APPLY THE DIFFERENTAPPROACHES?Th. Montag-Lessing (Paul Ehrlich Institute, Langen, Germany)P-153 REDUCTION OF BACTERIAL LOAD DURING PREPARATION OFPOOLED PLATELET CONCENTRATES FROM BUFFY COATS EXPLAINS ASIMILAR CONTAMINATION RATE AS IN APHERESIS PLATELETSH. Müller, A. Bayer, H. Mohr (DRK-Blutspendedienst NSTOB, Springe, Germany)87P-146 COMPARISON OF TWO SYSTEMS (BACT/ALERT VS SCANSYSTEM)FOR ROUTINE BACTERIAL DETECTION IN T-SOL BUFFY COAT PLATELETCONCENTRATESM. Lambermont, R. de Meuter, D. Sondag (Service du Sang, Belgian Red Cross, Brussels, Belgium)P-147 VALUE OF ANAEROBIC CULTURE IN BACTERIAL SURVEILLANCEPROGRAMME FOR PLATELET CONCENTRATESC. Lee, C.K. Lee, P.L. Ho, W.C. Tsoi, C.K. Lin (HK Red Cross Blood Transfusion Service,Hong Kong, China)P-154 GROWTH PROPERTIES OF DIFFERENT BACTERIA STRAINS INPLATELET CONCENTRATES AND CONSEQUENCES FOR THEAPPLICATION OF SCREENING METHODSS.B. Nicol, M. Schmidt, J. Brachert, Th. Montag (Paul Ehrlich Institut, Langen, Germany)P-155 DETECTION OF BACTERIAL CONTAMINATION IN PLATELETCONCENTRATES: A REAL TIME DNA POLYMERASE CHAIN REACTIONTEST IS FEASIBLE BEFORE TRANSFUSIONP. Pagliaro, C. Glingani (Ospedale Carlo Poma, Mantova, Italy)P-148 DETECTION OF BACTERIAL CONTAMINATION IN RED CELL UNITSUSING THE PALL ENHANCED BACTERIAL DETECTION SYSTEMC.P. McDonald, K. Goodhand, K. Wilkins, J. Colvin (National Blood Service, London,United Kingdom)P-149 ARE THE BACT/ALERT AND PALL ENHANCED BACTERIAL DETECTIONSYSTEMS SUITABLE FOR SCREENING PLATELET ADDITIVE SOLUTION(PAS) PLATELET CONCENTRATES?C.P. McDonald, J. Sapsford, J. Colvin, C. Biggs, K. Goodhand (National Blood Service,London, United Kingdom)P-156 DEVELOPMENT OF A REAL-TIME POLYMERASE CHAIN REACTION FORTHE DETECTION OF GRAM-POSITIVE BACTERIA IN PLATELET CONCENTRATESM. Piron, N. Casamitjana, M. Bes, L.l. Puig, S. Sauleda (Banc de Sang i Teixits, Barcelona, Spain)P-157 EVALUATION OF THE CORRECT USE OF VIRKON DISINFECTANT INREDUCING BACTERIAL CONTAMINATION OF PLATELETS COMPONENTSPREPARED IN TEHRAN BLOOD CENTER WITHIN SECOND HALF OF 2005M Sadeh (Islamic Azaad University, Tehran, Iran)P-158 NOVEL APPLICATION WITH QUENCHING DYE IMPROVES OPTIMIZEDSCANSYSTEMTM FOR RAPID BACTERIAL DETECTIONM.S. Schmidt, A. Themann, S.-B Nicol, T. Montag, W.K. Roth, E. Seifried, M.K. Hourfar(German Red Cross Institute Frankfurt, Frankfurt, Germany)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSION

PostersISBT2006PostersTOPIC 01.8The posters areon display fromMonday - ThursdayTOPIC 02.1The posters areon display fromMonday - ThursdayP-159 DEATH AFTER TRANSFUSION OF PLATELET CONCENTRATECONTAMINATED WITH KLEBSIELLA PNEUMONIAEP-166 MEASUREMENT OF P. VIVAX PARASITEMIA.I.B. Suh, S.W. Ryu, C.S. Lim, C.K. Lee, Y. Cho, Y.K. Kim, K.N. Lee (Kangwon Natl. Univ,M.S. Schmidt, S.-B Nicol, M.K. Hourfar, W. Sireis, W. Weichert, E. Seifried, T. MontagMedical Science Inst, Chunchun, South-Korea)(German Red Cross Institute Frankfurt, Frankfurt, Germany)Topic 02.1.88Topic 01.8.Blood Safety - TTD - Parasites and ProtozoaP-160 IMPLEMENTATION OF CHAGAS DISEASE SCREENING IN FRENCHBLOOD DONORSA. Assal, C. Cornillot, N. Baudoncourt, O. Garraud, G. Andreu (EFS Centre Atlantique,Tours, France)P-161 CORRELATION BETWEEN THE SPECIFIC SERUM IMMUNOGLUBULINES( IGE,IGG) WITH EOSINOPHILIA IN CYSTIC HYDATIDOSIS PATIENTSZ. Ghayour (School of Medicine, Isfahan, Iran)P-162 PREVALENCE OF TRYPANOSOMA CRUZI INFECTION AFTERSCREENING OF BLOOD DONORS AT RISK IN NORTHEAST SPAINM. Piron, R.M. Maymo, J.M. Hernandez, M. Verges, M. Portus, R. Fisas, N. Casamitjana,J. Munoz, J. Gascon, L.l. Puig, S. Sauleda (Banc de Sang i Teixits, Barcelona, Spain)P-163 EFFICACY OF THE LEUKOREDUCTION TO REDUCE THE RISK OFLEISHMANIA INFANTUM TRANSFUSION TRANSMISSION. STUDY IN BLOODDONORS FROM THE MAJORCA ISLAND (BALEARIC ISLANDS, SPAIN)C. Riera, P. Lopez-Chejade, R. Fisa, T. Serra, M. Sedeno, T. Jimenez, E. Girona, M. Mascaro,J. Muncunill, M. Udina, A. Forteza, M. Gallego, J. Carrio, M. Portus (Universitat deBarcelona/Facultad de Far, Barcelona, Spain)P-164 SERO - EPIDEMIOLOGICAL STUDY OF CHAGAS’ DISEASEAND SYPHILIS IN THE CENTENNIAL PROVINCIAL HOSPITAL ROSARIOARGENTINAP. Sciarratta, M.A. Operto, J. Valverde (Fac. Cs. Bioquímicas y Farmacéuticas, Rosario, Argentina)P-165 EVALUATION OF THE ARCHITECT SYPHILIS TP ASSAY IN A SWISSBLOOD BANK- A PROSPECTIVE COMPARISON WITH THE SERODIA TPPAASSAYRed Cells - ImmunohaematologyP-168 DIFFICULTIES IN THE DETECTION OF KIDD ANTIBODIESS. Adam, V. Kretschmer (Institut of Transfusion Medicine, Marburg, Germany)P-169 AN ACUTE HAEMOLYTIC TRANSFUSION REACTION (AHTR)DUE TO AN UNDETECTABLE ANTI-JKAS. Adam, G. Bringmann, M. Bieringer, H.J. Heyers, V. Kretschmer (Institut of TransfusionMedicine, Marburg, Germany)P-170 FLOW CYTOMETRY AND PANEL REACTIVE ANTIBODY METHODSFOR DETECTING ANTI-HLA CLASS-I ANTIBODIESM. Aghaeipour (Iranian Blood Transfusion Research Cente, Tehran, Iran)P-171 DETERMINATION OF A DISSOCIATION PARAMETER IN RED BLOODCELLS AGGLUTINATED BY MONOCLONAL ANTIBODY ANTI-A USING ALASER BACKSCATTERING TECHNIQUEL.V. Altube, P. Foresto, B. Riquelme, A. Marenzana, J. Valverde (UNR, Rosario, Argentina)P-172 IL-8 & TNF-A LEVELS IN DUFFY NEGATIVE BLOOD DONORSO.A. Asher, C. Pariente, H. Kanety, S. Gelman, E. Shinar, V. Yahalom (Blood Services Center,Magen David Adom, Ramat Gan, Israel)P-173 FIRST FINDING OF GY(A-) PHENOTYPE IN THE CZECH REPUBLICSINCE ITS DISCOVERY IN 1967. POSSIBLE RELATIONSHIP TO ORIGINALPROBANDS FOUND IN THE USA IN 1967-1968H. Banzetova, D. Bystricka, O. Cerna, M. Pisacka, J. Poole, J. Svobodna, P. Trubac(Hospital of Ceske Budejovice, Ceske Budejovice, Czech Republic)P-174 ABO BLOOD GROUP GENOTYPING IN CROATIAN BLOOD DONORSJ. Bingulac-Popovic, V. Drazic, J. Culej, I. Babic, Z. Hundric-Haspl, C. Maglov, M. Balija,I. Jukic (Croatian Institute of Transfusion Medic, Zagreb, Croatia)89C. Stebler, L. Infanti, M. Santoro, T. Rüefli, C. Doepfner, M. Rüesch (Blood Transfusion CenterBasel, Basel, Switzerland)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 02.1TOPIC 02.1P-175 ABO BLOOD GROUPS AND RISK OF THROMBOSISP-183 A NOVEL DO ALLELE COMBINATION NAMELY DOB-WLJ. Bingulac-Popovic, V. Drazic, I. Babic, J. Culej, M. Tomicic, M. Balija, I. JukicL.C. Castilho, W. Baleotti Jr, M.E. Reid, M. Rios, J. Pellegrino Jr, A. Fabron Jr, F. Costa(Croatian Institute of Transfusion Medic, Zagreb, Croatia)(Unicamp, Campinas, Brazil)P-176 THE COMPUTER COSSMATCH: THE VALIDATION AND 1ST.IMPLEMENTATION IN CZECH REPUBLICP-184 EVALUATION OF THE GALILEO AUTOMATED BLOOD BANK SYSTEMFOR WEAK D DETECTION ON BLOOD DONORSM. Bohonek, D. Horcickova, M. Blazkova, T. Lejdar, P. Svenda (Central Military Hospital,M. Chabert, M.J. Rodrigues, C. Cordeiro, P. Fernandes, V. Paquete, M. Rodrigues, J. Pereira,Prague, Czech Republic)P. Mendonca (Instituto Português do Sangue, Lisboa, Portugal)P-177 UNEXPECTED RESULTS IN BLOOD GROUP SEROLOGY:THE CHALLENGE OF IMMUNOHAEMATOLOGICAL PUZZLINGP-185 THE VALUE OF ELUTION TEST USING GEL MICROCOLUMNAGGLUTINATION METHOD FOR ACID ELUATESA.G. van den Bos, B.D. Steetzel, C. Mouton, S. Kapteijns-van Kordelaar, V.M.J. NovotnyP. Chalkia, E. Kostopoulou, A. Tsoukala, V. Avgoloupi, P. Didoudi, S. Intzepeli, V. Bakaloudi,(Radboud University Medical Center, Nijmegen, Netherlands)E. Ntinopoulou, H. Hassapopoulou, E. Hassapopoulou (Ahepa Hospital, Thessaloniki, Greece)90P-178 ASSESSMENT OF IMMUNOLOGICAL PROPERTIES OF MIRASOLPATHOGEN REDUCTION TREATED RED BLOOD CELLSK.A. Buytaert-Hoefen, H. Reddy, S. Doane, R. Goodrich (Navigant Biotechnologies,P-186 MOLECULAR GENETIC ANALYSIS AND FREQUENCY SURVEYOF H DEFICIENT PHENOTYPE IN FUJIAN POPULATIONQ. Chi, Y.J. Guo, W. Tang, Y. Chen, C.Q. Wang, G.L. Chen (Fujian Blood Center, Fuzhou, China)91Lakewood, Colorado, United States of America)P-179 EXPRESSION OF ABH ANTIGENS IN PATIENTS WITH PRECANCE-ROUS AND CANCEROUS ORAL LESIONSP-187 PATERNAL RHD ZYGOSITY: SEROLOGY VERSUS GENETIC ANALYSISM. Christiansen, W. Kjellberg, O.B. Petersen, N. Grunnet (Aarhus University Hospital, AarhusN, Denmark)C. Campi, S. García Borrás, L. Racca, A. Racca, C. Cotorruelo, C. Biondi (UniversidadNacional de Rosario, Rosario, Argentina)P-180 HIGH-THROUGHPUT DNA ANALYSIS FOR RED BLOOD CELLANTIGENS FACILITATES THE TRANSFUSION SUPPORT WITHANTIGEN-MATCHED BLOOD IN POLYTRANSFUSED PATIENTSL.C. Castilho, J. Pellegrino Jr, M. Mota, G. Hashmi, S. Shariff, M. Seul, F. Costa (Unicamp,Campinas, Brazil)P-181 DNA ANALYSIS IN A MICROARRAY AS A SUBSTITUTE FORDOMBROCK TYPING: A NOVEL ALLELE IN BRAZILIANSL.C. Castilho, W. Baleotti Jr, K. Ribeiro, D.C. Credidio, G. Hashmi, M.E. Reid(Unicamp, Campinas, Brazil)P-182 RHD GENOTYPING OF BLOOD DONORS MAY PREVENTALLOIMMUNIZATION BY D ANTIGENL.C. Castilho, T. Paixao, C. Barros, D.C. Credidio, K. Ribeiro, F. Costa(Unicamp, Campinas, Brazil)P-188 ACHIEVING REDUCED CYCLE TIMES FOR PRETRANSFUSIONTESTING WITH TEST ORDER ENTRY MODIFICATIONS ON AUTOMATIONC. Colavecchia, A. Coovadia, S. South (Sunnybrook & Womens College HS Centre, Toronto,Canada)P-189 MOLECULAR BACKGROUNDS FOR THE DCE (R0) HAPLOTYPEC. Cotorruelo, G. Munini, S. García Borrás, L. Racca, R. Di Mónaco, C. Biondi, A. Racca(Universidad Nacional de Rosario, Rosario, Argentina)P-190 ANALYSIS OF THE DEFORMABILITY OF ADHERED CELLS BY MEANSOF DIGITAL IMAGE PROCESSINGV. Danieli, A. D'Arrigo, D. Riquelme (Fac. Cs. Bioq. y Farm. - U.N.R., Rosario, Argentina)P-191 FLEXIBILITY, SAFETY AND HIGH TROUGHPUT IN SAMPLINGPROCESSUS OF BLOOD DONOR OR PATIENT SAMPLES FOR COMPLETEBLOOD GROUP SEROLOGY - EVALUATION OF A NEW AUTOMATE :HEMOS EVOLUTION (BIORAD)M. Delamaire, S. Gaucheron, S. Flageul, G. Semana (Etablissement Français du Sang,Rennes, France)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 02.1TOPIC 02.1P-192 HEREDITARY HEMOCHROMATOSIS: THE HAPTOGLOBIN 2-2 TYPEDISPLAYS A SIGNIFICANT BUT MODERATE INFLUENCE ON PHENOTYPICEXPRESSION OF THE PREDOMINANT C282Y HOMOZYGOUS GENOTYPEP-200 A NEW GENERATION OF ANTIBODY SCREENING TEST USINGE.M. TECHNOLOGY ON A FULLY AUTOMATED SYSTEM AND A MANUALWORKSTATIONG. le Gac, C. Ka, V. Scotet, I. Gourlaouen, L. Bryckaert, C. Férec (EFS-Bretagne, INSERMF. Herbert, A. Boulet, D. Buns, A. Delanoe, P. Desmet, V. Godefroy, J.M. Pelosin, S. Petit,U613, Brest, France)S. Sergent, O. Boulet, L. Fauconnier, S. Thorigny (Diagast, Loos, France)P-193 K NULL PHENOTYPE CAUSED BY PREMATURE STOP CODON INEXON 14 OF KEL GENE: A CASE REPORT.P-201 ABO DISCREPANCIES AFTER INTENSIVE CHEMOTHERAPY FORMALIGNANT DISEASESA. Doescher, F. Wagner, E.K. Petershofen (German Red Cross Blood Transf.Service,T.I. Izumi, Y. Okada, K. Kashiwazaki, S. Tsunoda, H. Kobayashi, M. Akutsu, Y. Kano (TochigiOldenburg, Germany)Cancer Center, Utsunomiya, Japan)P-194 MOLECULAR GENETIC RHCE CHARACTERIZATION OF 100 CASESWITH PROBLEMS IN AUTOMATED RH DETERMINATION.A. Doescher, E.K. Petershofen, F. Wagner (German Red Cross Blood Transf.Service,P-202 PERFORMANCE COMPARISON OF MEDION-MDMULTICARD,ID-DIAMED AND SCANGEL-BIORAD RHD/ABO SEROTYPING USING AMULTI-VARIANT, CAUCASIAN-SPECIFIC, GENOTYPED DONOR PANEL92Oldenburg, Germany)P-195 PERFORMANCE EVALUATION STUDY OF A NOVEL LATERAL FLOWASSAY FOR SIMULTANEOUS TYPING OF ABO, D, RHESUS SUBGROUPSAND K (“MDMULTICARD”)C.G. Geisen, P. Schwind, E. Seifried (DRK Blood Donor Service, Frankfurt, Germany)C. Gassner, E. Rainer, E. Pircher, L. Markut, G. Kormoczi, C. Jungbauer, D. Wessin,R. Klinghofer, H. Schennach, P. Schwind, D. Schonitzer (Central Institute for BloodTransfusion, Innsbruck, Austria)P-203 EVALUATION OF THE DIAGAST READY-TO-USE OLYMP RANGE FORTHE NEW ANALYSER OLYMPUS PK 730093P-196 DIRECT ANTIGLOBULIN TEST (DAT) WITH A WALKAWAY INSTRUMENT AUTOVUEL.W. Gustafsson (Karolinska, Stockholm, Sweden)P-197 GYPB SILENCING IN AFRICAN AMERICANS BUT NOT IN CAUCASIANSG. Hashmi, T. Shariff, Y. Zhang, K. Hue-Roye, D. Charles-Pierre, C. Lomas-Francis, M. Reid(Bioarrays Solutions, Warren, United States of America)P-198 SEROLOGIC DIFFERENTIATION BETWEEN PARTIAL D AND WEAK DAND CORRELATION WITH RHESUS PHENOTYPES CCEEE. Hassapopoulou, E. Kostopoulou, V. Bakaloudi, E. Ntinopoulou, P. Chalkia, P. Didoudi,V. Avgoloupi, S. Intzepeli, A. Tsoukala (AHEPA Hospital, Thessaloniki, Greece)L. Keyser, K. Keyser, C. Cordier, V. Godefroy, J.M. Pelosin, C. Gues, S. Simon, S. Thorigny(Diagast, Loos, France)P-204 LINKAGE DISEQUILIBRIUM OF RHD 1227A AND IVS7+293T LEADINGTO ABERRANT RNA SPLICING IN DEL INDIVIDUALSH.L. Eng, T.M. Lin, Y.F. Yang, Y.C. Wang, T.C. Liu, Y.H. Wang, Y.J. Lee, K.T. Lin (Chang GungMemorial Hosp and University, Kaohsiung County, Taiwan)P-205 THE FREQUENCY AND CLINICAL SIGNIFICANCE OF DELAYEDSEROLOGICAL TRANSFUSION REACTIONS IN KOREAN POPULATIONC. Kim, T. Park, E. Lee, H. Son (Pusan National University Hospital, Busan, South-Korea)P-206 THE ANTI-D PROGRAMME - THE SOUTH AFRICAN EXPERIENCEP-199 DBRBC- A NEW COLLABORATIVE RED BLOOD CELLBIOINFORMATICS RESOURCEM. Helmberg, M. Feolo, D. Hoffman, R. Dunivin, O. Blumenfeld (Medical University Graz,P. Fogg, E. Smart, C. Olsen, V. Somerset, V. Poovalingam (South African National BloodService ECR, Durban, South Africa)P-207 DEVELOPMENT OF A MONOCLONAL ANTI-GLOBULIN REAGENTGraz, Austria)H. Fraser, A. Mackie, D.A. Colligan, R.G. Drake, E. Shakir, J. Robb, A.G. Robb (ScottishNational Blood Transfusion Serv, Glasgow, United Kingdom)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 02.1TOPIC 02.1P-208 THE IMPORTANCE OF USING A COMBINATION OF D-TYPINGMETHODS AND REAGENTS IN PATIENTSE. Kostopoulou, E. Hassapopoulou, E. Ntinopoulou, V. Bakaloudi, P. Chalkia, V. Avgoloupi,P. Didoudi, S. Intzepeli, A. Tsoukala (AHEPA Hospital, Thessaloniki, Greece)P-217 DRB1 ALLELES IN ARGENTINIAN PATIENTS WITH CHAGAS DISEASES. García Borrás, O. Pellizon, C. Cotorruelo, C. Biondi, J. Beloscar, O. Bottasso, C. Diez,A. Racca (Facultad de Ciencias Bioquímicas, Rosario, Argentina)P-209 SIGNIFICANT DIFFERENCES IN THE SENSITIVITY OF DIFFERENTGEL CENTRIFUGATION TECHNIQUESV. Kretschmer, M. Bornmann, K. Schmidt, R. Karger (Institute Transfus. Med. Haemostaseol.,Marburg, Germany)P-218 CLASSIFICATION OF PARTIAL D VARIANTS BY SEROLOGICAL ANDMOLECULAR METHODSS.S. Kulkarni, K. Vasantha, S.C. Gupte, D. Mohanty, K. Ghosh (Institute ofImmunohaematology, Mumbai, India)P-210 COMPARATIVE ANALYSIS OF THE ABO AND RH CDE PHENOTYPEFREQUENCIES AMONG VARIOUS ETHNIC GROUPS IN PORT HARCOURT,NIGERIAA. Jeremiah, I. Buseri (Rivers State University of Sci & Tech, Port Harcourt, Nigeria)P-219 APLICATION OF FLOW CYTOMETRY IN DETERMINATION OFSUB-POPULATION OF RED BLOOD CELLN. Lebensohn, L. Di Tullio, J. Valverde, P. Foresto (Fac. Cs. Bioquímias y Farmacéuticas -UNR, Rosario, Argentina)94P-211 PARTIAL D (DNB) IN A PREGNANT WOMAN WITH RHD POSITIVESEROLOGY AND DEVELOPMENT OF ANTI-D: CASE REPORTV. Drazic, J. Mikulandra-Mratinovic, J. Bingulac-Popovic, S. Dajak, I. Babic, M. Balija, I. Jukic(Croatian Institute of Transfusion Medic, Zagreb, Croatia)P-212 A COMPARISON OF CONVENTIONAL TUBE TECHNIQUE AND GELTECHNIQUE IN EVALUATION OF DIRECT ANTIGLOBULIN TESTD. Khetan, R. Chaudhary, S. Das (SG Postgraduate Institute of Medical Sci, Lucknow, India)P-220 AN UNUSUAL CASE OF AN ANTIBODY TO A HIGH FREQUENCYANTIGEN IN A PATIENT WITH A POSITIVE DAT AND FREE AUTOANTIBODYE. Lee, M. Redman, R. Malde (National Blood Service, London, United Kingdom)95P-213 BLOOD GROUPING AUTOMATION IN A BLOOD TRANSFUSION CENTERV. Fakitsa, M. Papakonstantinou, A. Flangini, K. Maltezis, I. Flessiopoulou, G. Lyrakos,S. Giannoulea, H. Desilla, C.H. Antoniou, P. Alexiou, T. Micha, E. Sotiropoulou, K. Sofroniadou(District General Hospital of Nikea, Athens, Greece)P-214 ISOLATED MOTHER/CHILD MISMATCH IN THE RH SYSTEME.M. Dauber, M. Klintschar, D. Mayr, W.R. Mayr (Medical University of Vienna, Vienna, Austria)P-215 DIRECT COOMBS (DAT) IN NEWBORN CHILDREN WITHHEAMOLYTIC JAUNDICEE. Kostopoulou, E. Hassapopoulou, E. Ntinopoulou, P. Chalkia, S. Intzepeli, V. Avgoloupi,P. Didoudi, V. Bakaloudi, A. Tsoukala (AHEPA Hospital, Thessaloniki, Greece)P-216 ANTI-Mg FOUND IN ABO TEST REAGENT OF HUMAN ORIGIN -CASE REPORTR. Djordjevic, S. Draskovic, M. Sindjic, S. Tadic, M. Jovicic, Z. Smiljkovic, N. Tijanic, O. Ciric(National Blood Transfusion Institute, Belgrade, Serbia and Montenegro)P-221 STANDARDIZATION OF FETAL DNA EXTRACTION FOR NON INVASIVEPRENATAL RHD TYPINGJ. Legler, L. Liu, A. Ait Soussan, C.E. van der Schoot (University Clinics Goettingen,Goettingen, Germany)P-222 IMPAIRED INTERACTION IN RHD/RHAG-ANKYRIN COMPLEXACCOUNTS FOR RHD DEFICIENCY IN DEL PHENOTYPET.M. Lin, H.L. Eng, Y.F. Yang, T.C. Liu, Y.H. Wang, Y.J. Lee, K.T. Lin, Y.C. Wang(National Cheng Kung University, Tainan, Taiwan)P-223 COMPARISON OF SCANGEL, DIAMED, IN-HOUSE SPAT AND TUBELISS ANTIGLOBULIN TEST FOR ANTIBODY DETECTIONL.A. Mohabir, C. Womersley (Welsh Blood Service, Pontyclun, United Kingdom)P-224 FREQUENCY OF BLOOD GROUPS ABO AND RHESUS DIN THE GUINEAN POPULATIONA. Loua, M.R. Lamah, M. Camara (Centre National de Transfusion Sanguine, Conakry, Guinea)P-225 CHARACTERIZATION OF A NOVEL B(A) ALLELE WITH BBBA TYPE ATTHE ABO BLOOD GROUPL. Lu, Q. Yu, Y.Q. Su, Z.H. Deng (ShenZhen Institute Of TransfusionMedicin, Shenzhen, China)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 02.1TOPIC 02.1P-226 COMPARATIVE STUDY OF TUBE AND GEL TECHNIQUES FORCOMPATIBILITY TESTING AND ANTIBODY IDENTIFICATIONR.N. Makroo, S.G. Gautam (Apollo Hospitals, Delhi, India)P-234 APPLICATION OF FY GENOTYPING TO DETERMINE BLOODGROUP-SPECIFIC CHIMERISM AFTER ALLOGENEIC PERIPHERALBLOOD STEM CELL TRANSPLANTATIONP-227 RHD GENE MOLECULAR VARIANTS IN THE WESTERN PART OFFRANCE : IDENTIFICATION OF 13 NEW ALLELESC. le Marechal, C. Guerry, C. Benech, L. Burlot, F. Cordellier, M. Delamaire, C. Ferec(French Blood Center, Brest, France)M.A. Mota, A.A. Ciferri, R.A.A. Pereira, A.M. Sakashita, J.M. Kutner, L.M. Castilho(IEP/Hospital Albert Einstein, São Paulo, Brazil)P-235 IDENTIFICATION AND MOLECULAR CHARACTERIZATION OF HY ANDJOA NEGATIVE BLOOD DONORS IN SOUTHERN USAP-228 GENOTYPING OF DUFFY, KIDD, MNS BLOOD GROUPS :THE EFS PYRENEES MEDITERRANEE EXPERIENCEC. Maugard, R. Aznar, N. Chikh, C. Segarra, O. Bouix, J. Coste (EFS Pyrénées Mediterranée,Montpellier, France)M. Moulds, W. Long, Q. Chen, M. Stone, D. Tulley, E. Lowery, A. Steinmetz, J. Moulds(LifeShare Blood Centers, Shreveport, United States of America)P-236 ANTIBODY PREVALENCE IN A HETEROGENEOUS POPULATION OFPREGNANT WOMEN AND NEONATES96P-229 ANTI-JK3 ALLOANTIBODIES IN THE PATIENT WITH JK NULLPHENOTYPE AND JKA/JKA GENOTYPEE. Brojer, B. Michalewska, A. Kucmierz, M. Pelc-Klopotowska, A. Orzinska, H. Lopienska(Institute of Haematology and Blood Transfusion, Warsaw, Poland)P-230 EVALUATION OF THE DIAGAST ERYTHROCYTES MAGNETIZEDTECHNOLOGYL.A. Mohabir, C. Womersley, Y. Barbreau, A.S. Degryse, J.M. Pelosin (Welsh Blood Service,Pontyclun, United Kingdom)P-231 UNUSUAL ANTIBODY SPECIFICITY IN AN AFRICAN AMERICANPATIENT WITH U-VARIANT RED BLOOD CELLSC. Lomas-Francis, K. Hue-Roye, A. Fuchisawa, S.Y. Choo, C. m.d. Whitsett (New York BloodCenter, New York, United States of America)P-232 EVALUATION OF A NEW TECHNOLOGY FOR BLOOD GROUPING ANDPHENOTYPINGM.A. Mota, M.G. Aravechia, V.L. Wakim, A.M. Sakashita, J.M. Kutner, L.M. Castilho(IEP/Hospital Albert Einstein, São Paulo, Brazil)P-233 POST-TRANSFUSION HYPERHEMOLYSIS AFTER HEMOLYTIC TRANS-FUSION REACTION IN A PATIENT WITH SEVERE ANEMIA: CASE REPORTM.A. Mota, A.M. Sakashita, N. Hamerschlak, J.M. Kutner, L.M. Castilho (IEP/Hospital AlbertEinstein, São Paulo, Brazil)S. Mudahi-Orenstein, N. Lev, Y. Dakosta, O. Zelig, N. Manny (Hadassah Hebrew UniversityMedical Center, Jerusalem, Israel)P-237 DETECTION OF WEAK D TYPE 1, 2 AND 3 WITHIN WEAK D/C+ ANDWEAK D/E+ RECIPIENTS IN DAILY PRACTICE : SEROLOGY, MOLECULARBIOLOGY OR BOTH ?F. Noizat-Pirenne, M. Verdier, A. Lejealle, A. Mercadier, A. Fialaire-Legendre, C. Tournamille,P. Bonin, P. Bierling, H. Ansart-Pirenne (Etablissement Français du Sang, Créteil, France)P-238 A MODIFIED TREATMENT PROCESS FOR PREPARATION OF S-303RBC FOR PATHOGEN INACTIVATION SUBSTANTIALLY REDUCES THEPOTENTIAL FOR CROSS-REACTIVITYA. North, G. Garratty, M.A. Schott, P. Arndt, G. Castro, A. Erickson, P. Mintz, L. Corash (CerusCorporation, Concord, Ca, United States of America)P-239 THREE NEW FUT1 ALLELES ENCODE DEFECTIVE FUCOSYLTRANS-FERASES IDENTIFIED FROM PARA-BOMBAY PHENOTYPE INDIVIDUALSK. Ogasawara, H. Tsuneyama, M. Uchikawa, S. Itou, K. Tadokoro, M. Satake, K. Nakajima(Red Cross Central Blood Institute, Tokyo, Japan)P-240 A CASE OF SEVERE RH D ALLOIMMUNIZATION TREATED BYINTENSIVE PLASMA EXCHANGE AND HIGH-DOSE INTRAVENOUSIMMUNOGLOBULINP.M. Palfi, L. Matthiesen, J.O. Hilden, A. Selbing, G. Berlin (University Hospital, Linköping, Sweden)97INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 02.1TOPIC 02.1P-241 MCLEOD PHENOTYPE - PHENOTYPE AND GENOTYPE IN A CASEOF MCLEOD SYNDROME WITH SEVERE NEUROLOGICAL SYMPTOMESP-249 PROJECT IN DEVELOPING PANEL CELLS FOR ANTIBODYSCREENING AND IDENTIFICATION IN INDONESIAM. Písacka, L. Tilley, M. Kralova, J. Klempir, J. Roth (Instituteof Hematology and BloodR.S.E.G. Sjavitri Evi Gantini, T.H. Titik Herniwati, R.L. Crookes, M.R. Muhammad RizalTransfusion, Prague, Czech Republic)(CBTS Indonesian Red Cross, Jakarta, Indonesia)P-242 MEDIATORS OF THE SELECTIVE CLEARANCE OF SENESCENTERYTHROCYTESP-250 A REVIEW OF THE CLINICAL SIGNIFICANCE OF ANTI-RH19 ANDANTI-RH34 ANTIBODIES DETECTED IN SOUTH AFRICAN PATIENTSA. Racca, C. Biondi, M.A. Ensinck, S. García Borrás, L. Racca, C. Cotorruelo (Facultad deE.A. Smart, P. Fogg, S. Nadesan, I. Joseph (South African National Blood Service, EC,Bioquímica, Rosario, Argentina)Durban, South Africa)P-243 RHMOD PHENOTYPE CAUSED BY DOUBLE HETEROZYGOSITY FORTWO NEW ALLELES OF THE RHAG GENEP-251 USING NON-TRADITIONAL QUALITY TOOLS TO EVALUATEAUTOMATION FOR PRETRANSFUSION TESTINGA. Scharberg, H. Tsuneyama, K. Ogasawara, M. Uchikawa, H.H. Keller, K. Panter, J. Senne,F. South, T. Casina, W. Malomgre (Ortho-Clinical Diagnostics, Scottsdale, United States of America)98S. Penz, E. Richter, P. Bugert (DRK-BSD Baden-Wuerttemberg-Hessen, Baden-Baden, Germany)P-244 OUR EXPIRIENCES IN TYPING AND SCREENING RED CELLALO-ANTIBODIES IN SERA OF PATIENTS WHO ARE TESTED BY THECOLUMN AGGLUTINATION TECHNOLOGY ANTI-HUMAN GLOBULIN TESTB. Stankovic, M. Trkuljic (Institute of Transfusiology, Belgrade, Yugoslavia)P-245 B-CELL MEMORY AGAINST RHD ANTIGEN IN HYPERIMMUNIZEDDONORS IS MAINLY PRESENT IN A CD27 NEGATIVE IGM POSITIVEB-CELL SUBSETC.E. van der Schoot, C.E. van der Schoot, L.J. Gruneberg, O.H.M. Verhagen, G. Vidarsson,S.E. Dohmen (Sanquin Research, Amsterdam, Netherlands)P-252 THE FIRST TWO CASE REPORTS OF ANTI-JAHK (RH53)IN PREGNANT WOMENA. Scharberg, K. Panter, J. Senne, S. Penz, E. Richter, G. Bojarsky, M. Leuteritz (DRK-BSDBaden-Wuerttemberg-Hessen, Baden-Baden, Germany)P-253 MOLECULAR BASIS FOR A NOVEL LOW-FREQUENCY ANTIGEN INTHE MNS BLOOD GROUP SYSTEM, TDM. Uchikawa, H. Tsuneyama, K. Ogasawara, Y Suzuki, R. Yabe, T Enomoto, M Satake,K Nakajima (Tokyo Blood Center, Tokyo, Japan)P-254 THE EVALUATION OF GENOTYPES OF LEWIS BLOOD GROUP INKOREAN USING DIRECT SEQUENCING AND RFLP.99P-246 O BLOOD GROUP, WHERE ART THOU?A. Seltsam, C. Figueiredo, C. Das Gupta, O. Bock, R. Blasczyk (Hannover Medical School,Hannover, Germany)P-247 THE INCIDENCE OF DCE RH PHENOTYPE IN NAKASERO BLOODBANK DONORSP. Senyonga (Uganda Blood Transfusion Service, Kampala, Uganda)P-248 RBC ALLOANTIBODIES FREQUENCY IN PREGNANT WOMENL. Suput-Tomas, M. Paunovic, B. Jankovic-Orescanin, G. Buric (Clinical-Hospital Center"Zvezdara", Belgrade, Serbia and Montenegro)I.B. Suh, S.W. Ryu, J.S. Kim, C.S. Lim, C.K. Lee, Y. Cho, Y.K. Kim, K.N. Lee(Kangwon Natl. Univ, Medical Science Inst, Chunchun, South-Korea)P-255 IDENTIFICATION OF A NOVEL A1V-O1V HYBRID ALLELE WITH G829AMUTATION IN A CHIMERIC INDIVIDUAL OF AELBEL PHENOTYPEC.F. Sun, D.P. Chen, W.T. Wang, J.P. Liu (Chang Gung Memorial Hospital, Tao-yuan, Taiwan)P-256 EVALUATION OF MICROPLATE SYSTEM FOR ABOAND RH(D) BLOOD GROUPINGJ.S. Shukla, R. Chaudhary, D. Khetan, A. Sonker (SG Postgraduate Institute of Medical Sci,Lucknow, India)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 02.1TOPIC 02.1P-257 INVESTIGATIONS ON THE ROLE OF ANTIBODY FRAMEWORKSEQUENCES, AS DETERMINED BY VH GERMLINE GENE USAGE, ONANTI-D ACTIVITYP-265 NOVEL JKNULL ALLELES IN INDIVIDUALS OF DIFFERENT ETHNICORIGINSS. Wester, T. Johnson, T. Copeland, R. Storry, L. Olsson (Blood Centre, Lund, Sweden)100S.J. Thorpe, C. Ball, B. Fox, R. Thorpe, K.M. Thompson, A.F. Bristow (NIBSC, Potters Bar,United Kingdom)P-258 THE NUMBER OF REPEATS IN THE CBF/NF-Y ENHANCER VNTRREGION DOES NOT INFLUENCE THE LEVEL OF ABO TRANSCRIPTS INBLOOD AND ERYTHROPOIETIC CULTUREI. Thuresson, H. Dykes, T. Olofsson, L. Olsson, M. Chester (Department of LaboratoryMedicine,, Lund, Sweden)P-259 IMPORTANCE OF IMMUNEPROPHYLAXIS FOR HEMOLYTIC DISEASEOF THE NEWBORNO.W. Torres, F. Oliveto, M. Direne (Maternidad Sardá, Buenos Aires, Argentina)P-260 MOLECULAR BASIS FOR A NOVEL LOW-FREQUENCY ANTIGEN INTHE KELL BLOOD GROUPP SYSTEM, KYOM. Uchikawa, T. Onodera, K. Ogasawara, H. Tsuneyama, C. Toyoda, R. Yabe, T Enomoto,M Satake, K Nakajima (Tokyo Blood Center, Tokyo, Japan)P-261 MOLECULAR GENETIC ANALYSIS OF FUT1 AND FUT2 GENE INPARA-BOMBAY CHINESE: A NOVEL FUT1 ALLELE IS IDENTIFIEDP-266 TYPING DISCREPANCIES REVEAL TWO NEW KELNULL MUTATIONSIN THE INTRONS FLANKING EXON 8S. Wester, C. Ligthart, M.T. Steffensen, M. de Haas, R. Storry, M.L. Olsson (Blood Centre,Lund, Sweden)P-267 ADSORPTION OF ANTIBODIES USING DIFFERENT ADSORPTIONTECHNIQUESJ. de Wildt-Eggen, A. Scholten, J. Ebelties, M.J. Dijkstra-Tiekstra, E. Adema (Sanquin BloodBank North East, Groningen, Netherlands)P-268 BLOOD CHIMERISM LIMITED TO ONE OF THE TWINSE.M. Dauber, C. Wolf, A. Leo, W.R. Mayr (Medical University of Vienna, Vienna, Austria)P-269 DUFFY ANTIGEN EXPRESSION ON RETICULOCYTES DOES NOTALTER FOLLOWING BLOOD LOSS IN AN AUTOLOGOUS DONATION MODELM. Wood, C. Brown, P. Hutchinson, V. Markovska, I.J. Woolley (Australian Red Cross BloodService, Melbourne, Australia)P-270 FY EXPRESSION IS INCREASED IN SOUTHEAST ASIAN OVALOCYTOSISJ. Woolley, P. Hutchinson, J. Kazura, J. Reeder, A. Cortes (Monash Medical Centre, Clayton,101Y.Q. Su, T.L. Wei, Q. Yu, G.G. Wu, Y.L. Liang, S.Z. Ging (ShenZhen Institute Of TransfusionAustralia)Medicine, Shen Zhen, China)P-262 ALLOIMMUNISATION IN D NEGATIVE WOMEN FOLLOWING ROUTINEANTENATAL ANTI-D IMMUNOGLOBULIN PROPHYLAXIS (RAADP) IN THENORTH EAST OF SCOTLAND: A FIVE-YEAR RETROSPECTIVE STUDYP-271 THE ELUCIDATION OF MOLECULAT GENETIC BASIS FOR TEN NOVELABO BLOOD GROUP ALLELES IDENTIFIED IN CHINESE POPULATIONG.G. Wu, Q. Yu, Z.H. Deng, Y.L. Lian, Y.Q. Su (Shen-Zhen Institute of Transfusion Medic,Shen-zhen, China)J. Urbaniak, A. Greiss, C. Promwong, R. Witterick, J. Burnett (University of Aberdeen,Aberdeen, United Kingdom)P-263 ASSESSEMENT OF IRREGULAR RED CELL ALLOANTIBODIES INVOLUNTARY BLOOD DONORSE. Velkova, T. Makarovska-Bojadzieva, A. Hristova-Dimceva, I. Nikoloska, J. Angelovski,K. Dimitrovski, V. Stefanovska (Institute of Transfusion Medicine, Skopje, Macedonia)P-264 STUDY ABOUT THE FUT2 GENE STRUCTURE OF XINJIANG UIGHURAND HAN NATIONALITYW. Wei, S. Su (Transfusion Medicine, Shenzhen, China)P-272 A FAMILY INVESTIGATION OF A WEAK D TYPE 15 DONORW. Xiong, B.Ch. Yang, C.P. Shao (Shenzhen Blood Center, Shenzhen, China)P-273 GENERATION OF RHD-CE(2~9)-D ALLELE BY GENECONVERSION IN CISW. Xiong, C.P. Shao, B.Ch. Yang (Shenzhen Blood Center, Shenzhen, China)P-274 IGNT (GCNT2) MUTATION ANALYSIS OF ADULT I PHENOTYPE INISRAEL: DETECTION OF A NOVEL MUTATIONV.B. Yahalom, E. Pras, R. Goldman-Levi, A. Abu, O. Asher, D. Zadok, C. Levene, I. Avni,E. Shinar (Magen David Adom - NBS, Ramat Gan, Israel)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 02.1TOPIC 02.2The posters areon display fromMonday - ThursdayP-275 HLA ANTIGENS IN IRANIAN MAJOR BETA-THALASSEMIC PATIENTSTopic 02.2.102F. Yari, M. Sobhani, F. Sabaghi, M. Zaman vaziri (Iranian Blood Transfusion organization,Tehran, Iran)P-276 MOLECULAR POLYMORPHISM OF O ALLELES IN CHINESE HANPOPULATIONQ. Yu, Z.H. Deng, Y.L. Liang, G.G. Wu, Y.Q. Su, D.M. Wang (ShenZhen Institute OfTransfusionMedicin, Shenzhen, China)P-277 THE MOLECULAR BACKGROUND AND POLYMORPHISMOF DEL IN CHINESEZ. Zhu, Q. Li (Shanghai Blood Center, Shanghai, China)P-278 MOLECULAR AND FAMILY ANALYSES REVEALED TWO NOVELALLELES IN A SURVEY OF A CHINESE TRUE D– POPULATIONZ. Zhu, L. Ye, Z. Guo, Q. Li (Shanghai Blood Center, Shanghai, China)P-279 IMPORTANCE OF NONINVASIVE FETAL GENE EXAMINATIONIN ALLOIMMUNIZED MOTHERSB. Zupanska, A. Orzinska, M. Nowaczek-Migas, K. Guz, A. Gibala, J. Rumas-Bec, E. Brojer(Institute of Haematol.& Blood Transfusion, Warsaw, Poland)P-280 APPROACH TO A PATIENT WITH RED CELL AUTO ANDALLOANTIBODIES-CASE REPORTRed Cells - Immune Haemolytic AnaemiasP-284 ADVERSE HAEMOLYTIC TRANSFUSION EVENTS:CONSIDER THE ROLE OF DRUGSA.G. van den Bos, J. Gerrits-Kuiper, M.H.P.O. Moors, V.M.J. Novotny (Radboud UniversityMedical Center, Nijmegen, Netherlands)P-285 APPLICATION OF FLOW CYTOMETRY IN DETECTION OF RED CELLBOUND IGG IN AIHA: COMPARISON WITH CONVENTIONAL TUBETECHNIQUE AND GEL TESTR. Chaudhary, S. Das, R. Gupta (SG Postgraduate Institute of Medical Sci, Lucknow, India)P-286 ABO-HEMOLYTIC DISEASE OF THE NEWBORN (HDN):TWO YEARS OF EXPERIENCEM. Garcia Rosasco, G. Bassani, J. Valverde (National University of Rosario, Rosario, Argentina)P-287 CLINICAL RELEVANCE OF NON-RHESUS-D-IEA TITER ANDMONOCYTE-DRIVEN ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITYTEST RESULT FOR THE PREDICTION OF SEVERE HAEMOLYTIC DISEASEOF THE NEWBORN.M. de Haas, K. Bilgin, T. Vrijkotte, J.M. Koelewijn, M.A.M. Overbeeke, C.E. Van der Schoot,G.J. Bonsel (Sanquin, Amsterdam, Netherlands)103T.M. Makarovska-Bojadzieva (National Institute of Blood Transfusion, Skopje, Macedonia)P-281 THE USE OF GLYCATED HAEMOGLOBIN (HBA1C) FOR MONITORINGDIABETIC CONTROL IN NNEWI, SOUTH-EAST NIGERIAP-288 NON-INVASIVE FETAL RHD GENOTYPING AND FETAL SEXING INMATERNAL BLOODM. de Haas, B.E.M. Bossers, A. Ait Soussan, P.C. Ligthart, L.D.M. Schuitemaker,E.C. Okocha, A.L. Asomogha, R.N. Asomogha (Nnamdi Azikiwe University, Nnewi, Nigeria)G.C.M.L. Page-Christiaens, C.E. Van der Schoot (Sanquin, Amsterdam, Netherlands)P-282 TRANSFUSION OF NORMAL BLOOD TO PATIENTS WITH RAREADULT I PHENOTYPEP-289 IMMUNE HEMOLYSIS AFTER LIVER TRANSPLANTATIONZ. Hundric-Haspl, N. Jurakovic-Loncar, M. Tomicic, M. Balija, I. Jukic (Croatian Institute ofM Lin, Y.S. Chan, C.L. Wang, E.J. Hsueh (Mackay Memorial Hospital, Taipei, Taiwan)Transfusion Medici, Zagreb, Croatia)P-283 BLOOD GROUP GENOTYPES IN IRANIAN THALASSEMICPATIENTS & SOME BLOOD DONORSP-290 CLINICAL OUTCOMES OF ABO INCOMPATIBLE RED BLOOD CELL(RBC) TRANSFUSIONSM. Shaiegan, A. Azarkeivan, S. Samiei, Z. Ataee, M. Kavari, H. Lotfi, P. LotfiN.D. Kalmin, K. Janatpour, H.M. Jensen, P.V. Holland (South Texas Blood & Tissue Center,(IBTO Research Center, Tehran, Iran)San Antonio, United States of America)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 02.2TOPIC 02.3The posters areon display fromMonday - ThursdayP-291 EVALUATION OF THE SENSITIVITY OF THE DIRECT ANTIGLOBULINTEST (DAT) BY THE ROUTINE SEROLOGICAL TUBE TEST (DAT-T) AND BYTHE MICROCOLUMN GEL TEST (DAT-G) FOR WARM-TYPE AUTO-IMMUNEHAEMOLYTIC ANAEMIA (AIHA) DIAGNOSTICSP-300 ANTI-M IMMUNIZATION: A POSSIBLY UNDERDIAGNOSEDCAUSE OF FETAL HEMOLYTIC ANEMIA AND INTRAUTERINE DEATHA. Wikman, A. Edner, G. Gryfelt, B. Jonnson, J.I. Henter (Karolinska University Hospital,Stockholm, Sweden)E.K. Klausa, S.B. Bochenek, A.M. Misiaszek (Regional Centre of Transfusion Medicine,Wroclaw, Poland)P-292 PREDICTIVE VALUE AND SENSITIVITY OF FIRST TRIMESTERSCREENING FOR IRREGULAR ERYTHROCYTE ANTIBODIES TO DETECTNON-RHESUS-D-IEA-MEDIATED HAEMOLYTIC DISEASE OF THENEWBORN IN THE NETHERLANDSJ.M. Koelewijn, T.G.M. Vrijkotte, C.E. van der Schoot, G.J. Bonsel, M. de Haas (SanquinP-301 THE ASSOCIATION OF FCGAMMA RECEPTOR IIA (CD32)POLYMOPHISM AND IGG SUBCLASS CONCENTRATION IN MATERNALSERUM IN ABO HEAMOLYTIC DISEASE OF NEWBORNY. Zhang, M. Liu, S. Liu (Blood Reseach Lab, Xi'an, China)Topic 02.3.104Research and Landsteiner Lab, Amsterdam, Netherlands)P-293 RISK FACTORS FOR RHESUS-D-IMMUNIZATION DESPITE POST-AND ANTENATAL ANTI-D-PROPHYLAXISJ.M. Koelewijn, M. de Haas, T.G.M. Vrijkotte, C.E. van der Schoot, G.J. Bonsel(Sanquin Research and Landsteiner Lab, Amsterdam, Netherlands)P-294 AETIOLOGICAL FACTORS RELATED TO A POSITIVE DIRECTANTIGLOBULIN TEST (DAT) IN HIV INFECTED PATIENTSM. Lai, G. D'Onofrio, E. Visconti, E. Tamburrini, R. Cauda, G. Leone (Catholic UniversityImmunohematology Lab, Roma, Italy)P-295 LOWER HEMOGLOBIN LEVELS IN DAT POSITIVE HIV POSITIVEPATIENTS, ITS RELATIONSHIP WITH THE AGGLUTINATON STRENGHTSAND DIFFERENCES IN THE CLINICAL STAGESM. Lai, E. Visconti, G. D'Onofrio, E. Tamburrini, R. Cauda, G. Leone (Catholic UniversityImmunohematology Lab, Roma, Italy)P-298 A FAMILY OF HEMOLYTIC DISEASE OF THE NEWBORN FOR TWOGENERATIONS POTENTIALLY DUE TO ANTI-KGRed Cells - Antigen ModificationP-302 ANIMAL TRIALS OF MPEG MODIFIED RED BLOOD CELLSY. Qiu (Beijing Red Cross Blood Center, Beijing, China)P-303 EFFECTS OF SYNTHETIC POLYCATIONS ON ERYTHROCYTEMEMBRANE ANALYZED BY OPTICAL METHODSD. Riquelme, P. Grandfils, B. Fontana, M. Alessi, R. Valverde, G. Foresto, F. Relancio, F. Stoltz,A. Dumas (Fac. de Cs. Bioquímicas y Farmacéuticas, Rosario, Argentina)P-304 ABNORMAL GLYCOSILATION OF ABH ANTIGENS IN HUMAN SPERMAND ITS RELATIOSHIP WITH DNA DAMAGE ASSESED BY (TDT- MEDIATED-DUTP-NICK END LABELING) TUNEL ASSAY IN INFERTILE MENA.S. Brufman, Ch. Chaingam, E.A. Solis, E.G. Orellano (National University of Rosario,Rosario, Argentina)P-305 THE CA19-9 ANTIGEN AND THE LEWIS STATUS OF PATIENTSWITH RENAL PELVIS DILATATIONG Koritsiadis (Athens University, Laiko Gnrl Hospital, Athens, Greece)105J. Takahashi, S. Kubo, H. Takahashi, M. Hirashima, T. Ezaki, K. Kimura, M. Tsuzi, T. Nakade,M. Horie, Y. Tomorari, H. Matsukura, F. Hirayama, K. Tsubaki, H. Minowa, Y. Tani, H. Shibata(Japanese Red Cross Osaka Blood Center, Osaka, Japan)P-299 GRAFT VERSUS HOST ANTI-RH(D) FOLLOWING RH-INCOMPATIBLEORTOTOPTIC LIVER TRANSPLANTATION (OLT): A CASE REPORTD. Venturelli, M. Masetti, L. Bensi, M.G. Baldini, G. Gerunda, M. de Palma (AziendaPoliclinico, Modena, Italy)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 02.4The posters areon display fromMonday - ThursdayPOSTERS106Topic 02.4.Red Cells - TransfusionP-306 A FORTUITOUS BENEFIT OF RED BLOOD CELL EXCHANGE INTREATMENT OF A CHILD WITH ACUTE CHEST SYNDROMEC.F.M. Danielson, M. Heiney, W. Jackson, M. Skipworth, A. Miguel, L.J. McCarthy(Wishard Memorial Hospital, Indianapolis, United States of America)P-307 A MODIFIED TREATMENT PROCESS FOR PREPARATION OF S-303RBC FOR PATHOGEN INACTIVATION IN THREE DIFFERENT ADDITIVESOLUTIONS MAINTAINS RBC FUNCTIONA. Erickson, M.A. Schott, V.A. Lee, G.M. Castro, T. Peterson, A. North (Cerus Corporation,Concord, United States of America)P-308 HYPERHEMOLYSIS SYNDROMEV. Fakitsa, M. Papakonstantino, A. Flangini, F. Drini, G. Lyrakos, K. Maltezis, P. Stasinopoulou,L. Haliou, E. Erotokritou, K. Sofroniadou, M. Drosou (District General Hospital of Nikea,Athens, Greece)P-309 RETROSPECTIVE ANALYSIS OF TRANSFUSION RATE INHIP FRACTURE SURGERYV. Fakitsa, K. Maltezis, M. Papakonstantinou, J. Maniakis, T. Micha, E. Sotiropoulou,A. Flangini, F. Drini, N. Prevezas (District General Hospital of Nikea, Athens, Greece)P-314 THE IMPLEMENTATION OF RESTRICTIVE STRATEGY FOR PRBCSTRANSFUSION IN TREATMENT OF CARDIAC SURGERY PATIENTSE. Ambarkova Vilarova, M.Z. Mitrev, M. Blagoevska, C.A. Crvenpanova (Special Hospital forCardiosurgery, Skopje, Macedonia)P-315 IMPROVING BLOOD TRANSFUSION PRACTICE IN ADISTRICT GENERAL MATERNITY UNITR. Mudenha, R. Lindsay, V. Rodie, A. Todd, A.J. Thomson (Royal Alexandra Hospital,Glasgow, United Kingdom)P-316 HAEMOVIGILANCE: DETECTION OF ADVERSE REACTIONSASSOCIATED WITH BLOOD TRANSFUSIONZ. Cermakova (Faculty Hospital, Ostrava, Czech Republic)P-317 A FATAL CLINICAL DILEMMA MIMICKING AN INTRAVASCULARHAEMOLYTIC TRANSFUSION REACTIONR. Sinha (Singh), D. Roxby (Flinders Medical Centre, Adelaide, Australia)P-318 TRANSFUSED BLOOD COMPONENTS VERSUS THE RESERVEDFOR SURGICAL PATIENTSS. Ortakovska, M. Balamovski, T. Timova, M. Blagoevska, R. Grubovic (General Hospital,Gevgelija, Gevgelija, Macedonia)P-319 BLOOD TRANSFUSION PRACTICE-PUBLIC VERSUS PRIVATE HOSPITALS107P-310 ERYTHROCYTAIRE CHARGE SURFACE PROPERTIES DURING STORAGEP. Foresto, N. Lebensohn, M. D'Arrigo, J. Valverde (Fac. Cs. Bioquímias y Farmacéuticas -UNR, Rosario, Argentina)P-311 THE ESTABLISHMENT OF RED CELL BLOOD TYPE DATA BANK FORMN, P, KIDD, DUFFY AND LEWIS ANTIGEN SYSTEMSM. Liu, S. Ye, J. Qi (Blood Center of Shaanxi Province China, Xi`an, China)P-312 EVALUATION OF PRODUCT QUALITY AND DONOR SAFETYFOLLOWING DOUBLE UNIT RED CELL APHERESIS USING THE ALYXCOMPONENT COLLECTION SYSTEMA. Sen, K. Chatterjee (Armed Forces Transfusion Centre, New Delhi, India)P-313 EDUCATION OF NURSES IN TRANSFUSION THERAPYD. Sovic (University Hospital, Zagreb, Croatia)T.M. Makarovska-Bojadzieva, M. Blagoevska, J. Samonikov-Tosevska, R. Grubovik(National Institute of Blood Transfusion, Skopje, Macedonia)P-321 ONTARIO NURSE TRANSFUSION COORDINATORS (ONTRAC):A PROVINCIAL BLOOD CONSERVATION PROGRAMJ. Freedman, K. Luke, M. Escobar, M.B. Garvey, J.A. Chiavetta (St Michael's Hospital,Toronto, Ontario, Canada)P-322 RED CELL TRANSFUSION IN POLAND - A NATIONAL SURVEYA. Rosiek, A. Dzieciatkowska, M. Letowska (Institute of Hematology, Warsaw, Poland)P-323 COMPARISON OF OPERATOR PROCESSES FOR PRETRANSFUSIONTESTING ON THE ORTHO AUTOVUE INNOVA, GALILEO, AND CLASSICID-GEL STATION USING FAILURE MODES AND EFFECTS ANALYSISF. South, T. Casina, W. Malomgre (Ortho-Clinical Diagnostics, Scottsdale,United States of America)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 02.4TOPIC 02.4P-324 HAEMOGLOBINOPATHIES IN BLOOD DONORS FROM YOGYAKARTA,INDONESIA; MOLECULAR MUTATION AND THEIR IMPLICATION TOBLOOD TRANSFUSION PRACTICEM. Sofro, F. Lanni (YARSI University, Jakarta, Indonesia)P-333 ARE UK GUIDELINES FOR PROVISION OF BLOOD FOR PATIENTSWITH SICKLE CELL DISEASE FOLLOWED?J.L. White, C.E. Milkins, D. Benkhaled, M. Rowley (UK NEQAS (BTLP), Watford, United Kingdom)108P-325 RED BLOOD CELLS TRANSFUSION AT THE OBSTETRIC ANDGYNECOLOGIC DEPARTMENT OF THE CLINICAL HOSPITAL CENTERZVEZDARA IN BELGRADEJ.O.B. Jankovic Orescanin (Clinical Hospital Center Zvezdara, Belgrade, Serbia and Montenegro)P-326 THE MAJOR INTEGRAL PROTEINS OF RBCS LIPID RAFTS DURINGSTORAGEA. Kriebardis, M. Antonelou, K. Stamoulis, E. Economou-Petersen, L. Margaridis,I. Papassideri (University of Athens, Athens, Greece)P-327 IRREGULAR ANTIBODIES TO RED BLOOD CELLS IN PATIENTS ONCHRONIC HAEMODIALYSISG.P. Poposki, V.T. Tomanoski, S.M. Mena (Institute of Nephrology, Struga, Macedonia)P-334 THE USE OF BLOOD AND BLOOD COMPONENTS IN THEORTHOPEDIC DEPARTMENT DURING YEAR 2005E. Kocovska, M. Kocovski (Tetovo Hospital, Tetovo, Macedonia)P-335 STORAGE OF WHOLE BLOOD INFLUENCES THE RESPONSE OF REDCELLS TO AN ALKALINE STORAGE MEDIUMD. de Korte, H.G.H. Korsten, A.J. Verhoeven (Sanquin Research, Amsterdam, Netherlands)P-336 STORED RED CELL CONCENTRATES OF HEMOCHROMATOSISPATIENTS: ARE THEY DIFFERENT?M. Luten, B. Roerdinkholder-Stoelwinder, E. Rombout-Sestrienkova, H.J. Bos, W.J. de Grip,G.J.C.G.M Bosman, V.M.J. Novotny (Sanquin Blood Bank South East Region, Nijmegen,Netherlands)109P-328 EMPOWERMENT OF LABORATORY STAFF TO IMPLEMENT LOCALGUIDELINES IS HIGHLY EFFECTIVE IN PREVENTING INAPPROPRIATETRANSFUSIONS AND ENABLES BLOOD CONSERVATIONJ. Watts, D. Stokes, D. Green, T. Turner (Basildon University Hospital, Basildon, United Kingdom)P-329 NEW ADDITIVE SOLUTION FOR IMPROVED STORAGE OF REDBLOOD CELLS (RBC)M. Löf, C.F. Högman (University Hospital, Uppsala, Sweden)P-337 EVALUATION OF THE IN VITRO QUALITY OF FROZEN AND THAWEDRED CELLS PROCESSED WITH THE HAEMONETICS ® ACP ® 215J.W.M. Lagerberg, R. Truijens-de Lange, D. de Korte, A.J. Verhoeven (Sanquin Research,Amsterdam, Netherlands)P-330 EXTENDED RED CELL ANTIGEN TYPING OF BLOOD DONORS USINGTHE PK7200S. Valensky (Western Province Blood Transfusion Servi, Cape Town, South Africa)P-331 COMPARISON OF IN VITRO BLOOD COMPONENT QUALITY USINGTWO DIFFERENT DESIGN BUTANE-1,4-DIOL COOLING SYSTEMSP.F. van der Meer, M. Eijzenga, W. Karssing, R.N.I. Pietersz (Sanquin Blood Bank North WestRegion, Amsterdam, Netherlands)P-332 INVESTIGATION OF MIXING OF WHOLE BLOOD UNDER VARIOUSFLOW RATES USING THE HEMOLIGHT PLUS COLLECTION MIXERP.F. van der Meer, I.J. Bontekoe, R.N.I. Pietersz (Sanquin Blood Bank North West Region,Amsterdam, Netherlands)P-338 EFFECT OF THE PH ON THE ATP CONTENT AND GLYCOLITIC ACTI-VITY OF THAWED RED CELLSJ.W.M. Lagerberg, R. Truijens-de Lange, D. de Korte, A.J. Verhoeven (Sanquin Research,Amsterdam, Netherlands)P-339 CORRELATION BETWEEN REQUESTS OF BLOOD AND ITS PRODUCTSAND BLOOD TRANSFUSION IN A UNIVERSITY HOSPITAL IN GREECEK. Zervou, K. Ziciadis, E. Xanthi, A. Tzolou, E. Chrisostomou, F. Karabini (University Hospital ofIoannina, Ioannina, Greece)P-340 RED BLOOD CELL TRANSFUSION POSITIVELY IMPACTS SURVIVAL INPATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATIONS.G. Ganguly, P. Bradley, S. Patel, L. Divine, S. Skikne, C. Bodensteiner (University of KansasMedical Center, Kansas City, United States of America)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 02.4TOPIC 03.1The posters areon display fromMonday - ThursdayP-341 A CASE OF A PATIENT WITH MCLEOD PHENOTYPE AND CGD WHODID NOT PRODUCE ANTI-KX REGARDLESS OF PACKED RED CELLSTRANSFUSIONS FROM RANDOM DONORS DURING NONMYELOABLATIVECORD BLOOD TRANSPLANTATIONP-348 HAEMOSTATIC DISORDERS IN PATIENTS WITH EPH-GESTOSIST.T. Timova, L. Maninska, S. Ortakovska, E. Kocovska, R. Madzunkov, S. Kostovska(General hospital-Strumica, Strumica, Macedonia)Y. Tani, J. Takahashi, F. Hirayama, N. Hatakeyama, M. Yamamoto, Y. Kuroiwa, N. Mizue,M. Yoda, Y. Sakiyama, N. Suzuki, H. Shibata (Japanese Red Cross Osaka Blood Center,Topic 03.1.Osaka, Japan)P-342 MULTI-ETHNIC DONOR GENOTYPING ON THE COMMON SINGLENUCLEOTIDE POLYMORPHISMS ENCODING RED BLOOD CELL ANTIGENSDOES NOT RELIABLY PREDICT RED BLOOD CELL PHENOTYPESHaemostasis - Recent Therapeutic AdvancesP-349 PLATELET GEL IN POST-SURGICAL INFECTED WOUNDSHEALING IN HEART SURGERYP. A. Maaskant - van Wijk, M. Feskens, J.D. van Wintershoven, L. Douglas-Berger, M.S. Misso, B. Feola, L. Paesano, M. D'Onofrio, G. Fratellanza, E. D'Agostino, E.M. Bruno,Bogaerts, D.J. van Rhenen (Sanquin Bloodbank Southwest Region, Rotterdam, Netherlands)M. Nigro, A. Minerva (Unit Operative Haemapheresis, Caserta, Italy)110P-343 INCIDENCE OF ALLOIMMUNIZATION IN BLACKS FROM AFRICA VS. USAM. Moulds, G. Noumsi, A. Tounkara, Y. Guindo, J.M. Moulds (LifeShare Blood Centers,P-350 NEUROSURGERY IN A HEMOPHILIC CHILD WITH CENTRALNERVOUS SYSTEM HEMORRHAGE111Shreveport, La, United States of America)O.W. Torres, A.M. Ferro, S. Ouvina, S. Pascuccio, J. Pollola, G. Paoloski, D. Gercovich,P-344 RE-ESTABLISHING OF STORED RBC’S CHARACTERISTICS STUDIEDBY FLOW CYTOMETRYL. Di Tullio Budassi, F. Relancio, B. Riquelme, P. Foresto, J. Valverde (Fac. Cs. Bioq. y Farm -A. Paz, M.A. Cermelj (William Osler Institute, Buenos Aires, Argentina)P-351 RECOMBINANT FVII TREATMENT IN A HEMOPHILIA A PATIENT WITHHIGH TITER INHIBITOR AND CENTRAL NERVOUS SYSTEM HEMORRHAGEUNR, Rosario, Argentina)O.W. Torres, A.M. Ferro, S. Ouvina, S. Pascuccio, J. Pollola, G. Paoloski, D. Gercovich,P-345 RED BLOOD CELL PHENOTYPE DETERMINATION OF 2,345 NEWYORK BLOOD DONORS BY DNA ANALYSIS IN A BEADCHIP FORMATG. Hashmi, T. Shariff, J. Cristobal, Y. Zhang, C. Chau, M. Seul, P. Vissavajjhala, K. Hue-Roye,A. Paz, M.A. Cermelj (William Osler Institute, Buenos Aires, Argentina)P-352 THROMBOPHILIC MARKERS FREQUENCY IN THE PATIENTS WITHDEEP VENOUS THROMBOSISD. Charles-Pierre, C. Lomas-Francis, C. Baldwin, M. Reid (Bioarrays Solutions, Warren,B. Kostovska, M. Stegnar, V. Neceva, C. Dimova, J. Pejceva, M. Blazevska, L. JamovskiUnited States of America)(Institute of blood Transfusion, Skopje, Macedonia)P-346 ALLOIMMUNIZATION AGAINST RBC (RED BLOOD CELL)TRANSFUSIONS IN PATIENTS OF THE REGIONAL BLOOD BANKOF LONDRINA – PARANÁ - BRAZILTopic 03.2.M. Saito, M.R.S. Turra, A.N.J. Koti, K.M. Arai, L.G.F.T. Turkowski, C.C. FauneHaemostasis - Related to Blood Transfusion(Hemocentro Regional Londrina, Londrina, Brazil)P-347 AUTOMATED DOUBLE VS. STANDARD RBC COLLECTION:CHARACTERICS OF PRODUCTS AND ITS CLINICAL EFFICACYP-353 CRYOPRECIPITATE-REMOVED PLASMA 'CRYO-REMOVED PLASMA'AS A SOURCE OF FACTOR IX IN THE TREATMENT OF HEMOPHILIA BP. Lepatan, M. Chua, F. Hernandez, M. Montoya, J. Ong, E. Rodriguez (Hemophilia Center ofP. Accorsi, M. Dell'Isola, P. Striani, F. Esattore, S. Falorio, M. Profico, G. Di Bernardo,Cebu, Cebu, Philippines)A. Iacone, P. Accorsi (Pescara Civil Hospital, Pescara, Italy)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 03.2The posters areon display fromMonday - ThursdayTOPIC 03.3The posters areon display fromMonday - Thursday112P-354 BERNARD SOULIER SYNDROM IN IRANF. Razjou (Iranian Blood Transfusion Research Centre, Tehran, Iran)P-355 HAEMORHEOLOGICAL ALTERATIONS IN NIGERIANTRANSFUSED PATIENTSI. Ajayi (University of Benin, Benin City, Nigeria)P-356 CORRECTION OF HEMOSTASIS SYSTEM IN PATIENTSWITH TYPHOID BLEEDINGSB. Bahovadinov, A. Vahidov (Republican Sientific Centre of Blood, Dushanbe, Tajikistan)P-357 THE USE OF RECOMBINANT FVIIA (RFVIIA) IN PATIENTS WITHUNCONTROLLABLE SURGICAL OR POST SURGICAL BLEEDINGP. Kotsi, M. Gavalaki, I. Anastasopoulou, O. Katsarou, G. Kanellopoulou, A. Karafoulidou(Laikon General Hospital, Athens, Greece)P-358 ASSESSMENT OF FRESH FROZEN PLASMA USAGE AT THECLINICAL HOSPITAL CENTER RIJEKAN. Vukelic-Damijani, S. Balen, L. Caser (Clinical Hospital Center, Rijeka, Croatia)P-362 REMISSION OF SEVERE THROMBOTIC THROMBOCYTOPENICPURPURA REFRACTORY TO INTENSE PLASMA EXCHANGE WITH SMALLDOSES OF RITUXIMAB THERAPYI. Karadogan, A. Ugur-Bilgin, K. Temizkan, L. Undar (Akdeniz University School of Medicine,Antalya, Turkey)P-363 THERAPEUTIC PLASMA EXCHANGE IN THROMBOTICMICROVASCULAR SYNDROMSD. Barz (Institute of Transfusionmedicine, Jena, Germany)P-364 EMPLOYMENT OF HUMAN ALBUMIN SOLUTION AND FRESHFROZEN PLASMA AS FLUID REPLACEMENT IN PATIENTS TREATEDWITH PLASMAEXCHANGE FOR TTPL. Salvaneschi, C.G. Perotti, P. Bergamaschi, G.L. Viarengo, C. Del Fante (IRCCS Policlinico"San Matteo", Pavia, Italy)Topic 04.1.113P-359 FREQUENCY OF TRANSMISIVE VIRUS MARKERS AT HEMOPHILIANSIN CORELLATION WITH HEPATIC FUNCTIONS.K. Kostovska, V. Filipche, V.N. Neceva, P.J. Pejceva, I.S. Ilievska, D.V. Dejanova,D.N. Dimovska (Institute of Blood Transfusion, Skopje, Macedonia)Pathogen Reduction/Inactivation - Red CellsP-365 HEMOCOMPATIBILITY OF P-CAPT? PRION REDUCTION FILTERST. Lathrop, M. Poncheri, L. Gheorghiu, D. Hammond (American Red Cross, Rockville,United States of America)Topic 03.3.Haemostasis - Thrombotic Thrombocytopaenic Purpura (TTP)P-360 SOLVENT/DETERGENT TREATED PLASMA, OCTAPLAS ANDUNIVERSALLY APPLICABLE PLASMA, IN TTP AND HUS: QUANTIFICATIONOF ADAMTS13 AND FACTOR H LEVELSA. Heger, C. Kannicht, J. Römisch, T.E. Svae (Octapharma Pharmazeutika ProduktionsgmbH,Vienna, Austria)P-361 RELAPSING THROMBOTIC THROMBOCYTOPENIA PURPURAFOLLOWING CORONARY ARTERY VEIN GRAFT SURGERYR. Sinha (Singh), D. Roxby, C. Kollias (Flinders Medical Centre, Adelaide, Australia)Topic 04.2.Pathogen Reduction/Inactivation - PlateletsP-366 PLATELET CONCENTRATES PRODUCED BY THE ORBISAC BCSYSTEM AND TREATED WITH THE INTERCEPT BLOOD SYSTEM:EVALUATION OF THE IN VITRO PLATELET QUALITYS. Misso, M. Nigro, G. Fratellanza, G. Aurioso, E. D'Agostino, R. Sepulveres, E.M. Bruno,S. Formisano (Unit Operative Haemapheresis, Caserta, Italy)P-367 PHOTOCHEMICAL TREATMENT WITH AMOTOSALEN AND UVALIGHT INACTIVATED HIGH TITERS OF AN EMERGING SOUTH FRANCEVIRAL STRAIN OF WEST NILE VIRUSC. Vignoli, P. Gallian, A.M. Dombey, L. Lin, V. Mayaudon, Ph. de Micco (EtablissementFrançais du Sang, Marseille, France)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 04.2The posters areon display fromMonday - ThursdayTOPIC 04.2P-368 THE EFFICACY OF PHOTOCHEMICAL TREATMENT WITH AMOTOSALENAND UVA (INTERCEPTTM) FOR THE INACTIVATION OF TRYPANOSOMECRUZI (T.CRUZI) IN BUFFY COAT DERIVED PLATELET COMPONENTSE. Castro, N. Girones, J.L. Bueno, J. Carrion, M. Fresno (Centro de Transfusión Cruz RojaEspañola, Madrid, Spain)P-377 INACTIVATION OF HIGH LEVELS OF BACTERIA USING THE INTER-CEPT BLOOD SYSTEM UNDER ROUTINE BLOOD BANK PROCEDURESA. Ontanon, I. Romon, C. Hurtado, J. Hsu, L. Lin, V. Hermosa (Banco de Sangre deCantabria, Santander, Spain)P-369 THERAPEUTIC EFFICACY AND SAFETY OF TRANSFUSION OFPATHOGEN-INACTIVATED PLATELETS TO PEDIATRIC PATIENTSL. Van Haute, Y. Benoit, V. Bordon, B. De Moerloose, E. Vandecruys, S. Van Lancker,M. Van Vooren, B. Vandekerckhove (Red Cross Flanders, Gent, Belgium)P-378 IMPACT OF PHOTOCHEMICAL TREATMENT (INTERCEPT)ON PLATELET USE IN ROUTINE PRACTICEJ.C. Osselaer, C. Doyen, C. Chatelain, C. Debry, M. Goffaux, N. Messe, M. van Hooydonk,A. Sonnet, A. Bosly, J.S. Lin, L. Corash (Cliniques Universitaires de Mont Godinne, Yvoir,Belgium)P-370 PATHOGEN INACTIVATION OF TRYPANOSOMA CRUZI IN PLATELETCONCENTRATES WITH RIBOFLAVIN AND UV LIGHTL.J. Cardo, J. Salata, J. Mendez, H. Reddy, R. Goodrich (Walter Reed Army Institute ofResearch, Silver Spring, United States of America)P-379 A PROSPECTIVE OBSERVATIONAL COHORT SAFETY STUDY OF5,106 PLATELET TRANSFUSIONS PREPARED WITH PHOTOCHEMICALTREATMENT (INTERCEPT)J.C. Osselaer, N. Messe, T. Hervig, J.L. Bueno, E. Castro, A. Espinosa, A. Iacone, K. Junge,M. Jacquet, J. Flament, L. Corash (Cliniques Universitaires de Mont Godinne, Yvoir, Belgium)114P-371 AGITATION DURING TREATMENT IMPROVES THE INACTIVATION OFPATHOGENS IN PLATELET CONCENTRATES BY UVB IRRADIATIONH. Mohr, A. Bayer, F. Tolksdorf, W.H. Walker, T.H. Mueller (Blood Center of the German RedCross, Springe, Germany)P-380 ROUTINE PRODUCTION OF INTERCEPT-TREATED APHERESISPLATELET CONCENTRATES FOR PEDIATRIC PATIENTSM. Stiegler, V Witt, P Mörtl, G Leitner, P Höcker (Medical University of Vienna, Vienna, Austria)115P-372 TRANSFUSION OF PATHOGEN INACTIVATED PLATELETCONCENTRATES IN CHILDRENV.W. Witt, G. Stiegler, P. Höcker, C. Peters, H. Gadner (St. Anna Kinderspital, Vienna, Austria)P-374 STORAGE OF APHERESIS AND POOLED BUFFY-COAT PLATELETCONCENTRATES TREATED WITH PATHOGEN INACTIVATION USING THEINTERCEPT BLOOD SYSTEMP. Schlenke, V. Franck, L. Lin, H. Kirchner (University Lübeck School of Medicine, Lübeck,Germany)Topic 04.3.Pathogen Reduction/Inactivation - PlasmaP-381 QUALITY OF METHYLENE BLUE PLASMA OVER THE LAST FIVEYEARSA. Castrillo, A. Eiras, J. Cid, A. Castro, M. Adelantado, M. Abalo, C. Areal, J. Flores,J. Cabrera (Centro de Transfusion de Galicia, Santiago De Compostela, Spain)P-375 EVALUATION OF THE INTERCEPT BLOOD SYSTEM FOR AMICUSAPHERESIS PLATELET CONCENTRATES: MEETING TARGET PRODUCTCHARACTERISTICSM. Lambermont, R. de Meuter, G. Bastin (Service du Sang, Belgian Red Cross, Brussels, Belgium)P-382 COMPARATIVE STUDY OF TREATED AND UNTREATED FRESHFROZEN PLASMA AS SOURCE OF FIBRINOGEN CONCENTRATESOBTAINED FROM METHYLENE BLUE TREATED PLASMA FROMMACO PHARMA MACO-TRONIC SYSTEME. Lachert, J. Kubis, J. Antoniewicz-Papis, A. Goller, M. Letowska, G. Kulla(Institute of Hematology, Warsaw, Poland)P-376 PHOTOCHEMICAL PATHOGEN INACTIVATION OF HIGH-DOSE APHERESISPLATELET CONCENTRATES USING THE INTERCEPT BLOOD SYSTEMJ.C. Osselaer, C. Debry, M. Goffaux, M. van Hooydonk, V. Mayaudon, L. Lin, L. Corash(Mont-Godinne University Hospital, Yvoir, Belgium)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 04.3The posters areon display fromMonday - ThursdayTOPIC 05.1The posters areon display fromMonday - ThursdayP-383 MINI-POOL SOLVENT/DETERGENT VIRAL INACTIVATION OF PLASMAAND CRYOPRECIPITATE IN A DISPOSABLE BAG SYSTEM BY BLOODCENTERSTopic 05.1.Donor Management - Developing Donor ProgramsT. Burnouf, H.A. Goubran, M. Radosevich, M.A. Sayed, G. Gorgy, M. El-Ekiaby (HumanPlasma Product Services, Lille, France)P-390 A CASE - CONTROLLED STUDY OF CONTRIBUTING FACTOR FORVASOVEGAL REACTION IN BLOOD DONORS116P-384 MIRASOL PATHOGEN REDUCTION TREATED FRESH FROZENPLASMA MAINTAINS PROTEIN QUALTITYK.A. Buytaert-Hoefen, D. Gampp, R. Edrich, R. Goodrich (Navigant Biotechnologies,Lakewood, United States of America)P-385 COAGULATION FUNCTION IN FRESH FROZEN PLASMA PREPAREDWITH TWO PHOTOCHEMICAL TREATMENT METHODSJ.C. Osselaer, C. Debry, M. Goffaux, E. Dubuc, B. Chatelain, M. Rheinschmidt, L. Lin(Mont-Godinne University Hospital, Yvoir, Belgium)P-386 THERAFLEX MB-PLASMA PROCEDURE: PLASMA QUALITY AFTER15 MONTH STORAGE AND REDUCTION OF METHYLENE BLUE ANDPHOTOPRODUCTSS. Reichenberg, W.H. Walker, A. Hoburg, N. Müller (Maco Pharma International GmbH,Langen, Germany)L. Kasraian, A. Torab Jahromi, B. Farahangiz (IBTO Research Center, Shiraz, Iran)P-391 EDUCATIONAL PROGRAMS FOR HEALTH WORKERS, PATIENTS ANDRELATIVES, WITH SPECIAL TOPIC IN ONCOHEMATOLOGY DISEASES ANDTRASNFUSION MEDICINE SUPPORT, INCLUDING MANAGEMENT OF THEDONATION PROCESSC.D. Dufour, N. Carballido, F. Dufour, S. Bogosevich, J. Fischer, M.F. Morgante, A. Drago,M. Aleman, A. Di Cosimo, M.A. Candia, Z.P. Labrana, J. Maurizio, M.C. del Rodriguez, B. Coda,V. Garcia, A. Perotti, B. Riquelme, M. Martinez, S. Cersosimo, M.F. Bujia, F. Barros, N. Choudjury,L. Bouzas, E. Dufour (Argencord, Un Cordon para la Vida, Buenos Aires, Argentina)P-392 ENGAGING PRIVATE SECTOR IN BLOOD DONOR MOBILIZATIONN. Wangendo (Bloodlink foundation, Nairobi, Kenya)P-393 FREQUENCY OF BLOOD DONATIONS BY PEOPLE WITHHEREDITARY G-6-PD DEFICIENCY117P-387 COAGULATION FACTOR ACTIVITY IN 180 ML AND 325 ML UNITS OFPHOTOCHEMICALLY TREATED PLASMA (INTERCEPT PLASMA) AFTERSTORAGE FOR 12 MONTHS AT -18ºCL. Pinkoski, T. Peterson, J. Bayat, H. Evans, Y. Singh, L. Corash (Cerus Corporation,I. Bayramalibeily, A. Ragimov, N. Gaibov (Moscow Medicin Academy, Moscow,Russian Federation)P-394 EFFECT OF IMPLEMENTING THE BLOOD DONOR NATIONAL SELECTIONCRITERIA ON BLOOD UNITS DISCARD RATE, EGYPT EXPERIENCEConcord, United States of America)F. Moftah (NBTS, MOH, Giza, Egypt)P-388 FRESH FROZEN PLASMA FOR MANAGEMENT OF HEMOSTASISDURING MINOR AND MAJOR SURGICAL PROCEDURES ASSOCIATEDWITH COAGULOPATHYP-395 HEREDITARY HEMOCHROMATOSIS. TREATMENT AND BLOOD DONORSV. Fakitsa, M. Papakonstantinou, A. Flangini, V. Syriou, G. Lyrakos, K. Maltezis, K. Toumanidi,K. Sofroniadou (District General Hospital of Nikea, Athens, Greece)L. Corash, N. Bass, L. Petz, R. Steadman, M. Streif, J. McCullough, P.D. Mintz(Cerus Corporation, Concord, United States of America)P-389 STABILITY OF COAGULATION FACTORS IN PLASMA PREPARED WITHPHOTOCHEMICAL TREATMENT (INTERCEPT) STORED FOR ONE YEARP-396 COMPARISION EVALUATION OF HEMOGLOBIN (HB) MEASURMENTBY COLOR SCALE AND AUTOMATED CELL BLOOD COUNTER IN FEMALEBLOOD DONORSM.R. Deyhim (Iranian Blood Transfusion Research Centre, Tehran, Iran)J.P. Cazenave, H. Isola, M.L. Wiesel, D. Kientz, M. Laforêt, V. Mayaudon, L. Pinkoski, Y. Singh,L. Corash (Etablissement Français du Sang - Alsace, Strasbourg, France)P-397 DONORS WITH HYPERFERRITINEMIAG. Garozzo, P. Bonomo, L. Morando (Az. Ospedaliera Civile-Mparezzo, Ragusa, Italy)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 05.1TOPIC 05.1P-398 ELECTROPHORETIC CONTROL OF SERUM PROTEIN INVACCINATED PLASMA DONORS IN THE PLASMAPHERESIS PROGRAMP-407 DONOR SELECTION CRiTERIA AS A MEANS OF SAFE BLOODTRANSFUSION PRACTICES IN WESTERN UGANDAO. Savic, I. Jaglicic, M. Saracevic, N. Vavic, M. Sindjic, S. Pelevic (National Blood TransfusionL. Tumwesigye, G. Kansiime (Uganda Service, Fort Portal, Uganda)Institute, Belgrade, Serbia and Montenegro)P-399 DONOR CARE FOR DEFERRED DONORS IN A DEVELOPING COUNTRYP-408 SECURING ADEQUATE AND SAFE BLOOD SUPPLY FOR MULTITRANS-FUSED PATIENTS WITH THALASSAEMIA : A COMPUTERIZED PROGRAMMEJ.P. Allain, S. Owusu-Ofori, O. Opare-Sem, F. Sarkodie, R. Rahman (University of Cambridge,C. Politi, C. Politis, S. Fragatou, A. Antypas, C. Armyros, K. Ventiadi, V. Malamou, P. Katsea,Cambridge, United Kingdom)C. Richardson (Hospital "G.Gennimatas", Athens, Greece)P-400 INSIDENCE OF VIRAL MARKERS AND SYPHILIS ANTIBODIES INBLOOD DONORS OF HIGH SCOOLS IN KUMANOVOP-409 A PILOT PROJECT IN YOUTH BLOOD DONOR RECRUITMENTM. Dambuza, I. Tema, S. Gaolekwe, B. Gibbs, M. Kayembe, J. van Hasselt (Safe Blood forL. Slavkovska (Medical Center, Kumanovo, Macedonia)Africa Foundation, Johannesburg, South Africa)P-401 EVALUATION OF THE DOUBLE RED BLOOD CELLS COLLECTIONUSING ALYX IN KOREAN BLOOD DONORSP-410 NEW DONOR SYSTEM FOR THE PATIENT WITH THALESSEMIA:BLOOD MOTHER AND BLOOD FATHER118M.J. Kim, D.H. Seo, K.N. Lee, H.R. Chung, O.J. Jeong, N.S. Cho, I.K. Paik, H.O. Kim,J.S. Seo (Korean Red Cross, Seoul, South-Korea)D. Canatan, G. Alanoglu, H. Dirican, N. Balta, N.O. Oguz, K.C. Karadogan, R. Cosan(Suleyman Demirel University, Isparta, Turkey)119P-402 BLOOD-DONOR SHIP IN PROVINCIAL ADMINISTRATIONB. Belic, A. Stajic, E. Sumec (Assembly of Vojvodina, Novi Sad, Serbia and Montenegro)P-411 IMPACT OF ALLOGENEIC 2-UNIT RBC APHERESIS ON IRONSTORES OF BRAZILIAN BLOOD DONORSP-403 THERAPEUTIC RED CELL DEPLETION WITH THE CYMBALAUTOMATED BLOOD COLLECTION SYSTEMP. Poullin (University Hospital La Conception, Marseille, France)P-404 BLOOD DONOR CLUBS AS AN AVENUE FOR SUFFICIENT SAFE BLOODP.K. Mukuria, M. Wheeler, J. Mwangi (Hope World Wide, Nairobi, Kenya)P-405 PROJECT MANAGEMENT AS A RECOMMENDABLE APPROACH TOIMPROVE DONOR MANAGEMENT IN RESTRICTED ECONOMY COUNTRIES(PRELIMINARY RESULTS)A.M.J Mendrone Junior, C.A. Arrais, S.A.M. Gualandro, S.C. Chen, E.M. Murphy, E.C.S. Sabino,D.A.F. Chamone (Fundação Pro-Sangue/Hemocentro de SP, São Paulo, Brazil)P-412 EVALUATION OF THE DOUBLE RED BLOOD CELLS COLLECTIONUSING ALYX IN KOREAN BLOOD DONORSM.J. Kim, D.H. Seo, K.N. Lee, H.R. Chung, O.J. Jeong, N.S. Cho, I.K. Paik(Korean Red Cross, Seoul, South-Korea)Topic 05.2.C.Th. Smit Sibinga, A.P.M. Los, W.P.A. van der Tuuk Adriani (Academic Institute IDTM,Groningen, Netherlands)P-406 RECALLING BLOOD DONORS: A STUDY EVALUATING THEWILLINGNESS OF IRANIAN BLOOD DONORS TO DONATE AGAINAND TO BE RECALLEDM. Maghsudlu, M. Maghsudlu, S. Nasizadeh, M.M. Seyfi (Research Center-Iranbloodtransfusionorg, Tehran, Iran)Donor Management - Recruiting and Managing DonorsP-413 DONOR SATISFACTION - KEY POINT OF DONOR MANAGEMENTSTRATEGYR. Jovanovic, V. Kulidzan, V. Ubavin (Blood Transfusion Institute, Novi Sad, Serbia and Montenegro)P-414 DOUBLE RED BLOOD CELL COLLECTION WITH ALYX: AN ITALIANMULTICENTER EXPERIENCE ON DONOR ACCEPTANCE AND SAFETYP. Accorsi, G. Nardi, O. de Masi, D. Spadini, F. Gianmattei, S. Falorio, F. Esattore, A. Iacone(Pescara Civil Hospital, Pescara, Italy)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 05.2The posters areon display fromMonday - ThursdayTOPIC 05.2P-415 FACTORS IN THE LOW RECRUITMENT OF VOLUNTARY BLOODDONORS AMONG ELIGIBLE NIGERIANSJ.O. Adewuyi, H.O. Olawumi (University of Ilorin, Ilorin, Nigeria)P-424 PREVALENCE, SPECIFICITY AND TITRE OF ALLO-ANTIBODIES INVOLONTARY BLOOD DONATIONS AND IN THE CORRESPONDING BLOODPRODUCTSP-416 CHANGING BLOOD DONORS PROFILE IN RIO DE JANEIRO,BRAZIL: 1988-2004L.A. Amorim, M.E. Lopes, L.M. Amorim, M. Cardoso, C. Lobo, L. Silva, K.M.M. MottaB.M. Frey, E. Matheis, A. Böhlen-Bodmer, B. Grossrieder (Regional Blood Transfusion Service,Zürich, Switzerland)P-425 EVALUATION OF THE REACTIONS IN 77799 BLOOD DONATIONS(Hemorio, Rio De Janeiro, Brazil)G. Garozzo, L. Morando, C. Furnaro, M. Accardo, B. Campo, S. Parrino, G. Savasta,120P-417 WHOLE BLOOD DONOR DEFERRAL RATE AND REASONSFOR THE TURKISH POPULATIONO. Arslan, Y. Ozer (Ankara University, Ankara, Turkey)P-418 EFFECTS OF DONOR VARIABLES ON PLATELET YIELD IN DOUBLE-UNIT PLT CONCENTRATES COMPARED TO TRIPLE-UNIT PLT CONCENTRATESB. Baumann-Baretti, G.B. Jaster, K.P. Krause (Haema, Leipzig, Germany)P-419 VARIABILITY IN BLOOD DONOR SCREENING BY PHISICIANSAND CORRELATION WITH SEROLOGICAL MARKERS IN HEMOMINASFOUNDATION, BRAZILA.B.F. Carneiro-Proietti, F.C.M. Loureiro, A.N. MartinsL. Vitale, M. Cascone, P. Bonomo (Az. Ospedaliera Civile-Mparezzo, Ragusa, Italy)P-426 DONOR MOTIVATION AND RECRUITMENT PROCESS (SPECIALREFERENCE TO NEPAL RED CROSS, BLOOD TRANSFUSION SERVICEPROGRAM)K. Ghimire (Nepal Red Cross Society, Kathmandu, Nepal)P-427 SURVEY OF BLOOD DONATIONS IN REPUBLIC OF MACEDONIAFROM 1997 TILL 2005R. Grubovik, M. Blagoevska, M. Grubovik, V. Stefanovska, S. Kostovska, T. Makarovska,E. Velkova (National Institute for Transfusion Medic, Skopje, Macedonia)P-428 POLICE SERVICE AND BLOOD DONATION IN REPUBLIC OF MACEDONIA121(Hemominas Foundation, Belo Horizonte, Brazil)R. Grubovik, M. Blagoevska, M. Grubovik, S. Kostovska, V. Stefanovska, E. Velkova,P-420 KNOWLEDGE ABOUT BLOOD DONATION AND HIV INFECTIONSAMONG FIRST TIME AND REPEAT VOLUNTARY NON-REMUNARATEDBLOOD DONORS (VNRBD)N. Choudhury, J. Shah (Prathama Blood Center, Ahmedabad, India)T. Makarovska, J. Samonikov, S. Stojkoska (National Institute for Transfusion Medic, Skopje,Macedonia)P-429 A UNIQUE APPROACH TO DONOR RECRUITMENT WHEREBY APRIMARY SCHOOL ADOPTS A FIXED SITE DONOR CENTRE FOR A MONTHP-421 COMPARATIVE EVALUATION OF HEMOGLOBIN (HB) MEASUREMENTBY COLOR SCALE AND AUTOMATED CELL BLOOD COUNTER IN FEMALEBLOOD DONORSM Harris, I.W. Simpson, M. Griesel (South African National Blood Service (SANBS),Port Elizabeth, South Africa)P-430 TODAY AND TOMORROW (tm) CONCEPT IN DONOR RECRUITINGM. Deyhim (Iranian Blood Transfusion Research Centre, Tehran, Iran)M Harris, I.W. Simpson, M. Griesel (South African National Blood Service (SANBS),P-422 A TWO YEARS EXPERIENCE OF IMPLEMENTING DOUBLE RED CELLCOLLECTION WITH THE ALYX COMPONENT COLLECTION SYSTEMPort Elizabeth, South Africa)P-431 AUTOMATED COLLECTIONS, MAXIMIZING EVERY DONATIONG.A. Fabian (Institute for Transfusion Medicine Suhl, Suhl, Germany)R. Hein, S. Ballew, J. Gardner (United Blood Services, Las Vegas, United States of America)P-423 CERTIFICATION OF A PARTNERSHIP BETWEEN A BLOODTRANSFUSION ESTABLISHMENT (BTE) AND VOLUNTARY BLOODDONOR ASSOCIATIONS: A FIVE-YEAR EXPERIENCEP-433 VISTA INFORMATION SYSTEM: HOW DOES THE INCREASEDOPERATIONAL EFFICIENCY RESULT IN A FINANCIAL BENEFIT FORBLOOD CENTERS?G. Follea, C. Adjou, C. Cornet, L.H.B. Henry-Baudot (EFS, Nantes, France)F. Hofman, M. Debost, S. Rummler, M.A. Perez Vaquero (Gambro BCT, Zaventem, Belgium)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 05.2TOPIC 05.2P-434 THE IMPACTS OF RED BLOOD CELL SIZE ON THE HARVEST OFPLATELETS BY APHERESISP-443 LOOKING AT FACTORS GOVERNING FAILURE RATE IN PHLEBOTOMOYS.L. Loh, C.L. Toh, N. Mohd Amir, M. Koh, D. Teo (Health Sciences Authority, Singapore,H.Y.S Hung, W. Chiou-Hua, L. Wen-Chuan, L. Su-Jen, L. Kuo-Sin (Taipei BloodSingapore)Center,T.B.S.F, Taipei, Taiwan)P-435 A STUDY OF KNOWLEDGE, ATTITUDE AND PRACTICE OF WOMENABOUT BLOOD DONATIONP-444 COMPARISON OF HAEMOGLOBIN CONCENTRATION IN BLOODDONORS BEFORE AND AFTER DONATION, AND DETERMINATION OFTHEIR IRON STORESH. Javadzadeh Shahshahani (Research Center of Iranian BTO, Yazd, Iran)K.M. Magnussen, N.F.A. Fogh-Andersen (Herlev University Hospital, Copenhagen C,122P-436 KNOWLEDGE, ATTITUDE AND PRACTICE (KAP) STUDY ABOUTBLOOD DONATION IN THE URBAN POPULATION OF YAZD, IRAN, 2004H. Javadzadeh Shahshahani, M. Attar, M. Yavari (Research Center of Iranian BTO, Yazd, Iran)P-437 STRATEGIES FOR INCREASING SAFER BLOOD SUPPLIES IN KENYAE.M. Kitangala, J.A. Nyamongo, J. Mwangi (National Blood Transfusion Service Kenya,Nairobi, Kenya)P-438 NEW METHODS FOR DETERMINING HEMOGLOBIN/HEMATOCRITFOR DONOR ELIGIBILITYM. Kline, V. George, P. Sabol (American Red Cross, Rockville, United States of America)P-439 A STUDY OF THE SOUTH AFRICAN PUBLIC’S KNOWLEDGE,ATTITUDE AND PERCEPTIONS WITH REGARD TO BLOOD TRANSFUSIONP.M. Knox, R. Swanevelder, G. Nothard, I. Van Schalkwyk (South African National BloodService, East London, South Africa)P-440 IS THERE AN INCREASE IN DONOR DEFERRALS?P.M. Knox, M Mack (South African National Blood Service, East London, South Africa)P-441 PRODUCTION OF DOUBLE UNITS OF PRBC USING THE ALYXCOMPONENT COLLECTION SYSTEM IS A SAFE AND TIME SPARINGPROCEDUREC. Leitner, J. List, G. Stiegler, M. Horvath, A. Wagner, P. Hoecker (Clinic for Blood GroupSerology and Tran, Vienna, Austria)P-442 CURRENT STATUS OF PREPARATIVE GRANULOCYTE APHERESIS:DONOR SELECTION, INDICATIONS AND TECHNIQUESC. Leitner, G. Stiegler, J. List, N. Worel, P. Hoecker (Clinic for Blood Group Serology and Tran,Vienna, Austria)Bagsvaerd, Denmark)P-445 IRON STORES IN BLOOD DONORS LOW IN HAEMOGLOBINCONCENTRATION AND COMPARISON OF TWO METHODS FORMEASURING THE HAEMOGLOBINCONCENTRATIONK.M. Magnussen, N.B. Bork, L.A. Asmussen (Herlev University Hospital, Copenhagen C,Bagsvaerd, Denmark)P-446 RAPID RESULTS INITIATIVE APPROACH FOR DONORRECRUITMENT IN SRI LANKAH.A.C.S Manchanayake, Z.S. Bharucha (National Blood Transfusion Service, Colombo 05,Sri Lanka)P-447 FACTORS THAT MOTIVATE AND HINDER BLOOD DONATION IN GREECEO. Marantidou, L. Loukopoulou, E. Zervou, G. Martinis, A. Egglezou, K. Fountouli,E. Xassapopoulou, S. Noussis, P. Dimoxenou, M. Parara, M. Gavalaki, D. Mixopoulos,A. Maniatis (Asklipion Hospital, Athens, Greece)P-448 A COMPARISON OF DONOR RETURNS BEHAVIOR OF FIRST TIMEDONORS WHO WERE RECRUITED/NOT RECRUITED AFTER FIRSTDONATION IN ISFAHAN BLOOD TRANSFUSION CENTERZ. Massaeli, M.R. Jaberi, M.M. Hariri (Iranian Blood Transfusion Organisation, Isfahan, Iran)P-449 SHOULD WE CONTINUE TO COLLECT DONORS WITH SICKLEBLOOD CELL TRAITC. Maugard, O. Nasr, C. Bichouard, P. Aguilar-Martinez, J. Coste (EFS PyrénéesMediterranée, Montpellier, France)P-450 SHOULD WE CONTINUE TO COLLECT DONORS WITH SICKLEBLOOD CELL TRAITC. Maugard, O.N. Nasr, C.B. Bichouard, P.A.M. Aguilar Martinez, J. Coste (EFS Pyrénées123Mediterranée, Montpellier, France)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 05.2TOPIC 05.2P-451 DEFERRALS, AND TERMINATION OF DONATION AMONG YOUNGBLOOD DONORSA.H. Misje, V. Bosnes, H.H.E. Heier (Ullevål University Hospital, Oslo, Norway)P-460 FREQUENCY OF ADVERSE EVENTS DURING PLATELETPHRESISDONATIONS AND ITS IMPACT ON DONOR RETENTIONR. Sharma, K. Karan saluja, B. Beenu thukral, N. Neelam Marwaha (Postgraduate Institute ofMedical Educatation, Chandigarh, India)P-452 BLOOD DONORS: COMPARING WALK IN AND CALL RESPONSIVEDONORS IN A NATIONAL AND PRIVATE HOSPITAL IN NAIROBIO. Mwanda, H. Abdallah, H. Rana (University of Nairobi, Nairobi, Kenya)P-461 NON-SPECIFIC APPOINTMENTS WITH A PURPOSE –A NEW APPROACH TO TELE-RECRUITINGI.W. Simpson, M Griesel, M Harris, J Smith (South African National Blood Service (SANBS),Port Elizabeth, South Africa)124P-453 EFFECTS OF WARMING METHODS ON TEMPERATURE,CARDIAC AND IMMUNE FUNCTION IN PLATELET DONORSC.W. Park, H.J. Kim (Kangnam St. Mary's Hospital, Seoul, South-Korea)P-454 AVOIDING 'MARKETING MYOPIA' IN VOLUNTARY BLOODDONATION (WHAT IS WRONG WITH THE PROMOTION OF VOLUNTARYBLOOD DONATION?)B. Petrovic (University of Belgrade, Beograd, Serbia and Montenegro)P-455 SUITABILITY OF DONORS FOR ERYTHRO -THROMBOCYTAPHERESIS ON TRIMA ACCELR. Procházková, L.H. Hubácková, L.R. Rehorová (Regional Hospital Liberec, Liberec,Czech Republic)P-456 ADVERSE REACTIONS IN BLOOD DONORSH. Ranganathan (Global Hospital, Hyderabad, India)P-457 THE STUDY OF THE HONESTLY OF BLOOD DONORS INRESPECTING TO QUESTIONS WITH A SPECIAL FOCUS ON HIVF. Razjou (Iranian Blood Transfusion Research Centre, Tehran, Iran)P-458 BETA TESTING OF A NEW ELECTRONIC SELF-ADMINISTEREDDONOR QUESTIONNAIRE SYSTEMM. Weidenhausen, M. Winter, B. Selle, C. Schmitt (Haemonetics GmbH, Munchen, Germany)P-459 CAN THE MINIMUM DONATION INTERVAL BE REDUCED WITHOUTINCREASING THE THRESHOLD HEMOGLOBIN REQUIREMENT?...A FEASIBILITY STUDY USING SERUM FERRITIN AS AN INDICATOR OFIRON STORESJ.N. Shah, D. Theyventheran, H.H. Tan, M. Koh (Health Sciences Authority, Singapore, Singapore)P-462 FERRITIN LEVELS IN DOUBLE RED CELL DONATIONS COMPAREDTO WHOLE BLOOD DONATION, A 2 YEAR OBSERVATIONC. Stebler, L. Infanti, B. Eiche, M. Santoro, H. Lüscher, M. Rüesch (Blood Transfusion CenterBasel, Basel, Switzerland)P-463 GRANULOCYTE APHERESIS DONORS: THE IMPACT OFHYDROXYETHYL STARCH ON BLOOD COAGULATIONM. Stiegler, V. Kolovratova, G. Leitner, P. Höcker (Medical University of Vienna, Vienna, Austria)P-464 REPORT OF A STUDY OF THE VISTATM INFORMATION SYSTEM(GAMBROBCT) CONNECTED TO TRIMA R ACCEL (GAMBROBCT) TMCELL SEPARATORS FOR THE NATIONAL BLOOD SERVICE (NBS).“THE SOUTHAMPTON EXPERIENCE”A. Thompson (National Blood Service, Southampton, United Kingdom)P-465 AVAILABILITY OF VOLUNTEER DONOR BLOOD IN YOGYAKARTACITY INDONESIAT. Triyono, B. Mulyono (Sardjito Hospital, Yogyakarta, Indonesia)P-466 REASONS FOR THE DEFERRAL OF VOLUNTARY BLOOD DONORS INFIVE TRANSFUSIOLOGY DEPARTMENTS OF NORTHEASTERN SLOVENIAV. Urlep Salinovic, I. Maracic, P. Leber, J. Pajk, E. Kava‰, D. Ulezic Paucic, M. Seruga,L. Strmcnik (Maribor Teaching Hospital, Maribor, Slovenia)P-467 GEOGRAPHICAL MODELING OF DONOR ACTIVITY IN RELATIONTO TRANSFUSION INFRASTRUCTURE BY DEFINED DONOR CENTRECATCHMENT AREA, TO ENABLE EFFECTIVE DEPLOYMENT OFRESOURCES AND MAXIMIZE SAFE DONATIONSR.A. Wagner, R. Swanevelder (Strategis, Centurion, South Africa)125INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 06.1The posters areon display fromMonday - ThursdayTOPIC 07.1The posters areon display fromMonday - ThursdayP-468 ELIGIBILITY CRITERIA FOR DOUBLE RED CELL APHERESIS UNITS :QUESTIONNAIRE ANALYSISF. Schooneman, J.J.H. Huart, S.V. van Laer (EFS Nord de France, Lille, France)P-469 IMPLEMENTATION AND DEVELOPPEMENT OF MULTICOMPONENTAPHERESIS IN THE PARIS REGIONG. Woimant, C. Fretz, D. Puydupin, D. Benomar, D. Lemau, P. Anceau, E. Pelissier,J.L. Beaumont, P. Bierling (EFS Ile de France, Paris, France)P-470 RESTRICTING PREDONATION HEMOGLOBIN TESTING TO DONORSAT RISK FOR LOW HEMOGLOBIN VALUES – SURVEY OF 81319 WHOLEBLOOD DONATIONSM. Ziemann, C. Brockmann, D. Steppat, G. Washington, H. Kirchner, P. Schlenke}}Topic 07.1.Clinical Transfusion Practice - Leucocyte DepletionP-475 RESIDUAL LEUCOCYTE PHENOTYPING IN LEUCODEPLETEDRED BLOOD CELL CONCENTRATESM.F.A. Alves, P. Laranjeira, N. Guerra, A. Paiva, L. Pais, P. Neto (HUC, Coimbra, Portugal)P-476 QUALITY CONTROL OF RED BLOOD CELL BUFFY-COAT REMOVED,OUR EXPERERIENCEV. Durro, A Abazaj, S Spahiu, S Seferi (NBTSA, Tirana, Albania)P-477 QUALITY OF LEUKOCYTE REMOVAL FILTERS USED IN MARMARAUNIVERSITY HOSPITAL BONE MARROW TRANSPLANTATION UNIT(UKSH, Campus Lübeck, Luebeck, Germany)S. Erdal, E. Birtas Atesoglu, I. Kaygysuz, S. Aktas, F. Noyan, C. Adiguzel, P. Engin, Z. Gulen,126Topic 06.1.Plasma Derivatives and Fractionation -Clinical Indications for Plasma DerivativesS. Sisman, G. Ataman, G. Yaman, M. Cetiner, T. Firalati Tuglular, M. Bayik (Marmara University,Istanbul, Turkey)P-478 A MODIFIED NAGEOTTE HEMACYTOMETER METHOD FORCOUNTING LEUKOCYTES IN LEUKOREDUCED WHOLE BLOOD,RED CELL AND PLATELET PRODUCTS127P-471 AUDIT ON THE USE OF FRESH FROZEN PLASMA IN ADULTS IN AGENERAL TEACHING HOSPITAL IN KUWAITH.M. Al-Abdulrazzak, H. Al-Wazzan, S. Al-Muhareb, R. Marouf (Kuwait central blood bank,M. Kline, V. George, J. Webb (American Red Cross, Rockville, United States of America)P-479 A COMPARISON OF LEUCODEPLETION FILTERS (LABORATORY ANDBEDSIDE USE) FOR FILTRATION OF RED BLOOD CELLSHawalli, Kuwait)B. Sawant, S. Jathar, P. Kadam, S. Rajadhyaksha (Tata Memorial Center - ACTREC,P-472 DEVELOPMENT OF A HIGH THROUGHPUT SEMI-AUTOMATEDMOLECULAR BEACON ASSAY FOR PARVOVIRUS B19S. Jones, J. Chappa, N. Kalmin, K. Leighton, L. Myers (South Texas Blood & Tissue Center,Navi Mumbai, India)P-480 PROFILE OF CD14+ CELLS IN PLATELET CONCENTRATE AT DAY-6STORAGE IN YOGYAKARTA INDONESIASan Antonio, United States of America)T. Triyono, B. Mulyono, U. S. Intansari (Sardjito Hospital, Yogyakarta, Indonesia)P-473 A PROSPECTIVE AUDIT OF TRANSFUSION REQUESTS IN A TERTIARYCARE HOSPITAL FOR THE USE OF FRESH FROZEN PLASMA (F.F.P.)P-481 MONOCYTE COLLECTION WITH MCS+H. Vrielink, P.F. van der Meer, E. Liu, J.J. Zwaginga, R.N.I. Pietersz (Sanquin Blood Bank NorthR.N. Makroo, S.G. Gautam (Apollo Hospitals, Delhi, India)West Region, Amsterdam, Netherlands)P-474 DETERMINATION OF PROPORTION OF ABO BLOOD GROUPS INMANUFACTURE OF BIOPLASMA FDP®: A UNIVERSAL PLASMA?C. Rochat, P.M. Larkin (National Bioproducts Institute, Pinetown, South Africa)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 07.2The posters areon display fromMonday - ThursdayTOPIC 07.3The posters areon display fromMonday - ThursdayTopic 07.2.Clinical Transfusion Practice - Massive Transfusion/ResuscitationP-482 ROLE OF BLOOD TRANSFUSION IN CARDIAC SURGERIES ATUNIVERSITY TEACHING HOSPITAL LUSAKA ZAMBIAP-488 ACCEPTANCE OF SELF-TREATMENT IN HEMOPHILIC PATIENT:A TRAINING METHODS.H. Kavari (Darab Azad University, Darab, Iran)P-489 TEN YEARS EXPERIENCE WITH PEDIATRIC APHERESISA. Kemahli, N. Solaz, N. Karaca, V. Arslan (Ankara University, Ankara, Turkey)128M. Chama, K. Muyinda, K. Mulenga, T. Sakala, P. Kumwenda (Zambia National BloodTransfusion, Lusaka, Zambia)P-483 MASSIVE TRANSFUSION DURING SPLENECTOMY ANDCOAGULATION DISORDERSV. Jovanoska, N.M. Nikoloski, D.B. Dimeski, M.T. Momiroska, V. Spirkoska, M.T. Momiroska(JZU General Hoospital, Prilep, Macedonia)P-484 SUCCESSFUL TREATMENT OF A PATIENT WITH AML AND ACLOSTRIDIUM PERFRINGENS SEPSIS WITH MASSIVE HEMOLYSISF. Knutson, N. Alsadauri, A. Kinch (Clinical Immunology and Transfusion Medi, Uppsala, Sweden)P-485 EFFECTS OF PERIOPERATIVE BLOOD TRANSFUSION ON THECYTOKINE RESPONSE AND PROGNOSIS IN PATIENTS AFTER TOTALHIP AND KNEE ARTHROPLASTYP-490 PEDIATRIC BLOOD BANKING PRACTICE AT ANKARA UNIVERSITYFACULTY OF MEDICINEA. Kemahli, N. Solaz, S. Aydogan, N. Karaca (Ankara University, Ankara, Turkey)P-491 DECREASING THE RISKS OF TRANSFUSION THERAPY IN CHILDRENHOSPITAL WITH SIMPLE MEASURES: SUCCESSFUL CHANGES IN USE OFFRESH FROZEN PLASMA AFTER ANALYSIS OF ITS MISUSE WITH CLINICI-ANS EVERY SIX MONTHSD. Pirc-Tiljak (Croatian Institute of transfusion medicine, Zagreb, Croatia)P-492 FREQUENCY OF TRANSFUSION REACTIONS IN TRANSFUSIONDEPENDANT THALASSAEMIA MAJOR PATIENTSH.A. Zaheer, K. Hasan, S. Ahsan, S. Aslam (Pakistan Institute of Medical Sciences,Islamabad, Pakistan)129I. Korzh, I. Fedotova, V. Nemtsova (Kharkov Medical University, Kharkov, Ukraine)Topic 07.4.Topic 07.3.Clinical Transfusion Practice - Paediatric Transfusion PracticeP-486 ANEMIA AND THE USE OF RED BLOOD CELLS IN PREGNANTWOMEN IN CLINIC FOR OBSTETRIC AND GYNECOLOGY IN SKOPJEClinical Transfusion Practice - Blood SubstitutesP-493 CORRELATION BETWEEN ENDOTHELIAL HAEMOSTATIC MARKERSIN PATIENTS REQUIRING URGENT TRANSFUSION WITH A RED CELLSUBSTITUTEM. Blagoevska, R. Grubovik, M. Stojovski, M. Grubovik, J. Samonikov, T. MakarovskaO. Korzh, S. Krasnokutskiy, G. Kotchuev (Kharkov Medical Academy, Kharkov, Ukraine)(National Institute for Transfusion Medicine, Skopje, Macedonia)P-487 GRANULOCYTE TRANSFUSIONS FROM G-CSF-STIMULATEDRELATED DONORS FOR THE TREATMENT OF SEVERE INFECTIONS INNEUTROPENIC PEDIATRIC PATIENTS.P-496 CLINICAL EFFICIENCY OF GRANULOCYTES IN NEUTROPENICCHILDRENS. Rummler, F. Heinemann, K. Althaus, Th. Lorenzen, F. Zintl, D. Barz (University HospitalJena, Jena, Germany)J.J. Juscinska, N.E. Nowakowska, M. Zaborowska-Soltys, P.A. Ploszynska, B.A. Balcerska(Regional Center forTransfusion Medicine, Gdansk, Poland)P-497 COMPARISON OF GRANULOCYTE COLLECTION FROMG-CSF TREATED AND UNTREATED DONORSS. Rummler, F. Heinemann, K. Althaus, Th. Lorenzen, D. Barz (University Hospital Jena, Jena,Germany)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 07.5The posters areon display fromMonday - ThursdayTOPIC 07.5130Topic 07.5.Clinical Transfusion Practice - Non-infectious Hazards of TransfusionP-498 VALIDATING THE RADIOTHERAPY LINEAR ACCELERATOR VARIAN23 EX MACHINE FOR BLOOD IRRADIATION USING BIOLOGICAL INDICESC. Anyaegbu, A. Abdelaal, M. Malaker, H. Weatherburn, M. Anwar, M. Hafiz, M. Kassar,J. Desonza, D. Friend (King Abdul Aziz Medical City-WR, Jeddah, Jeddah, Saudi Arabia)P-499 THREE TRALI CASES ASSOCIATED WITH ONE DONOR WITH HLA IIANTIBODIES: A LOOKBACK STUDYA.M. Beckers, D. van Stein, K. Sintnicolaas, L. Porcelijn, A. Brand, D.J. van Rhenen(Sanquin Blood Bank South West region, Rotterdam, Netherlands)P-500 IRON OVERLOAD IS A MOST IMPORTANT ADVERSE EFFECT OFLONG-TERM TRANSFUSION THERAPY IN MYELODYSPLASTIC SYNDROMEJ. Cermak, L. Walterova, M. Pisacka (Institute of Hematology and Blood Transfusion, Praha 2,Czech Republic)P-501 THE IMPACT OF USING MALE DONOR PLASMA ON HAEMOVIGILANCEREPORTS OF TRANSFUSION RELATED ACUTE LUNG INJURY (TRALI) INTHE UKC.E. Chapman, L.M. Williamson, H. Cohen, D. Stainsby, H. Jones (National Blood Service,UK, Newcastle Upon Tyne, United Kingdom)P-505 INCIDENCE OF TRALI AND RESPIRATORY COMPLICATIONS IN THEQUEBEC HEMOVIGILANCE SYSTEMP. Robillard, K.I. Karl Itaj, A.C. Chapdelaine (Quebec Public Health Institute, Montreal, Canada)P-506 A SIMPLE SENSITIVE ELISA FOR THE DETECTION OF HAPTOGLOBINDEFICIENCY AND THE CHARACTERISTICS OF THE IDENTIFIED CASESE. Shimada, Y. Watanabe, T. Mazda, H. Okazaki, K. Tadokoro, T. Juji (The Japanese RedCross, Tokyo, Japan)P-507 TRANSFUSION RELATED LUNG INJURY (TRALI) DUE TO ANTI-HLACLASS II ANTIBODIESM. Tomicic (Croation Institute of Transfusion Medici, Zagreb, Croatia)P-508 REDUCED RATE OF ADVERSE REACTIONS TO PLASMA REDUCEDPOOLED PLATELET UNITS – POSSIBLE ROLE OF MINOR INCOMPATIBLETRANSFUSIONSF. Wagner, W. Adamo (DRK Blutspendedienst NSTOB, Springe, Germany)P-509 USE OF AN ELECTRONIC BARCODE CHECKER TO IMPROVE THESAFETY OF BEDSIDE ADMINISTRATION OF BLOODJ.P. Wallis, S. Whitehead (Freeman Hospital, Newcastle Upon Tyne, United Kingdom)P-510 TRALI AT FREEMAN HOSPITAL SINCE THE INTRODUCTION OF MALEDONOR ONLY FRESH FROZEN PLASMA.131P-502 THREE YEARS HAEMOVIGILANCE OF METHYLENE BLUE-TREATEDFRESH FROZEN PLASMA : NO INCREASE IN TRANSFUSION REACTIONINCIDENCEM.C. Deneys, D. Latinne, C. Guerrieri, P. Baele (Cliniques Universitaires Saint Luc, Brussels,Belgium)J.P. Wallis, S. Whitehead, C.E. Chapman (Freeman Hospital, Newcastle Upon Tyne, UnitedKingdom)P-511 TYPE I HEREDITARY HEMOCHROMATOSIS: ROLE OF BODY MASSINDEX ON THE PHENOTYPIC EXPRESSION OF THE C282Y/C282 ANDC282Y/H63D GENOTYPESP-503 ETHYLENE OXIDE (ETO) AND TRANSFUSION-INDUCED ADVERSEREACTIONS IN A PATIENT ON MAINTENANCE HEMODIALYSISV. Scotet, G. le Gac, M.C. Mérour, A.Y. Mercier, B. Chanu, C. Ka, C. Mura, J.B. Nousbaum,C. Férec (Inserm U 613, Brest, France)A. Kokubunji, R. Murata, R. Imaizumi, Y. Otaki, S. Imoto, S. Kai (Hyogo College of Medicine,Nishinomiya, Japan)P-504 ANTI-GRANULOCYTE ANTIBODY DETECTION BY SOLID-PHASEASSAY USING A MAGNETIC FORCET. Mazda, H. Kamada, T. Tamai, Y. Watanabe, H. Okazaki, K. Tadokoro (Japanese Red CrossCentral Blood Institute, Tokyo, Japan)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 08.1-3The posters areon display fromMonday - ThursdayTOPIC 09.1The posters areon display fromMonday - ThursdayTopic 08.1-3.Auto-TransfusionP-512 PREOPERATIVE AUTOLOGOUS BLOOD DONATION IN TOTAL KNEEARTHROPLASTY: AN ITALIAN SINGLE-CENTRE EXPERIENCEG. Aprili, M. Franchini, M. de Gironcoli, G. Gandini (Servizio Trasfusionale, Verona, Italy)P-513 COST-EFFECTIVENESS OF AUTOLOGOUS HAEMOTHERAPY METHODSP-521 REASONS AGAINST THE RETRANSFUSION OFUNWASHED WOUND BLOODE.N. Hansen (University of Regensburg, Regensburg, Germany)P-522 SAFETY AND EFFICACY OF AUTOLOGOUS DRAINAGE BLOODREINFUSION FOLLOWING TOTAL KNEE ARTHROPLASTY PREPAREDWITH HYDROGEN PEROXIDEJ.D. Kolt, D. Robin, A. Carr, D. Chew, I.J. Critchley, R. Horton (St. George Hospital,R. Karger, V. Kretschmer (Philipps University Marburg, Marburg, Germany)New South Wales, Australia)P-514 EFFECTIVE PRE-OPERATIVE AUTOLOGOUS BLOOD DONATION INORTHOPAEDIC SURGERYE.K. Klausa, J.M. Majda, W.W. Wodzislawski, R.K. Kozlowski (Regional Centre of TransfusionMedicine, Wroclaw, Poland)Topic 09.1.Stem Cells - Peripheral Blood and Bone Marrow Progenitor Cells132P-515 SEROLOGIC INFECTION TESTING OF AUTOLOGOUS BLOOD DONORSM. Lukic, B. Golubic Cepulic, I. Bojanic, F. Plenkovic, S. Mazic, Z. Ivankovic, B. Tripkovic, M.·ulentic, K. KorÏinek, D. Orlic (Clinical Hospital Center Zagreb, Zagreb, Croatia)P-523 HIGH QUALITY OF PERIPHERAL BLOOD PROGENITOR CELLSCOLLECTED BY A CONTINUOUS FLOW BLOOD CELL SEPARATORAND A DUAL STAGE SEPARATION CHAMBER133P-516 THE PREDEPOSIT AUTOLOGOUS BLOOD PROGRAM OF THE NATIO-NAL ORTHOPAEDIC HOSPITAL LAGOS, NIGERIA (1992-2004)O.E. Nnodu, C.O. Maduka (National Orthopaedic Hospital, Lagos, Nigeria)P-517 NEW AUTOMATED APHERESIS SYSTEM FOR SINGLE ORDOUBLE-DOSE RED CELL COLLECTION WITH ADVANTAGES OFREDUCED EXTRACORPOREAL VOLUME FOR AUTOLOGOUS USEW. Nussbaumer (Univ.-Hospital Innsbruck, Innsbruck, Austria)M. Alberti, D. Graziano, C. Falco, G. Mele, L. Pezzullo, M. Di Somma, M. Macrì(Aorn "Cardarelli", Marano Di Napoli, Italy)P-524 PERIPHERAL BLOOD OPPOSING BONE MARROWTRANSPLANTATION FOR MALIGNANT AND AUTOIMMUNE DISEASESB. Balint, M. Trkuljic (Institute of Transfusiology, Belgrade, Serbia and Montenegro)P-525 TUMOR CELLS, BONE MARROW AND PERIPHERAL BLOOD STEMCELLS ASSESSMENT AFTER LONG TERM CRYOPRESERVATION (LTC)P-518 OUTCOME OF PREOPERATIVE AUTOLOGOUS BLOODDONATION IN ELDERLY PATIENTSE. Rodriguez, R.J. Fernández, B. Amerise, A. Skripnik Strelecki (Fundación HemocentroBuenos Aires, Buenos Aires, Argentina)P-519 RECENT ADVANCES AND PROBLEMS OF THE AUTOLOGOUSBLOOD TRANSFUSIONH. Tsuno, A. Kamijo, N. Hori, Y. Kudo, M. Murakami, S. Masuda, A. Mabuchi, S. Sone,M. Matsuhashi, K. Takahashi (The University of Tokyo, Tokyo, Japan)P-520 SUCTION-INDUCED HEMOLYSIS DURING BLOOD SALVAGEE.N. Hansen, J. Kling, G. Roth, M.T. Pawlik (University of Regensburg, Regensburg, Germany)C.D. Dufour, H. Longoni, M.A. Sorrentino, C. Merlo, M. Bascoy, E. Pastorino Aubri,P. Luchetta, A. Robinson, C. Di Risio - Bianchi, P. Franchini (Navy Hospital Buenos Aires,Buenos Aires, Argentina)P-526 OPTIMIZING PERIPHERAL BLOOD STEM CELL (PBSC) COLLECTIONIN PAEDIATRIC PATIENTSG. Bezuidenhout (South African National Blood Service (SANBS), Johannesburg, South Africa)P-527 FACTORS PREDICTING MOBILIZATION AND COLLECTION OFPERIPHERAL BLOOD PROGENITOR CELLS IN PATIENTS AFFECTED BYHAEMATOLOGICAL MALIGNANT DISEASESC. Falco, M. Alberti, D. Graziano, S. Palmieri, G. Scalia, P. Morabito, M. Di Somma, M. Macrì(Aorn "Cardarelli", Naples, Italy)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 09.1TOPIC 09.2The posters areon display fromMonday - ThursdayP-528 EVALUATION OF AUTOLOGOUS PERIPHERAL CD34+ CELL DOSEUSING IDEAL OR ACTUAL BODY WEIGHTC.T.G. Gonzalez, A. Zubair, D. Gastineau, R. Beveridge, J. Winters, H. Adams, J. Slack,J. Maningo-Salinas, C. Befort, B. Nolot, A. Torloni (Fairfax-NoVA Hematology Oncology,Herndon, United States of America)P-536 GENE AND HAPLOTYPE FREQUENCIES FOR THE LOCI HLA-A,HLA-B, HLA-DR BASED ON OVER 20000 CHINESE HEMATOPOIETICSTEM CELL DONORSJ.L. Sun, K.M. Du, M. Fu, Y. Sun, Y. Jin, J.H. Xie, Y. Ji, J.H. Yang, Y.H. Ji, Z. Zhang, Z. Mao,D.Z. Liu, K.C. Qian, Z. Zhu (The Transfusion Institute of SBC, Shanghai, China)P-529 DURABLE REMISSION OF RECURRENT THROMBOTICTHROMBOCYTOPENIC PURPURA AFTER AUTOLOGOUS STEM CELLTRANSPLANTATION. A CASE REPORTD. Graziano, C. Falco, L. Pezzullo, M. Alberti, S. Rocco, M. Di Somma, M. Macrì (Aorn"Cardarelli", Naples, Italy)P-537 MONITORING OF THE HEMATOCRIT DURING APHERESIS FOR PBSCWITH THE AMICUS SYSTEM IN VERY SMALL CHILDREN AND ADOLESCENTSV.W. Witt, E. Beiglböck, G. Fritsch, C. Peters, H. Gadner (St. Anna Kinderspital, Vienna, Austria)P-530 MONOCYTE ENRICHMENT FROM LEUKAPHERESIS PRODUCTSUSING THE ELUTRA CELL SEPARATORH. Kim, J. Suh, O. Kwon (Yonsei University, Seoul, South-Korea)Topic 09.2.Stem Cells - Umbilical Cord Blood Stem Cells134P-531 BLOOD RHEOLOGY IN PERIPHERAL BLOOD STEM CELL DONORSM. Mariano, M. Ballestri, F. Ferrari, A. Donelli, P. Bresciani, A. Cuoghi, M. Quartieri, F. Narni(Transfusion Medicin Policlinic Hospital, Modena, Italy)P-538 THE STUDY OF EXPANSION AND MULTIPOTENCY OF CORD BLOODSTEM CELLS AFTER TWO TIMES FREEZING AND THAWINGA. Atashi, M. Soleimani, M. Hafizi (Tarbiat Modarres University, Tehran, Iran)135P-532 MEDIUM TO LONG TERM SURVIVAL OF PATIENTS RECEIVINGCRYOPRESERVED PERIPHERAL BLOOD STEM CELLSS.B. Marrs (South African National Blood Service, Gauteng, South Africa)P-539 LEGAL NEEDS TO REGULATE AND PROMOTE THE CONSERVATIONOF CORD BLOOD STEM CELLS FOR ALLOGENIC TRANSPLANTATION INARGENTINAR. Di Tullio Budassi, M.A. Spósito, L. Di Tullio Budassi (Ctro. Invest. Der. de la Ancianidad-UNR, Rosario, Argentina)P-533 IDENTIFICATION OF CD34+/CD61+ MEGAKARYOCYTICPROGENITORS BY REAL TIME PCR QUANTIFICATION AS PREDICTOR OFLATE PLATELET RECOVERY AFTER AUTOGRAFTING IN NON-HODGKINLYMPHOMA PATIENTSK.R. René Nielsen, R. Steffensen, J. Baech, H.E. Johnsen (Aalborg Hospital, Aalborg, Denmark)P-540 THERMOGENESIS AXP AUTOXPRESS PLATFORM ANDBIOARCHIVE SYSTEM FOR AUTOMATED CORD BLOOD BANKINGL. Dobrila, J. Chapman, D. Marr, V. Kumar, P. Coelho, P. Rubinstein (National Cord BloodProgram at New York, New York, United States of America)P-534 PROGNOSTIC FACTORS FOR HEMATOPOIETIC STEM CELLMOBILIZATION SUFFICCIENCY FOR TWO TRANSPLANTS USING ONLYG-CSF AND THE DEVELOPMENT OF A PROGNOSIS INDEXC. Pinto Rebello, C. martins Nogueira, R. Schafel (UFRJ- BRASIL, Rio De Janeiro, Brazil)P-541 DOES CORD BLOOD TRANSPLANTATION (CBT) HAVE A FUTURE INARGENTINA AND LATIN AMERICA?C.D. Dufour, M.A. Sorrentin, P. Luchetta, A. Mino, L. Rizzo, P. Franchini, E. Pastorino Aubry,C. Merlo, A. Robinson (Navy Hospital Buenos Aires, Buenos Aires, Argentina)P-535 PERIPHERAL BLOOD PROGENITOR CELL MOBILIZATION ANDCOLLECTION IN 23 PATIENTS WITH SYSTEMIC MULTIPLE SCLEROSISA. Ribeiro, A.M.K. Sakashita, K.C.A. Alvarez, N. Hamerschlak, J.M. Kutner, A.N. Cipolletta,R.A.A. Pereira (IIEP Hospital Israelita Albert Einstein, Sao Paulo, Brazil)P-542 UMBILICAL CORD BLOOD BANKING: ARGENTINA’S UNRELATEDPROGRAMC. Gamba, A. Marcos, S. Casini, E. Ramos, A. Bernasconi, C.Y. Marcos, G. Theiler, L. Casimir,E. Del Pozo (National Public Cord Blood Bank, Ciudad Autonoma De Buenos Aires, Argentina)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 09.2TOPIC 10.1The posters areon display fromMonday - ThursdayP-543 CHARACTERIZATION OF MEGAKARYOCYTES PROGENITOR CELLSDIFFERENTIATED FROM UMBILICAL CORD BLOOD CD133+ AND CD133-CELLSM. Kheirandish, M. Aghaeii Pour, A. Firozi, A. Pourfathaollah, A. Tabatabaeian, S. Vaeli,S. Niroomanesh, M. Ebtekar, A. Goodarzi (Iranian Blood Transfsion Research Center, Tehran, Iran)P-550 EVALUATION OF INTRACELLULAR PERFORIN IN CD56+ CELLS INCORD AND PERIPHERAL BLOODM. Kheirandish, A. Firozi, M. Ebtekar, M. Aghaeii Pour, A. Tabatabaeian (Iranian BloodTransfsion Research Center, Tehran, Iran)P-544 EX VIVO EXPANSION OF MEGAKARYOCYTES PROGENITOR CELLSFROM UMBILICAL CORD BLOOD CD133+ AND CD133- CELLSM. Kheirandish, A. Firozi, A. Pourfathaollah, A. Tabatabaeian, S. Niroomanesh, A. Goodarzi,S. Vaeli (Iranian Blood Transfsion Research Center, Tehran, Iran)P-551 COMPARISON OF INTRACELLULAR PERFORIN IN CD8+ CELLS INCORD AND PERIPHERAL BLOOD IN RESTING CONDITIONM. Kheirandish, A. Firozi, M. Ebtekar, M. Aghaeii Pour, A. Tabatabaeian, A. Goodarzi (IranianBlood Transfsion Research Center, Tehran, Iran)136P-545 COMPARATIVE ANALYSIS OF THE PREVALENCE OF ABNORMALINFECTIOUS DISEASE TESTS IN SCREENING OF WHOLE BLOOD DONORSAND UMBILICAL CORD BLOOD DONORS IN A SINGLE INSTITUTION INBRAZILA. Ribeiro, J.M. Kutner, M.B. Polite, A.T. Kondo, C.S. Guerra, S.V.F. Santos, R.M. Miranda(IIEP Hospital Israelita Albert Einstein, São Paulo, Brazil)P-552 TREATMENT OF CHRONIC GRAFT VERSUS HOST DISEASE (CGVHD) BYEXTRACORPOREAL PHOTOCHEMOTHERAPY WITH A NEW CE CERTIFIEDUV A IRRADIATION MACHINEH. Ullrich, N. Kroeger, J. Schrum, A. Zander, P. Kühnl (University Clinics, Hamburg, Germany)Topic 10.1.137P-546 UMBILICAL CORD BLOOD: SAFETY OF THE STEM CELL PRODUCTCAN BE IMPLEMENTED BY NAT TRIPLEX ASSAYL. Salvaneschi, P. Bergamaschi, C.G. Perotti, L. Bellotti, C. Parisi, A. Marchesi, V. Galiazzo,R. Poma, C. Del Fante, G.L. Viarengo (IRCCS Policlinico "San Matteo", Pavia, Italy)Platelet - TransfusionP-553 PROSPECTIVE AND RANDOMIZED COMPARATIVE STUDY OFPLATELETPHERESIS USING TWO CELL SEPARATORS BASED ONINTERMITTENT AND CONTINUOUS FLOW CENTRIFUGATIONR.N. Makroo, V. Raina, P. Kumar, S. Gautam (Apollo Hospitals, Delhi, India)Topic 09.3.Stem Cells - Cellular TherapiesP-547 APHERESIS EXPERIENCE OF SULEYMAN DEMIREL UNIVERSITYBLOOD BANK APHERESIS UNITD. Canatan, G. Alanoglu, M. Polat, S. Ogut (Suleyman Demirel University, Isparta, Turkey)P-548 THE STUDY ON THE MECHANISMS OF V?24NKT CELLS FROMHUMAN PERIPHERAL BLOOD CELLS IN ANTI-TUMOR IMMUNITYH. Fan, J. Yang, B. Zheng (Shanghai Blood Center, Shanghai, China)P-549 TIME COURSE ASSAY AFTER TRANSFECTION SHOW DENDRITICCELLS LOADED WITH K562 RNA CAN EXPRESS P210BCR-ABL PROTEINL. Gao, H.H. Fan, Y. Ren, X.X. Nie, Y Liu, Y.M. Yang, R.F. Xie, K.C. Qian (Shanghai BloodCenter, Shanghai, China)P-554 ROLE OF PLATELET TRANSFUSION IN THE MANAGEMENT OFDENGUE PATIENTS IN A TERTIARY CARE HOSPITALR.N. Makroo, S.G. Gautam (Apollo Hospitals, Delhi, India)P-555 THE EFFECT OF PRESTORAGE FILTRATION ON PLATELETACTIVATION IN PLATELET CONCENTRATESA. Solaimany ferizhandy, M. Aghaee Por, P. Pourfatholla (Iranain Blood Transfusion ORGRresearch, Tehran, Iran)P-556 QUALITY OF APHERESIS PLATELET CONCENTRATES COLLECTEDBY COBE SPECTRA OR TRIMA ACCEL AND STORED FOR 7 DAYSN. Tynngard, T. Lindahl, M. Trinks, M. Studer, G. Berlin (Linköping University Hospital,Linköping, Sweden)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 10.1TOPIC 10.1P-557 SINGLE DOSE PLATELET PREPARATION (OUR EXPERIENCE)K. Milenkov, P. Gerasimova, K. Dukovski, L.J. Samonikova (Institute of Blood TransfusionP-566 OPTIMISATION OF COLLECTION STRATEGIES USING THREE APHERESISPLATFORMS TO MAXIMISE DONOR ELIGIBILITY AND PLATELET SUPPLYof-Skopje, Skopje, Macedonia)S. Lechner, R.G. Gassler, S.A. Sima (Austrian Red Cross, Klagenfurt, Austria)P-558 STORAGE OF BUFFY-COAT-DERIVED PLATELETS IN ADDITIVESOLUTIONS: FLOW CYTOMETRY ANALYSIS OF PLATELET QUALITYAT 4 DEGREES C STORAGEP-567 INVESTIGATION OF COMPOYIELD, A WHOLE BLOOD FILTER THATDOES NOT REMOVE PLATELETSP.F. van der Meer, I.J. Bontekoe, R.N.I. Pietersz (Sanquin Blood Bank North West region,P. Sandgren, M. Hansson, H. Gulliksson, A. Shanwell (Karolinska University Hospital,Amsterdam, Netherlands)Stockholm, Sweden)P-559 IN VITRO EVALUATION OF THREE ADDITIVE SOLUTIONS FOR THESTORAGE OF PLATELETSP-568 PARAMETERS OF CENTRAL HEMODYNAMICS IN PREGNANTWOMEN BEFORE AND AFTER OPERATION PERIOD IN THE CONDITIONSOF AUTODONATION OF PLASMAL. Larrea, M.J. Belenguer, E. Costa, C. Franco, C. Herreros, C. Leon, M. Gil, I. Saiz, M.D.B. Bahovadinov, B. Zajdulloev (Republican Sientific Centre of Blood, Dushanbe, Tajikistan)138Garcia, M.A. Soler, R. Roig (Centro Transf de la Comunidad Valenciana, Valencia, Spain)P-560 THE RISK FACTOR ANALYSIS FOR PLATELET ANTIBODY(POSITIVE)PATIENTS REQUIRING PLATELET TRANSFUSIONP-569 EVALUATION OF THE NEW C-SDP MCS+ PROTOCOL: APHERESISPLATELET CONCENTRATES IN ADDITIVE SOLUTIONM. Mariano, I. Varinelli, R. Roncaglia, A. Mansi, I. Lonetti, M. de Palma139W. Shen, J.L. Wang, D.Z. Liu (Shanghai Blood Center, Shanghai, China)P-561 SURVEY OF EXTENDED SHELF LIFE PLATELETS AT THE WELSHBLOOD SERVICER. Ahya, G. Rowe, R. Jones (Welsh Blood Service, South Glamorgan, United Kingdom)P-562 MCS+ APHERESIS PLATELETS: 7-DAY STORAGE IS FEASIBLEH. Vrielink, P.F. van der Meer, R.N.I. Pietersz (Sanquin Blood Bank North West Region,Amsterdam, Netherlands)P-563 EFFECT OF IRRADIATION ON PLATELET CONCENTRATES INPLATELET ADDITIVE SOLUTION, STORED FOR 8 DAYSP.F. van der Meer, L.A.E. Liefting, R.N.I. Pietersz (Sanquin Blood Bank North West region,Amsterdam, Netherlands)P-564 EFFECTS OF INTERRUPTION OF AGITATION ON IN VITROPARAMETERS OF PLATELET CONCENTRATES STORED IN COMPOSOL-PS(Transfusion Medicine, Modena, Italy)P-570 INFLUENCE OF THE CITRATE CONCENTRATION IN PLATELETCONCENTRATES FROM TRIMA ACCEL (GAMBRO BCT)K. Althaus, S. Rummler, Th. Lorenzen, S. Straube, G. Nowak, D. Barz (University HospitalJena, Jena, Germany)P-571 ANTICOAGULATION, ACTIVATION AND THE ADHESION ABILITY OFPLATELETS IN CONCENTRATESK. Althaus, S. Rummler, S. Straube, Th. Lorenzen, G. Nowak, D. Barz (University HospitalJena, Jena, Germany)P-572 ADDITION OF ACETATE ALLOWS FOR THE MAINTENANCE OF THEQUALITY OF MIRASOL PATHOGEN REDUCTION TREATED PLATELETS INA LOW PLASMA ENVIRONMENT FOR 7 DAYSK.A. Buytaert-Hoefen, R. Goodrich, N. Hovenga, J. Li (Navigant Biotechnologies, Lakewood,United States of America)P.F. van der Meer, L.A.E. Liefting, R.N.I. Pietersz (Sanquin Blood Bank North West region,Amsterdam, Netherlands)P-565 NON-INVASIVE MEASUREMENT OF PLATELET CONCENTRATE PHWITH A FIBER OPTIC FLUORESCENCE DETECTORP-573 SUCCESFUL PLATELET TRANSFUSION IN PATIENTS WITH ACOMBINATION OF HLA- HPA AND PLATELET AUTOANTIBODIESA.G. van den Bos, Y.C.M. van Berkel, L. Porcelijn, T.A.S. Tomson, J.A.H.G. Wollersheim,V.M.J. Novotny (Radboud University Medical Center, Nijmegen, Netherlands)D. de Korte, R. Vlaar, C.W.N. Gouwerok, I. de Cuyper, E.J. Klip, M.W. Reed, S. Geelhoed,A.J. Verhoeven (Sanquin Research, Amsterdam, Netherlands)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 10.1TOPIC 10.2The posters areon display fromMonday - ThursdayP-574 EFFICACY OF FENWAL-AMICUS BLOOD CELL SEPERATORIN DOUBLE DOSE PLATELET COLLECTIONO. Arslan, S. Gurak (Ankara University, Ankara, Turkey)P-583 PROTEIN PROFILE CHANGES IN PRESTORAGE AND POSTSTORAGEIRRADIATED PLATELET CONCENTRATES : USING PROTEOMICSTECHNOLOGYP-575 QUALITY ASSESSMENT OF BAGS FOR SEVEN-DAY STORAGE OFPRESTORAGE FILTERED PLATELET CONCENTRATE POOLM. Strauss Patko, T. Vuk, C. Maglov, M. Balija, I.J. Jukic (Croatian Institute of TransfusionMedici, Zagreb, Croatia)S. Ryu, I. Suh, N. Cho, K. Lee, C. Lim, C. Lee, Y. Kim, Y. Cho, S. Yoon (Kangwon NationalUniversity, Chuncheon, Kangwon-do, South-Korea)P-584 AUTOMATIZATION OF PLATELET COMPONENTS PREPARATIONPROCESS EXPERIENCE OF CRSP SINCE 2003P-576 EFFECTS OF STORAGE INDUCED PLATELET MICROPARTICLES ONTHE INITIATION AND PROPAGATION PHASE OF BLOOD COAGULATIONM.O. Ramoa Rodrigues, M. Pacheco, S. Oliveira, F. Quelhas, S. Maia (Portuguese BloodInstitute, Porto, Portugal)J.F.W. Keuren, E.J.P. Magdeleyns, T. Lindhout, J. Curvers (Sanquin Blood Bank Southeast140Region, Maastricht, Netherlands)P-577 EFFECT OF MICROPARTICLES FROM PLATELET CONCENTRATESON HAEMOSTASIS IN A THROMBOCYTOPENIC PERFUSION MODELJ.F.W. Keuren, E.J.P. Magdeleyns, J. Curvers, T. Lindhout (Sanquin Blood Bank SoutheastRegion, Maastricht, Netherlands)Topic 10.2.Platelet - ImmunologyP-585 A PROSPECTIVE STUDY OF NEONATAL ALLOIMMUNETHROMBOCYTOPENIA – A SINGLE INSTITUTIONAL STUDY IN TAIWAN141P-578 EVALUATION OF 4 DIFFERENT METHODOLOGIES FOR PLATELETANTIBODY SCREENNING (PAS) IN TRANSFUSED PATIENTSR. Fontão-Wendel, L.C.N. Silva, C.B.R. Savioli, P. Borelli, S. Wendel (Blood Bank - HospitalSirio Libanês, São Paulo, Brazil)C.H. Tzeng, P.S. Chen, H.M. Liu, Y.R. Chen, J.Y. Lyou, H.Y. Hu, J.S. Lin (Taipei VeteransGeneral Hospital, Taipei, Taiwan)P-586 RELEASE OF POTENTIAL IMMUNOMODULATORY FACTORS DURINGPLATELET STORAGEP-580 NATION-WIDE PROTOCOL FOR THE MEASUREMENT OF CD62P ANDANNEXIN V-BINDING IN PLATELET CONCENTRATESP.F. van der Meer, J. Curvers, A.J. Verhoeven, J. Scharenberg, J. Heeremans, W. Kuipers,M. Eijzenga, D. de Korte, J. de Wildt (Sanquin Blood Bank North West Region, Amsterdam,O. Garraud, F. Cognasse, F. Boussoulade, P. Chavarin, S. Acquart, P. Fabrigli, B. Lamy(French Regional Blood Bank, Saint Etrienne, France)P-587 HUMAN PLATELETS ACTIVATE PERIPHERAL BLOOD B CELLS ANDINCREASE THE PRODUCTION OF IMMUNOGLOBULINSNetherlands)O. Garraud, F. Cognasse, H. Hamzeh-Cognasse, P. Chavarin, S. Acquart, Y. Richard (FrenchP-581 PROTEIN PROFILE CHANGES IN PLATELET CONCENTRATEACCORING TO STORAGE: USING PROTEOMICS TECHNOLOGYS. Ryu, I. Suh, N. Cho, K. Lee, Y. Cho (Kangwon National University, Chuncheon,Kangwon-do, South-Korea)Regional Blood Bank, Saint Etrienne, France)P-588 DIRECT COMPARISON BETWEEN ELISA AND MAIPA IN THEMEASUREMENT OF ANTI-HPA-1A (IN IU/ML AND AU/ML) IN NEONATALALLOIMMUNE THROMBOCYTOPENIAP-582 PROTEIN PROFILE CHANGES IN PRESTORAGE AND POSTSTORAGELEUKOFILTERED PLATELET CONCENTRATE: USING PROTEOMICSTECHNOLOGYH. Bessos, M. Matviyenko, M. Killie, S. Urbaniak (Scottish Blood Transfusion Service,Edinburgh, United Kingdom)S. Ryu, I. Suh, N. Cho, K. Lee, C. Lim, M. Whang, S. Kwon, Y. Cho (Kangwon NationalUniversity, Chuncheon, Kangwon-do, South-Korea)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 10.2TOPIC 10.3The posters areon display fromMonday - ThursdayP-589 PSEUDOTHROMBOCYTOPENIA, THROMBOCYTOPENIA ANDANTIPLATELETS ANTIBODIES IN BLOOD DONORSM. Palange, A. Agresti, D. Fioravanti, F. Terlizzi, A. Di Lorenzo, P. Iudicone, M. Miceli, C. Amedeo,R. Colaceci, A. Tudisco, S. Berardini, E. Mannella (A.O. "S. Camillo - Forlanini", Roma, Italy)P-590 IN VITRO EVALUATION OF PLATELET EXPRESSING P-SELECTIN ANDPLATELET AGGREGATION IN STORED PLATELET CONCENTRATESA. Gharehbaghian, S. Sadri, M. Aghayeepour, S. Vaeli, M. Karbasizadeh, J. Ghaledi,Z. Atarchi, M. Ahmadinejad, T. Shashaani, A. Tabatabaeeyan, F. Kami, F. BabahosseiniTopic 10.3.Platelet - BiologyP-597 ASSESSMENT OF IN VITRO PLATELET ACTIVATION AFTER ADPSTIMULI USING FLOW CYTOMETRY AND ADVIA 120Y.A. Lim, S.R. Cho, W.G. Lee, S.M. Lee, S.W. Kim (Ajou University School of Medicine,Suwon, South-Korea)P-598 PLATELET ADDITIVE SOLUTION FOR EXTENDED PLATELET STORAGE(The Research Center of IBTO, Tehran, Iran)A. Castrillo, M. Adelantado, A. Castro, M. Abalo, C. Areal, J. Cid, A. Eiras, J. Flores, J.142P-591 THE OBJECTIVE INTERPRETATION OF THE RESULTS OFMIXED-PASSIVE HEMAGGLUTINATION (MPHA) METHOD BYTHE APAS-2000 SYSTEMM. Matsuhashi, N.H. Tsuno, K. Takahashi (The University of Tokyo, Tokyo, Japan)P-592 FETAL/NEONATAL ALLOIMMUNE THROMBOCYTOPENIA:ANTENATAL SCREENINGG. Fratellanza, A. Fratellanza, A. D'Ambra, S. Misso, B. Feola, L. Paesano, M. D'Onofrio,E. D'Agostino, S. Formisano (University of Naples "Federico II", Naples, Italy)P-593 COST-UTILITY ANALYSIS OF ANTENATAL SCREENING FORNEONATAL ALLOIMMUNE THROMBOCYTOPENIAM.K. Killie, J. Kjeldsen-Kragh, A. Husebekk, B. Skogen, J.A. Olsen, I.S. Kristiansen(University Hospital of Northern Norway, Tromsø, Norway)Cabrera (Centro de Transfusion de Galicia, Santiago De Compostela, Spain)P-599 DYNAMIC OBSERVATIONS FOR YEARS ON PLATELETAPHERESISCONCENTRATES CRYO-PRESERVED AT MINUS EIGHTY DEGREESCENTIGRADE (I): IN VITRO CHANGES OF ADHESION, AGGREGATIONAND FACTOR III ACTIVITYW.G. Zhu, L.K. Kong (Shenzhen Blood Center, Shenzhen, China)P-600 BLOOD SAMPLES EXPOSED TO 4 DEGREES C: EFFECTS ON APLATELET ADHESION AND AGGREGATION TEST – THE CONE ANDPLATELET ANALYSER (CPA) – IMPACT RP. Sandgren, G. Naess, A. Shanwell (Karolinska University Hospital, Stockholm, Sweden)P-601 OSCILLATION OF GPIIB/IIIA SURFACE EXPRESSION IN PLATELETS,A NOVEL MEASURE OF SUBACUTE ACTIVATION143P-594 PLATELET ANTIBODIES IN TRANSFUSED THAI PATIENTSA. Romphruk, C. Puapairoj, J. Prasertsang, C. Wanhakit, S. Wiengnon, C. Sirijeerachai,G. Wong, J. Ma (Canadian Blood Services, Edmonton, Alberta, Canada)P-602 PLATELET ACTIVATION DURING TRIMA ACCEL SYSTEM SEPARATIONC. Leelayuwat (Khon Kaen University, Khon Kaen, Thailand)J. Antoniewicz-Papis, E. Lachert, A. Goller, J. Kubis, A. Rosiek, D. Piotrowski, M. LetowskaP-595 CHARACTERIZATION OF HUMAN PLATELET ANTIGENS INTHE ARGENTINEAN POPULATION(Institute of Hematol. and Blood Transf., Warsaw, Poland)P-603 EFFECT OF EXTRACELLULAR PH ON PLATELET CONCENTRATESD.A. De la vega Elena, S. dr. Oyonarte, N. dr. Nogués, P.D. prof. Blanzaco, E. dr. Theiller,D. de Korte, D.W.C. Dekkers, I. de Cuyper, R. Verhaar, P.F. van der Meer, A.J. VerhoevenM.A. dr. Raillon, S. dr. Chialina, E. prof. Solis, A. dr. Fernández Montoya, V. prof. Crespo Ferrer,(Sanquin Research, Amsterdam, Netherlands)A. prof. Campos Muñoz, E. dr Muñiz-Diaz (Hospital Italiano Garibaldi, Rosario, Argentina)P-596 IMMUNE PLATELET TRANSFUSION REFRACTORINESS (PTR):PLATELET ANTIBODY TESTING AND TRANSFUSION SUPPORTP-604 REGULATION OF PHOSPHATIDYLSERINE EXPOSURE BYTHE AMP-DEPENDENT KINASE IN HUMAN PLATELETSD. de Korte, D.W.C. Dekkers, I. de Cuyper, C.W.N. Gouwerok, A.J. VerhoevenH. Pearson, W. Grimm, J. Moss, N. Watson, S. Gordon, P.M. Dennington, H. Dunckley(Sanquin Research, Amsterdam, Netherlands)(Australian Red Cross Blood Service, Sydney, Australia)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 11.1The posters areon display fromMonday - ThursdayTOPIC 11.2The posters areon display fromMonday - ThursdayP-605 COMPARISON OF PH IN PLATELET CONCENTRATES WITH ADDITIVESOLUTIONS III MODIFIED FOR 9 DAYSP-614 SANBS NOW TO ACCREDITATIONB. Mr. Watt (South African National Blood Service (SANBS), Roodepoort, South Africa)N.V. de Valensart, M. Leclercq, A. Rapaille, D. Sondag, M. Lambermont (Service du Sang,Belgian Red Cross, Liège, Belgium)P-606 PLATELET COUNTING USING VARIOUS HEMATOLOGYCELL ANALYZERSM.J. Dijkstra-Tiekstra, W. Kuipers, A. Setroikromo, J. de Wildt-Eggen(Sanquin Blood Bank North East Region, Groningen, Netherlands)P-607 EFFECT OF STORAGE TIME OF WHOLE BLOOD ON PLATELETCONCENTRATES IN VARIOUS PLATELET SYSTEMSM.J. Dijkstra-Tiekstra, W. Kuipers, A. Setroikromo, C.J. van Delden, J. de Wildt-Eggen(Sanquin Blood Bank North East Region, Groningen, Netherlands)P-615 FROM THEN TO ACCREDITATIONB. Mr. Watt, B. Hlalukana, D. Hill (South African National Blood Service (SANBS),Roodepoort, South Africa)P-616 CHANGE CONTROL: A USEFUL TOOL FOR MANAGINGCHANGES IN CITMD. Sarlija, T. Vuk, M. Balija, I. Jukic (Croatian Institute of Transfusion Medic, Zagreb, Croatia)P-617 FORMULATING A MISSION STATEMENT FOR THE ZAMBIA NATIONALBLOOD TRANSFUSION SERVICET Sakala, M Chama, K Muyinda, M Mulenga (Zambia National Blood Transfusion, Lusaka, Zambia)144P-608 FACTOR XIII ACTIVITY IN PLATELET RICH AND POOR PLASMA.I.B. Suh, S.W. Ryu, C.S. Lim (Kangwon Natl. Univ, Medical Science Inst, Chunchun, South-Korea)Topic 11.2.145Quality Management - Industry PerspectiveTopic 11.1.Quality Management - RegulatoryP-609 E-TEACHING IN TRANSFUSION MEDICINE FOR MEDICAL STUDENTSP-618 USING NEW QUALITY TOOLS FROM LEAN MANUFACTURING TOEVALUATE PRETRANSFUSION TESTING WORK PROCESSESP. Bonomo, S. South, W. Malomgre, C. Criscione (Azienda Ospedaliera Civile MPA Ragusa,Ragusa, Italy)R.M. Moog (University Clinics Essen, Essen, Germany)P-610 QUALITY CONTROLS OF HEMOCOMPONENTSP-619 RESULTS IN APPLYING LEAN QUALITY TOOLS TO PRETRANSFUSIONTESTING PROCESSES IN A LARGE METROPOLITAN HOSPITAL IN ITALYS. Misso, L. Paesano, M. D'Onofrio, B. Feola, G. Fratellanza, E. D'Agostino, M. Nigro,A. Bulla, F. Curti, S. South, W. Malomgre (ASO San Giovanni Battista, Torino, Italy)A. Minerva, S. Formisano (Unit Operative Haemapheresis, Caserta, Italy)P-611 THE NEW GUIDELINES FOR TRANSFUSION PRACTICE (TP) AND THENEW INDICATION CRITERIA OF BLOOD PRODUCTS FOR TRANSFUSIONIN JAPANK. Takahashi (The University of Tokyo, Tokyo, Japan)P-612 BIOLOGIC PRODUCT DEVIATIONS MONITORING: DOES ADECREASE IN NUMBER EQUATE WITH IMPROVED PROCESS CONTROL?P-620 USING LEAN TOOLS TO ASSESS WORK PROCESSES IN A LARGETRANSFUSION SERVICE BEFORE IMPLEMENTING AUTOMATIONA. Dada, S. South, T. Casina (Clinic of University of Regensburg, Regensburg, Germany)P-621 TAKING LESSONS FROM HENRY FORD AND APPLYING THEM TOPRETRANSFUSION TESTINGC. Colavecchia, L. Merkley, A. Coovadia, J. Callum, M. Reis, T. Casina, S. South(Sunnybrook & Womens College HS Centre, Toronto, Canada)C.F.M. Danielson, J. Vian, M. Rasmussen, A. Parker (Wishard Memorial Hospital, Indianapolis,United States of America)P-613 A JOURNEY THROUGH THE EARLY DAYS OF BLOOD TRANSFUSIONP-622 GOING LEAN IN AN AUSTRALIAN TRANSFUSION SERVICEK. Toumpas, S. South, W. Malomgre (Queensland Medical Laboratory, West End, Australia)D.W. Brown, D. Hill (South African National Blood Service, Bloemfontein, South Africa)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 11.2TOPIC 11.3The posters areon display fromMonday - ThursdayP-623 PROCESS IMPROVEMENTS IDENTIFIED IN A UK TRANSFUSIONSERVICE LABORATORY WITH QUALITY TOOLS FROM LEANMANUFACTURINGP-631 BLOOD BAGS WITH INTEGRATED RFID-LABELS TO PROVIDEA COMPLETE TRACEABILITY FROM PRODUCTION TO PATIENT:FIRST ROUTINE EXPERIENCES AND FUTURE PROSPECTSF. South, W. Malomgre (Ortho-Clinical Diagnostics, Scottsdale, United States of America)T. Wagner, J. Zimmermann, G. Schwondra, U. Ockenfuss, M. Behague, F. Bidet,P-624 OUR EXPERIENCES IN INTRODUCING THE QUALITY SYSTEM ISO9001:2000V. Urlep Salinovic, I. Maracic, B. Majcen Vivod, L. Lokar, B. Bizjak, P. Leber (Maribor TeachingW. Kaufmann, G. Lanzer (University Hospital Graz, Graz, Austria)P-632 IMPLEMENTATION OF ISBT 128 BLOOD LABELING IN IRANIANBLOOD TRANSFUSION ORGANIZATIONHospital, Maribor, Slovenia)M. Fallah Tafti, M. Fallah Tafti, M. Mahmoodian Shooshtari, A. Talebian (Research CenterP-625 PRODUCTION OF STANDARDIZED LABILES BLOOD PRODUCTS FROMA SINGLE WHOLE BLOOD DONATION AT THE EFS–ALSACE BLOOD CENTERBlood Transfusion Org., Tehran, Iran)P-633 VALIDATION OF COMPUTER SYSTEMS - A NEW CHALANGE FOR QAH. Isola, F. Bigey, D. Kientz, C. Waller, M. Laforet, M.L. Wiesel, J.P. CazenaveO. Frenkel, G. Roshkin, S. Abramov, R. Goldman-Levy, B. Rubin, V. Yahalom, E. Shinar(EFS-ALSACE, Strasbourg, France)(National Blood Services, Ramat-gan, Israel)146P-626 ANALYSIS OF QUALITY CONTROL DATA IN THE ASSESSMENT OFLEUKOREDUCED BLOOD PRODUCTSP-634 TECAN TE-POOLSAFE(TM) BALANCE MODULE ALLOWSMONITORING OF THE POOLING PROCESS FOR NAT-TESTING147C. Jenkins, D. Devine, S. Doyle (Canadian Blood Services, Ottawa, Canada)M.K. Hourfar, M. Koller, R. Kehrli, A. Themann, W.K. Roth, E. Seifried, M. SchmidtP-627 USING LEAN TOOLS TO IDENTIFY IMPROVEMENT OPPORTUNITIESIN NINE TRANSFUSION SERVICES IN FIVE COUNTRIESF. South, W. Malomgre, T. Casina (Ortho-Clinical Diagnostics, Scottsdale, United States of America)(German Red Cross, Institute Frankfurt, Frankfurt, Germany)P-635 HIGHLY SENSITIVE AND FULLY AUTOMATED HBV DNA EXTRACTIONWITH THE QIAGEN BIOROBOT MDX TO INDENTIFY CHRONIC HBV CARRIERSM.K. Hourfar, A. Themann, V. Brixner, E. Seifried, M. Schmidt (German Red Cross, InstituteFrankfurt, Frankfurt, Germany)Topic 11.3.Quality Management - Automation and Data ProcessingP-636 TAQMAN NADIS ENABLES FULL MONITORING OF NAT SCREENINGAND PRODUCTION OF NAT REAGENTSP-628 THE USE OF ISBT 128, A QUALITY SYSTEM FOR STANDARDIZEDBAR CODE LABELLING OF BLOOD PRODUCTS WORLD WIDE. FOURYEARS OF EXPERIENCE IN NORWAYG.S. Aandahl, T.R. Knutsen, K. Nafstad (Akershus University Hospital, Oslo, Norway)M.S. Schmidt, A. Themann, V. Brixner, E. Seifried, M.K. Hourfar (German Red Cross InstituteFrankfurt, Frankfurt, Germany)P-637 EVALUATION OF THE COLLECTION LEUKOREDUCED DOUBLE REDCELL CONCENTRATES BY HAEMONETICS MCS PLUSP-629 AUTOMATION OF BLOOD BANK TESTS IMPROVE THEEFFECTIVENESS OF THE LABK.C. Kwon, C. Ihm (Chungnam National University, Taejeon, South-Korea)P-630 A STRATEGIE FOR FAST, RAPID AND COST- EFFECTIVE DETERMINATIONOF CELL VITALITY PARAMETERS DURING STORAGE OF PACKED RBC’SA. Doescher, E.K. Petershofen, C. Vogt, C. Grote, T. Mueller (German Red Cross BloodTransf.Service, Oldenburg, Germany)G.A.O.B. Barna, R.K.F. Guillaume, C.R. Kamakura, S.R. Matana, A. Mendrone Jr, M.V. Moço,P.C. Sierra, S.M. Winkaler, P.E. Dorlhiac-Llacer, D.A.F. Chamone (Pro-Sangue Sao PauloBlood Center, Sao Paulo, Brazil)P-638 EVALUATION OF THE UNIVERSAL BLOOD COMPONENT EXTRACTORPRESSOMAT FOR MORE AUTOMATION IN WHOLE BLOOD SEPARATIONC. Stebler, L. Infanti, M. Santoro, T. Rüefli, M. Brändle, A. Fahrni, M. Rüesch (BloodTransfusion Center Basel, Basel, Switzerland)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 11.4The posters areon display fromMonday - ThursdayTOPIC 11.4P-639 BLOOD BANK BILLING: CUSTOMIZING, INTERFACING, OPTIMIZINGAND STANDARDIZINGP-647 LOOK BACK STUDY OF SERCONVERTED DONORS -WHAT'S THE MESSAGE?K. De Smidt, B. Hendrickse, H. Harneker, E. Erasmus (Western Province Blood Transf. Serv.,V.B. Yahalom, O. Frenkel, R. Daniel, V. Gendelman, A. Korbs, E. Shinar (Magen David Adom -Pinelands, South Africa)NBS, Ramat Gan, Israel)P-648 HAEMOVIGILANCE IN SLOVENIA 2002-2005Topic 11.4M. Potocnik, M. Macek, V. Hra‰ovec, B. Bizjak, S. Maver, I. Bricl (Blood Transfusion CentreQuality Management - HaemovigilanceP-640 TRALI:FRANCE MAKES UP FOR ITS LOST TIMEof Slovenia, Ljubljana, Slovenia)P-649 MANAGEMENT OF EVENTS IN CITMT. Vuk, D. Sarlija, M. Balija, I. Jukic (Croatian Institute of Transfusion Medic, Zagreb, Croatia)148D.R. Rebibo, L.H. Hauser, J.Y.M. Muller, R.D. Dorne, F.D. Ducroz, O.F. Fontaine, K. Lee,M.C.M. Merillon, F.M. Meyer, H.O.M. Odent-Malaure, N. Ounnoughene, C.R. Rieux,A.S. Slimani, M. Tazerout, G.A. Andreu (EFS, Paris, France)P-641 A FIVE YEARS FOLLOW UP OF POSTTRANSFUSION REACTIONSREPORTED TO THE BLOOD TRANSFUSION INSTITUTE IN NOVI SADB. Pekovic, G. Dimitrijevic (Blood Transfusion Institute, Novi Sad, Serbia and Montenegro)P-642 LEUKOCYTE ANTIBODIES IN BLOOD DONORS AND A LOOKBACKON RECIPIENTS OF THEIR BLOOD COMPONENTSK. Maslanka, H. Michur, B. Zupanska, R. Mika-Witkowska, E. Sobczak, A. Smolarczyk,J. Rumas-Bec, D. Domanska, B. Wlodarczyk (Institute of Haematol and Blood Transf.,Warsaw, Poland)P-643 HEMOVIGILANCE IN THE HRADEC KRALOVE UNIVERSITY HOSPITAL- 3 YEARS SURVEY OF TRANSFUSION INCIDENTSV. Rehacek, J. Podzimkova, H. Jirousova (University Hospital, Hradec Kralove, Czech Republic)P-644 REFERENCE SAMPLE ARCHIVING FOR BLOOD DONORSP-650 THE TRANSFUSION REPORTS OF GRADE 0 : A NATIONALDESCRIPTIVE ANALYSIS ON TWO YEARS OF FRENCH PRACTICEK. Martinière, K. Martinière, M.P. Vo Mai, J.J. Cabaud, J.F. Legras, P. Zorzi(Afssaps, Saitn-Denis, France)P-651 HAEMOVIGILANCE - A LABORATORY PERSPECTIVEL. Ramsundar, E. Smart (South African National Blood Service,ECR, Durban, South Africa)P-652 THE FIRST TWO YEARS OF NATIONAL HEMOVIGILANCE REPORTINGIN THE NETHERLANDSJ.C. Wiersum-Osselton, M.R. Schipperus (TRIP Dutch National Hemovigilance Office,The Hague, Netherlands)P-653 LACK OF HBV TRANSMISSION BY RED BLOOD CELL AND PLATELETCONCENTRATES FROM CHRONIC HBV DNA POSITIVE/HBSAG NEGATIVEDONOR WITH ANTI-HBC AND ANTI-HBE ANTIBODIES.E. Brojer, D. Boguszynska, K. Kledzik, M. Dobrowolna, E. Brojer, M. Letowska, G. Liszewski,J. Styczynski (Institute of Haematology and Blood Transfusion, Warsaw, Poland)149N. Solaz, A. Kemahli, S. Aydogan, S. Mert (Ankara University, Ankara, Turkey)P-645 A HEMOVIGILANCE STUDY OF THE APPROPRIATENESS OF FRESHFROZEN PLASMA TRANSFUSION IN SINGAPOREP-654 TIME-TRENDS OF ACUTE AND DELAYED IMMUNOLOGIC TRANS-FUSION REACTIONS IN E-FIT, THE FRENCH HEMOVIGILANCE DATABASEP. Renaudier, M.P. Vo Mai, N. Ounnoughene, P. Breton, S. Cheze, A. Girard, L. Hauser, J.F. Legras,M. Alcantara, J. Ng, B.C. Koh, H. Tan (Health Sciences Authority, Singapore, Singapore)D. Rebibo, S. Schlanger, C. Waller, C. Caldani (Hopital de la Croix Rousse, Lyon, France)P-646 AN AUDIT OF BLOOD ORDERING PRACTICEP-655 DANISH REGISTRATION OF TRANSFUSION RISK (DART)J. Mesaric, M. Herceg, C. Maglov, I. Jukic (Croatian Institute of Transfusion Medicine, Zagreb,E. Morling Taaning, J. Jorgensen, K. Riisom (Herlev Hospital, University of Copenhagen,Croatia)Herlev, Denmark)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 12.0TOPIC 13.0The posters areon display fromMonday - ThursdayTopic 12.0P-664 METHODS FOR IMPROVING RECOVERED PLASMA YIELDSBlood Inventory Management, including Disaster ManagementP-656 THE IMPACT OF THE INTERNET FOR RECRUITMENT OF FIRST TIMEDONORS IN A UNIVERSITY BLOOD TRANSFUSION SERVICER.M. Moog, K. Fourné (University Clinics Essen, Essen, Germany)P-657 IMPACT OF HOSPITAL TRANSFUSION COMMITTEE ON FRESHFROZEN PLASMA USAGEY.Y. Huang, C.C. Yang, W.H. Shih, Y.C. Sung (Cathay General Hostipal, Taipei, Taiwan)K Myers, L. Fults, N. Kalmin, K. Riggins (South Texas Blood & Tissue Center, San Antonio,United States of America)P-665 THE ROLE OF THE SURGICAL CLINICS IN CLINICAL USE OF BLOODN. Borici, E. Berberi, I.Seferi (National Transfusion Centre,Tirana, Albania)P-666 EFFECTIVE BLOOD INVENTORY MANAGEMENTP.B. Prcic-Knezevic (Health Center Subotica, Subotica, Serbia and Montenegro)P-667 PLASMA COMPONENTS AVAILABLE FOR IMMEDIATE TRANSFUSION150P-658 THE ELECTRONIC CROSSMATCH AND VALIDATION OF GUIDELINECOMPLIANCE BY LABORATORY STAFF, PRIOR TO BLOOD ISSUE, ISHIGHLY EFFECTIVE IN BLOOD CONSERVATION ENABLING A 29%REDUCTION IN BLOOD USE IN ONE YEARJ. Watts, D. Stokes, D. Green, T. Turner (Basildon University Hospital, Basildon, United Kingdom)P-659 APHERESIS DONATIONS, DO THEY IMPLY AN EXCESSIVE COST ANDNOT ENOUGH ADVANTAGES?A.C. Norda, O. Åkerblom, F. Knutson (Uppsala University Hospital, Uppsala, Sweden)P-668 UNDERSTANDING THE DYNAMICS OF THE BLOOD SUPPLY CHAIN:IS PREDICTION POSSIBLE?J.F. Chapman, R. Hick, R.D. Wilding (Blood Stocks Management Scheme, London, United Kingdom)P-669 HEMOLYSIS EVALUATION IN RETURNED RED BLOODCELLS CONCENTRATESL.A. Amorim, L.M. Amorim, T.M. Ferreira, J.F. Oliveira, M.E. Lopes (Hemorio, Rio De Janeiro, Brazil)151M. Jimenez-Marco, M. Galmes, M. Sedeno, E. Girona, A. Forteza (Fundacio Banc de SangBalears, Palma De Mallorca, Spain)P-660 PLATELET INVENTORY MANAGEMENT ACROSS THEBLOOD SUPPLY CHAINTopic 13.0Structure and Governance of Blood Transfusion ServicesJ.F. Chapman, R. Hick, M. Jelly (Blood Stocks Management Scheme, London, United Kingdom)P-661 PLATELET AUDIT: ASSESSMENT AND UTILIZATION OF THISPRECIOUS RESOURCE FROM A TERTIARY CARE HOSPITALK. Saluja, B. Thakral, R.R. Sharma, N. Marwaha (PGIMER, Chandigarh, India)P-662 WHAT PARAMETERS PREDICT CHANGES IN THE USE OF REDBLOOD CELL CONCENTRATESC.J. van Delden, W.J. Hoekstra (Sanquin, Groningen, Netherlands)P-663 COMPARISON OF DOUBLE DOSES PLATELET COLLECTIONS FROMTWO APHERESIS DEVICESM. Jimenez-Marco, A. Forteza, E. Girona, M. Sedeno, A. Forteza (Fundacio Banc de SangBalears, Palma De Mallorca, Spain)P-670 SUPPLIMENT OF SAFE BLOOD TRANSFUSIONT.T. Timova, L. Maninska, D. Stambolieva (General hospital-Strumica, Strumica, Macedonia)P-671 ORGANIZATION AND MANAGEMENT OF TRANSFUSION MEDICINES.B. Balen, N. Vukelic Damijani (Clinical Hospital Center Rijeka, Rijeka, Croatia)P-672 A NATIONAL BLOOD POLICY IS BORNF. Moftah (NBTS, MOH, Giza, Egypt)P-673 NEEDS AND ESSENTIALS FOR NATIONALLY SUPPORTED STRCUTUREAND ORGANISATION OF THE BLOOD SUPPLY: THE SANQUIN MODELC.Th. Smit Sibinga (Academic Institute IDTM, Groningen, Netherlands)P-674 BLOOD- FROM EXTREMELY RISKY TO SINCERE: THE NEED FORPOSTACADEMIC LEADERSHIP DEVELOPMENTC.Th. Smit Sibinga (Academic Institute IDTM, Groningen, Netherlands)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 13.0TOPIC 14.0The posters areon display fromMonday - Thursday152P-675 BILATERAL INVOLVEMENT OF HEALTH AUTHORITIES, THE KEY TOSUCCESSFUL COOPERATION PROGRAMMESC. Hossenlopp, A. Beauplet, P. Herve (Etablissement Francais du Sang, Paris, France)P-676 EVALUATION OF HOSPITAL BLOOD TRANSFUSION COMMITTEESAND RETURN RATE OF UNUSED BLOOD IN IRANS. Zolfaghari, D. Bashash, S. Amini Kafi Abad, G. Heidari Rad, M. Shariati (Iranian BloodTransfusion organization, Tehran, Iran)P-677 POSITIVE IMPACT OF NATIONAL SOCIETY TO LAST DECADEPROGRESSES IN BLOOD BANKING & TRANSFUSION MEDICINEPRACTICE IN TURKEYN. Solaz, K. BBTST (Ankara University, Ankara, Turkey)P-678 TWENTY-TWO FRENCH SPEAKING COUNTRIES FROM AFRICA TOBUILD UP LONGER TERM BLOOD SAFETY STRATEGIESC. Hossenlopp, M. Chassaigne, K. Kezzal, M. Ardjoun, A. Beauplet (Etablissement Francaisdu Sang, Paris, France)P-679 THE PROFIT OF CONTROLLING THE COSTS AND MARGINS OFTRANSFUSION MEDICINE: AN EXPERIENCE OF THE ACTIVITY BASEDCOSTING (ABC) METHODG. Follea, L. Deslande (EFS, Nantes, France)P-680 THE CONTRIBUTION OF BLOOD TO HOSPITAL REVENUEIN THE UNITED STATESJ. Macpherson, C. Brown Mahoney, L. Katz, C. Bianco (America's Blood Centre, Washington,United States of America)Topic 14.0Transfusion in Resource Limited CountriesP-682 SOCIETAL MARKETTING: THE WAY TO ACHIEVE 100% VOLUNTARYNON-REMUNERATED BLOOD DONORS (VNRBD) AND TO ATTAIN 100%COMPONENT PREPARATION IN DEVELOPING COUNTRIESN. Choudhury, J. Shah, B. Buch (Prathama Blood Center, Ahmedabad, India)P-683 AUDIT OF REQUISITION FORMS FOR RED CELLSH. Ranganathan (Global Hospital, Hyderabad, India)P-684 HIGH INCIDENCE OF HAEMOLSINS AMONG SICKLE CELL ANAEMIA(SCA) PATIENTS WITHIN CALABAR METROPOLISA. Anyanwu, A.O. Emeribe, J. Akpotuzor, I. Ajayi (Ambrose Alli University, Ekpoma, Nigeria)P-685 QUALITY ASSESSMENT OF HOSPITAL BLOOD BANKS IN BOTSWANAM. Gaolekwe, S. Gaolekwe, C. Pule, B. Gibbs, M. Kayembe, J. van Hasselt, K. Ntshambiwa(Safe Blood for Africa, Johannesburg, South Africa)P-686 ETHNIC COMPOSITION OF BLOOD DONORS POOLJ. Samonikov Tosevska, T. Uzunovska, S. Stojkoska, M. Bucevska, T. Makarovska-Bojadzieva,B. Blagoevska (City Hospital surgical clynic, Skopje, Macedonia)P-688 ALGORITHM FOR RECALL OF HIV REACTIVE INDIAN BLOODDONORS BY SEQUENTIAL IMMUNOASSAYS ENABLES SELECTIVE DONORREFERRAL FOR COUNSELINGB. Thakral, K. Saluja, R.R. Sharma, N. Marwaha (PGIMER, Chandigarh, India)P-689 TRANSFUSION MEDICINE TRAINING IN REPUBLIC TAJIKISTAN153P-681 BLOOD TRANSFUSION IN ALGERIAK.I. Souami, S. Senoussaoui, N. Benchehida, N. Kaouadji, N. Bouzid, N. Bouzid, S. Mokrani,K. Kezzal (National Blood Agency (Ministery of heathl, Algiers, Algeria)B. Bahovadinov, L. Murotov (Republican Sientific Centre of Blood, Dushanbe, Tajikistan)P-690 PROBLEMS OF RECRUITING BLOOD DONORS IN THE REPUBLIC OFTAJIKISTANB. Bahovadinov, S. Edalieva (Republican Sientific Centre of Blood, Dushanbe, Tajikistan)P-691 APPRAISAL OF PLATELET UTILIZATION PRACTICE AT A TEACHINGHOSPITAL BLOOD BANK IN INDIAA. Verma, P. Pandey, D. Khetan, R. Chaudhary (Sanjay Gandhi P.G.I., Lucknow, India)P-692 COST-EFFECTIVENESS OF INTERVENTIONS ENSURING BLOODTRANSFUSION SAFETY IN AFRICAM. van Hulst, N. Dhingra, C.Th. Smit Sibinga, M.J. Postma (GUIDE/Martini Hospital,Groningen, Netherlands)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 14.0TOPIC 15.0The posters areon display fromMonday - ThursdayP-693 BLOOD TRANSFUSION DEMAND AND SUPPLY AT EIGHT HOSPITALSIN KENYAP-702 IS SERBIA A RESOURCE LIMITED COUNTRY-CONCERNINGTRANSFUSIONJ. Mwangi, L.H. Marum, J.A. Nyamongo (Centers for Disease Control and Preventi, Nairobi, Kenya)G. Dimitrijevic, B. Pekovic, L. Sikimic, C. Gavrancic, G. Bogdanovic (Blood transfusionP-694 EVALUATION OF EFFICACY AND EFFICIENCY OF THE HEMOMINASFOUNDATION, A PUBLIC, CENTRALIZED TRANSFUSION SERVICE IN BRAZILInstitute, Novi Sad, Serbia and Montenegro)P-703 ESTABLISHMENT OF A NATIONAL BLOOD SERVICE IN NIGERIAA.B.F. Carneiro-Proietti, J.M.G. Cioffi, T.M.G. Menicucci (Hemominas Foundation, BeloF. Ayo (Federal Ministry of Health Nigeria, Abuja, Nigeria)Horizonte, Brazil)P-695 KNOWLEDGE OF GUIDELINES, ATTITUDE TOWARDS BLOODSAFETY AND TRANSFUSION PRACTICE: AN INDIAN EXPERIENCEP-704 A RAPID SCALE UP OF THE BLOOD SAFETY PROGRAMME IN ZAMBIAK. Muyinda, K. Mulenga, N. Chikwese (Zambia National Blood Transfusion Servic, Lusaka, Zambia)K. Chaudhary (Dr. Ram Manohar Lohia Hospital, New Delhi, India)154P-696 ORGANISATIONAL AND SOCIAL FACTORS AFFECTINGTRANSFUSION PRACTICE: NEED FOR CONTEXTUAL ADAPTATIONOF INTERNATIONAL GUIDELINESK. Chaudhary (Dr. Ram Manohar Lohia Hospital, New Delhi, India)P-697 BLOOD SAFETY SITUATION IN THE WHO AFRICAN REGION IN 2004Topic 15.0Emerging TechnologiesP-705 INVITRO EVALUATION OF CYTARABIN INDUCED APOPTOSIS ONLEUKEMIC BLASTS ( AML & ALL )M. Zandieh, M. Safari Fard, M. Nikogoftar. (Iranian Blood Transfusion Company, Tehran, Iran)155J.B. Tapko, O. Sam, A.J. Diarra-Nama (W.H.O., Brazzaville, Congo)P-698 EVALUATION OF DETECTION TESTS OF HIV (MUREX HIV 1-2-0, MUREXHIV AG/AB COMBINATION) AND OF THE HEPATITIS B (MUREX HBSAG) INTHE NATIONAL CENTER OF BLOOD TRANSFUSION OF CONAKRYP-706 A COMPARISON OF SERPREVALENCE OF BLOODBRON INFECITONSAMONG REGULAR, SPORADIC AND FIRST TIME BLOOD DONORS INISFAHAN: AUGUST 2002 MARCH 2003Z. Massaeli, M.R. Jaberi, M. Maghsodlu (Iranian Blood Transfusion Organisation, Isfahan, Iran)A. Loua, F. Sylla, M. Camara, M.A. Bah (Centre National de Transfusion Sanguine, Conakry, Guinea)P-699 IMPACT ON THE ORGANIZATION OF SAFE BLOOD SERVICES TORESPOND TO THE INCREASE IN DEMAND FOR BLOOD COMPONENTSDURING THE RAINY SEASON IN COTE D’IVOIREP-707 EFFICIENCY OF PLASMAPHERESIS FOR PREVENTION AND EARLYTHERAPY OF MULTIPLE ORGAN DYSFUNCTION SYNDROMA. Ragimov, S. Poreshina, I. Solovyeva, M. Babaev, E. Salimov, L. Alekseeva, I. Bayramalibeyli(National Research Center of Surgery, Moscow, Russian Federation)S. Konaté, S. Doukouré, T. Dogbo, N. Abbe-Koffi, A. Sasse, C. Fretz, J. Siquet,D. Sondag-Thull, P. Rao, J.J. Fournel (National Blood Transfusion Center, Abidjan, Ivory Coast)P-700 COSTING OF BLOOD PRODUCTS AND SERVICES IN AHYPERINFLATIONARY ENVIRONMENTP-708 BLOOD COMPONENT FRACTIONATION: IMPACT OF EMERGINGTECHNOLOGIESJ. Cid, M. Claparols, J.M. Hernández, A. Pinacho, P. Ortiz, L. Puig, R.P. Pla(Banc de Sang i Teixits, Barcelona, Spain)Z. Musekiwa, A. Mupuwi, G. Nyashanu, J. Jowa (National Blood Service Zimbabwe, Harare,Zimbabwe)P-701 REJECTED BLOOD COMPONENTS BY QC IN THE PRODUCTIONFORCE IMPLEMENTATION OF A QA SYSTEMO. Todorovska, K. Dimitrovski, V. Stefanovska, D.N. Dimovska (Institute of TransfusionMedicine, Skopje, Macedonia)P-709 ERYTHROCYTAPHERESIS IN THE TREATMENT OF EMOCHROMATOSISM. D'Onofrio, L. Paesano, S. Misso, B. Feola, E. D'Agostino, G. Fratellanza, A. D'Ambra,A. Minerva (AOU "Federico II", Napoli, Italy)P-710 CONCEPTION OF BLOOD FREEZING PROGRAM IN CZECH REPUBLICM. Bohonek (Central Military Hospital, Prague, Czech Republic)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006PostersTOPIC 15.0TOPIC 16.0The posters areon display fromMonday - ThursdayP-711 USERS’ EVALUATION OF AN AUTOMATIC SYSTEM FOR WHOLEBLOOD PROCESSING: ATREUS (VERSION BETA 2.1 AND 2.5)L. Larrea, C. Herreros, M.D. Garcia, M. Gil, E. Costa, I. Saiz, M.A. Soler, R. Roig(Centro Transf de la Comunidad Valenciana, Valencia, Spain)P-712 PURITY OF PLASMA OBTAINED IN ROUTINE BY THE ATREUS 2C+ SYSTEMA.M. Sward-Nilsson, S. Andersson, A. Johansson, P. de Smet (Lund University Hospital,Lund, Sweden)P-713 N VITRO QUALITY OF RED BLOOD CELLS OBTAINED AFTERAUTOMATED SEPERATION OF WHOLE BLOOD BY THE ATREUS2C+ SYSTEM AND STORED FOR 42 DAYSA.M. Sward-Nilsson, M. Jeansson, E. Gintse, M. Callaert (Lund University Hospital, Lund, Sweden)P-720 A NEW TELECONSULTATION SYSTEM FOR PRETRANSFUSION TESTINGP. Rozman, P. Rozman, I. Bricl, M. Urbajs, M. Macek, M. Breskvar, M. Meza, J. Tasic(Blood Transfusion Centre of Slovenia, Ljubljana, Slovenia)P-721 FLOW CYTOMETRY TESTING OF GRANULOCYTE-ASSOCIATED ANTI-BODIES (GA-ABS) IN ADULT PATIENTS: FACTORS AFFECTING OUTCOMESI.Z. Ivankovic, B. Golubic Cepulic (Clinical Hospital Center Zagreb, Zagreb, Croatia)P-722 WHOLE BLOOD COLLECTION WITH PROPORTIONAL CONTINUOUSANTICOAGULATION USING THE ABC AUTOMATE (MACOPHARMA)F. Bigey, H. Isola, M.L. Wiesel, J.P. Cazenave (EFS - ALSACE, Strasbourg, France)P-714 QUALITY OF THE PLATELET CONCENTRATES DERIVED FROMATREUS BUFFY COATSA.M. Sward-Nilsson, M. Jeansson, E. Gintse, M. Callaert (Lund University Hospital, Lund, Sweden)P-723 MACOTRACE ® SYSTEM : TRACEABILITY FROM COLLECTION TOBLOOD ISSUING USING RFID TECHNOLOGY WITHIN MACOPHARMABLOOD PACKS AND EQUIPMENTL. Larrea, M. Ortiz de Salazar, A. Chaves, A. Blanquer, M.A. Soler, I. Ample, P. Dussert(Centro Transf de la Comunidad Valenciana, Valencia, Spain)156P-715 DEVELOPMENT OF AN IN-LINE PORTABLE NON-ELECTRICALLYPOWERED BLOOD AND INTRAVENOUS FLUID WARMERD. Roxby, M. McEwen, J. Robson, R. Woolford (Flinders Medical Centre, Adelaide, Australia)P-724 AUTOMATED PROCESSING OF PLATELET CONCENTRATES USINGORBISAC SYSTEMM. Santos, A.R. Ferreira, G. Sousa (Instituto Português do Sangue, Lisbon, Portugal)157P-716 NEUTROPHIL FUNCTION IS PRESERVED IN A POOLED GRANULO-CYTE COMPONENT PREPARED FROM WHOLE BLOOD DONATIONSS. Bashir, E. Massey, S. Stanworth, R. Cardigan (National Blood Service, Essex, United Kingdom)P-717 EIGHT YEARS EXPERIENCE OF THE ELECTRONIC CROSSMATCHDEMONSTRATES IMPROVED EFFICIENCY AND A HIGHLY EFFECTIVEBLOOD CONSERVATION STRATEGY RESULTING IN A 29% REDUCTION INBLOOD USE IN ONE YEARJ. Watts, D. Stokes, D. Green, T. Turner (Basildon University Hospital, Basildon, United Kingdom)Topic 16.0Evidence Based Transfusion MedicineP-725 HIGH-DOSE PLATELET TRANSFUSION INCREASES THETRANSFUSION INTERVAL: RESULTS OF A META-ANALYSISJ. Cid, M. Lozano, L. Puig (Banc de Sang i Teixits, Barcelona, Spain)P-718 COMPARISON OF MANUAL BIOVUE ANTIBODY IDENTIFICATIONWITH AUTOMATED IDENTIFICATION USING AUTOVUE INNOVA ANDRESOLVIGEN 3 SOFTWARED. Roxby, M. Phillips, M. Kraft (Flinders Medical Centre, Adelaide, Australia)P-726 THE TNF-ALPHA 308 POLYMORPHISM IS ASSOCIATED WITHPERSISTENT MICROCHIMERISM IN TRANSFUSED SEVERE TRAUMA PATIENTST.H. Lee, R. Gill, M.P. Busch (Blood Systems Research Institute, San Francisco,United States of America)P-719 SUPPRESSIVE EFFECT OF CASPASE 3 GENE EXPRESSION IN CELLSTRANSFECTED WITH SHRNA EXPRESSION VECTORL. Gao, H.H. Fan, J. Yang, X.X. Nie, R.F. Xie, Y Liu, Y.M. Yang, K.C. Qian (Shanghai BloodCenter, Shanghai, China)P-727 IMMUNOSUPPRESSIVE EFFECT OF AUTOLOGOUS OR ALLOGENEICBLOOD TRANSFUSION IN ORTHOPEDIC SURGICAL PATIENTSS. Misso, B. Feola, M. D'Onofrio, L. Paesano, G. Fratellanza, E. D'Agostino, A. D'Ambra,P. Amato, A. Minerva, S. Formisano (Unit Operative Haemapheresis, Caserta, Italy)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

PostersISBT2006TOPIC 16.0TOPIC 17.0The posters areon display fromMonday - ThursdayP-728 ERYTHROCYTAPHERESIS IN HEREDITARY HEMOCHROMATOSISPATIENTS – A STUDY OF IRON ELIMINATIONV. Rehacek (University Hospital, Hradec Kralove, Czech Republic)P-735 EARLY DIAGNOSIS AND MANAGEMENT OF POSTPARTUMTHROMBOTIC MICROANGIOPATHY WITH PLASMA EXCHANGE USINGSINGLE DONOR PLASMA AS REPLACEMENTM.S. Shrivastava, S. Naved, A.J. Jain, G.M. Modi (Bhopal Memorial Hospital ( BMHRC),Bhopal, India)158P-729 SANITARY PERSONNEL EXPOSURE TO HBV, HCV AND HIV VIRUSESTRANSMITTED THROUGH BLOOD: THE PROBLEM AND ITS PREVENTIONC. Veneti (General Hospital Saint Olga, Athens, Greece)P-730 VERIFICATION THAT REQUESTS FOR BLOOD ARE GUIDELINECOMPLIANT PRIOR TO ISSUE OF BLOOD FROM THE LABORATORYENABLES THE IMPLEMENTATION OF EVIDENCE BASED TRANSFUSIONPRACTICEJ. Watts, D. Stokes, D. Green, T. Turner (Basildon University Hospital, Basildon, United Kingdom)P-731 SUCCESSFUL MANAGEMENT OF A SEVERE STEROID-RESISTANTWARM AUTOIMMUNE HEMOLYTIC ANEMIA WITH PLASMA EXCHANGEA. Verma, S. Sinha, R. Chaudhary, V.L. Ray (Sanjay Gandhi P.G.I., Lucknow, India)P-736 BLOOD-VOLUME; A DECISION TOOL TOWARDS MORE EVIDENCEBASED COLLECTION AND/OR TRANSFUSION OF BLOOD AT THE LEVELOF THE INDIVIDUAL DONOR OR PATIENT.P.A.H. van Noord, P. VanNoord, I. Veldhuizen, C. Puylaert, E. Rombout, W. de Kort(Julius Center UMCU, Utrecht, Netherlands)P-737 TEN YEARS OF BLOOD TRANSUFSIONS: USE,DISEASE AND SURVIVALM.P. Janssen, C.L. van der Poel, W.P. Schaasberg, G.J. Bonsel, B.A. van Hout(UMC Utrecht, Utrecht, Netherlands)159P-732 TRANSFUSION REQUIREMENTS FOR PATIENTS UNDERGOINGMULTI-VISCERAL AND INTESTINE-ONLY TRANSPLANTATIONC.F.M. Danielson, J. Vian, M. Rasmussen, M. Skipworth, W. Jackson, C. McCormick,S. Rothenberger, A. Miguel, E. Vianna, J. Tector III, A. Fridell, P. Mishler, A. Waxman, S. Smith,C. Goggins (Wishard Memorial Hospital, Indianapolis, United States of America)Topic 17.0P-733 THE CONTRIBUTION OF THE HOSPITAL TRANSFUSION MEDICINECOMMITTEE IN THE RATIONAL USE OF BLOOD AND BLOOD PRODUCTSIN ORTHOPEDIC SURGERYL. Sikimic, G. Dimitrijevic, G. Bogdanovic (Institute of Orthopedic surgery and trau, Beograd,Serbia and Montenegro)Other - History of Blood TransfusionP-738 AN EFFICIENT METHOD FOR IMMORTALIZATION OF GENETICSDISORDERS PATIENTS’ LYMPHOCYTES BY EPSTEIN-BARR VIRUS (EBV)Z. Sharifi, M. Parsania, A. Talebian (Research Center of IBTO, Tehran, Iran)P-739 HOW MANY TIMES CAN A PERSON BE TRANSFUSED IN JAPAN?S. Inaba, N. Kinukawa (Kanagawa Red Cross Blood Center, Yokohama, Japan)P-734 SHORT-TERM AND LONG-TERM SURVIVAL OF TRANSFUSED RBCS:A COMPARISON BETWEEN STORED RCC OF SHORT AND LONG SHELFLIFEM. Luten, B. Roerdinkholder-Stoelwinder, N.P.M. Schaap, J. Curvers, H.J. Bos, W.J. de Grip,G.J.C.G.M Bosman, V.M.J. Novotny (Sanquin Blood Bank South East Region, Nijmegen,Netherlands)P-740 A DONOR AND A GENTLEMAN - MR. AHMET ANDICEN; PORTRAITOF A RECORD OWNER BLOOD DONOR OF TURKEYN. Solaz (Ankara University, Ankara, Turkey)P-741 DEVELOPMENT OF BLOOD TRANSFUSION IN THE REPUBLIC OFMACEDONIAV.S. Stefanovska (Institute of Blood Transfusion, Skopje, Macedonia)P-742 AN HISTORICAL OVERVIEW OF THE USE OF APHERESISTECHNOLOGY IN SOUTHERN AFRICA (A GRANDMOTHER LOOKS BACK)A.M. Anderson (Haemotec (Pty) Ltd, Edenvale, South Africa)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSION

ISBT Business MeetingsISBT2006Key InformationISBT BUSINESS MEETINGSKEY INFORMATION160Saturday, 2 September08.30 – 16.30 ISBT Board of Directors Room 1.6408.00 – 14.00 ISBT/ICSH Expert Panel in Molecular Biology Room 1.6108.00 – 16.00 ISBT WP on Haemovigilance Room 2.6313.00 – 17.30 ISBT WP on Automation and Data Processing Room 1.6314.00 – 16.00 ISBT WP on Platelet Immunobiology Room 1.6114.00 – 18.00 ISBT WP on Red Cell Surface Room 2.6614.00 – 18.00 ISBT WP on Transfusion Transmittable Diseases Arabella SheratonSunday, 3 September09.00 – 18.00 ISBT WP on Transfusion Transmittable Diseases Cullinan Hotel12.00 – 14.00 ISBT/ICSH Expert Panel in Molecular Biology Room 2.6314.00 – 18.00 ISBT WP on Blood Supply Management Room 2.66Monday, 4 September10.00 – 12.00 ISBT WP on Rare Donors Room 2.6612.00 – 14.00 ESTM Scientific Committee Room 2.63Tuesday, 5 September07.00 – 08.00 ISBT ISAC Arabella Sheraton11.45 – 13.00 ISBT General Assembly Auditorium13.00 – 15.00 ISBT Publication Committee Room 2.63Wednesday, 6 September08.00 – 10.00 ISBT Education Committee Room 1.41-1.4412.00 – 14.00 ISBT WP on Socio Economics Room 2.6312.00 – 14.30 ISBT Board of Directors Room 2.66VenueCape Town International Convention Centre (CTICC)Convention Square, 1 Lower Long StreetCape Town 8001, South AfricaTel: + 27 21 410 5000, Fax: + 27 21 410 5001Website: www.capetownconvention.comRegistration hoursThe registration area in the CTICC will be open at the following hours:Saturday, 2 SeptemberSunday, 3 SeptemberMonday, 4 SeptemberTuesday, 5 SeptemberWednesday, 6 SeptemberThursday, 7 SeptemberExhibition hoursSunday, 3 SeptemberMonday, 4 SeptemberTuesday, 5 SeptemberWednesday, 6 SeptemberThursday, 7 September12.00 – 18.00 hours07.30 – 19.00 hours08.00 – 18.30 hours08.00 – 15.00 hours08.00 – 18.30 hours08.00 – 14.00 hours18.45 – 20.45 hours09.30 – 18.30 hours09.00 – 15.00 hours09.00 – 18.30 hours09.00 – 14.00 hoursBadgesAll participants and accompanying persons will receive a personal badge uponregistration. You are kindly requested to wear your name badge when attendingany meeting or social gathering. Only participants who are wearing their namebadge will be admitted to the lecture halls.161OTHER MEETINGSPlease note: accompanying persons and exhibitors will not be admitted to thescientific sessions. Accompanying persons do have free access to the exhibition.Tuesday, 5 September09.00 – 10.00 General Assembly African Society Room 1.41-1.44INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Key InformationISBT2006Key InformationKEY INFORMATIONKEY INFORMATION162Name badges have been color-coded a follows:ISBT (Board) MembersRedOrganising CommitteeGreenDelegatesTransparentAccompanying PersonsYellowExhibitorsBluePressOrangeCertificates of AttendanceCertificates of Attendance will be available at the Registration Desk as ofTuesday, 5 September, 12.00 hours.Coffee and Tea BreaksDuring session-breaks coffee and tea will be served free of charge to delegateswearing name badges on the exhibition floor.Cloakroom and LuggageA cloakroom including a luggage storage area is located in the registration area.It will only be available on the last two days of the congress for luggage storage.Currency and Banking serviceThe unit of currency in South Africa is the South African Rand (ZAR). South Africa hasa decimal currency system with one Rand equalling 100 cents. The exchange rate is1 Euro equals 8 ZAR. Facilities for cashing traveller’s cheques are available at banks(operating hours: week days from 09.00 to 15.30, Saturdays from 08.30 to 11.00)and at most hotels. Banks are closed on Sundays. Foreign exchange agencies areopen during the week and on Saturdays. Automatic teller machines are open 24hours and are located at most banks as well as at the Congress Venue. Internationalcredit cards (Visa, Diners Club, Mastercard and American Express) are accepted atthe majority of hotels, restaurants and shops.Eating Out in Cape TownMost restaurants are open until 23.00 hours and many stay open later.Please note that all restaurant service charges are included in the bill. If you deemthe service good enough to warrant a tip, we suggest a tip of about ten percent.More information for reservations are available at the Social Desk.Electricity SupplyThe electricity supply in South Africa is 220-240 volts, 50 Hz. The connection forappliances is a round three-pin plug. Most hotels provide dual-voltage, two-pinrazor sockets (100-120 volts and 220-240 volts).First AidThere is a First Aid/Medical room close to the registration area. The opening hoursare 08.00 – 17.00 hours, from Saturday until Thursday.HealthThere are no compulsory vaccination requirements for persons entering South Africa,although a certificate for yellow fever may be required if you are entering from certainSouth American or sub-Saharan African countries. However, certain parts of the countryhave been designated as malaria risk areas. If you intend travelling to one of theseareas, it is essential that you take prophylaxis before arrival and whilst in the area.Protective clothing and insect repellents should also be used. Cape Town is a malariarisk free area. South African doctors and dentists are highly trained professionals andhospitals are well equipped. Participants are requested to make their own arrangementswith respect to health insurance prior to departure and consult their local generalpractitioner for personal expert advice. For international travel and health advisoriesplease visit the WHO website at www.who.int/ith or www.cdc.org. It is safe to drink tapwater throughout South Africa. However, for those who prefer bottled mineral water, thisis readily available in various stores. Smoking is prohibited by law in most public buildingsin South Africa (airports, Cape Town International Convention Centre, restaurants, etc.)except in designated smoking areas.InternetWireless internet connection is available in most hotels. There will be two internetareas in the Exhibition Area, where participants will be able to get access to their mail.Liability and InsuranceThe XXIX th International Congress of the ISBT accepts no liability for any personalinjury, loss or damage of property belonging or additional expenses incurred to congressparticipants either during the congress or as result of delays, strikes or any othercircumstances. Participants are requested to make their own arrangements with respectto health and travel insurance.163INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Key InformationISBT2006Key InformationKEY INFORMATIONKEY INFORMATIONLanguageThe official congress language will be English. Simultaneous interpretation will notbe provided.LunchLunch is included in the registration fee. Lunch will be provided in the Exhibition Areaand at the entrance of the meeting rooms where Satellite Symposia will take place.Shopping in Cape TownMost shops in the city centre and suburbs are open between 08.00 and 17.00 or 17.30.Shops in some major malls may only open at 09.00 and close at 21.00 or even later(especially at the V&A Waterfront), and are open on Sundays and most public holidays.Government agencies still keep to traditional weekday only hours. Most banks closeat 15.30 and have limited Saturday morning opening times. Muslim-owned businessesclose at noon on Fridays and re-open at 13.00.For those participants who have registered for the Educational and State Of The ArtReviews on Sunday, 3 September, lunch tickets will be handed out.SmokingSmoking is NOT allowed in the Convention Centre.164Message Desk (Registration Area)At the Message Desk participants can leave or collect messages. The desk will belocated in the Registration Area.SecurityFor those participants who have not previously visited South Africa, or Cape Town,and are concerned about personal safety, we wish to assure all visitors that CapeTown is like any other major city, which has good and bad areas. Common sensewill ensure a trouble free and enjoyable congress and vacation. We advise you notto walk alone after dark in unpopulated streets. Ostentatious displays of wealthshould be avoided at all times. During the Congress the information desk at theCTICC and your hotel’s concierge will be able to assist you with information onplaces to visit and the appropriate means of transport.Services provided at desks in the Registration Area include:E-mail Service: Internet access in the Exhibition HallExhibition Information: Exhibition Desk in the Registration AreaHotel Accommodation: Last-minute availability at the Hotel Deskin the Registration AreaLost and Found: Information Desk in the Registration AreaToursTickets for sale at the Social Desk in the Registration AreaStaffIf you have any questions, the members of the congress staff, who can be recognisedby their ISBT shirts, will be very pleased to assist you. Please do not hesitate to contactthem if you have any questions.TippingGratuities are expected in South Africa.A guideline is the following. airport porters ZAR 5.00 per item taxis 10% restaurant staff tipping 10%TransportTravel by RoadWhen visiting Cape Town delegates will mostly arrive and depart by air. On arrival,please be advised that public transport is limited, but getting around is relatively simpleand convenient using taxis or hired car. To rent a car you will need a current SouthAfrican or an international driver’s license. It is possible to rent a car in one city andreturn it in another.Travel to and from Cape Town International AirportCape Town International Airport is 30 km from the Victoria & Alfred Waterfront andcity centre. As public transport is limited, getting back from your hotel to the airportcould be costly and inconvenient. Turners Conferences can book and arrange yourtransfer for you back to the airport. Please come to the travel and tours desk in theregistration area.165INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Key InformationISBT2006Scientific InformationKEY INFORMATIONSCIENTIFIC INFORMATION166Airport schuttle transfer Pre-booked On arrival& prepaid (no pre-bookingOne way charge between ZAR120.00 / ZAR120.00 / €15 per person.Cape Town International €15 per person Subject to specific dates whenAirport & Cape Town centralan official airport desk is& Waterfront hotelsoperational - 2 & 3 SeptemberUseful Telephone and Fax NumbersTelephoneHotel Desk +27 21 410 51 81Registration Desk +27 21 410 51 80Speaker Ready Room +27 21 410 51 82Travel and Tours Desk +27 21 410 51 81VAT / Tax RefundsVAT of 14% is levied on nearly all goods and services. Foreign tourists may claimback VAT paid on items that will be taken out of the country. Original tax invoices,foreign passport, plus all the items on which a refund is claimed, must be presentedat the VAT Refund Administration Office or an appointed Customs and Excise Officialon departure, and the total VAT on these items will be refunded.Please note that there is no VAT included in your registration fee.WeatherSeptember in Cape Town heralds the start of spring. The weather is fair with maximumdaytime temperatures ranging from 16° C to 24° C.Important Notice for Chairpersons and SpeakersAll chairpersons and speakers are kindly requested to be in the session room at least10 minutes before the beginning of the session.AbstractsAbstracts are printed as a supplement of Vox Sanguinis and on a seperate CR rom.All abstracts are listed in the Programme Book.Certificates of AttendanceCertificates of Attendance will be available at Registration Desk as of Tuesday,September 5, 12.00 hours.FellowshipsThanks to the ISBT and the AfSBT, the Organising Committee has awarded severalpeople from low income countries from all over the world with a fellowship.ISBT Science SeriesMost papers of the invited speakers are printed in the newly introduced ISBT ScienceSeries. The papers are also published on the CD rom.Poster walksPoster-walks are going to be held for the first time this year. This new event is introducedin order to gain a maximum benefit from the scientific work presented and tocreate a lively interaction between poster authors, moderators and interested congressparticipants. Poster-walks will be organised during the poster sessions onMonday, 4 September and Wednesday, 6 September (17.30 - 18.30 hours). Posterauthors, moderators and interested congress participants are kindly requested to bepresent at the first poster in their poster session at the beginning of the presentationtime (17.30 hours). Snacks and drinks will be served.167Poster AreaPosters will be presented in the Poster Area, which is located in the Exhibition area(see floor plan, page 178)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

Scientific InformationISBT2006Scientific InformationSCIENTIFIC INFORMATIONSCIENTIFIC INFORMATIONPoster Mounting Posters should be mounted on Monday, 4 September 2006 as of 09.00 hours. Posters should be mounted with double sided tape only. Assistance and material for mounting the posters will be available from set-uptime (see below), at the poster desk in the poster area.Poster Viewing and Presentation Posters will be on display in the poster area for four days and will be open forviewing during exhibition hours. Poster authors are requested to be present at their poster during the entirepresentation time (see below) to attend the Poster-walks. During these walks,an expert in the field will discuss posters in the same poster session, togetherwith interested congress participants.Poster Material Removing Material should be removed before 12.00 hours on Thursday, September 7. If posters are not removed within the time for dismantling,your poster will be removed and destroyed by the congress organiser.Speaker Ready RoomThe Speaker Ready Room is located in room 1.51 on the first floor of the CTICC. Speakersare requested to bring their presentations to the Speaker Ready Room on USB stick,CD-Rom or Zip-diskette at least 3 hours before your presentation is scheduled. Youmay also bring your laptop for copying your presentation to the main computer, whichwill be used for sending the presentations to the different meeting rooms. The use ofyour own laptop during your presentation is NOT possible.Opening hours of the Speaker Ready Room are as followsSaturday, 2 September 15.00 – 18.00 hoursSunday, 3 September 07.30 – 18.00 hoursMonday, 4 September 07.30 – 18.00 hoursTuesday, 5 September 07.30 – 15.00 hoursWednesday, 6 September 07.30 – 18.00 hoursThursday, 7 September 07.30 – 12.00 hours168Responsibility for Poster PresentationsThe Organising Committee does not assume any responsibility for material displayedon the poster boards.Power Point PresentationsOnly Power Point presentations made in Microsoft Office XP or earlier versions willbe accepted.Programme ChangesThe organisers cannot assume liability for any changes in the programme due toexternal or unforeseen circumstances. Changes will be mentioned on the messageboard in the registration area.169INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

ISBT AwardsISBT2006ISBT AwardsISBT AWARDSISBT AWARDSISBT Presidential AwardOn the initiative of the Foundation Transfusion Medicine in Amsterdam, The Netherlands,the Council of the International Society of Blood Transfusion (ISBT) has instituted theISBT Presidential Award. This very prestigious Award is presented once every two yearsat the International Congress of the ISBTISBT AwardThe ISBT Award will be granted to some-one who has done an outstanding contributionto the educational aspects of blood transfusion and transfusion medicine. Theaward ceremony will take place during the ISBT General Assembly on Tuesday,5 September, 11.45-13.00 hours. (Auditorium)170The Award is granted to a senior person who has made eminent contributions totransfusion medicine or a related field through original basic or applied research, thepractice of transfusion therapy or through a significant educational and/or servicecontribution to the field. The goals of these contributions and the effect thereof have hada significant input in transfusion medicine. At this Congress, the special ISBT PresidentialAward Symposium will be organised on September 5 th , at which the selected nomineewill present a lecture covering his expertise. Also presentations by other specialistson issues related to the field of the nominee will be presented. In the evening of theday of the Symposium, an invitational gala dinner will be held to honour the winner ofthe ISBT Presidential Award.In 2000 the Award was granted to P.L. Mollison (United Kingdom), in 2002 to H.J. Alter(USA) and in 2004 to D.J. Anstee (United Kingdom) and J.P. Cartron (France). The Awardwinner of 2006 is C.F. Högman (Sweden).Professor Högman developed preservation fluids (e.g. SAGM) that elongated theshelf life of red blood cells to 42 days. Due to his research, optimal preservation ofred blood cells is now standard practice World wide and has made blood transfusionmore effective than ever before.International Women in Transfusion AwardIn 2004, for the first time in their collective histories, three of the major transfusionmedicine organizations in the world – the AABB, the BBTS and ISBT – were led bywomen professionals. To commemorate this occurrence, these 3 organizations agreedto establish this unique award to honor women for lifetime achievements in transfusionmedicine and science.Through this award, the three organizations will strive to regularly acknowledge womenprofessionals whose cumulative record – in original research, innovative educationalmethods or outstanding clinical practice – demonstrates important and significantcontributions to the body of medical and/or scientific knowledge or to the understandingand practice of transfusion medicine.This year the prize is awarded to Dr. Marion Reid from the New York Blood Centre.The award winning lecture will be presented on Tuesday, 5 September, 09.00 – 09.30hours. (Auditorium)171Jean Julliard PrizeThe Jean Julliard Prize was established in memory of the first Secretary-General of theSociety. It is reserved for doctors and scientists under 40 years of age in recognitionof recently completed work on blood transfusion medicine and science.The Prize is awarded every two years at the International Congress. This year the19 th prize is awarded to Dr. Masja de Haas of Sanquin Diagnostic Services (Amsterdam,the Netherlands) for her paper “High-throughput genotyping for red cell blood groupsand platelet antigens in transfusion medicine”. Dr. de Haas will receive the Jean JulliardPrize on Tuesday, 5 September, 08.30-09.00 hours. (Auditorium)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSION

Registration InformationISBT2006Social ProgrammeREGISTRATION INFORMATIONSOCIAL PROGRAMMMERegistration AreaThe registration area is located in the ‘Cape Town International Convention Centre(CTICC) near the main entrance.Registration HoursThe registration area in the CTICC will be open at the following hours:Saturday, 2 SeptemberSunday, 3 SeptemberMonday, 4 SeptemberTuesday, 5 SeptemberWednesday, 6 SeptemberThursday, 7 SeptemberRegistration fees on site12.00 – 18.00 hours07.30 – 19.00 hours08.00 – 18.30 hours08.00 – 15.00 hours08.00 – 18.30 hours08.00 – 14.00 hoursISBT member* € 550,-ISBT Non-member € 670,-Accompanying Person € 100,-Students** € 225,-South African and AfSBT participants € 225,-Fees on site can be paid in Euro, South African Rand (Only for South African Citizens) or by Credit CardSunday, 3 September 200617.45 – 20.45 hoursOPENING CEREMONY, OPENING OF THE TRADE EXHIBITION,WELCOMING COCKTAIL FUNCTIONDelegates are welcomed to Cape Town by the President of the ISBT and are theninvited to experience the vibrant beat of Africa to get pulses racing. Meet and greetnew and old colleagues at the opening of the trade exhibition. Snacks and drinkswill be served.Wednesday, 6 September 200619.00 – 24.00 hoursAFRICAN THEME EVENINGA magical dining experience to be savoured under a starlit sky – a sensory extravaganza!The tree-lined garden is filled with Bedouin tents and gazebos made fromwrought iron, and tree houses almost reaching the clouds – clad with beautiful handcrafted copper water features. An unparalleled dining experience in an exceptionalsetting that embodies modern, sophisticated Africa, while exuding its generosity.Price : € 40,– per person(For more information please come to the Social Programme Desk.)*) For ISBT members who paid the membership fee for 2006.**) To qualify for the students fee, please show an identification assigned by your head of training.Tuesday, 5 September 200607.00 – 08.00 hours172What is included in the feeParticipants Admission to the Scientific Programme, the Satellite Symposia, the Exhibition,the Opening Ceremony, the Welcome Reception and the General Excursion A copy of the Final Programme, Abstract Book and the ISBT Scientific Series. Certificate of Attendance CD Rom with Abstracts and Papers Coffee, Tea and LunchAccompanying persons Half Day morning tour Cape Town Orientation, the General Excursion (Tuesdayafternoon), Opening Ceremony, Welcome Reception, Closing CeremonyFUN RUN (supported by the Western Province Blood Transfusion Services)As we move into Spring in Cape Town, you are invited to take part in the ISBT fun run/walk. Two distances are available for your participation, a 2,5 km and a 5 km route.The routes start and finish at the same point and are run in a figure 8 configuration.The course runs along the promenade on the Sea Point sea front. You will needwalking/running shoes, suitable clothing, a top in case the weather is cool and all yourenthusiasm. Come and enjoy the fresh sea air and enter into the spirit of Cape Town!(For more information please come to the Social Programme Desk.)173INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

ISBT2006EXCURSION PROGRAMMEEXCURSION PROGRAMMEMonday, 4 September 200609 00 – 12.00 hoursTuesday, 5 September 200615.00 – 19.00 hoursCITY ORIENTATION TOURThis tour gives you the opportunity to discover the spirit of the Mother City, experienceher vibrant cultures and history. Start the morning with a drive through the sceniccoastal towns of Clifton and Sea Point. Visit Green Market Square, District Six and walkthrough the Company Gardens. This scenic tour will also take you past the Housesof Parliament, City Hall, The Castle and Slave Lodge.CHAPMANS PEAK TOURThis afternoon tour will take you past the famous beaches of Clifton and Camps Bay.Drive along Chapmans Peak, where the views are breathtaking and on to Constantia.You will stop at Kirstenbosch Gardens where you will have the opportunity to take awalk through the gardens before returning to Cape Town.174175ACCOMPANYING PERSONS ONLY(Included in the accompanying persons registration fee)REGISTERED DELEGATES AND ACCOMPANYING PERSONS(included in your registration fee)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

ISBT2006FLOORPLANGROUND FLOORFLOORPLANSECOND FLOOR3628293049483332 3413141516171504731*1819 20378 38353710 11 1244*ISBT Central Office3535 35LEGEND17614339FIRST FLOOR413 5 7 9372 4 6 8 391 Auditorium I2 The Ballroom (West and East)3 The Boardroom 1.304 Room 1.405 Room 1.506 Room 1.607 Room 1.708 Auditorium II9 Room 1.9010, 11 Meeting Rooms12 Roof Terrace Room13 Exhibition Hall 1A14 Exhibition Hall 1B15 Exhibition Hall 216 Exhibition Hall 317 Exhinition Hall 418 Registration Foyer19 Jasminum Restaurant20 Strelitzia Restaurant28 Arabella Sheraton Grand Hotel29 Canal Head & Ferry Terminal30 Convention Square31 Hotel Foyer32 Entrance33 Business Centre34 Entrance Foyer35 Entrances36 Marshalling Yards37 The Gallery38 150 Seat á la carte Restaurant39 Auditorium II Foyer41 The Lounge43 Auditorium I Foyer Terrace44 Roof Terrace48 Coffee Shop49 Convenience Store177INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

ISBT2006EXHIBITION FLOOPLANEXHIBITORSCOMPANYBOOTH NOCOMPANYBOOTH NO17865Internet Café56585461 6460 622739742520 2657461059364421156 1134 35Posters355242319 4337CateringAreaposter desk333231Catering Area1430 4942 2848 291325251 53 45502263 475 8 164118403819 9a 1217Internet CaféAABB 30ABBOTT Diagnostics 27Adcock Ingram Critial Care 38Africa Society for Blood Transfusion 53Alba Bioscience 55Andreas Hettich GmbH & Co. KG 19ADRP 32Asahi Kasei Medical Co. Ltd. 11BAG - Biologisches Analysen systemGmbH 40Baxter 2Bio-Rad 16Biomerieux 56Biopure Corporation 49Biotest AG 18Blackwell Publishing Ltd. 65Cape Craft and Design Institute 59Capricorn Biologics (PTY) Ltd 61Cerus Corporation 36Chiron 9Cryo Bio System 66Dade Behring Marburg GmbH 26Delcon s.r.l. 47DIAGAST 28DiaMed AG 4Dometic S.àr.l 24Eckert&Ziegler Bebig GmbH 21Fresenius Transfusions GmbH 15Gambro BCT 3GRIFOLS 20Haemonetics 12Hamilton Bonaduz AG 44Healthcare Technologies 64Heim Group 42Helmer 8Hemocue AB 25ICCBBA, Inc 35Ilex Medical Ltd9aInlog International 46International Specialty Products (ISP) 23ISBT Central Office Registration AreaXIVIII th Regional ISBT Congress, Asia 33XVII th Regional ISBT Congress, Europe 31XXX th Int. Congress ISBT, 2008 34Ilex Medical Ltd.9aITL Corporation 58JMS Singapore Pte Ltd 41Lmb Technologie GmbH 23MacoPharma 6Mak-System International Group 13MDS Nordion 37Medinfo International Hemoservice 63Medion Diagnostics AG 39National Bioproducts Institutes 51Nebo a/s 43Netripples Software Ltd 57Octapharma 45Olympus Life and MaterialScience Europa 29Ortho-Clinical Diagnostics 1Pall Life Sciences 5RJ Consani (Pty) Ltd. 62Roche Diagnostics 17Sanquin Reagents 14South African National Blood Service 50SSEM Mthembu 22Streetwires 60Terumo Corporation Dubai Branche 7Thermo Electron Corporation 54Vifor (international) Inc. 48Western Province BloodTransfusion Service 52Wyndgate Technologies 10179EntranceEntranceINTERNATIONAL SOCIETY OF BLOOD TRANSFUSION XXIX TH INTERNATIONAL CONGRESS OF THE ISBT

ISBT2006LIST OF EXHIBITORSLIST OF EXHIBITORS180ISBT Central Office (entrance registration area)Address : Jan van Goyenkade 11 , 1075 HP, Amsterdam, The NetherlandsTel : +31 206793411Fax : +31 206737306E-mail : info@isbt-web.orgWebsite : www.isbt-web.orgThe ISBT is a scientifc society of world reknown. It was founded in 1935, bringing togetherprofessionals in Blood Transfusion and Transfusion Medicine from more than 85 countries. TheISBT organises every even year in international congress and every odd year two regionalcongresses in Europe and Asia.1 Ortho-Clinical DiagnosticsAddress : 1001 US Hwy, Route 202, 8869 Raritan, NJ, United States of AmericaTel : +1 9087043652Fax : +1 9082188694E-mail : mrichar3@ocdus.jnj.comWebsite : www.orthoclinical.comOrtho-Clinical Diagnostics, a Johnson & Johnson company, is a leading provider of high-valuediagnostic solutions for the global health care community. Committed to developing the mostadvanced tests for early detection or diagnosis of disease, the Company brings products tomarket that provide timely information and help to facilitate better medical decisions. Ortho-Clinical Diagnostics provides blood screening and typing products that help to ensure the safetyof the world's blood supply. In addition, through its patented MicroSlide(tm) and enhanced chemiluminescencetechnologies, the Company transformed the way that clinical laboratories performtesting. Worldwide, health care professionals rely on Ortho-Clinical Diagnostics for innovativediagnostic solutions that promote effective diagnoses and enhanced patient care.2 BaxterAddress : Im Breitspiel 13, 69126 Heidelberg, GermanyTel : +49 6201397261Fax : +49 6221397305E-mail : brigitte_huhn-kiele@baxter.comWebsite : www.baxter.com.Baxter, through its subsidiaries, assists health-care professionals and their patients with the treatmentof complex medical conditions, including cancer, hemophilia, immune disorders, kidneydisease and trauma. The company applies its expertise in medical devices, pharmaceuticalsand biotechnology to make a meaningful difference in patients' lives. For more information aboutBaxter please visit the website.3 Gambro BCTAddress : Ikaroslaan 41, 1930 Zaventem, BelgiumTel : +32 27150560Fax : +32 27210770E-mail : inge.vancraen@gambrobct.comWebsite : www.gambrobct.com.Gambro BCT, a global leader in blood bank technology, delivers new ideas and new energy tothe blood bank industry through world-class, innovative products and services. Stop by our boothto learn more about our current and future product offerings impacting whole blood processing,blood safety and automated collections. For our full product range please visit our website.4 DiaMed AGAddress : Pra Rond 23, 1785 Cressier s/Morat, SwitzerlandTel : +41 266745111Fax : +41 266745445E-mail : info@diamed.chWebsite : www.diamed.comDiaMed specializes in research and development, production and global services for laboratorydiagnostic products. DiaMed is the leading company in blood group group serology, with overa million tests performed daily, world wide using the ID-System. For more than 20 years, DiaMedhas also produced coagulation reagents in liquid, ready to use form. Its newest innovation is inplatelet function testing. From up-to-date small pipetting automates to complex walk-away systems,you will find the ideal equipment tailored to your specific needs.5 Pall Life SciencesAddress : Walton Road, Farlington , PO61TD, Portsmouth, United KingdomTel : +44 2392303484Fax : +44 2392303324E-mail : wally_brown@pall.comWebsite : www.pall.com181INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

ISBT2006LIST OF EXHIBITORSLIST OF EXHIBITORS182Pall Life Sciences provides an ever-increasing product and technology portfolio in filtration, separationand purification systems for hospitals, blood donation services and the plasma fractionationindustry. Pall's medical filters are used extensively in blood centers and hospitals for patientsrequiring blood transfusions, open-heart surgery, organ transplants, dialysis, intravenous feedingand breathing therapy. Pall's newest medical products in prion reduction filtration and bacteriadetection help to increase safety in transfusion medicine. In the pharmaceutical area, our innovationsinclude new membranes for virus filtration (nanofiltration), sterilizing-grade filters, and abroad range of process chromatography sorbents and membrane chromatography devices.6 MacoPharmaAddress : Rue Lorthiois, 59420 Mouvaux, FranceTel : +33 320118430Fax : +33 320118486E-mail : info@macopharma.comWebsite : www.macopharma.comMacoPharma is an innovator in global healthcare with expertise in the fields of transfusion andinfusion. The Company has become the largest supplier of in-line leukoreduction filtration setsin Europe and is expanding its efforts into the biotechnology field by developing products for cellexpansion, in addition to cell/organ processing and freezing. One of MacoPharma's aims is toprovide a comprehensive range for the reduction of infectious agents in plasma, platelets and redcells. This is conducive with the MacoPharma product development strategy of the continuousquest, through partnerships, for improved safety, efficacy, and quality of transfusion, infusionand biothechnologie.7 Terumo Corporation Dubai BrancheAddress : 22nd Floor Arbift Tower, 20291 Dubai, United Arab EmiratesTel : +97 142212220Fax : +97 142213330E-mail : terumodubai@terumodb.aeWebsite : www.terumo.co.jpTerumo Transfusion Systems has established an international reputation through tireless research,unique company philosophy focused on quality and state-of- the-art technology for the benefitsof donors, medical staff and patients. The product range includes blood bags, IMUGARD LeukocyteRemoval Filters and other blood banking accessories, well supported by advanced blood processingequipment such as Terumo Sterile Tubing Welder, Terumo Tube Sealer and TerumoAutomatic Component Separator that contribute largely to transfusion medicine.8 HelmerAddress : 15425 Herriman Boulevard, 46060 Noblesville, In, United States of AmericaTel : +1 3177739073Fax : +1 3177739082E-mail : dholpuch@helmerinc.comWebsite : www.helmerinc.comHelmer’s focus is serving the blood bank community. Our products are available through anextensive network of distributors worldwide. Helmer manufactures Platelet Storage Systems whichinclude Platelet Incubators and Platelet Agitators, Plasma Thawing Systems, and Refrigeratorsand Freezers exclusively at our headquarters in Noblesville, Indiana, USA. We also offer an automaticCell Washing System. Stop by for more information on any of our products.9 ChironAddress : 10 Rue de Chevreul, 91250 Surenes, FranceTel : +33 155490031Fax : +33 147725315E-mail : veronique_lecercle@chiron.comWebsite : www.chiron.comDedicated to preventing transfusion-transmitted diseases, CHIRON, a Novartis business, deliversinnovative quality products and exemplary service to meet the needs of the transfusion communityworldwide. The PROCLEIX ® ULTRIO ® , HIV-1/HCV and WNV Assays, developed in collaborationwith Gen-Probe, use state-of-the-art NAT technology to detect viral RNA and/or DNA in donatedblood and plasma. The automated PROCLEIX ® TIGRIS ® System enables smaller pool sizes andindividual donor testing. (ULTRIO and TIGRIS are not available for commercial sale in the U.S.)9a Ilex Medical Ltd.Address : IsraelTel : +972 39385501Fax : +972 39385502E-mail : mbs@ilexmedical.comWebsite : www.ilexmedical.comILEX Medical Ltd is a leading supplier of equipment and supplies for blood banks, clinical laboratoryand critical care.With offices in Israel, South Africa, Turkey and Russia and exclusive distributionagreements from leading companies such as Chiron, Abbott Diagnostics, bioMerieux,Instrumentation Laboratory, Immucor Gamma and others.ILEX Medical Ltd scope of activities183INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

ISBT2006LIST OF EXHIBITORSLIST OF EXHIBITORS184also includes Medical turnkey projects, biotechnology start-ups; Orsyx division of ILEX developsand supplies laboratory information systems (LIS) to major international diagnostics companiesas well as special LIS projects for the blood banks.10 Wyndgate TechnologiesAddress : Bat. AAGIS - P.A.L. St. Isidore, 6200 Nice, FranceTel : +33 4937198 86Fax : +33 493728511E-mail : bruno@wyndgate.comWyndgate Technologies ® , a division of Global Med Technologies ® , Inc., offers Information Managementsoftware designed by blood bankers for blood bankers. Wyndgate will present its newVein-to-Vein ® software suite, which not only inherits all of the acclaimed features of SafeTrace ® andSafeTrace Tx ® but also incorporates many new features and technologies based on customerknowledge, Wyndgate's many years of industry experience and input from blood bankers fromaround the world. This new software will be marketed internationally, including Canada, Europe,the Middle East, Africa and Asia, in the second semester of 2006. Committed to safety andregulatory compliance, Wyndgate's professional services include project management, training,installation support, and assistance with electronic data import, validation and integration. Ourpartnership continues with Service 360 ® , Wyndgate's commitment to the very best customerservice in the industry.11 Asahi Kasei Medical Co. Ltd.Address : MD Kanda Bldg, 9F Kanda Mitoshirocho, Chiyoda-ku,101-8482 Tokyo, JapanTel : +81 332597726Fax : +81 332595899E-mail : saijo.nb@om.asahi-kasei.co.jpWebsite : www.asahi-kasei.co.jp/medical/en/Asahi Kasei Medical is a world leader in research, development, and production of medical devicesfor blood treatment and purification. Our products are deeply based on unique and advancedmembrane separation and adsorption technologies. Asahi, a pioneer in leukoreduction, is alsoone of the world leading suppliers of filters to remove viruses in the production of biotherapeuticsand will be exhibiting wide range of Sepacell filters for both red cell and platelet products.12 HaemoneticsAddress : Wolfratshauser Strasse 84, 81379 Munich, GermanyTel : +49 8978580718Fax : +49 8978580761E-mail : p.freund@haemonetics.deWebsite : www.haemonetics.comHaemonetics (NYSE: HAE) is a global company engaged in the design, manufacture and worldwidemarketing of automated blood processing systems. These systems address important medicalmarkets: surgical blood salvage, blood component collection, plasma collection, and bloodcomponent safety. To learn more about Haemonetics' products and markets, visit its website atwww.haemonetics.com.13 Mak-System International GroupAddress : 10 Avenue de la Grande Armee, 75017 Paris, FranceTel : +33 144090404Fax : +33 144090650E-mail : sales.fr@mak-system.netWebsite : www.mak-system.netMAK-SYSTEM is a world leader in developing WEB-enabled software systems for managingblood banking and blood transfusion activities. MAK-SYSTEM’s feature-rich solutions are currentlyimplemented in almost 40 countries, including 20 national installations. ePROGESA, eTrace Lineand eRisk Line have been designed to help blood banks and hospital transfusion services secureand trace blood units and components from donor to patient in accordance with national,European and International regulations and standards.14 Sanquin ReagentsAddress : Plesmanlaan 125, 1066 CX Amsterdam, NetherlandsTel : +31 205123599Fax : +31 205123570E-mail : reagents@sanquin.nlWebsite : www.sanquinreagents.comFrom its start as a pioneer in blood transfusion over 60 years ago, Sanquin (formerly CLB) hasdeveloped into a cornerstone of the public health sector in the Netherlands. Sanquin Reagents,part of the Research Division, develops and produces a comprehensive line of reagents for diagnosticpurposes and for use in research according to ISO 9001 and ISO 13485 standards.185INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

ISBT2006LIST OF EXHIBITORSLIST OF EXHIBITORSProducts of Sanquin Reagents are distributed in more than 35 countries worldwide. Productgroups: Cellbind, affinity based card system for different immuno-hematology tests,MAGISTERfully automated system dedicated for Cellbind cards, Monoclonal and polyclonal blood groupingreagents, Reagent red blood cells, including panels for quality control and proficiency testing,Kit for platelet cross-matching (MASPAT).17 Roche DiagnosticsAddress : 4300 Hacienda Drive, CA 94588 Pleasanton, United States of AmericaTel : +1 8008468000Fax : +1 9255481829Website : www.roche-diagnostics.com18615 Fresenius Transfusions GmbHAddress : Pfingstweide 53, 61169 Friedberg, GermanyTel : +49 617260 8479Fax : +49 61726086313E-mail : maura.trumpp@fresenius-hemocare.comWebsite : www.fresenius-kabi.comFresenius HemoCare – the blood care company – is an international company, active in the fieldof blood collection and treatment. Fresenius HemoCare provides a complete range of products,services and methods, developed to achieve highest quality blood products. The product portfolioranges from disposables and processing devices including data management systems for bloodcomponent processing to computer-operated cell separators used for donations as well astherapeutic applications.16 Bio-RadAddress : 3, Boulevard Raymond Poincare, 92430 Marnes la Coquette, FranceTel : +33 147956217Fax : +33 147956186E-mail : bruno.slizewicz@bio-rad.comWebsite : www.bio-rad.comBio-Rad Laboratories, Inc is a multinational manufacturer and distributor of life science researchproducts (Instruments and Reagents for Electrophoresis, Liquid Chromatography, Amplification,DNA Microarrays, TSE diagnostic …) and clinical diagnostics (Instruments and Kits for DiabetesMonitoring, Microbiology, Quality Controls, Toxicology, Blood Virus, AutoImmune diseases,Immuno-Hematology …). Based in California, it serves more than 70,000 research and industrycustomers worldwide. Bio-Rad France employs 1000 people in its R&D laboratories, productionplants, customer support organisation and its sales and marketing departments.Roche creates flexible, automated PCR-based NAT systems designed to help the transfusioncommunity deliver the safest possible blood and blood products sooner. Roche has a history ofinnovation in blood screening, developing the first single-tube multiplex NAT assay for HIV-1,HCV, and HBV (Japan 1999) and receiving FDA approval for the first NAT HBV blood screeningtest (US 2005). Today, Roche continues to meet the changing needs of this essential communitywith the new modular cobas s 201 system and cobas TaqScreen multiplex test, now with CE-IVDstatus in Europe. The cobas s 201 system provides unprecedented flexibility in automation, withmultiple configuration options for testing which is truly "screening your way.18 Biotest AGAddress : Landsteinerstrasse 5, 63303 Dreieich, GermanyTel : +49 6103801444Fax : +49 6103801880E-mail : hubert_boetsch@biotest.deWebsite : www.biotest.deBiotest offers a broadly based and innovative product line for diagnostic purposes in immunohaematology:Seraclone ® - Reagents for ABO Blood Typing, Seraclone ® - Reagents for Rh BloodGrouping , Rare Blood Grouping Sera, Anti Human Globulins (Coombs), Enzymes and Supplements,Reagent Red Blood Cells for Antibody Screening and Identification, Erytype/ErytypeS -Microtest Plates for Blood Grouping, Solidscreen II- Microtest Plates for Antibody Screening,Serafol ® Bedside Testing, Fully Automated Blood Grouping Serology with Biotest TANGO ® .187INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

ISBT2006LIST OF EXHIBITORSLIST OF EXHIBITORS19 Andreas Hettich GmbH & Co. KGAddress : Foehrenstrasse 12, 78532,Tuttlingen, GermanyTel : +49 74617050Fax : +49 7461705122E-mail : info@hettichlab.comWebsite : www.hettichlab.com21 Eckert&Ziegler Bebig GmbHAddress : Robert-Roessle-Strasse 10, 13125 Berlin, GermanyTel : +49 30941084130Fax : +49 30941084112E-mail : bebig@ezag.deWebsite : www.bebig.com188The development of modern laboratory centrifuges is closely linked to the history of the Hettich-Zentrifugen Company. Hettich’s roots go back more than one hundred years. Today’s productrange comprises a complete program of centrifuges for virtually every centrifuging task requiredin practice: e.g. microlitre, hematocrit, benchtop, underbench, floorstanding, blood bank, roboticcentrifuges, refrigerated and non-refrigerated as well as cell washers.20 GRIFOLSAddress : C/Marina 16-18, Torre Mapfre 30th Floor, 8005, Barcelona, SpainTel : +34 9935710900Fax : +34 9935710474E-mail : mkt.diagnostic@grifols.comWebsite : www.grifols.comSince 1940 GRIFOLS has developed services and products to secure health and well-being ofhumanity. Specialized in the health and pharmaceutical sector, GRIFOLS researches, develops,manufactures and markets plasma derivatives, intravenous therapy products, clinical nutrition,diagnostic instruments and reagents, and medical materials. GRIFOLS is committed to TransfusionMedicine and guarantees quality and safety from donation to transfusion. In this field, GRIFOLSoffers blood bags, including Leucored ® System for in-line leucoreduction, viral inactivation ofplasma for transfusion, blood typing instruments, DG Gel ® cards and software equipment forHemovigilance requirements.Founded in 1992, Eckert & Ziegler BEBIG GmbH develops, produces and sells isotope technologyfor medical use, especially for gamma irradiation and cancer therapy.The products of the companyinclude gamma irradiation devices for research and transfusion medicine, seed implants and afterloadersfor brachytherapy and block cutting and compensator milling devices for radiotherapy.22 SSEM MthembuAddress : P.O. Box 2530, Johannesburg 2000, South AfricaTel : +27 114448184Fax : +27 114448171E-mail : info@ssemmthembu.co.zaWebsite : www.ssemthembu.co.zaSSEM Mthembu is the appointed distributor for the JMS range of blood bags & medical devicesin Sub Sahara Africa. SSEM Mthembu supply JMS products for any need in modern blood transfusionapplications. JMS range of blood bags are of superior product quality and have a longand laudable reputation for assurance. SSEM Mthembu have the expertise to assist bloodbanks in South Africa and Africa with all their blood bag & equipment requirements. Branchesare located in Jhb, Cpt, Dbn as well as E cape and Free State. Our Product specialist for bloodproducts is Carol Collett contactable on +27 72807216623 Lmb Technologie GmbHAddress : Möslstrasse 17, D-85445 Schwaig, GermanyTel : +49 8122880960Fax : +49 81228809660E-mail : info@lmb.deWebsite : www.lmb.de189Established in 1982, Lmb Technologie GmbH has focussed its activities on development,manufactureand distribution of high-quality products for blood collection, blood conservation andstorage. This is a part of our product-range: SEPAMATIC SL, BAGMATIC SL, CLIMATIC CHAMBERSCLIMAX, PLATLET AGITATORS, TRANSPORT BOXES, DONOR LOUNGES, SMART LABELTECHNOLOGY.INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

ISBT2006LIST OF EXHIBITORSLIST OF EXHIBITORS19023 International Specialty Products (ISP)Address : 1361 Alps Road, 07470 Wayne, NJ, USATel : +1 9736283383Fax : +1 9736284185Website : www.radsure.comISP’s radiation-sensitive products provide a quality system to assure compliance with blood irradiationregulations. RAD-SURE ® Indicators attach to units of blood and provide positive, visualverification of irradiation. DOSE-MAP ® validates and maps the performance of blood irradiators.24 Dometic S.àr.lAddress : 17, Op der Hei, 9809 Hosingen, LuxembourgTel : +352 920730-1Fax : +352 920731-300E-mail : medical.systems@dometic.luWebsite : www.dometic.luThe modern range from Dometic Medical Systems comprises blood, pharmaceutical and laboratoryrefrigerators, freezers, ultra-cold freezers (to –86˚C) and transport boxes.Sensitive medicalitems such as vaccines, blood and blood components, temperature-sensitive pharmaceuticals,tissues and iological samples are stored in the appropriate optimum conditions without anyrisks.Different sizes and specifications of equipment are available to offer the most appropriatesolutions. Dometic is ISO 9001:2000 and ISO 14001 certified.25 Hemocue ABAddress : PO Box 1204, 26223 Ängelholm, SwedenTel : +46 431458200Fax : +46 431458225E-mail : kda@hemocue.seWebsite : www.hemocue.comHemoCue is a leader in Point-of-Care testing with products for the measurement of hemoglobinand glucose in whole blood and low levels of albumin. The products are manufactured with nobatch-to-batch variation, allowing any healthcare professional the ability to obtain laboratoryquality results; anytime, anywhere. All products are based on factory-calibrated instruments andproprietary reagent microcuvettes. Well over 150 000 HemoCue instruments are in daily useworldwide. www.hemocue.com26 Dade Behring Marburg GmbHAddress : P.O. Box 1149, 35001 Marburg, GermanyTel : +49 6421 39 6271Fax : +49 6421 39 4594E-mail : amos_czarny@dadebehring.comWebsite : www.dadebehring.comThe complete approach to automated infectious disease Testing, Dade Behring commands thelead for the most extensive combination of assays and analyzers using microtitration plates forinfectious disease testing of patients and blood donor samples. Dade Behring is offering completeintegrated solutions for blood banks, hospital- and commercial labs with the proven and reliablesystems: BEP 2000 Advance, BEP ® III and Quadriga BeFree. Come to visit us at our booth no. 26.27 ABBOTT DiagnosticsAddress : 100 ABBOTT Park Road, AP6C-4 , 60064 Abbott Park, iL,United States of AmericaTel : +1 8479377176E-mail : stuart.eberstein@abbott.comWebsite : www.abbott.comFor more than a century, Abbott Laboratories has been working to help people around the worldin their pursuit of healthy lives. We are a broad based health care company that discovers, develops,manufactures and markets innovative products and services – from prevention and diagnosis totreatment and care. Scientific innovation drives our growth. Abbott combines science and innovationto develop solutions to the world’s health care challenges. Our goal is to help peoplelive longer, healthier lives through leading pharmaceuticals and medical products, includingdiagnostics, medical devices and nutritional products.28 DIAGASTAddress : Parc Eurosanté 251, Ave Eugène Avinée- BP9, 59374 Loos Cedex, FranceTel : +33 320965353E-mail : contact@diagast.comWebsite : www.diagast.comDIAGAST develops, products and markets innovative in-vitro diagnostics tools for use in publicand private laboratories (biological analysis), blood banks, blood transfusion establishments….DIAGAST focus is on Immunohaematology and its predicted field in the transfusion compatibilityQWALYS ® 2 is a fully-automated centrifuge-less system for your tests of blood grouping, phenotyping,antibody screening, identification and cross-matching. It perfectly answers to your needs191INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

ISBT2006LIST OF EXHIBITORSin terms of safety and traceability. FREELYS® Nano is an ingeniously compact manual mini-labfor your IH tests.29 Olympus Life and Material Science EuropaAddress : Wendenstrasse 14-18, 20097 Hamburg, GermanyTel : +49 4023773842Fax : +49 4023773973E-mail : walter.ulm@olympus-europa.comWebsite : www.olympus-europa.comOlympus serves its customers with solutions that meet the highest quality standards and needsof laboratories and blood banks. We are committed to improve our products as well as to increaseefficiency, productivity and safety in our customer laboratories whilst at the same time driving areduction in their overall costs.As solution provider we do not only offer products for blood grouping,clinical chemistry and immunochemistry but also solutions for pre- and post-analytical workflowimprovements by laboratory automation systems.30 AABBAddress : 8101 Glenbrook Road, 20814 Bethesda MD, United States of AmericaTel : +1 3012156569Fax : +1 3019076869E-mail : michelle@aabb.orgWebsite : www.aabb.orgAABB is an international, not-for-profit association dedicated to the advancement of science andthe practice of transfusion medicine and cellular and related biological therapies. The associationis committed to improving health by developing and delivering standards, accreditation andeducational programs and services that optimize patient and donor care and safety.LIST OF EXHIBITORS31 XVII th Regional ISBT Congress, Europe (2007)Address : Eurocongres, Jan van Goyenkade 11, 1075 HP Amsterdam, NetherlandsTel : +31 206793411Fax : +31 206737306E-mail : isbt.madrid@eurocongres.comWebsite : www.isbt-web.org/madridThe XVII th Regional Congress of the ISBT, Europe will take place in the Palacio Municipal deCongressos in Madrid, Spain (23 - 27 June, 2007).32 ADRPAddressE-mailWebsite: P.O. Box 540524, Grand Prairie, 75054-0524 TX,United States of America: membership@adrp.org: www.adrp.orgThe Association of Donor Recruitment Professionals is committed to being a leader in providingeducation, development and resources for the donor recruitment profession.33 XIVIII th Regional ISBT Congress, Asia (2007)Address : Eurocongres, Jan van Goyenkade 11, 1075 HP Amsterdam, NetherlandsTel : +31 206793411Fax : +31 206737306E-mail : isbt.hanoi@eurocongres.comWebsite : www.isbt-web.org/hanoiThe XVIII th Regional Congress of the ISBT, Asia will take place in the Melia Hotel in Hanoi, Vietnam(10 - 13 November, 2007).19234 XXX th International Congress ISBT (2008)Address : Eurocongres, Jan van Goyenkade 11, 1075 HP Amsterdam, NetherlandsTel : +31 206793411Fax : +31 206737306E-mail : isbt.macau@eurocongres.comWebsite : www.isbt-web.org/macauThe XXX th International Congress of the ISBT will take place in Macau, China (6 - 12 June, 2008).193INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

ISBT2006LIST OF EXHIBITORSLIST OF EXHIBITORS35 ICCBBA, IncAddress : 204 St. Charles Way, Unit 179E, PA 17402 York,United States of AmericaTel : +1 7178454790Fax : +1 7178459727E-mail : slind@iccbba.comWebsite : www.isbt128.orgISBT 128 sets a global standard for the identification, labeling and information processing of humanblood, tissue and organ products across international borders and disparate health care systems.The standard has been designed and perfected over a 12 year period to ensure the highestlevels of accuracy, safety and efficiency for the benefit of donors, patients and official ISBT 128licensed facilities worldwide.MDS Nordion offers self-contained blood irradiators used for the prevention of TA-GVHD. TheGammacell irradiators are accurate, cost-effective options for high processing volumes, and thenew Raycell X-ray blood irradiator provides another choice for the smaller volume hospital orblood bank. MDS Nordion specializes in radioisotopes, radiation, and related technologies usedto diagnose, prevent and treat disease. MDS Nordion is part of MDS Inc. international healthand life sciences company. Visit us at the ISBT Capetown booth number 37!38 Adcock Ingram Critial CareAddress : P.O. Box 6888, 2000 Johannesburg, South AfricaTel : +27 114948254Fax : +27 114942338E-mail : kerry.maree@tigerbrands.comWebsite : www.adcock.co.za36 Cerus CorporationAddress : 2411 Stanwell Drive, 94520 Concord, CA, United States of AmericaTel : +1 9252886369Fax : +1 9252880184E-mail : jocelyn_hsu@cerus.comWebsite : www.cerus.comAdcock Ingram Critical Care is South Africa’s largest supplier of hospital products, blood systemsand accessories. The Transfusion Therapies Division provides a portfolio of products to serve theneeds of Blood Transfusion Services and the patients they serve. The products are manufacturedunder license to Baxter Healthcare International, together we develop innovative technologiesand products to enhance the safety and quality of transfusion and to maximize donor comfort andsafety, in South Africa.Cerus Corporation (NASDAQ:CERS) is developing novel technologies within the fields of bloodsafety, cancer, and infectious disease. The company designed the INTERCEPTTM Blood Systemto enhance the safety of donated blood components by inactivating viruses, bacteria and leukocytes.The INTERCEPT Blood System for platelets is currently marketed in Europe and a CEMark dossier was submitted for the plasma system. To provide a comprehensive blood safetystrategy, the INTERCEPT Blood System for red blood cells is currently in development.39 Medion Diagnostics AGAddress : Bonnstrasse 9, 3186 Dudingen, SwitzerlandTel : +41 264928501Fax : +41 264928657E-mail : joe.wilms@medion-diagnostics.comWebsite : www.medion-diagnostics.com19437 MDS NordionAddress : 447 March Road, K2K1X8 Ottawa, Ontario, CanadaTel : +1 6135922790Fax : +1 6135926937Website : www.mds.nordion.comThe Swiss based Medion Diagnostics AG continues the tradition of Immunohematology reagentsthat began 50 years ago with Merz and Dade covering a range of more than 100 products -liquid antisera, reagent red blood cells, enhancer and centrifuges. The organization is FDA licensedand ISO 9001:2000 and 13485:2003 certified. At the ISBT 2006 Medion is presenting its awardwinning MDmulticard, a novel credit card sized device for multiparameter determination of bloodgroups based on lateral flow principles. With this technique, 10 blood group parameters can bedetermined in 5 minutes requiring only 2 manipulations. No centrifugation step is needed. Theresults can be read as macroscopically visual bands and remain stable for days.195INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

ISBT2006LIST OF EXHIBITORSLIST OF EXHIBITORS40 BAG - BiologischesAnalysensystemGmbHAddress : Amtsgerichtsstrasse 1-5, 35423 Lich, GermanyTel : +496404 925-0Fax : +496404 925-350E-mail : henschel.gabi@bag-germany.comWebsite : www. bag-germany.com42 Heim GroupAddress : 9 Cadde 103/13 Kirkkonaklar, 06610 Ankara, TurkeyTel : +90 3124964360Fax : +90 3124956770E-mail : a.basaran@heim-group.comWebsite : www.heim-group.com196BAG gives undivided attention to the continual improvement of accuracy in patient diagnosticby developing and manufacturing of innovative state-of-the-art in-vitro diagnostic reagents andtest systems. BAG test systems for HLA Tissue Typing, Blood Group Typing, Infectious Diseasesand Sterilization Monitoring are well introduced to Hospital Laboratories and Transfusion Centres.You are cordially invited to visit our booth (# 40). Our staff will be more than happy to provideyou with detailed information on our company as well as our products, especially on our latestdevelopment of BAGene SSP kits for determination of ABO blood groups, RH types, Kell, Kidd,Duffy systems and HPA specificities on a molecular genetic basis.41 JMS Singapore Pte LtdAddress : 40 Ang Mo Kio Industrial Park 1, 569620 Singapore, SingaporeTel : +65 64571144Fax : +65 64579564E-mail : zaini@jmss.com.sgWebsite : www.jmss.com.sgAs a world leading manufacturer and supplier of medical disposables, we offer a wide range ofhigh quality products for Infusion and Transfusion Therapy, Dialysis, Blood Banking and MedicalEquipment. Our Quality System, certified under ISO 13485 : 2003 , operates under highly efficientmanufacturing processes and stringent quality control before delivery to global medical facilities.Safeguarding and improving the lives of our patients, has been and will continue to be our steadfastcommitment – The Bridge to Good Health Care.HEIM Group is the manufacturer of blood autotransfusion and separation systems. Heim Groupis serving from two marketing points located in Germany and Turkey; As Heim Group, our aimis to supply a new solution to blood transfusion business worldwide. SANGOFER ® is a BloodSeparation Device which allows you to make an immediate separation of fresh donor blood intoplasma and red blood cell components. TRANSOLOG ® is a closed low vacuum system forpost-operative autologous direct re-transfusion for total knee and hip replacement.43 Nebo a/sAddress : Roervangsvej 30, 4300 Holbaek, DenmarkTel : +45 59485959Fax : +45 59485960E-mail : pharmacosmos@pharmacosmos.comWebsite : www.pharmacosmos.com/Nebo a/s markets low molecular weight iron dextran for IV, IM and total dose infusion (TDI),registered by Watson as INFeD ® in the US and by Nebo as CosmoFer ® outside the US. Worldwidesales exceed 50 million doses in approximately 30 countries. Numerous scientific publicationsdocument a lower ADE rate than with traditional high Mw iron dextran and a unique toxicologicalprofile.44 Hamilton Bonaduz AGAddress : Via Crusch 8, 7402 Bonaduz, SwitzerlandTel : +41 816606060Fax : +41 816606070E-mail : infoservice@hamiltonrobotics.comWebsite : www.hamiltonrobotics.com197HAMILTON is a leading provider of robotic workstations for liquid handling, with 25 years of expertiseas a supplier to the clinical as well as the blood bank market. The product portfolio includespipetting robots, ELISA processors and complete sample preparation systems for nucleic acidINTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

ISBT2006LIST OF EXHIBITORSLIST OF EXHIBITORS198testing (pooling), ELISA and other applications in molecular diagnostics. HAMILTON has corecompetences in the development and manufacturing of instruments according to CE IVD andFDA requirements.45 OctapharmaAddress : Seidenstrasse 2, CH 8853 Lachen, SwitzerlandTel : +41 554512121Fax : +41 554512110E-mail : marc.maltas@octapharma.chWebsite : www.octapharma.comOctapharma is a global biopharmaceutical company with more than 20 years experience in theresearch, development, production, and sale of plasma-derived protein products for treatmentof coagulation disorders, immune disturbances, and intensive care. At ISBT 2006, Octapharmawill participate in the exhibition (booth number 45) and feature our pharmaceutically licensed,proven alternative to FFP, Octaplas. We are also pleased to sponsor a lunchtime symposium onTuesday, September 5 from 13:15 – 14:45 in room 1.61 – 1.64.46 Inlog InternationalAddress : 225 Rue de L'Etang, 69760 Limonest, FranceTel : +33 478665353Fax : +33 472521093E-mail : sales@inlog.comWebsite : www.inlog.comINLOG INTERNATIONAL SOFTWARE are dedicated to management, traceability and safety ofBlood Transfusion. Complete functionalities cover the entire field from blood collection, to productdelivery and recipients follow up. Scalability, security and ergonomics: rely on the most advancedtechnologies (Windows ® , relational databases, WEB.) Proven Quality: design, development,implementation and customer support processes are validated, frequently audited and ISO9000certified. Easily translatable Software: already available in French, English, German, Spanish orGreek. Almost every language can be delivered on order within weeks.47 Delcon s.r.l.Address : Via Matteucci 25/26, 20043 Arcore (Mi), ItalyTel : +39 039617670Fax : +39 039617677E-mail : info@delcon.itWebsite : www.delcon.itDELCON is a ISO9001:2000 and ISO13485:2004 certified company for designing, production,sale and technical service of Medical Devices. Our main specialization is on blood componentsseparators, blood collection monitors and tube sealers. DELCON sell all over the world sincethe year 2000 and currently have more then 4000 units installed. O.E.M. and partnership arealso available upon request.48 Vifor (international) Inc.Address : Rechenstrasse 37, 9001 St. Gallen, SwitzerlandTel : +41 712728484E-mail : info@vifor.comWebsite : www.vifor.comVifor (International) Inc. is a Swiss company specialised in unique iron preparations for human useand is dedicated to the treatment of iron deficiency anaemia. Its main product is the i.v. preparationVenofer ® (iron sucrose). The absence of dextran gives Venofer ® an unprecedented safety profile.FDA approved since 2000, Venofer ® has rapidly become the most prescribed i.v. iron worldwide.49 Biopure CorporationAddress : 11 Hurley Street, 2139 Camebridge, Ma, USATel : +1 6172346553Fax : +1 6172346575E-mail : mzapata@biopure.comWebsite : www.biopure.comBiopure Corporation’s mission is to introduce revolutionary new drugs that deliver lifesaving oxygen.Using its patented and proprietary technology, Biopure has pioneered the development andmanufacture of oxygen therapeutics, a new class of pharmaceuticals for human and veterinaryuse that deliver oxygen to the body's tissues. The company's lead product for human use,Hemopure ® [hemoglobin glutamer – 250 (bovine) is commercially available in South Africa forthe treatment of adult surgical patients who are acutely anemic and for the purpose of eliminating,delaying or reducing the need for allogenic red blood cells.199INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

ISBT2006LIST OF EXHIBITORSLIST OF EXHIBITORS20050 South African National Blood ServiceAddress : Private Bag X 14, Weltevreden Park 1715, South AfricaTel : +27 0800119031 (toll free)Fax : +27 117619052E-mail : nicoletted@inl.sanbs.org.zaThe mission of the South African National Blood Service (SANBS), an association of voluntary,non-remunerated blood donors, is to provide all patients with sufficient safe, quality blood productsand medical services related to blood transfusion in an equitable, cost effective manner. A constantchallenge faced by SANBS, in addition to other threats to the safety of the blood supply(such as the impact of high HIV infection rates), is to instill a culture of safe blood donation in apreviously fragmented community. Effective strategies are consequently in place to recruit andretain voluntary, non-remunerated blood donors. Education is key in the process of acquiringand maintaining sufficient safe blood in the country, as it provides information on who can donateblood, and also on who cannot donate blood for whatever reason (e.g. medical condition, lifestylebehaviour risk, etc). Numerous educational initiatives are employed to ensure that regularblood donors become accustomed to a culture of safe blood donation and to ensure a committedand safe blood donor base for the future. Policies of good governance include participationin blood conservation programmes, supporting other medical organisations and employing theassistance of community-based organisations that share in the commitment to sufficient safeblood in South Africa.51 National Bioproducts InstitutesAddress : Private Bag X9043, 3610 Pine Town, South AfricaTel : +27 317196789Fax : +27 317085614E-mail : mullera@nbi-kzn.org.zaWebsite : www.nbi-kzn.org.zaThe NATIONAL BIOPRODUCTS INSTITUTE (NBI) is a “not-for-profit” manufacturer of a comprehensiverange of plasma derived medicinal products made mainly from plasma donated byhealthy, voluntary, non-remunerated donors and supplied by the Blood Transfusion Services (BTS)of South Africa. NBI strives to ensure the safety, quality, efficacy and cost-effectiveness of theseproducts and to achieve national self-sufficiency for South African patients, and where surplusesexist, regional sufficiency for patients in countries of the Southern African Development Community(SADC).52 Western Province Blood Transfusion ServiceAddress : Old Mill Road, Howard Place, 7450 Pinelands, South AfricaTel : +27 215076300Fax : +27 215310322E-mail : marketing@wpbts.org.zaWebsite : www.wpbtsmedical.org.za / www.blood.org.zaThe Western Province Blood Transfusion Service is based in Cape Town, with regional branchesin three smaller centers within the Western Cape, and collects approximately 130 000 units ofblood per annum, which are processed into cellular products and fresh plasma products.WPBTS additionally has an active platelet apheresis programme, and a fractionation plantwhere albumin and factor 8 concentrates are produced. The service is a community basedregional health organisation formed by an association of voluntary blood donors, dedicated toproviding the safest blood products and efficient service to the community, while operating atthe highest professional and ethical standards and remaining a viable organisation. WPBTS is aSANAS (South African National Accreditation System) accredited blood transfusion service (NoB0001). Our quality management system ensures systematic working methods, ultimatelybenefiting both blood donors and blood product recipients.53 Africa Society for Blood TransfusionAddress : Private Bag X9043, 3610 Pinetown, South AfricaTel : +27 31 7196789Fax : +27 31 7085614E-mail : larkinp@nbi-kzn.org.zaThe AFRICA SOCIETY for BLOOD TRANSFUSION (AfSBT) was constituted in 1997 to serve theneeds of the African continent and Indian Ocean Islands. The goals of the AfSBT are to pursue,promote and maintain the highest level of ethical and professional standards in blood transfusionand related disciplines, facilitate the exchange of information between its members, act as aresource institution for individual blood transfusion services or national governments in the fieldof blood transfusion and encourage regional collaborative programmes in blood transfusionpractice.201INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

ISBT2006LIST OF EXHIBITORSLIST OF EXHIBITORS20254 Thermo Electron CorporationAddress : 81 Wyman Street , 02454 Walthamma, United States of AmericaTel : +15084827000E-mail : natalie.dalecky@thermo.comWebsite : www.thermo.comFrom sample preparation to sample analysis through data interpretation, service and support,Thermo offers total end-to-end laboratory solutions. Our analytical instruments, scientific equipment,services, and software are used in life science, drug discovery, environmental and industriallaboratories. Discover how thermo’s blood banking solutions can improve your process fromcollection point to storage.55 Alba BioscienceAddress : Ellen's Glen Road, EH17 7QT Edinburgh, United KingdomTel : +44 1315365907Fax : +44 1315365997E-mail : customer.services@albabioscience.co.ukWebsite : www.albabioscience.co.ukALBA BIOSCIENCE is one of the largest manufacturers of monoclonal blood grouping reagents,supplying vital products to hospitals, blood services and healthcare companies in over 30 countries.With a wide ranging portfolio in blood grouping; haematology; haemostasis; and immunology,we meet the specialised needs of customers worldwide. Our high quality GMP facility is based inEdinburgh, Scotland, home to one of the UK's leading biotech clusters. This facility has diagnosticmonoclonal production; cell culture; formulation; fill,label & packing; freeze drying capablities.We can also offer specialist technical services & regulatory advice. Come and visit us on stand 55.56 BiomerieuxAddress : Chemin de L'Orme , 69280, Mary-l'etoile, FranceTel : +33 478872000Fax : +33 478872090E-mail : sylvie.vincent@eu.biomerieux.comWebsite : www.biomerieux.combioMerieux is a leading international diagnostics group, specializing in in vitro diagnostics forclinical and industrial applications. With 2005 sales of 994 million euros, bioMérieux ranks as theeighth largest biological diagnostics company worldwide. Visit the bioMérieux booth 56 for informationon our innovative solutions for your infectious disease screening needs. These cover completeimmunoassay systems including HBsAg and HIV assays, the fully automated DAVINCI ® andDAVINCI ® Quattro instruments and MECS PE data management software, as well asBacT/ALERT ® Microbial Detection systems for platelet testing.57 Netripples Software LtdAddress : 83/1, Sriniagar Colony, Hyderabad , 500 073 Andhra Pradesh, IndiaTel : +91 4023750849Fax : +91 4023751338E-mail : shashi@netripples.comWebsite : www.netripples.com.Netripples is a Global Health care IT solution provider with a reach of over 21 world marketsthrough its offices and partners. 12 years of track record with over 350 IT Installations anddeployment of Health Care worldwide. Specialists in Blood Bank Software,. HIS, THIS, EMRDental and Pharmacy Software etc., Netripples is only company with over 17 Modules webbased comprehensive Browser based software for Blood Banks. Blood Bank Software Modulesinclude, Donor Management, Mobile Blood Banking, Hematology, ImmunoHeamotology, BloodInventory, Components Preparation, Blood Procurement, Health education, Haemostatis,Hemophilia, Transfusion Microbiology, Cord Blood, HLA Labs, MIS reports etc.,Prominent usersare Red Cross, Red Crescent, central Blood Banks in India, Malaysia, Iran, Middle East andmore. A must see software live at Stall here in ISBT.58 ITL CorporationAddress : 1925 Isaac Newton Square East, Suite 480 , 20190 Reston, Va, USATel : +1 7034356700Fax : +1 7034356717E-mail : loudermilk@itlus.comWebsite : www.itlcorporation.comITL Corporation is a medical device company that specializes in blood banking and ergonomicsuppliers and equipment. ITL’s award winning needle guards and integrated safety systems forboth the blood and renal care markets are used extensively in blood collection centers.and hospitalsfor patients requiring blood transfusions, plasma products or haemodialysis. Together with customizedergonomic equipment, ITL is facilitating improved safety in the workplace, contributing topatient comfort and lowering healthcare costs.203INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

ISBT2006LIST OF EXHIBITORS59 Cape Craft and Design InstituteAddress : 75 Harrington Street, East City, Cape Town, South AfricaTel : +27 214603982Fax : +27 214605101E-mail : naidooml@cput.ac.zaWebsite : www.capecraftanddesign.org.zaContributing to the Western Cape’s drive to Build a better home for all, the Cape Craft & DesignInstitute supports craft producers, networks all players in the product-to-market chain, promotesCape Craft and encourages unlimited creativity and innovation. Cape crafters produce décor &homeware, jewellery & fashion accessories, craft art, traditional craft, corporate gifts, and gifts& novelties.60 StreetwiresAddress : 77 Shortmarket Street, 8001 Cape Town, South AfricaTel : +27 214262475Fax : +27 214260860E-mail : info@streetwires.co.zaWebsite : www.streetwires.co.zaSTREETWIRES AS A COMMUNITY DEVELOPMENT PROJECT Unemployment is the major hurdlefacing our country, leading to numerous other social ills in the form of crime, poverty and thehampering of community growth and development. As mentioned before, one of the primaryaims of Streetwires is to create sustainable, meaningful long-term employment for as manyunemployed and needy South Africans as possible. By providing people with a workplace, permanentemployment, a sense of purpose and access to resources like skills training and personaldevelopment, we are helping to improve the life of many formerly destitute South Africans. Sinceour humble beginnings in October 2000, we have grown from an original team of two artists andtwo marketing coordinators, into a thriving concern employing over 100 formerly unemployedpeople, most of whom have learnt their livelihood through training within Streetwires.LIST OF EXHIBITORS61 Capricorn Biologics (PTY) LtdAddress : P.O. Box 2491, Randburg , 2125 Johannesburg, South AfricaTel : +72 11683 9504Fax : +27 11683 9507E-mail : capsbio@global.co.zaCapricorn Biologics is a South African company which manufactures innovative products forblood processing, collection and tranfusion. All enquiries are welcome.62 RJ Consani (Pty) LtdAddress : P.O. Box 282, 7535 Belville, South AfricaTel : +27 219454261Fax : +27 219481929E-mail : markl@consani.orgWebsite : www.consani.orgRJ Consani (Pty) Ltd is a general engineering company that specializes in manufacturing highquality and well designed products. Established in 1974, it is still owned and managed by thefounder, Robert Consani. The company has combined innovation and design in order to offeryou a medical chair that is comfortable, safe and easy to use as well as practical and affordable.This lounger is specifically designed to meet the needs of the "on the move" specialists i.e. dentists,clinics and blood transfusion services.204205INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

ISBT2006LIST OF EXHIBITORSLIST OF EXHIBITORS63 Medinfo International HemoserviceAddress : Le Crystal Palace - 369 Promenade des Anglais, 06200 Nice, FranceTel : +33 493144601Fax : +33 493144675E-mail : kketari@medinfo.frWebsite : www.medinfo.fr65 Blackwell Publishing Ltd.Address : 9600 Garsington Road, Oxford, OX4 2DQ, United KingdomTel : +44 1865776868Fax : +44 1865714591E-mail : helen.clements@oxon.blackwellpublishing.comWebsite : www.blackwellhematology.comMEDINFO is one of the leading companies specialized in the field of software for Blood Transfusion.Our software -HEMATOS IIG, HEMOBANK IIG, TELECAR IIG and HEMOTRACE IIGmeetall the needs of Blood Transfusion Centres and Blood Banks from the blood collection upto the transfusion of the patient. Many Blood Transfusion Centres and Blood Banks, all over theworld, had chosen our software to manage their activities: NBS in England, the EFS in France,and many others in Belgium, Brazil, Chile, Romania, Saudi Arabia, Spain, Tunisia, etc.Blackwell Publishing is a leading publisher in hematology and transfusion. We publish many of thetop journals in the field, including the official journal of the ISBT – Vox Sanguinis and Transfusion– official journal of the AABB. We are also pleased to announce our new publishing partnershipwith NATA – come to the stand to pick up your new look copy of Transfusion Alternatives inTransfusion Medicine. For more information on all our books and journals visit www.blackwellhematology.com64 Healthcare TechnologiesAddress : P.O. Box 60282, Table View, 7439 Cape Town, South AfricaTel : +27 215541363Fax : +27 215544903E-mail: : info@ healthcaretechnologies.co.zaWebsite : www.healthcaretechnologies.co.za66 Cryo Bio SystemAddress : Cryo Bio System, 29 rue Tronchet, 75008 Paris, FranceTel : +33 149240505Fax : +33 149240501E-mail : contact@cryobiosystem-imv.comWebsite : www.cryobiosystem.com206Healthcare Technologies import and distribute a wide range of Laboratory equipment, Reagents,Diagnostic kits and Consumables for the South African Healthcare market which incorporates:* Private Pathology Laboratories* Government Pathology Laboratories* Hospitals (Private and State)* Blood banks* Academic Institutions* Pharmacies / GP'sHealthcare Technologies has been in operation for 6 years and a national network of branches hasbeen setup which together with our distributors gives us the opportunity of rendering a superiorservice to all areas of Southern Africa with the emphasis on "Customer Care".Cryo Bio System manufactures and markets a concept for cryopreservation of biological samplesbased on the CBS High Security Straw. Product line includes High Security straws, specificequipment for filling, sealing and labelling of straws, storage goblets and racks for nitrogen freezersand mechanical freezers.207INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

ISBT2006MAP OF CAPE TOWNSPEAKERS INDEXLEGENDA1ED Educational and State of the art reviews page 19 - 242PL Monday Plenary Session page 252PS Monday Parallel Session page 26 - 383PL Tuesday Plenary Session page 41 - 424PL Wednesday Plenary Session page 454PS Wednesday Parallel Session page 46 - 585PS Thursday Parallel Session page 61 - 67208Arabell Sheraton Grand Hotel 1Cullinan Inn 2Holiday Inn Waterfront 3Protea Hotel North Wharf 4Holiday Inn Cape Town 5Protea Hotel Victoria Junction 6Protea Hotel Seapoint 7Protea Hotel Pier Place 8Capetonian 9Protea Hotel Breakwater Lodge 10City Oodge V&A Waterfront 11St George’s Hotel 12Townhouse 13Cape Town Lodge 14Radisson Hotel Waterfront 15 AAllain J.P., 1ED-04-01,2PS-11-02Alter H., 4PS-28-03Ashford P., 5PS-35-03Assal A., P-108*Aubuchon J.P., 2PS-05-01Auerbach M., 2PS-12-03Avent D., 5PS-38-01Ayo F., 4PS-24-02BBenatar S., 4PL-04-01Benjamin R.J., 4PS-23-03, 5PS-34-01Blajchmann M.,2PS-06-01Boukef K., 1ED-06-01Boulton F., 4PS-25-03Brojer E., P-110*Buchel R., 4PS-18-02Burnouf T., 4PS-18-01Busch M.P., 4PS-28-01Bust L., 5PS-39-01CCaldani C., 4PS-29-04Chapel H., 2PS-04-01Chapman J.F., 2PS-08-01Churchill S., 4PS-26-04Coghlan P.J., 5PS-31-03Contreras M., 2PS-14-02DDahourou H., 4PS-24-08Daigneault S., 4PS-19-02Daniels G., 1ED-E7-02Dann E., 2PS-10-04Dash C., 4PS-18-04Décary F., 2PS-09-02,5PS-31-01Delage G., 2PS-05-02Delalat B., 5PS-33-02Desbois I., 5PS-33-03Devenish A., 1ED-04-02Devine V., 5PS-38-03Dhingra N., 1ED-02-01,4PS-26-01Dickmeiss E., 2PS-05-04Dijkstra-Tiekstra M.J.,2PS-04-04Dodd R., 5PS-37-02Dorn I., 5PS-33-05Dzik S., 4PS-21-01EEglin R., 1ED-07-01Emmanuel J., 2PS-03-02Erichsen K., 2PS-12-03Eronen M., 5PS-39-02FFang C.T., 2PS-05-03Farrugia A., 2PS-01-01Fisher T., 5PS-32-02Flegel A., 2PS-15-03Foxcroft Z., 2PS-13-04Franceschi D., 4PS-21-04GGasova Z.G., 2PS-10-03Giangrande P., 1ED-05-02Gogarty F., 2PS-03-03209INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

ISBT2006SPEAKERS INDEXSPEAKERS INDEX210Goodnough L.T., 2PS-07-01, 2PS-12-02Gorham M., 2PS-09-03Gray G., 4PS-23-01Groot F. de, 2PS-13-03Gunther K., 5PS-36-02HHaas M. de, 3PL-02-01,4PS-17-03Hansen E.N., 2PS-07-03Hardcastle T., 4PS-27-03Hareuveni M., 2PS-01-05Heddle N., 4PS-16-02Henry S.M., 5PS-32-03Hervig T., 5PS-34-03Heyns A., 4PS-28-04,5PS-40-01Hift R., 2PS-11-03Hillyer C., 5PS-31-02,5PS-36-01Högman C.F., 3PL-03-04Holland P.V., 1ED-03-02,4PS-19-01IInaba S.I., 5PS-38-04Ironside J., 2PL-01-01,4PS-20-03JJames M., 2PS-04-03Jones J., 4PS-25-04KKanhai H., 2PS-02-02Karger R., 2PS-07-02Kew M., 2PS-11-01Kirsten G., 2PS-02-01Kleinman S., 5PS-37-01Knels R., 5PS-35-02Koelewijn J.M., 4PS-17-05Koh M., 2PS-08-02Kurtzberg J., 1ED-01-02LLeduc S, 4PS-29-05Leiby D., 4PS-20-02Lemieux R., 2PS-04-02Levien L.J., 4PS-22-03Lin C.K., 1ED-02-02,P-128*Lomas-Francis C.,4PS-30-03Lund N., 4PS-23-04MMagdeleyns E.J.P.,4PS-21-03McClelland B., 1ED-03-01,2PS-12-01, 4PS-16-01McCullough J., 5PS-33-01Mendelow B., 5PS-38-02Mikkelsen N., 2PS-03-01Moghtadaei M., 4PS-25-05Molyneux E., 1ED-06-02Munk C., 5PS-35-01Murphy E.L., 2PS-11-04Murum L., 4PS-26-02Muyinda K., 4PS-24-06Mwangi J., 4PS-24-07NNance S., 4PS-30-04Ness P., 4PS-17-02Newham J.A., 2PS-01-04Nichol A., 4PS-27-01Niekerk A., 4PL-04-02Noorman F., 2PS-08-03Novitzky N., 5PS-36-03OOlatunji R., 4PS-24-03Olsson M.L., 2PS-15-01,5PS-32-01Ouwehand W., 2PS-13-01Owusu-Ofori S., P-106*PPadilla A., 4PS-18-03Pape A., 4PS-22-01Pepper M., 1ED-01-01Petrovic I.B., 4PS-19-04Pietersz R.N.I., 3PL-03-02Poel, C.L. van der,2PS-01-02Poole J., 4PS-30-01Poovalingam V.,4PS-19-05Popovsky M.A.,2PS-14-01,4PS-25-02Prowse C., 2PL-01-02,5PS-34-05RRasonglès P., 5PS-34-04Rebulla P., 3PL-03-03Reesink H., 3PL-03-05Reid M.E., 3PL-02-02Robillard P., 4PS-29-01Rosin N., 4PS-24-05Rowe W., 5PS-33-04SSachs J.H., 2PS-02-04Sachs J.H., 4PS-17-04Sawyer L., 5PS-34-02Sayers M.H., 4PS-19-03Schmidt M.S., 2PS-05-05,5PS-37-03, 5PS-37-04Schmidt P., 5PS-40-02Schneider H., 5PS-40-03Schoot C.E., 2PS-15-02Scuracchio P., P-108*Shanwell, A., 2PS-14-04Seidel K.E.J., 5PS-39-03Seidl C., 2PS-01-03Seifried E., 2PS-10-02Semple J., 4PS-17-01Shanwell E., 2PS-14-04Sher G., 2PS-09-01Sims C., 4PS-25-01Slavin S., 2PS-10-01Smart E., 4PS-30-02Smethurst P., 2PS-13-02Smit Sibinga C.Th.,2PS-08-04, 3PL-03-01Steyn E., 4PS-27-02Stramer S.L., 4PS-28-02Strauss R., 1ED-08-01,1ED-08-02, 2PS-02-03Strengers P.F.W.,4PS-26-03Svensson L., 2PS-15-04TTitlestad K., 4PS-29-02Thaikruea L., P-136*Tuddenham E.,1ED-05-01,4PS-21-02VVamvakas E.C.,2PS-06-02Vrielink H., 5PS-39-05Vuk T., 5PS-39-04WWagner F., 4PS-30-05Wendel S., 4PS-20-01Whittaker S., 4PS-16-03Wijst J.G., 4PS-29-03Wilkinson R., 4PS-24-01Williams G., 4PS-24-04Williamson M., 2PS-14-03,4PS-23-02Winslow B., 4PS-22-02Woimant G., 2PS-07-04Wu Q., 2PS-03-04ZZhu Y.M., 2PS-09-04,4PS-30-05* Presented during the symposium of the ISBT Working Party on TTD (page 30)211INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

International Society ofBlood TransfusionISBT2006International Society ofBlood TransfusionINTERNATIONAL SOCIETYOF BLOOD TRANSFUSIONThe International Society of Blood Transfusion(ISBT) is a scientific society of world renown,founded in 1935, bringing together professionalsinvolved in Blood Transfusion and TransfusionMedicine, from more than 80 countries.Partnerships• Association of Donor RecruitmentProfessionals (ADRP)www.adrp.org• Council of Europewww.coe.int• International Council for Standardisationin Haematology (ICSH)• International Federation of Red Crossand Red Crescent Societies (IFCRS)www.ifrc .org• World Federation of Hemophilia (WFH)www.bloodline.net• World Health Organisation (WHO)www.who.intISBT members are to be found in blood banks,university medical schools, research laboratories,general hospitals, pharmaceutical companies…• International Federation of BloodDonor Organisations (IFBDO)www.fiods.org212Activities and initiativesCongressesOne of the aims of the ISBT is to create global and regional opportunities for thepresentation of research, new developments and changing concepts in blood transfusionmedicine and science. Every even year an ISBT International congress is organised.Regional congresses are organised every odd year.Standing Committees• Constitution and by-laws• Education• Ethics• Jean Julliard Prize• Nomination• Publications• Vox SanguinisAWARDS• ISBT Award• ISBT Presidential Award• International Woman inTransfusion Award• Jean Julliard PrizeISBT/ICSH Expert panels• Blood group serology• Molecular biology• Preparation andstandardisation of bloodgroup reagentsWorking parties• Automation and dataprocessing• Blood supplymanagement• Granulocyteimmunobiology• Haemovigilance• Paediatric transfusion• Platelet immunobiology• Rare blood donors• Socio-economics aspectsof blood transfusion• Terminology for red cellsurface antigens• Transfusion transmittablediseasesWorking relations•American Association ofBanks (AABB)www.aabb.org•Council for International Organisationof Medical Sciences (CIOMS)www.cioms.ch•European Blood Alliance (EBA)www.eba-web.org•International Council for Commonalityin Blood Banking Automation, Inc.(ICCBBA)www.computype.com•International Plasma FractionationAssociation (IPFA)www.sanquin.nl/ipfa• International Society ofHaematology (ISH)www.ish-world.org•International StandardsOrganisation (ISO)www.iso.org•Network for Advancement ofTransfusion Alternatives (NATA)www.nataonline.com•Thalassaemia InternationalFederation (TIF)www.thalassaemia.org.cy213INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

International Society ofBlood TransfusionVOX SANGUINISVox Sanguinis reports on important, novel developmentsin transfusion medicine. Original papers, reviews andinternational fora are published on all aspects of bloodtransfusion and tissue transplantation, comprising thefollowing four main sections :• Transfusion - Transmitted Disease and its Prevention• Blood Component Collection and Production• Transfusion Medicine and New Therapies• Immunohaematology and ImmunogeneticsISBT2006www.blackwellpublishing.comWhy become anISBT member ?International Society ofBlood TransfusionISBT membership opens up the whole world of blood transfusionand transfusion medicine, enabling you to establishcontacts with fellow members in other countries and continents,and participate in international events. ISBT members receive :• Vox Sanguinis• Transfusion Today• ISBT basic documents (administrative, technical...)• A reduced fee for attending ISBT international andregional congresses.TRANSFUSION TODAYIs the quarterly newsletter of the ISBT. Read in more than80 countries,TT is the reference bulletin in transfusionmedicine; it gives exclusive and up to date informationworldwide and ensures the dissemination of knowledgethroughout the various world regions.Who can become an ISBT member ?ISBT membersThere are several categories of members :• Individual Members• Affiliate members (blood establishments, institutions...)Other ISBT Publications• The ISBT Code of Ethics forBlood Donation and Transfusion• Guidelines for validation ofAutomated Systems in Bloodbanking• State of the Art reviews• Abstract books• Monographs• Guidelines to members• Honorary MembersThrough the Board of Directors, Standing Committees,Working Parties and Expert Panels, ISBT members have theopportunity to take an active role in the organisation of theSociety’s activities, on an international or regional level.214• Congress proceedings• Membership list215INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT

ISBT2006NOTES216INTERNATIONAL SOCIETY OF BLOOD TRANSFUSION